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SUMMARY
Summary
The cellular abundance of a protein is regulated at many different steps includ-
ing transcription, splicing and translation of its encoding mRNA but also degra-
dation of both, the mRNA and the protein. One regulator influencing some of
these processes are Argonaute (Ago) proteins which are guided by an associat-
ing small RNA molecule to complementary mRNAs in the cytoplasm resulting
in their translational repression and degradation. Apart from their cytoplasmic
function which is conserved across many species, some Ago proteins were also
found to influence protein abundance at the step of mRNA transcription in the
nucleus of cells. There, Ago proteins bound to a small RNA recognize nascent
transcripts of mRNAs and transposable elements by complementary base pairing
leading to their transcriptional silencing. This is often linked to the recruitment
of chromatin modifying factors. The nuclear function of Ago proteins, which was
studied especially in yeast, plants and worms, was found to be inducible also in
human cells by targeting Ago to chromatin by promoter complementary small
RNA species [Meister, 2013]. Therefore, the question after endogenous triggers
and the genomic target sites of this potential function emerged.
In order to identify potential target gene loci in human somatic cells and mouse
embryonic stem cells, we examined Ago chromatin interaction sites by apply-
ing two complementary techniques, Chromatin Immunoprecipitation (ChIP) and
DNA Adenine Methyltransferase Identification (DAMID). For a genome wide
characterisation of chromatin binding sites both techniques were combined with
next generation sequencing. At first, we analysed the chromatin interaction sites
of Ago 1 and 2 by comparing data sets derived from ChIP experiments using
three different antibodies each. However, the really low number of overlapping
peaks (<11) from the three different ChIP experiments as well as the bad signal-
to-noise level of the data, suggested either lack of strong chromatin interaction
sites or experimental failure.
As ChIP experiments are highly dependent on the performance of the antibody
under these harsh conditions, we next applied the antibody-independent DAMID
approach. This method deduces chromatin association sites from DNA-methyla-
tion events caused by a recombinant fusion protein consisting of a DNA methyl-
transferase from E. coli and the target protein. The successful establishment of
the method was shown by the results for a positive control which were in agree-
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ment with the literature [Vogel et al., 2006]. However, the validation of the pre-
dicted nuclear Ago-binding sites by ChIP experiments failed for the human cell
line, which could be due to the lack of replicates needed to identify enrichment
sites with a low false-positive rate or the absence of true chromatin binding sites
of Ago in human somatic cells. For mESC only few significant peaks were de-
tected which are currently validated by our collaboration partner. Excitingly,
both DAMID experiments showed high enrichment of mitochondrial DNA se-
quences in Ago samples compared to controls. Therefore, we tested a potential
mitochondrial localisation of Ago proteins, which was also suggested by hints in
the current literature but was not thoroughly assessed [Bian et al., 2010; Bandiera
et al., 2011; Sripada et al., 2012; Zhang et al., 2014]. Assisted by the expertise of
the lab of Prof. Dr. P. Rehling in mitochondrial biology, we analysed import and
localisation of Ago in mitochondria. While some of the experiments supported
a potential inter membrane space localisation, no evidence for matrix-import re-
quired for specific interaction of Ago proteins with mitochondrial DNA could be
found. When the results from mitochondrial localisation were combined with in
depth analysis of the sequencing reads form the DAMID experiments, it appeared
that a high fraction of the reads were highly amplified non-specific mitochondrial
fragments reducing the complexity of DNA library. As implied in the literature
[Casbon et al., 2011], this low complexity has a negative influence on quantifica-
tion of the lower abundant DNA fragments in the library. In addition, hints for
a correlation between amplification of non-specific mitochondrial DNA and the
extent of cytoplasmic localisation of the Dam-fusion protein could be found.
When the results of the DAMID experiment from human cells were compared
with another related study [Benhamed et al., 2012], some overlap of Ago-chro-
matin interaction sites was found. However, these sites ranked rather low in the
bioinformatic analysis probably due to the high level of non-specific amplifica-
tion of mitochondrial sequences, high background noise and the lack of replicate
experiments. This was likely aggravated by a strong cytoplasmic localisation of
human Ago proteins compared to their low abundance in the nucleus.
In conclusion, we can assume that the DAMID approach is also feasible for Ago
proteins but needs further improvements like nuclear targeting and depletion
of mitochondrial sequences. Based on our results we can only speculate about
a nuclear function of Ago proteins. Several studies showed induction of Ago-
chromatin association under special conditions like cellular senescence, transfec-
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tion of promoter complementary siRNAs or DNA double strand break repair
[Benhamed et al., 2012; Kim et al., 2006; Janowski et al., 2006; Wei et al., 2012].
However, others suggested Ago-chromatin binding under steady-state condi-
tions to regulate alternative splicing and silencing or activation of transcription
[Allo et al., 2009; Ameyar-Zazoua et al., 2012; Huang et al., 2013a]. In order to
clarify the controversially discussed nuclear functions of Ago proteins, antibody-
independent techniques like DAMID are needed to critically assess the proposed
mechanisms.
iii
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Chapter 1
Introduction
1.1 The Discovery of Argonaute Proteins
The first member of the Argonaute (Ago) family of proteins to be discovered was
Argonaute 1 in Arabidopsis thaliana [Bohmert et al., 1998]. He named the gene
after the octopus Argonauta argo due to the squid like phenotype of the mutant
plant (Figure 1.1). Ago plays a role in germination, development of leaves and
inflorescence, which is apparent from the radial symmetry of the stem leaves
instead of an adaxial/abaxial differentiation or the lack of branching of the stem
for the homozygous mutant. The flowers of mutant plants also fail to develop
a proper pistil, anthers and pollen which causes complete sterility of the plants
[Bohmert et al., 1998]. Sequence comparisons revealed that Argonaute proteins
are conserved in many different organisms ranging from archaea to mammals
[Swarts et al., 2014]. The eukaryotic part of the family of Argonaute proteins will
be described in Section 1.2.
A hint on the molecular function of Argonaute proteins came from a genetic
screen in Caenorhabditis elegans for factors involved in a mechanism called RNA
interference (RNAi) [Tabara et al., 1999]. RNAi was discovered by Fire et al. [1998]
when they used long dsRNAs to repress the expression of a complementary gene
in C. elegans. As already low amounts of the dsRNA were sufficient to silence
an excess of endogenous transcripts, they proposed a catalytic component to be
involved in the depletion of these transcripts. In addition, they suggested tar-
geting of chromatin or transcription as alternative explanations for the observed
repression [Fire et al., 1998]. The catalytic complex postulated by Fire et al. [1998]
was soon identified to comprise an Argonaute protein bound to a single stranded
1
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small RNA with a length ranging from 21 to 30 bp [Hamilton and Baulcombe,
1999; Tabara et al., 2002]. In the case of C. elegans these small RNAs derive from
the long dsRNA used in the experiment by Fire et al. [1998]. Today, small RNAs
are divided into three main classes which comprise small interfering RNAs (siR-
NAs), microRNAs (miRNAs) and Piwi interacting RNAs (piRNAs) and are fur-
ther explained in Section 1.3.
Figure 1.1: Squid like Ago mutant of A.
thaliana. Picture of a 35-day-old ago1-1
seedling, taken from Bohmert et al. [1998].
All the mechanisms proposed by Fire
et al. [1998] to explain RNAi are con-
served in different groups of organisms
and are referred to as post transcrip-
tional gene silencing (PTGS) and tran-
scriptional gene silencing (TGS). In the
first process Argonaute is guided by a
small RNA to target an mRNA by com-
plementary base pairing and mediates,
in most of the cases, degradation of the
target RNA [Huntzinger and Izaurralde,
2011]. This will be explained in section
Section 1.4 with a focus on human cells.
In the second mechanism an Argonaute
protein associates with a small RNA in
the cytoplasm and is subsequently im-
ported into the nucleus [Guang et al.,
2008]. There the small RNA-Ago com-
plex associates with nascent transcripts by complementary base pairing [Verdel
et al., 2004; Bühler et al., 2006; Guang et al., 2010] and leads to inhibition of RNA
PolII [Burkhart et al., 2011; Guang et al., 2010] and silencing of the gene at the chro-
matin level [Gu et al., 2012; Bühler et al., 2006]. Following a short introduction to
chromatin and transcription, which are both influenced by TGS (Section 1.5.1),
examples of TGS mechanisms from several organisms will be described in Sec-
tion 1.5. The insights from these model systems will help to interpret the diver-
gent publications on this process in the human system, which set the basis for the
initiation of this project.
Today, the field of RNAi is still strongly expanding and has a high impact on bi-
ological and medical research. SiRNAs as tools for silencing of specific genes to
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study their biological function in mammalian cells are commonly used in molec-
ular biology laboratories [Elbashir et al., 2001]. Furthermore, small RNA de-
rived methods for cancer diagnostics and therapy are constantly improved [Fa-
rooqi et al., 2014]. But even in the general public RNAi gained awareness, when
C. Mello and A. Fire were awarded the Nobel Prize for physiology and medicine
in 2006.
1.2 The Argonaute Family of Proteins
The eukaryotic family of Argonaute proteins is divided into four clades: the Try-
panosoma Ago, the WAGO, the Ago and the Piwi family of proteins [Swarts
et al., 2014]. The protozoan parasite Trypanosoma brucei comprises two Ago-like
proteins TbAgo1 and TBPWI1, of which only the first one is required for RNAi
[Durand-Dubief and Bastin, 2003]. TbAgo1 is mainly targeting retrotransposon
transcripts by cleavage, thus protecting the parasite from the deleterious effects
of these mobile genetic elements. WAGO proteins are C. elegans specific Arg-
onaute proteins, which are involved in PTGS and TGS mechanisms and bind to
small RNAs with a length of 22 nt and a 5′-tri-phosphorylated G as the first base
[Swarts et al., 2014]. The human genome encodes for eight proteins of the Arg-
onaute family. Four proteins belong to the Ago clade (Ago1-4) and four proteins
are part of the Piwi clade (Hili, Hiwi, Hiwi2, Hiwi3) [Ender and Meister, 2010].
The proteins of the Ago clade are often found in the cytoplasm or the nucleus
and bind to siRNAs and miRNAs. They trigger PTGS and TGS processes of var-
ious transcripts in the cell. The Piwi proteins interact with piRNAs and function
mainly in the control of transposable elements in the germline [Swarts et al., 2014].
1.2.1 The Domain Organisation of Argonaute Proteins
Argonaute proteins consist of two lobes, the first one containing the N-terminal
and PAZ (PIWI-AGO-ZWILLE) domain which is connected via a hinge region
to the second lobe comprising the MID and PIWI domain [Schirle and MacRae,
2012]. The N-terminal domain is required for cleavage activity [Hauptmann et al.,
2013] and presumably assists in unwinding of the small RNA duplex during load-
ing of the RISC complex [Meister, 2013]. Interaction with the 3′-end of one strand
of the small RNA duplex is mediated by the PAZ domain [Song et al., 2003; Lin-
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gel et al., 2003; Ma et al., 2004]. The bound RNA strand is called the guide strand,
as it binds by complementary base paring to the target RNA and thus mediates
the specific interaction between the target RNA and the Argonaute protein. In
Piwi proteins the PAZ domain is specific for the 2′-O-methylated 3′-end of piR-
NAs. The MID domain forms a basic nucleotide binding pocket and harbours
the phosphorylated 5′-end of the single stranded small RNA. In addition, also
stacking interactions between a conserved tyrosine in the MID domain and the 5′-
base of the small RNA stabilise the binding [Boland et al., 2010; Frank et al., 2010;
Faehnle and Joshua-Tor, 2010]. The paring with the target RNA is assisted by the
MID domain which additionally interacts with nucleotide 2-7 or 8 of the small
RNA, the so called seed sequence of the small RNA [Ha and Kim, 2014]. Cleav-
age activity is conveyed to Ago2 by the PIWI domain which resembles RNAseH
[Meister et al., 2004; Liu et al., 2004] and Piwi proteins [Brennecke et al., 2007; Gu-
nawardane et al., 2007]. The cleavage activity is conferred to Ago2 by a catalytic
tetrade consisting of the amino acids DEDH (more generally DEDX, where X is D
or H) [Nakanishi et al., 2012] in combination with two domains in the N-terminus.
These N-terminal domains were identified by comparison of Ago2 with Ago3
which also contains the catalytic tetrade but is defective in target RNA cleavage
[Hauptmann et al., 2013]. The other two members of the Ago clade Ago1 and 4
have also lost cleavage or slicing activity [Meister et al., 2004; Hauptmann et al.,
2013].
However, slicing is only found in the case of perfect complementarity between
the Ago2 bound siRNA or miRNA guide strand and the target transcript. This
Ago-small RNA complex is commonly referred to as the small RNA induced si-
lencing complex (RISC) [Hammond et al., 2000]. For most miRNAs imperfect
base pairing of the Ago bound guide strand and the target RNA is observed.
This complex is therefore called miRNA containing RISC (miRISC) or microri-
bonucleoprotein (miRNP) [Meister, 2013].
1.3 Classes and Biogenesis of small RNAs
The main principles in biogenesis of small RNAs will be described for the three
main classes: siRNAs, miRNA and piRNAs.
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SiRNAs
SiRNAs are ~21 nt in size and mostly derive from endogenous or exogenous long
dsRNAs. In fission yeast, plants and worms these long dsRNAs have various
sources: First, long dsRNAs are formed by transposable elements, convergent
transcription by antisense promoters, from viral genomes following infection,
natural antisense transcripts or inverted repeats, which have also been identi-
fied as source of endo-siRNAs in mouse oocytes [Bologna and Voinnet, 2014; Gr-
ishok, 2013; Watanabe et al., 2008; Tam et al., 2008; Kawamura et al., 2008; Ghildiyal
et al., 2008]. Second, in fission yeast, worms and plants there is a mechanism for
secondary siRNA production. Recruited by a RISC complex bound to a target
transcript, an RNA-dependent-RNA-polymerase (RdRP) associates with the tar-
get RNA and replicates a second strand to form a long dsRNA molecule [Bologna
and Voinnet, 2014; Grishok, 2013]. As the RISC complex can later dissociate and
trigger the generation of many long dsRNAs, this leads to strong enhancement of
the RNAi response. Third, feeding (C. elegans) or transfection of cells with long
dsRNA also triggers an RNAi response in invertebrates and plants [Fire et al.,
1998; Hammond et al., 2000; Bologna and Voinnet, 2014]. In mammalian cells long
dsRNAs, however, induce the interferon response which is part of the immune
response to viral infections and causes inhibition of translation and apoptosis. In
contrast, the transfection of short dsRNAs <27 nt results in efficient induction of
RNAi in cultured mammalian cells [Elbashir et al., 2001].
Apart from secondary siRNAs in C. elegans the long dsRNAs are processed into
siRNAs by an RNAse-III-like enzyme, called Dicer or Dicer-like in plants [Hut-
vagner et al., 2001; Ha and Kim, 2014]. Dicer proteins have a size of ~200 kDa and
contain several functional domains which are described in the following. The
ATP binding and the helicase domain bind to one end of the dsRNA and serve
as interaction domain with associated proteins. These are followed by the do-
main of unknown function (DUF283). The PAZ domain is similar to the one of
Argonaute proteins (Section 1.2) and recognises the 2 nt overhang at the 3′-end
of dsRNAs. In mammals it additionally binds to a phosphorylated 5′-end [Ha
and Kim, 2014; Grishok, 2013]. This explains the preference of Dicer for over-
hanging ends over blunt ends of its substrate dsRNAs [Vermeulen et al., 2005].
Two RNAse-III-like domains form an intermolecular dimer and are required for
endonucleolytic cleavage of the dsRNA. In case a 2 nt overhang at the 3′-end of
the dsRNA is present, the region between the PAZ and RNAse-III-like domains
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functions as a “molecular ruler” and results in Dicer producing small RNAs of
a discrete size ranging from 20 to 24 nt depending on the isoform and species
[Vermeulen et al., 2005; MacRae et al., 2006]. Last, Dicer contains a dsRNA bind-
ing domain RBD [Ha and Kim, 2014]. The binding to substrate RNAs as well as
processing and efficiency of Dicer are regulated by associating proteins reviewed
in Ha and Kim [2014]. In plants, worms and files small RNAs are protected from
degradation by the methyltransferase HEN1, adding a methyl-group to the 2′-O
at the 3′-end [Ha and Kim, 2014]. Subsequently, these siRNAs are loaded into
Ago proteins and unwound resulting in a single strand remaining bound, which
requires the heat-shock protein 90 (HSP90) chaperon and is further described in
[Dueck and Meister, 2014].
MiRNAs
Another species of small RNAs loaded into Ago proteins are miRNAs. Theses
are encoded in the genome and transcribed by RNA Polymerase II (RNA PolII)
into long primary miRNAs (pri-miRNA) transcripts, which can base pair due to
partial reverse complementarity in certain regions and form so called stem loop
or hairpin structures [Lee et al., 2004a] (see Figure 1.2). These are recognized
and processed into precursor-miRNAs (pre-miRNA) of ~70 nt by the Micropro-
cessor complex consisting of the proteins Drosha, an RNase-III-like enzyme [Lee
et al., 2003] and DGCR-8 [Gregory et al., 2004]. Drosha is a nuclear protein of
~160 kDa. Similar to Dicer described above, Drosha contains two RNAse-III-like
domains forming an intramolecular dimer. Therefore, it cleaves pri-miRNA to
yield a hairpin carrying at one end a phosphorylated 5′-end opposite to a 2 nt
3′-overhang (see Figure 1.2). As the dsRBD of Drosha is not sufficient for pri-
miRNA interaction, DGCR8 is required [Gregory et al., 2004; Ha and Kim, 2014].
This ~90 kDa protein localises to the nucleus and contains two dsRBDs to as-
sociate with pri-miRNAs. The C-terminal part of DGCR8 interacts with Drosha
[Ha and Kim, 2014]. Recent reports by Weitz et al. [2014] and Quick-Cleveland
et al. [2014] suggest the involvement of a Fe III heme group bound to DGCR8 in
the recognition of the basal and/or the apical transition from single stranded to
double stranded RNA. DGCR8 serves thus as molecular ruler, resulting in the
cleavage of pri-miRNA 11 bp from the basal junction of the stem loop by Drosha
[Han et al., 2006]. The newly created pre-miRNA hairpin is then transported into
the cytoplasm by Exportin 5 which forms an export complex with the pre-miRNA
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and RAN-GTP. After release of the pre-miRNA in the cytoplasm it is bound and
further processed by Dicer (see Figure 1.2). The helicase domain of Dicer interacts
with the terminal loop of the pre-miRNA while the 5′-end and the 3′-overhang
are bound by the PAZ domain. In complex with the dsRBDs containing proteins
TRBP or PACT Dicer processes the pre-miRNA into a ~22 nt long miRNA duplex
[Bernstein et al., 2001; Grishok et al., 2001; MacRae et al., 2006]. The miRNA bio-
genesis process is regulated by a wide range of factors influencing for example
pre-miRNA processing by Dicer or its degradation which are reviewed in Treiber
et al. [2012]. In addition to this, miRNAs can also derive from different sources so
called MIRTRONS were miRNA are encoded in introns or from precursor tRNAs,
from which they are released during splicing [Meister, 2013]. These pathways are
either Drosha or Dicer independent [Meister, 2013]. One prominent Dicer inde-
pendent example is miRNA-451. Its precursor pre-miR-451 is bound by Ago2 and
entirely dependent on its slicing activity and the shortening by an exonuclease to
reach its mature form. As miRNA-451 is vital for erythrocyte maturation, Ago2
knockout leads to early death of mice [Cheloufi et al., 2010; Cifuentes et al., 2010].
Finally, the mature miRNA duplexes are loaded into Ago proteins requiring the
chaperone HSP90 [Dueck and Meister, 2014].
The loading of siRNAs and miRNAs is influenced by the length and the 5′-nu-
cleotide in plants and worms [Grishok, 2013; Bologna and Voinnet, 2014]. The
loading into D. melanogaster Agos is dependent on unpaired regions, bulges, in
the miRNA leading to incorporation into Ago1 or the perfect, complementary
siRNAs or miRNAs resulting in association with Ago2 [Ha and Kim, 2014]. In
mammals all Ago proteins are equally loaded with small RNAs, however, the
strand with the less stably paired 5′-end is preferentially selected as the guide
strand bound to Ago [Meister, 2013].
PiRNAs
The last class of small RNAs are the Piwi interacting RNAs, called piRNAs, which
are conserved in flies, fish and mammals [Meister, 2013] (Piwi proteins see Sec-
tion 1.2). These 25-33 nt long small RNAs are expressed in the germline and
generated in a Drosha and Dicer independent pathway. PiRNAs derive either
from different piRNA clusters consisting of defective transposon copies or from
transposable elements (TEs) including long terminal repeats (LTR), short and
long interspersed elements (SINE/LINE) and internal repeats (IR) [Aravin et al.,
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2003, 2007; Saito et al., 2006; Gunawardane et al., 2007].
PiRNA Biogenesis
For primary piRNA production, one or both strands of these piRNA clusters
are transcribed, presumably by a bidirectional promoter, and form long single
stranded RNAs which are bound by Piwi proteins and trimmed at the 3′-end by
a yet unknown exonuclease [Thomson and Lin, 2009]. Some of these primary
piRNAs induce secondary piRNA generation and amplification by the so called
Ping-Pong cycle [Brennecke et al., 2007; Saito and Siomi, 2010; Aravin et al., 2007].
A primary antisense piRNA in complex with a Piwi protein binds by comple-
mentary base pairing to a sense transcript from the same piRNA cluster or an
actively transcribed transposon. Due to its slicing activity the Piwi protein cre-
ates a new 5′-end on the sense transcript exactly 10 nt away from the binding
site of the 5′-end of its own bound piRNA. The sense transcript with its new
5′-end is then bound by another Piwi protein and transformed into a new piRNA
by degradation of its 3′-end by a yet unknown exonuclease. Subsequently, the
Piwi protein bound to the sense piRNA is targeted to an anti-sense transposon
or piRNA cluster transcript, which leads to generation of new anti-sense piRNAs
[Brennecke et al., 2007; Aravin et al., 2007]. This mechanism is supported by the
finding of pairs of sense and antisense piRNAs which show an overlap of ex-
actly 10 nt. In addition, often a preference for a 5′-U of the antisense piRNA is
found. While there is no preference observed for the 5′-end of the sense piRNA,
which is opposite to the cleavage site of the antisense piRNA and no bias is ex-
pected, there is a strong enrichment for an A at position 10 of the sense piRNA.
However, this A is complementary to the 5′-U of the antisense piRNA [Brennecke
et al., 2007; Aravin et al., 2007; Gunawardane et al., 2007]. After association of the
5′-end with the MID domain of the Piwi protein, the 3′-end of piRNAs is pro-
tected by 2′O-methylation involving Hen1 [Kirino and Mourelatos, 2007; Saito
et al., 2007; Horwich et al., 2007].
Tudor proteins involved in PiRNA generation
Another important family of proteins involved in the piRNA biogenesis are the
Tudor proteins, which are found in flies (i.e. Tudor, PAPI, spnE) and mammals
(TDRD1,2,4-7,9) [Siomi et al., 2011; Iwasaki et al., 2015]. Tudor proteins interact
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with symmetric dimethyl arginine modifications in the N-terminus of Piwi pro-
teins and are needed for several processes [Iwasaki et al., 2015]. Thus, Tudor is in-
volved in quality control of piRNA production by interacting with Piwi proteins
during the Ping-Pong cycle [Iwasaki et al., 2015], whereas TDRD1 is required for
correct localisation of Mili (a mouse Piwi protein) in the cytoplasm [Siomi et al.,
2011]. Even though many Tudor proteins have been identified and linked to the
piRNA pathway, their exact functions still need to be determined.
piRNA Functions
The role of piRNAs in germline development is twofold. In the early phase piR-
NAs protect the genome of germline cells by silencing (PTGS and TGS) of trans-
posable elements [Aravin et al., 2007; Brennecke et al., 2007]. In a later stage in de-
velopment of mammalian testis, piRNAs were suggested to associate with mR-
NAs by imperfect base pairing, thus leading to mRNA degradation. This step
seems necessary for the maturation of functional sperm cells, which contain only
little mRNA and condensed nuclei [Gou et al., 2014].
1.4 Overview on PTGS at the Model of Human Cells
In the cytoplasm mature miRNA, endo- or exo-siRNA duplexes, processed by
many different organism-specific pathways (see Section 1.3), are incorporated
into Ago proteins. In most cases they guide the RISC or miRNP by complemen-
tary base pairing to the 3′-UTR of the target RNA, however, binding to the 5′-UTR
or the ORF has also been observed [Huntzinger and Izaurralde, 2011] (Figure 1.2).
When targeted by the RISC or miRNP the capped and poly-adenylated mRNA is
in a closed loop conformation awaiting translation by the ribosome. The loop
is formed by the mRNA, the eukaryotic translation initiation factor E (eIF4E)
recognising the 5′-cap of the mRNA and eIF4G which mediates the interaction
with the poly-A binding proteins (PABPC) associated with the 3′-end of the RNA
[Huntzinger and Izaurralde, 2011]. The recognition of a target RNA by the guide
strand of the RISC or miRNP is accomplished by two distinct ways.
First, small RNAs and also some animal miRNAs are perfectly or nearly perfectly
complementary to the target RNA over their entire length. Here, especially the
interaction of the bases 10 and 11 of the guide strand with the target transcript
enable cleavage of the latter by Ago2 [Huntzinger and Izaurralde, 2011].
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Figure 1.2: Overview of the PTGS mechanism in human cells. Most miRNAs are tran-
scribed by RNA PolII into pri-miRNAs. These stem loop containing transcripts are recog-
nized by the Microprocessor complex, consisting of the RNAse-III-like enzyme Drosha and
DGCR-8. Via cleavage near the base of the stem, pre-miRNA hairpins are generated by the
Microprocessor complex and exported to the cytoplasm by Exportin-5. However, also other
Drosha-independent processes for pre-miRNA formation exist. The pre-miRNA hairpins
are subsequently bound by Dicer in complex with TRBP which removes the loop structure to
yield a miRNA duplex. After miRNA or siRNA loading mediated by chaperones, miRNPs or
RISC complexes consisting of an Ago protein and the guide strand of a miRNA or siRNA are
formed. The Ago protein is then recruited to a target transcript by complementary base pair-
ing of its bound small RNA. After association of TNRC6 proteins, which interact with an Ago
protein and Poly-A binding proteins on the transcript, the translation of the transcript is ei-
ther repressed or enzymes for transcript degradation are recruited. These comprise the dead-
enylase complexes Pan2-Pan3 and CAF1-CCR4-NOT, the decapping complexes DCP1/DCP2
and the 5′-3′-specific exonuclease XRN1 [Huntzinger and Izaurralde, 2011].
The 3′-ends of the sliced RNA are subsequently degraded by the 5′-3′-exonuclease
XRN1 starting at the unprotected 5′-end of the fragment [Orban and Izaurralde,
2004]. The second part of the mRNA with a free 3′-end is attacked by the exo-
some, a multimeric assembly of 3′-5′ exonucleases [Orban and Izaurralde, 2004].
The exosome is also involved in mRNA surveillance pathways like nonsense-
mediated decay by which aberrant stop codons in an mRNA are detected result-
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ing in the degradation of the latter [Parker and Song, 2004].
Second, most miRNAs recognise their target mRNA mainly by Watson-Crick base
pairing of the seed sequence (2-7 or 8 nt, see Section 1.2), which is in case of weak
interaction assisted by bases towards the 3′-end of the small RNA [Huntzinger
and Izaurralde, 2011; Meister, 2013]. Then, one of three TNRC6 (A/B/C) pro-
teins associates with the mRNA bound miRNP (Figure 1.2). These paralogues
of the D. melanogaster GW182, contain several characteristic glycine-tryptophane
(GW) repeats which bind into two tryptophan binding pockets on the surface
of Ago proteins [Schirle and MacRae, 2012]. In addition, TNRC6 proteins con-
tain two PABPC-binding domains, which enables them to interact with PABPCs
located at the 3′-end of the target transcript. Finally, TNRC6 family proteins re-
cruit the deadenylase complexes Pan2-Pan3 and CAF1-CCR4-NOT to the target
mRNA [Braun et al., 2011; Chekulaeva et al., 2011]. Following deadenylation, the
mRNA is either stored in a translationally silenced state, which is rather cell type
specific [Huntzinger and Izaurralde, 2011], or decapped by DCP1/DCP2 com-
plexes [Chen et al., 2009] (Figure 1.2). The mRNA deprived from its 5′-end is
subsequently degraded by the 5′-3′-specific exonuclease XRN1 [Huntzinger and
Izaurralde, 2011].
1.5 TGS Pathways in Different Species
The following description of small RNA pathways in different species focuses
on mechanisms of TGS in the nucleus and the required interaction partners. As
the chromatin network builds the molecular framework for TGS mechanisms the
main features and regulators will be introduced.
1.5.1 The Chromatin Environment of TGS
The DNA of a human cell comprises ~3 ∗ 109 bp. In order to store and function-
ally use the DNA inside the eukaryotic nucleus, several layers of compaction,
named chromatin, are needed as well as proteins which reorganise this structure
to make DNA accessible for the transcription, replication and repair machinery.
The basic building block of chromatin is the nucleosome which consists of ~145 bp
of DNA wrapped around an octamer of histone proteins. The disc-shaped oc-
tamer is assembled by two copies of each histone: H2A, H2B, H3 and H4 [Al-
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berts et al., 2002]. Nucleosomes are connected by a short linker DNA to form
the 10 nm-fibre, which resembles beads on a string [Alberts et al., 2002]. Fibre-
fibre interactions then drive the creation of higher compaction levels eventually
resulting in condensed chromosomes. Apart from cell division, when condensed
chromosomes are formed, chromatin is found in two states: heterochromatin or
euchromatin. Even though this classical view is more and more abandoned in
current research describing several mixed chromatin states [Luger et al., 2012], it
still helps to understand the basic principles. These different states show remark-
able differences in DNA methylation status, incorporation of histone variants,
post-translational modification (PTM) of histone N-terminal tails and associated
proteins. The enzymes responsible of DNA modification are DNA methyltrans-
ferases (i.e. DNMT1-3 proteins) which predominantly methylate DNA at the cy-
tosine of CpG dinucleotides [Denis et al., 2011]. Whereas DNMT1 serves mainly
by re-methylating hemi-methylated DNA during cell division, DNMT3A and
DNMT3B are required for symmetric de novo methylation of CpGs at imprinted
loci in the germline [Denis et al., 2011]. Lysine residues of protruding histone
tails are altered by methyl- and acetyltransferases (HMTs and HATs) and the re-
spective demethylating and deacetylating enzymes (HDMs and HDACs). Other
proteins involved in transition between states are nucleosome chaperones for the
exchange of histone variants and nucleosome remodelling enzymes which influ-
ence the position of nucleosomes along the DNA. Last also transcription factors
which bind to specific DNA sequences and prepare a binding site for RNA poly-
merases and insulator proteins separating heterochromatic from euchromatic re-
gions (CTCF) shape the accessibility of the chromatin [Zhou et al., 2011].
Euchromatin
Euchromatic regions are marked by histone modifications mediating a permis-
sive state. Thus, PTM of histone tails comprising monoubiquitylation of His-
tone H2B (H2Bub1) accompanied by di/tri-methylation of histone H3 at lysine 4
(H3K4me2, H3K4me3), acetylation (ac) of histone H4 and the histone variant
(H2A-Z) are found especially at transcriptionally active promoters [Luger et al.,
2012; Teves et al., 2014]. Actively transcribed regions accumulate H3K36me3 and
H3K79me2 at the N-terminal tails of histones and H3K4me1, H3K4me2, H3K27ac
are enriched at enhancers [Zhou et al., 2011; Luger et al., 2012].
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Heterochromatin
In contrast, heterochromatin is described as transcriptionally silent, rather con-
densed form of chromatin. It is found at both ends of the chromosome, the telom-
eres, and at the site where sister chromatides are associated, the centromeres.
Both regions are rich in repetitive elements like α-satellites and are often referred
to as constitutive heterochromatin. In addition, heterochromatin is used by the
cell for transcriptional inactivation at the second X chromosome in females of
mammals or certain genomic regions silenced in differentiated cells [Alberts et al.,
2002]. The heterochromatin is marked by several modifications ranging from
DNA-methylation for long term genetic silencing to post-translational modifica-
tion of histone H3 at H3K9me2/H3K9me3 or H3K27me3 [Zhou et al., 2011]. These
modifications recruit distinct chromodomain proteins like heterochromatin bind-
ing protein 1 (HP1α, β) associating with H3K9me2 or the polycomb repressive
complex 1 (PRC1) which interacts with H3K27me3 [Grewal and Elgin, 2007]. HP1
is a binding platform for HMTs and HDACs which cause spreading and mainte-
nance of heterochromatin, a mechanism conserved from yeast to humans [Grewal
and Elgin, 2007]. The polycomb repressive complex 2 (PRC2), which incorporates
the histone methyltransferase EZH2, is, in contrast, recruited by deacetylation of
H3K27 and causes its methylation to H3K27me3. Then a PRC1 complex asso-
ciates with H3K27me3 catalysing monoubiquitylation of histone H2A at lysine
119, another silencing mark, and formation of heterochromatin [Chen and Dent,
2014]. In addition, also specific histones are found in heterochromatin for exam-
ple macroH2A which accumulates on the inactivated X chromosome or the cen-
tromere specific Cenp-A (CenH3) which is needed for sister chromatid separation
[Luger et al., 2012].
A mechanism tightly linked to chromatin is transcription. The nucleosome and
higher compaction levels of chromatin form a barrier to RNA Polymerases, which
they have to overcome in order to enable mRNA and protein production in a cell
(Section 1.5.2).
1.5.2 Transcription
In eukaryotes there are three RNA polymerases which transcribe DNA into RNA.
RNA PolI and III are engaged in the transcription of ribosomal rRNA genes. RNA
PolIII is in addition required for formation of tRNA and several small RNAs.
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RNA PolII transcribes all protein coding genes as well as many small and long
non-coding RNAs [Alberts et al., 2002]. The activity of RNA PolII is mainly reg-
ulated by the phosphorylation state of its C-terminal domain (CTD), which con-
tains multiple heptad repeats (YSPTSPS) [Hsin and Manley, 2012]. For initiation
of transcription the unphosphorylated RNA PolII associates with a complex of
general transcription factors (TFII A, B, D, E, F, and H) bound to the promoter
region of a gene [Hsin and Manley, 2012]. After binding to the promoter, RNA
PolyII is phosphorylated at serine 5 and starts to synthesise a short stretch of
RNA assisted by TFII H, which comprises DNA helicase activity and unwinds
the DNA double strand for RNA PolII to enter [Hsin and Manley, 2012]. Then
RNA PolII is stalled at the promoter till elongation is initiated. During elonga-
tion phosphorylation at serine 2 increases while it is successively removed from
serine 5 [Hsin and Manley, 2012]. In addition to these, more modifications of the
CTD have been identified which are reviewed in Hsin and Manley [2012].
For transcription RNA polymerases need to progress through DNA organised
in arrays of nucleosomes. In the case of RNA PolII nucleosomes are translo-
cated to yield way for the processing polymerase by ATP dependent remodellers
[Studitsky et al., 2004]. The detailed mechanisms of nucleosome remodelling
required for transcription by RNA PolI to III remain poorly understood. Tran-
scription by RNA PolII leads to local melting of the DNA double strand at the
promoter creating positive supercoils in front and negative supercoils behind.
Positive supercoiling destabilises nucleosomes [Teves et al., 2014]. However, for
efficient transcription RNA PolII is dependent on nucleosome remodellers, his-
tone chaperones, histone modifying enzymes and elongation factors. Facilitates
Chromatin Transcription (FACT) is a nucleosome chaperone which belongs to
a set of proteins minimally required for RNA PolII transcription through chro-
matin in vitro [Teves et al., 2014]. It is activated by the monoubiquitylation of
histone H2B (H2Bub1), which is a mark for active promoters as described in Sec-
tion 1.5.1. FACT is suggested to weaken histone-DNA contacts to enable RNA
PolII progression, however, the exact mechanism is controversially discussed.
Also, ATP-dependent remodelling complexes are implicated in transcription by
RNA PolII but due to their number and redundancy their precise role could not be
determined. There are four main families of chromatin remodellers comprising
SWI/SNF, ISWI, INO80, and CHD. Whereas SWI/SNF proteins were suggested
to evict H2A-H2B and whole nucleosomes, ISWI remodellers were found to as-
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semble nucleosomes and induce their regular spacing [Teves et al., 2014]. INO80
and CHD proteins serve also regular spacing of nucleosomes, while INO80 is
additionally involved in deposition and removal of H2A-Z at TSS nucleosomes
[Teves et al., 2014]. Therefore, RNA PolII was recently suggested to play an im-
portant role for correct nucleosomal spacing in transcribed regions of the genome
[Struhl and Segal, 2013].
A chromatin silencing mechanism which is dependent on transcription for re-
cruitment of its subunits is found at the centromeres of fission yeast and is de-
scribed in the next section.
1.5.3 Fission Yeast a Role Model for TGS
Nearly 13 years ago a study conducted by Volpe et al. [2002] linked heterochro-
matin formation in S. pombe to RNAi. Heterochromatin formation has been found
at three sites in the fission yeast chromatin: at centromeres, telomeres and the
mating type locus. While an RNAi based mechanism is essential for the estab-
lishment of heterochromatin at centromeres, it is redundant for heterochromatin
formation at telomeres and the mating type locus [Aravind et al., 2000; Volpe et al.,
2002; Woolcock and Bühler, 2013]. The role of RNAi in heterochromatin forma-
tion at pericentric repeats is illustrated in Figure 1.3.
Small RNA induced heterochromatin formation
Recognition of the target locus is mediated by the RNA induced transcriptional si-
lencing (RITS) complex, which consists of an Ago protein (Ago1), Chp1 and Tas3
[Verdel et al., 2004]. Fission yeast contains only one Ago protein, which is essen-
tial and is loaded with an siRNA assisted by the Ago siRNA chaperone complex
(ARC). Chp1 is a chromodomain protein (see Section 1.5.1), which stabilises the
binding of Ago1 to pericentric chromatin by interacting with methylated H3K9
[Holoch and Moazed, 2015]. However, Chp1 is not only binding to but is also
required for H3K9 methylation at centromeres as deletion of Chp1 leads to loss
of this modification from histone H3 [Sadaie et al., 2004]. Tas3 is a glycine tryph-
tophan (GW) containing protein which binds Ago1 by its GW motif and interacts
with the C-terminal half of Chp1 by its N-terminal domain and thus stabilises
the trimeric protein complex [Schalch et al., 2011]. RITS is loaded with an siRNA
generated by Dcr1 from transcripts of non-coding repetitive elements [Reinhart
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Figure 1.3: The role of RNAi in heterochromatin formation in fission yeast.
At yeast centromeres an RNAi-dependent mechanism is required for heterochromatin for-
mation. A small RNA processed by the RNAase III-enzyme Dcr1 is loaded into Ago1 by the
chaperone complex ARC. Ago1 complexes with the chromodomain protein Chp1 and the
GW containing Tas1 protein and forms the RNA-induced silencing complex (RITS). The RITS
is recruited by complementary base-paring interaction of its bound siRNA and a nascent
RNA PolII transcript to the pericentric chromatin. Mediated by Stc1 the RITS complex as-
sociates with the histone methyltransferase Clr4. Subsequent methylation at H3K9 results
in binding of the chromodomain proteins Chp1/2 and Swi6. In addition, the RITS complex
interacts with the RNA-dependent RNA Polymerase Complex (RDRC) consisting of Rdp1,
Hrr1 and Cid12. This complex synthesises a second strand to the Ago1 bound nascent tran-
script. This double stranded RNA is processed by Dcr1 and loaded into the RITS complex
causing a positive feedback loop, which leads to further spreading of the heterochromatin
along the centromeres. The silencing mark H3K9me2/3 and the recruitment of heterochro-
matin protein 1 homologues Swi6 and Chp2 is required for heterochromatin formation and
its stable maintenance. (Similar to [Holoch and Moazed, 2015])
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and Bartel, 2002; Volpe et al., 2002; Verdel et al., 2004] and associates with chro-
matin by base pairing interactions of the Ago-bound small RNA and a nascent
transcript [Verdel et al., 2004; Bühler et al., 2006]. Then the Clr4 methyltransferase
complex (CLRC) is recruited by RITS. This step is mediated by Stc1, which has
been shown, to interact with RITS and CLRC [Bayne et al., 2010]. Stc1 consists
of two zinc finger domains ZF1 and ZF2 implicated in Ago1 interaction and an
unstructured C-terminal domain, which is sufficient for binding of the CLRC [He
et al., 2013]. The subunit Clr4, the sole H3K9 methyltransferase known in fission
yeast [Aravind et al., 2000], mediates the H3K9 methylation enabling the binding
of the chromodomain proteins Chp1, Swi6 and Chp2. Swi6 and Chp2 (HP1 ho-
mologues) maintain the H3K9 methylation and heterochromatin [Bannister et al.,
2001; Sadaie et al., 2004].
Finally, the RNA-dependent RNA polymerase complex (RDRC) is recruited to the
nascent transcript, which contains the RNA-dependent RNA polymerase (Rdp1),
a helicase Hrr1 and the non-canonical poly(a) polymerase Cid12 [Motamedi et al.,
2004]. Hrr1 is highly similar to DEAD box RNA helicases of the Smg2 family,
which have been linked to the RNAi response also in other species [Motamedi
et al., 2004; Dalmay et al., 2001]. The Cid12 protein contains a nucleotidyltrans-
ferase domain and belongs to the family of Trf4/Trf5 poly(A) polymerases [Halic
and Moazed, 2010]. A second RNA strand is synthesised to the RITS bound
nascent transcript by the RDRC complex (see Figure 1.3). The resulting dsRNA is
then processed by Dcr1 into siRNAs which are in turn loaded into Ago1 causing
further spreading of the heterochromatin [Bühler et al., 2006].
Initiation of siRNA Mediated Heterochromatin Formation
The primary trigger for RITS has recently been discovered by Halic and Moazed
[2010]. The ssRNAs incorporated into RITS can be supplied by two different
mechanisms both dependent on slicer activity of Ago1. The first one is based on
priRNAs, which are supposed, to stem from degradation products of centromeric
transcripts. These are degraded by the exosome, loaded into Ago1 [Holoch and
Moazed, 2015] and trimmed to the required length by the 3′-5′-exonuclease Tri-
man [Marasovic et al., 2013]. The loaded Ago1 assembles into a RITS complex
leading to H3K9 methylation by recruitment of CLRC. In the second suggested
pathway, priRNA loaded Ago1 binds to Tas3 and forms a primer for RDRC on
centromeric transcripts [Halic and Moazed, 2010]. The dsRNAs produced are
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then further processed by Dicer and incorporated into Ago1. According to Halic
and Moazed [2010] Ago1 may be part of a RNA surveillance pathway, detecting
low level aberrant transcripts from repetitive elements, leading to genomic silenc-
ing. However, more studies have to be performed, to elucidate the ribonucleases
and trimming enzymes involved in this process.
1.5.4 Silencing by TGS in A. thaliana
A. thaliana comprises 10 different Ago proteins, which can be grouped into three
different clades: Ago1, 5, 10; Ago2, 3, 7 and Ago4, 6, 8, 9 [Mallory and Vaucheret,
2010]. The loading of Ago proteins follows certain loading preferences for the
identity of the 5′ nucleotide and for the length of the incorporated small RNA
strand [Bologna and Voinnet, 2014]. However, TGS is mediated solely by the
Ago4 clade of proteins, as piRNAs are absent from plants [Matzke and Mosher,
2014].
Generation of small RNAs for the class of Ago4 proteins
The small RNAs derive mainly from transposons and dispersed repeats in an
RNA PolIV and RNA-dependent RNA Polymerase 2 (RDR2) dependent pro-
cess [Zhang et al., 2007]. RNA PolIV and RDR2 associate with the SNF2-like
chromatin-remodelling factor classy 1 (CLSY1) (see Figure 1.4 and Section 1.5.2),
which supports their localisation and interaction in the nuclear compartment
[Smith et al., 2007]. RNA PolIV and RDR2 knockout plants demonstrated, that
the precursors of 90% of the 24 nt siRNAs involved in TGS are dependent on
RNA PolIV transcription and overlap with the siRNA set, whose biogenesis relies
on RDR2 [Zhang et al., 2007]. Restoring of wild-type RNA PolIV by crossing of
knockout plants (nrpd1a/1b and nrpd2a/2b both RNA PolIV subunits) deficient
for 24 nt siRNAs led to full re-establishment of 24 nt siRNAs in the F1 generation,
suggesting an siRNA-independent recruitment mechanism for RNA PolIV to its
genomic targets [Zhang et al., 2007]. One of those factors recruiting RNA PolIV
to a subset of loci is SHH1 (Figure 1.4), which binds methylated H3K9 in com-
bination with unmodified H3K4 [Law et al., 2013]. The RDR2 derived dsRNAs
are then recognised and cleaved into 24 nt long small RNAs by the ribonuclease
Dicer-like 3 protein (DCL3). After siRNA export to the cytoplasm Ago4 is loaded
with small RNAs assisted by the chaperone HSP90 (see Figure 1.4). The class
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Figure 1.4: TGS mechanism in plants.
RNA PolIV is recruited to chromatin by proteins like SHH1, where it starts transcription.
Subsequently, it associates with the remodeller CLSY1 and RDR2, which synthesises as sec-
ond RNA strand resulting in dsRNA molecule. This is cleaved into 24 nt siRNAs by DCL3,
which are then exported to the cytoplasm for loading into Ago proteins. Following HSP90-
dependent small RNA loading Ago4 translocates into the nucleus and is targeted by com-
plementary base pairing of is bound siRNA and a nascent RNA PolV-dependent transcript
to loci destined for silencing. Ago4 together with RDM1 recruit the DNA methyltransferase
DRM2 which in turn de novo methylates DNA and thus initiates heterochromatin formation
at the target loci (similar to Matzke and Mosher [2014]).
of Ago4 proteins show a strong preference for an adenine at the 5′-end of their
associated siRNAs [Bologna and Voinnet, 2014].
In addition, also siRNAs with a length of 21 and 22 nt are produced from trans-
acting small RNA producing (TAS) loci and transposable elements [Wu et al.,
2012; McCue et al., 2014]. Firstly, transcripts of the TAS loci are targeted by specific
miRNAs bound to Ago1 and sliced. These cleaved transcripts are stabilised by
suppressor of gene silencing 3 (SGS3), which recruits the RNA-dependent RNA
Polymerase 6 (RDR6) producing dsRNAs [Matzke and Mosher, 2014]. Secondly,
RNA PolII dependent transcripts from transposable elements are also transcribed
into dsRNA by an RDR6-dependent process. Both types of RDR6 dependent
dsRNAs are further processed mainly by DCL4 into siRNAs serving in PTGS by
Ago1 and DCL1 into 21 nt siRNAs bound to Ago4/6 [Matzke and Mosher, 2014;
Wu et al., 2012; McCue et al., 2014].
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Ago4 and Ago6 mediated TGS
TGS is then mediated by a process referred to as RNA-dependent DNA methy-
lation (RdDM), which relies on RNA PolV as a binding platform for Ago4 and
Ago6 [Matzke and Mosher, 2014]. The recruitment of RNA PolV to chromatin
is suggested to depend in part on SUVH2 and SUVH9, which are inactive mem-
bers of the SU(VAR)3–9 histone methyltransferase family (Section 1.5.1) but are
still able to recognize pre-existing methylated DNA [Matzke and Mosher, 2014].
In addition, RNA PolV is also found at sites which lack pre-existing methylation
and triggers de novomethylation [Matzke and Mosher, 2014] (compare Figure 1.4).
Furthermore, RNA PolV associates with chromatin by binding to the DDR com-
plex, which consists of the putative chromatin remodellers DRD1, DMS3 and the
plant specific single-stranded DNA-binding protein RDM1 [Matzke and Mosher,
2014]. At the chromatin RNA PolV synthesises transcripts that seem to serve as
a scaffold for siRNA-mediated binding of Ago4/6 (see Figure 1.4), as the tran-
scripts are 5′-capped but deficient for poly(A) tails [Matzke and Mosher, 2014;
Wierzbicki et al., 2008]. Following recruitment of Ago proteins, the complex is
stabilised by the association of Ago4/6 with GW repeats in the large subunit
NRPE1 (NRPD1b + NRPD2a) of RNA PolV similar to human TNRC6-Ago in-
teractions [El-Shami et al., 2007] (explained in Section 1.4). Expression of a cat-
alytically inactive Ago4 mutant in an Ago4 knockout background revealed that
slicer activity is only partially required for silencing by RdDM [Qi et al., 2006].
Ago4/6 in complex with the RNA PolV associated RDM1 then recruit the DNA
methyltransferase DRM2, which belongs to the DNMT3 family of proteins [Xie
et al., 2012; Naumann et al., 2011; Kuhlmann et al., 2014] (see Section 1.5.1). Similar
to DNMT3A in mammals DRM2 mediates de novo cytosine DNA methylation at
symmetric CG (see Figure 1.4), but also at symmetric CHG (H is adenine, thymine
or cytosine) and asymmetric CHH sites, which are confined to the binding region
of the siRNA-Ago4/6 complex [Naumann et al., 2011; Kuhlmann et al., 2014]. The
TGS by RdDM is probably reinforced by the histone methyltransferases SUVH5
and SUVH6, which bind methylated DNA and mediate heterochromatin forma-
tion by histone H3K9 methylation. In turn H3K9 methylation seems to regulate
biogenesis of 24 nt siRNAs, which recruit RdDM and DRM2, to build a self re-
inforcing loop similar to the mechanism described for fission yeast [Stroud et al.,
2014] (compare Section 1.5.3).
20
1.5. TGS Pathways in Different Species INTRODUCTION
TGS in the Plant Germline
The last A. thaliana Ago to mention from this clade is Ago9, which is involved in
regulation of megaspore development from somatic ovule tissue [Olmedo-Monfil
et al., 2010]. On the one hand, it prevents multiple differentiation of somatic ovule
cells into megaspores which further divide and give rise to the female gameto-
phyte including the germline. On the other hand, it may silence transposons in
female gametes and accessory cells. In addition, Ago9 is expressed in anthers and
seed coats.
The Role of TGS in Heterochromatin Formation
RdDM seems to take place only at intergenic transposons and genes containing
transposons, where it serves especially in de novo methylation of these loci as
knockout plants for DCL3, RDR2 and Ago4 confirmed [Chan et al., 2004]. Un-
like S. pombe pericentromeric heterochromatin formation is established and main-
tained mostly by RNAi-independent processes [Matzke and Mosher, 2014]. Fur-
ther functions for Ago-mediating RdDM were implicated in pathogen defence,
stress response and genomic imprinting [Matzke and Mosher, 2014; Vu et al.,
2013].
1.5.5 TGS Mechanisms in Drosophila
The D. melanogaster genome encodes for five Argonaute proteins, Ago1 and Ago2,
which are found in all cells, and Piwi, Aub (Aubergine) and Ago3, which are pre-
dominantly located in the germ line [Hutvagner and Simard, 2008]. Of these
proteins only Ago2 and Piwi were implicated in TGS mechanisms. Ago2 asso-
ciates with exogenous siRNAs produced by Dicer2 (Dcr2) in combination with
the dsRNA-binding protein R2D2. The latter mediates efficient loading of siRNAs
into Ago2 [Liu et al., 2003]. The siRNA specificity of Ago2 was shown by Oka-
mura et al. [2004], generating Ago1 and Ago2 knockout flies. Ago1 knockouts
were defective in miRNA-mediated translational repression, late embryonic le-
thal and sterile. In contrast, Ago2 depletion inhibited siRNA RISC formation
but had no influence on fertility. Additionally, Ago2 is loaded with endogenous-
siRNAs, called endo-siRNAs, resulting in the PTGS and potential TGS of target
TEs in somatic tissue [Kawamura et al., 2008; Ghildiyal et al., 2008]. This is further
supported by Dcr2 knockdown cells and Dcr2 mutant ovaries, which lack endo-
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siRNAs and show increased transcription of some TEs [Kawamura et al., 2008].
Furthermore, Ago2 knockdown correlated with increased TE expression level.
Potential Ago2-mediated TGS
Several reports suggest that Ago2 has also a nuclear function in addition to the
cytoplasmic control of transcripts (PTGS) from repeat elements [Deshpande et al.,
2005; Peng and Karpen, 2007]. In the nucleus, Ago2 is supposedly needed for
pericentric heterochromatin formation during embryonic development [Desh-
pande et al., 2005]. Applying immunofluorescence on Ago2 mutant fly embryos,
defects in chromosome condensation, nuclear kinesis and assembly of spindle
apparatus could be detected [Deshpande et al., 2005]. In addition, silencing of
transgenes inserted in percentric regions was also diminished in heterozygous
mutants [Deshpande et al., 2005]. Thus, both observations could be explained by a
role of Ago2 in pericentric heterochromatin formation but direct evidence is miss-
ing. In a later study the RNAi machinery was suggested to be involved in nucleoli
organisation [Peng and Karpen, 2007]. Assessing nucleoli number and H3K9me2
in Ago2 and Dcr2 mutant larvae Peng and Karpen [2007] found increased num-
bers of nucleoli and reduced levels of H3K9me2 at rDNA loci. This links the
RNAi machinery to a histone mark of heterochromatin, which was shown to be
dependent on the histone methyltransferase Su(var)3–9 [Peng and Karpen, 2007].
While these findings are reminiscent of TGS pathways components described for
A. thaliana, C. elegans and S. pombe, a self-reinforcing loop is missing as flies lack an
RNA-dependent RNA polymerase [Bologna and Voinnet, 2014; Lee et al., 2004b;
Bühler et al., 2006] (see also Section 1.5.3, Section 1.5.4, Section 1.5.6). Cernilogar
et al. [2011] detected Ago2 also in the nucleus of somatic cells. However, using
ChIP and immunofluorescence experiments they found Dcr2 and Ago2 at active
transcription sites potentially regulating RNA PolII promoter pausing under heat
shock conditions, thus opposing a role of Ago2 in TGS. Thus, the involvement of
Ago2 in a TGS mechanism remains controversial.
TGS in the Germline of Flies
The second important RNAi pathway is mediated by the Piwi family of proteins,
Piwi, Aub and Ago3, which are predominantly expressed in the gonads [Hut-
vagner and Simard, 2008; Saito et al., 2006]. In detail, Aub and Ago3 are only
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expressed in the cytoplasm of germ cells of both genders [Saito and Siomi, 2010].
There, Aub and Ago3 function in PTGS and degradation of transcripts derived
from repetitive elements [Li et al., 2009a; Nishida et al., 2007; Gunawardane et al.,
2007; Brennecke et al., 2007]. In contrast, Piwi is found in the nucleus of ovaries
(somatic and germ cells) [Brennecke et al., 2007]. However, in testis it is restricted
to somatic niche cells, which maintain the germ cells [Saito and Siomi, 2010]. Ac-
cording to the current model, Piwi bound to a piRNA enters the nucleus and
is targeted by complementary base pairing to nascent transcripts from transpos-
able element encoding loci [Huang et al., 2013b; Tianfang Ge and Zamore, 2013].
There, it associates with the C-terminus of heterochromatin protein 1a (HP1a) by
direct interaction, which was shown by Brower-Toland et al. [2007] using yeast
two-hybrid assays. Applying Piwi mutants defective in nuclear localisation and
slicer activity Sienski et al. [2012] showed that silencing of certain TEs is depen-
dent on nuclear Piwi, but not on its slicer function. In addition, Piwi seems to re-
cruit the histone methyltransferase Su(var)3–9, which di-methylates histone H3
(H3K9me2) [Huang et al., 2013b]. This modification is in turn bound by HP1a
which results in heterochromatin formation and depletion of RNA PolII from re-
spective loci [Huang et al., 2013b]. These findings are further supported by Piwi
knockdown in ovaries combined with transcript, RNA PolII and H3K9me3 ChIP
analyses. Here, Le Thomas et al. [2013] found that TEs show increased transcrip-
tion rates, RNA PolII recruitment and reduced histone H3K9 methylation levels.
Primary piRNAs seem to derive from heterochromatic piRNA clusters which are
not targeted for silencing by Piwi (reviewed in [Tianfang Ge and Zamore, 2013]).
Finally, opposing results based on HP1 ChIP experiments were presented by
Moshkovich and Lei [2010], which indicate an endo-siRNA and piRNA indepen-
dent mechanism for heterochromatin formation at TE encoding loci. However,
due to the conclusive findings by Brower-Toland et al. [2007]; Sienski et al. [2012];
Le Thomas et al. [2013]; Huang et al. [2013b] arguing in favour of a Piwi dependent
mechanism the results by Moshkovich and Lei [2010] are strongly questioned by
Tianfang Ge and Zamore [2013].
1.5.6 Worms, Where RNAi was Discovered
In C. elegans there are 26 Argonaute proteins described [Dueck and Meister, 2014],
which function in processes ranging from TGS to epigenetic memory. Associated
with these Ago proteins are several classes of small RNAs, which can be grouped
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due to their length (21, 22, 26 nt), the 5′- and 3′-modifications and the identity of
the 5′-base [Grishok, 2013]. These are miRNAs, 22G 5′-tri-phosphorylated siR-
NAs, 21U RNAs also known as worm piRNAs and 26G endo-siRNAs. However,
only four of these 26 Argonaute proteins are involved in regulation of transcrip-
tion in the nucleus. These can be divided in nuclear RNAi defective 3 (NRDE3)
involved in TGS in somatic cells and heritable RNAi defective (HRDE1/WAGO9)
together with PRG1 and CSR1 which influence heterochromatin formation and
transcription in the germline (see Figure 1.5).
TGS in Somatic Cells by NRDE3
In somatic cells of C. elegans TGS is catalysed by the NLS-containing Argonaute
NRDE3 [Guang et al., 2008]. For nuclear import to proceed, NRDE3 needs to as-
sociate with small RNAs in the cytoplasm [Guang et al., 2008]. These so-called
secondary siRNAs derive from exogenous RNAs or endogenous mRNAs, which
are targeted by the Ago proteins RDE1 or ERI1 loaded with primary, Dicer1-
dependent exo- or endo-siRNAs. Then, the Ago-targeted RNAs are bound by an
RNA-dependent RNA Polymerase complex (RdRP), generating dsRNAs which
yield secondary 22G 5′-tri-phosphorylated siRNAs [Guang et al., 2008] (compare
Figure 1.5). Following nuclear import, secondary siRNA-loaded NRDE3 asso-
ciates with pre-mRNA transcripts and recruits NRDE2, a serine/arginine-rich
protein [Guang et al., 2010]. Subsequent binding of the protein NRDE1 to the
siRNA-targeted pre-mRNA causes TGS by inhibition of RNA-PolII transcription
during the elongation phase and removal of the polymerase [Guang et al., 2010;
Burkhart et al., 2011] (see Figure 1.5). In addition to inhibition of RNA-PolII, also
NRDE4-dependent recruitment of NRED1 to chromatin and methylation of H3K9
was observed at target gene loci of NRDE3 [Burkhart et al., 2011]. NRDE2/3-
dependent nuclear TGS resulting in H3K9me marks at the pre-mRNA-encoding
genes was further confirmed on a genome wide scale by Gu et al. [2012]. Fur-
thermore, the histone methyltransferase SET-25 and the HP1 homologue (HPL2),
which binds to methylated H3K9, were shown to be involved in stable hete-
rochromatin formation in somatic cells [Ashe et al., 2012; Shirayama et al., 2012;
Juang et al., 2013]. In summary, a close resemblance with the TGS mechanisms
observed in yeast and plants (compare Section 1.5.3, 1.5.4) is seen, which differ
mainly by the localisation and mechanism of secondary siRNA production by an
RdRP.
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a TGS in somatic cells 
Figure 1.5: TGS mechanisms in C. elegans.
a) Exogenous or endogenous double stranded RNAs are bound by Dicer and processed into
primary siRNAs, which are loaded into the Ago homologue RDE1. For generation of sec-
ondary siRNAs (22G RNAs), RDE1 binds to a complementary transcript and recruits an
RdRP. After synthesis of a complementary strand, secondary siRNAs are produced which are
loaded into NRDE3. Following nuclear import, NRDE3 associates with NRDE2 and NRDE1
to inhibit RNA PolII transcription. Subsequently, a complex of NRDE1 and NRDE4 recruits
histone methyltransferases, which initiate heterochromatin formation requiring the HP1 ho-
mologue HPL2. b) In the germline, the loading and targeting of nascent transcripts and the
encoding gene is basically similar to somatic cells, here the Ago protein HRDE3 is involved.
However, secondary siRNAs (22G RNAs) can additionally derive from foreign RNAs, which
are recognised by the Ago homologue PRG1 bound to 21U RNAs, and are also generated by
an RdRP dependent process. Furthermore, another Ago homologue CSR1 interacts with 22G
RNAs, which are complementary to endogenous transcripts. After nuclear import, CSR1 pro-
tects its complementary loci from silencing by inhibiting HRDE1-mediated processes. This
means that HRDE1 in collaboration with CSR1 establish a germline memory of self and non-
self sequences. (Adapted with minor modifications from [Holoch and Moazed, 2015].)
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TGS in the Germline
The Ago protein HRDE1 (WAGO9) is responsible for TGS of transposable ele-
ments in the germline [Gu et al., 2009; Yigit et al., 2006; Grishok, 2013]. Similar
to NRDE3, HRDE1 is loaded with secondary siRNAs derived from endogenous
or exogenous RNA targets of RDE1 or ERI1 as described above. Additional sec-
ondary siRNAs incorporated into HRDE1 are generated by a mechanism depen-
dent on the Ago homologue PRG1, which is loaded with C. elegans piRNAs (21U
RNAs) (see Figure 1.5). Reminiscent of D. melanogaster piRNA clusters (see Sec-
tion 1.5.5), 21U RNAs are transcribed by RNA PolII from two clusters on chro-
mosome IV and other sites in the germline [Grishok, 2013]. Every 21U RNA-
encoding sequence contains a conserved promoter sequence 34 bp-upstream from
the start [Ruby et al., 2006; Cecere et al., 2012]. They associate exclusively with the
Piwi homologue PRG1 from C. elegans, which was shown by animals carrying a
mutant PRG1 gene [Batista et al., 2008; Das et al., 2008]. These piRNAs are inde-
pendent of Dicer processing and protected by HENN1-mediated methylation at
the 3′ end [Grishok, 2013]. Following targeting of a transcript by 21U RNAs, 22G
5′-tri-phosphorylated secondary siRNAs complementary to the target at regions
upstream of the 21U binding site are produced involving an RdRP complex [Ashe
et al., 2012; Bagijn et al., 2012; Luteijn et al., 2012].
After loading with a secondary siRNA in the cytoplasm, HRDE1 is imported into
the nucleus and targeted by complementary base paring to nascent transcripts
(see Figure 1.5). There, it interacts with NRDE2 and NRDE1 and inhibits RNA
PolII transcription. In addition, NRDE4 recruits NRDE1 to the HRDE1-associated
chromatin, which results in induction of H3K9me3 by the histone methyltrans-
ferases SET-25 and SET-32 [Ashe et al., 2012; Buckley et al., 2012]. Furthermore,
the HP1 ortholog HPL2 was shown to be involved in heterochromatin forma-
tion at the targeted loci [Ashe et al., 2012]. Interestingly, PRG1-dependent sec-
ondary siRNAs are only needed for initiation of heterochromatin formation at
target loci, while trans-generational silencing requires HRDE1, NRDE2, HPL-2
and the methyltransferases SET25/32 [Ashe et al., 2012; Shirayama et al., 2012;
Bagijn et al., 2012; Luteijn et al., 2012].
26
1.5. TGS Pathways in Different Species INTRODUCTION
Self and Non-Self RNA Mechanism
There is a big class of endogenous secondary siRNA, 22-G RNAs, found espe-
cially in the germline of C. elegans. These small RNAs are generated by processes
depending on RdRP complexes and can be further divided in WAGO-associated
small RNAs, which target mRNAs by PTGS and TGS, and CSR1-bound 22G
RNAs, which are complementary to several thousand protein coding genes of
C. elegans [Gu et al., 2009; Claycomb et al., 2009]. However, there was no silencing
effect observed for the CSR1-associated endo-siRNAs. On the one hand, Clay-
comb et al. [2009] found that CSR1 is targeted to chromatin and needed for chro-
mosome segregation in mitosis and meiosis. In addition, CSR1 was implicated
in 3′-UTR processing of histone pre-mRNAs, in part explaining the lethal phe-
notypes of CSR1 pathway mutants and chromatin condensation defects in CSR1
knockdown experiments [Avgousti et al., 2012]. On the other hand, Cecere et al.
[2014] analysed the role of CSR1 in regulation of gene expression and found that
the CSR1 promoted sense transcription by RNA PolII. Its loss, however, led to
reduced expression of many target genes [Claycomb et al., 2009; Avgousti et al.,
2012].
Combining the knowledge on PRG1 from the previous section with the findings
on CSR1, a model for differential target regulation could be deduced [Seth et al.,
2013]. In depth analysis of 21U RNA targeting mechanism revealed that only par-
tial complementarity is required for initiation of the TGS pathway, thus allowing
the recognition of a broad spectrum of non-self RNAs by PRG1 [Shirayama et al.,
2012]. In contrast, CSR1 counteracts heterochromatin formation and promotes ex-
pression of genes in the germline [Seth et al., 2013]. From these findings, a model
was deduced, which suggests that 21U RNAs bound to PRG1 are able to target
any foreign transcript and supply HRDE1 with complementary siRNAs leading
to TGS of the foreign RNA and its encoding sequence. CSR1 bound 22G RNAs,
however, protect protein coding genes of C. elegans from silencing by HRDE1
[Luteijn et al., 2012; Shirayama et al., 2012; Seth et al., 2013] (compare Figure 1.5).
As the silencing and protecting/activating signal are transgenerationally trans-
mitted, they are named small RNA-induced epigenetic silencing (RNAe) and
small RNA-induced epigenetic gene activation (RNAa), respectively [Seth et al.,
2013]. However, still many open questions remain regarding the phenotype of
animals mutant for PRG1 and CSR1 and their role in TGS.
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1.5.7 TGS Pathways in Mammals
A prerequisite for TGS in human cells in the nuclear localisation of Ago proteins.
This was conclusively shown in cellular fractionation experiments [Rüdel et al.,
2008; Robb et al., 2005; Chu et al., 2010] and also in vivo, by using GFP-tagged
Ago2 in combination with cross-correlation spectroscopy [Ohrt et al., 2008]. With
this technique a ratio of 4:1 for cytoplasmic versus nuclear Ago2 was suggested
[Ohrt et al., 2008]. For cytoplasmic RISC (cRISC) a molecular weight of 3 MDa was
estimated, while the size of nuclear RISC (nRISC) was determined with 158 kDa.
In order to test the siRNA loading of cRISC and nRISC, experiments using micro-
injection of siRNAs in combination with wheat germ agglutinin (WGA), which
inhibits nuclear transport [Finlay et al., 1987], were performed [Ohrt et al., 2008].
These experiments separated the cytoplasmic protein machinery from the one in
the nucleus and suggested that siRNA loading of both RISCs is restricted to the
cytoplasm [Ohrt et al., 2008]. Applying MS analysis on purified Ago-complexes
led to the identification of Importin 8 (Imp8). While initial hints for an Ago import
function of Imp8 were observed, the main function of Imp8, however appears to
be the cytoplasmic targeting of RISC to specific target mRNAs [Weinmann et al.,
2009].
In addition, also slicing activity of Ago2 in the nucleus was proposed by experi-
ments targeting 7SK snRNA [Robb et al., 2005]. Using siRNA against the nuclear
7SK snRNA, they showed efficient cleavage of the target RNA presumably by an
Ago2-dependent mechanism. This is supported by the observation of a correctly
sized cleavage product in nuclear and cytoplasmic fractions and in vitro tests with
nuclear and cytoplasmic lysates, which were incubated with 5′-labelled target
RNAs.
Transcriptional Gene Regulation in Somatic Cells Induced by siRNAs
One step further in elucidating a potential role of nuclear Ago in transcriptional
regulation was taken by several publications starting form 2004, which applied
exogenous siRNAs directed against promoter sequences (see Table 1.1).
SiRNA induced Transcriptional Gene Silencing After transfection of promo-
ter specific siRNAs, several studies observed reduced mRNA or protein expres-
sion levels of the respective target proteins (EF1a, CDH1, PR, AR, MYP, COX2)
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[Morris et al., 2004; Ting et al., 2005; Janowski et al., 2005]. Inspired by the work
in other organisms (see Sections 1.5.3, 1.5.4, 1.5.5, 1.5.6), these studies also indi-
cated DNA-methylation [Morris et al., 2004] or silencing histone modifications
[Janowski et al., 2005] to be involved in the human TGS mechanism. Using stable
shRNA expressing HeLa cells or siRNAs, to target the promoter region of CCR5
and the tumor suppressor RASSF1A, Kim et al. [2006] suggested a role for a net-
work consisting of Ago1, TRBP2 and RNA PolII in TGS in human cells. Also, the
polycomb repressive complex PRC2, which comprises methyltransferase activity
and is involved in heterochromatin formation [Chen and Dent, 2014], (compare
Section 1.5.1), was implicated to be recruited via Ago1. Then, PCR2 should in-
duce histone H3 modifications (H3K27me3, H3K9me2) at these loci and mediate
heterochromatin formation. In addition, they also found enrichment of Ago1 at
the promoters of MYT1 and CCR5 in untreated HeLa cells [Kim et al., 2006].
In the breast cancer cell line T47D the promoters of huntingtin (htt), progesterone
and androgen receptor (PR, AR) were analysed for TGS by targeting with spe-
cific siRNAs [Janowski et al., 2006]. All gene loci responded with reduced tran-
scription, however using the same approach in MCF7 cells, no response for PR
(siRNAs: PR26, PR24), which has a lower expression level in these cells, was ob-
served. A role of histone modifications could not be confirmed, as suggested by
[Kim et al., 2006]. Applying siRNA knockdown and ChIP experiments for Ago1
and Ago2, Janowski et al. [2006] suggest that both proteins are necessary for tran-
scriptional silencing and associate with the respective promoters. Puzzling is,
however, the fact that none of the indicated Ago proteins complements the si-
lencing effect under knockdown of its homologue. Only recently, the study from
Janowski et al. [2006], was confirmed by Cho et al. [2014], who used and improved
their TGS-model in T47D cells. The findings on an inhibition of siRNA-mediated
TGS upon Ago2 knockdown were extended by a dependence on SETDB1, which
was shown to interact with Ago2 in IP experiments, but is recruited to the AR
promoter only after Ago2 binding [Cho et al., 2014]. TGS at the androgen pro-
moter coincided with the accumulation of the heterochromatic marks H3K9me3,
H3K27me3 and its modifier the polycomb repressor complex 2 (PRC2) with its
methyltransferase component EZH2, all in Ago2- and SETDB1-dependent fash-
ion. Only under combined histone modifications a loss of RNA PolII at the AR
proximal promoter was observed. In addition, they found Ago2 to associate with
an antisense transcript and a chromatin remodelling complex consisting of SIN3A
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and HDAC1, which interacts with SETDB1. Upon targeting with siRNAs against
the AR promoter, only the mRNA transcription level decreased, while the anti-
sense transcript level remained constant. In their study Cho et al. [2014] found
no DNA methylation activity associated with the AR promoter under silencing
conditions. In agreement with the study of Cho et al. [2014], Gary Felsenfeld
suggested SETDB1 as methyltransferase involved in Ago2 TGS at the Keystone
conference on “Noncoding RNAs in Development and Cancer” in 2013.
SiRNA induced Transcriptional Activation In contrast to TGS observed by ear-
lier studies, Li et al. [2006] used siRNAs targeting CDH1, p21 and VEGF promot-
ers leading to various effects from none to strong induction of transcription de-
pendent on the cell line, which was termed transcriptional activation [Li et al.,
2006; Janowski et al., 2007]. Further support for this observation was contributed
by Janowski et al. [2007] for the promoter of PR in MCF7 cells (compare Table 1.1).
This is presumably due to the different epigenetic modifications found at the pro-
moter regions of the cells lines used. Several other loci examined, failed, to gen-
erate an activating response [Li et al., 2006; Janowski et al., 2006], suggesting that
the gene activation is not a general and conserved phenomenon. At the activated
CDH1 promoter, a reduction of silencing histone modification (H3K9me2/3) was
measured, following targeting [Li et al., 2006]. DNA methylation seemed, how-
ever, not to be involved and Ago2 was identified as effector protein [Li et al.,
2006].
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siRNA-EF1a transfection HEK-293 EF1a, EF1a-GFP target mRNA levels, NucRunOn gene silencing . [Morris et al., 2004] DNA methylation
siRNA-CDH1 transfection HCT-116 ,MCF7 CDH1 target mRNA and protein levels gene silencing . [Ting et al., 2005] H3K9me2
siRNA-PR9/RP24/
AR/MVP/COX2
transfection T47D progestron and androgen
receptor (PR, AR), ma-
jor vault protein (MVP),
cyclooxygenase-2
target mRNA and protein levels gene silencing . [Janowski et al., 2005]
siRNA/shRNA-
CCR5/RASSF1A
transfection HEK-29, HeLa CCR5, RASSF1A target mRNA and protein levels,
ChIP
gene silencing Ago1 [Kim et al., 2006] EZH2(PCR2), H3K27me3,
TRBP2
. . HeLa MYT1, CCR5 ChIP gene silencing Ago1 [Kim et al., 2006] EZH2(PCR2), H3K27me3,
TRBP2
siRNA-CDH1 transfection PC-3, HeLa CDH1 target mRNA and protein levels gene activation Ago2 [Li et al., 2006] (-) H3K9me2/3
siRNA-p21 transfection PC-3, MCF7,
HeLa
p21 target mRNA and protein levels gene activation Ago2 [Li et al., 2006]
siRNA-p21 transfection HEK-293, J82,
LNCaP, T24
p21 target mRNA and protein levels mild gene activation Ago2 [Li et al., 2006]
siRNA-
CDH1/p21/VEGF
transfection HeLa VEGF target mRNA levels gene activation Ago2 [Li et al., 2006]
siRNA-
PR24/PR26/AR/Htt
transfection T47D Progersteron and Andro-
gen receptor, Huntingtin
target mRNA and protein levels,
NucRunOn, ChIP
gene silencing Ago1/Ago2 [Janowski et al., 2006]
siRNA-PR24/26 transfection MCF7 Progersteron receptor target mRNA and protein levels no effect . [Janowski et al., 2006]
siRNA-PR11/26 transfection MCF7 Progesteron receptor target mRNA and protein levels gene activation . [Janowski et al., 2007] (+) H3K4me2
siRNA-PR/AR transfection MCF7, T47D Progesteron receptor target mRNA and protein levels,
RIP
gene activation/si-
lencing
Pan-Ago [Schwartz et al., 2008] antisense transcript bound
by Ago, HP1γ, hnRNPK
siRNA-PR/AR transfection Progersteron receptor target mRNA and protein levels,
RIP
gene activation/si-
lencing
Ago2 [Chu et al., 2010] antisense transcript
siRNA-AR50, PR26 transfection T47D Progersteron receptor, An-
drogen receptor
target mRNA and protein levels,
RIP
gene silencing Ago2 [Cho et al., 2014] SETDB1, (+) H3K9me3, (+)
H3K27me3, PRC2 (EZH2),
antisense transcript,
SIN3A, HDAC1
miR-373 transfection PC3 CDH1, CSDC2 target mRNA levels gene activation . [Place et al., 2008] .
miR-373 transfection HCT-116 CDH1, CSDC2 target mRNA levels gene activation
(CSDC2)
. [Place et al., 2008] .
miR-373 transfection LNCaP CDH1, CSDC2 target mRNA levels no effect . [Place et al., 2008] .
miR-320 transfection HEK-293 POLR3D target mRNA levels, ChIP gene silencing Ago1 [Kim et al., 2008] EZH2(PCR2), H3K27me3
miR-320 endogenous HEK-293 POLR3D target mRNA levels antagomiR gene silencing . [Kim et al., 2008] .
miR-423-5p transfection T47D Progesteron receptor,
IGSF1
target mRNA levels, RIP gene silencing Ago2 [Younger and Corey,
2011]
H3K9me2, antisense tran-
script
miR-372, miR-373,
miR-520c-3p
transfection T47D Progesteron receptor target mRNA levels gene silencing . [Younger and Corey,
2011]
miR-423-5p endogenous MCF7, T47D Progesteron receptor target mRNA levels + an-
tagomiR
no effect . [Younger and Corey,
2011]
miR-423-5p transfection MCF7 IGSF1 target mRNA levels gene silencing . [Younger and Corey,
2011]
continued on the next page
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miR671 inducible HEK-293 CDR1 target mRNA levels gene silencing Ago2 (slicer) [Hansen et al., 2011] circular antisense tran-
script
miR671 endogenous HEK-293 CDR1 target mRNA levels + an-
tagomiR
gene silencing Ago2 (slicer) [Hansen et al., 2011] circular antisense tran-
script
miRNAs endogenous WI-38 (senes-
cent)
E2F target genes (PCNA,
CDCA8, CDC2, CCNA2)
RIP-Seq, Small RNA-IP-Seq, mi-
croscopy, target mRNA levels
gene silencing Ago2 [Benhamed et al.,
2012]
(+) H3K27me3, (+)
H3K9me2
miR-let7f, miR185 transfection WI-38 (pre-
senescent)
CDC2, CDCA8 (miR-let-
7f), ORC6L (miR-185)
RIP, Small RNA-IP, ChIP, target
mRNA levels
gene silencing Ago2 [Benhamed et al.,
2012]
(+) H3K27me3, (+)
H3K9me2
miRNAs endogeonus PC-3 ChIP-Seq, target mRNA levels
(microarray Ago1 kd), micro-
scopy
gene activation Ago1 [Huang et al., 2013a] (+) H3Kme4
miRNAs endogeonus PC-3 PIK3CA, PRKCH, CDC6,
and RRM1
ChIP gene activation Ago1 [Huang et al., 2013a]
miRNAs endogeonus PC-3/ RWPE SMC1A, CDC20, SMAD3,
BUB1
ChIP, target mRNA levels (less
then 2 fold change)
gene activation Ago1 [Huang et al., 2013a]
Table 1.1: Overview of studies regarding small RNA-mediated transcriptional gene regulation.
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A Unifying Mechanism for Transcriptional Silencing and Activation In sev-
eral follow up papers by the Corey lab [Janowski et al., 2007; Schwartz et al., 2008;
Chu et al., 2010] working with MCF7 and T47D cell lines, the above described
findings were refined. Thus, some siRNAs (PR11, PR26) targeting the promoter
of PR could be found, which activated transcription from the PR gene in MCF7,
while others (PR9) were shown to silence PR in T47D [Schwartz et al., 2008]. Gene
activation was linked to an increase in histone H3K4me2/3 and reduction of hi-
stone H3K9 and H3K14 acetylation [Janowski et al., 2007]. In contrast to this
finding on differential histone modification, all of these three activating histone
modifications were implied to be associated with gene activation or bivalent pro-
moters by Karmodiya et al. [2012]. The chromatin interaction of the RISC at the
PR promoter, was explained by long antisense transcripts, spanning the region in
question [Schwartz et al., 2008]. Using Ago ChIP, RIP and biotin labelled siRNA
pull-down, Ago association with chromatin at the promoter and direct interac-
tion with the antisense transcript by complementary base pairing of the bound
small RNA could be shown [Schwartz et al., 2008]. The accumulation of RNA
PolII at the siRNA activated promoter and reduction of RNA PolII levels at si-
lenced loci support their findings. Finally, also HP1γ, was detected in ChIP ex-
periments at the PR promoter. HP1γ, a member of the heterochromatin binding
proteins, interacts with histone H3K9me and is implicated in heterochromatin
formation [Chen and Dent, 2014] (see Section 1.5.1). Treating the cells with an ac-
tivating siRNA led to reduction of HP1γ association and thus relieve of silencing,
while the interaction was unchanged for the silencing siRNAs, specific for the
PR promoter. Analysing Ago1 to 4 in parallel, Chu et al. [2010] showed nuclear
localisation for all Ago proteins. However, they found only evidence for Ago2 be-
ing involved in transcriptional silencing and activating pathways in MCF7 and
T47D cells [Janowski et al., 2007; Schwartz et al., 2008; Chu et al., 2010]. Additional
proteins involved in the modification of histones and their interaction with Ago2
were not yet described. This lack of mechanistic details renders the observations
on transcriptional activation and silencing by promoter targeted siRNAs strongly
controversial in the field.
Transcriptional Gene Regulation by miRNAs in Somatic Cells
Using bioinformatic prediction several miRNAs complementary to gene promo-
ter sequences were identified [Place et al., 2008; Kim et al., 2008; Younger and
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Corey, 2011] (compare Table 1.1). Gene activation was observed by targeting
the CDH1 and CSDC2 promoters in different cell lines with transfected miR-373
[Place et al., 2008]. In contrast, Ago1-dependent gene silencing was observed at
the promoter of POLR3D, when HEK-293 cells were transfected with miR-320
[Kim et al., 2008]. Younger and Corey [2011] tried to link gene silencing at the
PR gene [Janowski et al., 2006; Schwartz et al., 2008] to endogenous sources by
predicting miRNA complementary to the PR promoter. While they found several
miRNAs resulting in gene silencing (compare Table 1.1), they in depth studied
miR-423-5p mediated TGS [Younger and Corey, 2011]. For TGS to occur, they
found the seed sequence (2-8 nt) of miR-423-5p as well as interaction of Ago2
with a promoter associated antisense transcript to be required. In addition, the
histone silencing mark H3K9me2 was induced by miR-423-5p-dependent TGS.
Finally, they analysed endogenous miR-423-5p function in T47D and MCF7 cells
by transfection with antagomiRs. These are 2′-O-methyl modified ssRNAs fully
complementary to miR-423-5p, which bind to their target miRNA and cause its
degradation. However, in both cell lines no increase of PR transcription was ob-
served after treatment with antagomiRs. Therefore, Younger and Corey [2011]
conclude that, while transfected miR423-5p can induce TGS, the endogenous
miRNA is not mediating this function in T47D or MCF7 cells.
Recently, a report by Huang et al. [2013a] described a role of Ago1 but not Ago2 in
transcriptional gene activation by applying ChIP-Seq in prostate adenocarcinoma
PC-3 cells. Interestingly, this interaction was Dicer and thus presumably small
RNA dependent. By correlating the Ago1- with H3K4me3-ChIP-Seq results, they
could identify Ago1 bound to TSS of active genes. In order to prove their findings,
the TSS of the active genes PIK3CA, PRKCH, CDC6, and RRM1 were tested by
ChIP and shown to be enriched for Ago1 and RNA PolII. From the comparison
of their ChIP-Seq data with expression array data from cells treated with siRNA
against Ago1 they drew the conclusion, that Ago1 promotes transcription of a
subset of genes. Given the lack of replicates in the ChIP-Seq experiments the
genome wide predictions by this study have to be interpreted rather carefully.
A quite different example of miRNA mediated TGS was presented by Hansen
et al. [2011], who found miR-671 to silence transcription from the CDR1 gene.
During further analysis they showed that miR-671, which is antisense to a se-
quence proximal to the transcription start site of CDR1, binds to a circular anti-
sense transcript deriving from the CDR1 gene locus. This binding is mediated by
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Ago2 and leads to cleavage of the circular antisense transcript coinciding with re-
duced transcription of CDR1 mRNA [Hansen et al., 2011]. In summary the study
shows a stabilising effect of a circular antisense RNA on transcription of the gene
locus encoded mRNA. However, further studies are need to gain more mechanis-
tic insight of the proposed pathway.
Recently, Benhamed et al. [2012] found Ago proteins from senescent primary
lung fibroblast cells (WI-38) to be associated with E2F-target gene promoters (320
bound promoters) in ChIP experiments (pan-Ago) compared to pre-senescent
control cells (77 bound promoters), which was supported by nuclear Ago local-
isation in microscopic experiments. E2F is a transcription factor involved in cell
cycle regulation which interacts with the tumor suppressor Retinoblastoma pro-
tein (RB1). Additionally, they isolated small RNAs from RNA-IP experiments
with a pan-Ago-specific antibody and an H3K9me2-directed antibody. Using
ChIP experiments at several E2F target promoters they could establish a coin-
ciding association of Ago2 with the repressive histone marks H3K27me3 and
H3K9me2 at these loci. Supported are these findings by a reduced expression
from the targeted loci, which is relieved upon Ago2 knockdown. Furthermore,
they validated their findings at the promoters of CDC2 and CDCA8 targeted by
let-7f and ORC6L targeted by miRNA-186, which were identified by their small
RNA-IP-Seq experiment. A silencing and heterochromatin inducing function for
let-7f on E2F target promoters was shown in luciferase reporter assays in combi-
nation with Ago2 and the repressor RB1 and in ChIP and nuclear run on assays
in vivo. Still missing in the description of the TGS pathway of Benhamed et al.
[2012] are factors like SUV39 and a link to RNA PolII. Also reproductions of these
findings by independent groups are required.
Endogenous siRNAs with a Potential Function in TGS
Another view to nuclear Argonaute function comes from the finding of endo-
siRNAs in human somatic cells like HeLa and HEK293. Yang and Kazazian [2006]
set out, to confirm the post-transcriptional silencing of TE in somatic cells by us-
ing a L1 reporter construct. This was generated by fusing the 5′-UTR of L1 to GFP
and followed by integration in 293 FlipIn-cells. They detected endo-siRNAs by
northern blotting, which derive from long dsRNAs (~400 bp) generated by pair-
ing of the L1 transcript with transcripts generated from an antisense promoter
(ASP) located in the 5′-UTR of L1. This is also supported by experiments using
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siRNAs generated from a dsRNA of a full length LINE element (L1RP) by recom-
binant Dicer, which were co-transfected with reporter constructs consisting of the
5′-UTR of L1RP or L1.3 and firefly luciferase. These L1RP-derived siRNAs could
target not only the 5′-UTR of L1RP, but also of the related LINE element (L1.3)
due to 98% sequence homology in this region [Soifer et al., 2005]. Deletion con-
structs lacking the ASP led to accumulation of transcripts, due to the loss of L1
siRNAs [Yang and Kazazian, 2006].
In addition, both groups applied retrotransposition experiments with reporter
constructs carrying a promoter and either GFP or a resistance marker in antisense
orientation fused to the LINE element. Both reporters contained the γ-globin in-
tron in the orientation of the LINE element. Therefore, the marker could only
be detected after transcription, splicing, retro-transcription and insertion. Here,
the destruction of the ASP and thus endo-siRNA production gave rise to retro-
transposition events [Yang and Kazazian, 2006]. In case of treatment with siRNAs
derived from the 5′-UTR, the retro-transposition could be reduced [Soifer et al.,
2005]. In ChIP experiments, they examined the loading of wild type L1 constructs
and the ones lacking a functional ASP with RNA PolII [Yang and Kazazian, 2006].
As the RNA PolII association was comparable for both constructs, they concluded
post-transcriptional targeting of L1 by RNAi. Given that long dsRNA induces
an interferon response in mammalian cells, they supposed that the dsRNA de-
rived from the L1 5′-UTR is diced in the nucleus, followed by post-transcriptional
degradation by an RNAi mechanism. The nuclear localisation of Dicer is also
supported by other studies [Doyle et al., 2013; Gagnon et al., 2014]. In contrast
to exogenous siRNAs targeting promoters (see above, Section 1.5.7), the poten-
tially nuclear endo-siRNAs derived from 5′-UTR of LINE elements lead to post-
transcriptional degradation and do not modify the transcription process at the
target locus [Yang and Kazazian, 2006].
TGS in Mammalian Germ Cells
Mouse Piwi Proteins The knockout of Piwi proteins leads to opposing pheno-
types for male and female mice. Whereas the loss of any of the Piwi proteins leads
to male sterility accompanied by stop of meiosis in spermatocytes and reduction
of germ cells (Miwi2), females are fertile and normal [Carmell et al., 2007; Deng
and Lin, 2002; Kuramochi-Miyagawa et al., 2004]. Mili and Miwi proteins are
loaded with piRNAs derived from primary piRNA clusters [Aravin et al., 2007;
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Vourekas et al., 2012] (see Section 1.3). Given that Miwi2 shuttles between the cy-
toplasm and the nucleus, a model is proposed in which the piRNA amplification
cycle of Mili and Miwi2, supplies nuclear Miwi2 with antisense sequences needed
for targeting of TE genes for DNA-methylation [Aravin et al., 2008], while Mili is
involved in PTGS of TE transcripts in the cytoplasm [Iwasaki et al., 2015]. By
analysing Mili and Miwi2 knockout animals using high-throughput sequencing,
in situ hybridisation and bisulfite sequencing an increase in TE (LINE, IAP) ex-
pression accompanied by a reduction in DNA methylation was observed [Aravin
et al., 2007; Carmell et al., 2007; Kuramochi-Miyagawa et al., 2008]. Finally, Mili
(E12.5) and Miwi2 (E15.5) expression coincides with de novo methylation of TEs
by the DNA methyltransferases Dnmt3a, Dnmt3b and the cofactor Dnmt3L at
embryonic day E16.5 to E18.5 [Kuramochi-Miyagawa et al., 2008]. A downstream
function of Dnmt3L in the Piwi TGS pathway is further supported by knockout
experiments. Absence of Dnmt3L resulted in a complete loss of DNA methyla-
tion, while piRNA levels remained unchanged for some classes of TEs and in-
creased for others [Aravin et al., 2008]. These findings imply that mammalian
Piwis are involved in genomic silencing of TEs by DNA methylation, reminiscent
of the TGS mechanism in plants (Section 1.5.4). However, many factors involved
in the Piwi-mediated TGS mechanism are still unknown and need to be charac-
terized.
In addition to silencing of TEs, Mili and Miwi2 were also suggested being in-
volved in de novo DNA methylation of the imprinted locus Rasgrf1, hinting to a
role of Piwi proteins in epigenetic regulation of genes [Watanabe et al., 2011]. Un-
like Mili, the Piwi protein Miwi loaded with pachytene piRNAs seems to have a
function in PTGS of mRNAs in the cytoplasm of developing sperm cells [Thom-
son and Lin, 2009; Reuter et al., 2011; Grivna et al., 2006].
Human Piwi Proteins The function of human Piwi proteins is mostly analysed
in cancer and somatic cells, whereas their role in the germline most likely resem-
bles the one described above for their mouse homologues. This is suggested by
analysis of Piwi proteins form seminomas, which are germ cell tumours of the
testis [Qiao et al., 2002]. There are several publications on human Piwis in can-
cer cells as reviewed by Thomson and Lin [2009]. Expression of human Piwis in
somatic cells and cancer cell lines was tested by qPCR experiments [Keam et al.,
2014]. Here, only Hiwi2 showed an expression level of 10% compared to testis
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[Qiao et al., 2002; Keam et al., 2014]. The protein expression level of Hiwi2 in
breast cancer cells was also similar to the one observed in somatic cells [Keam
et al., 2014]. However, the protein expression of Hili and Hiwi was not assessed.
In contrast to Miwi2, Hiwi2, which was detected using a Miwi2 antibody recog-
nizing also Hiwi2, showed cytoplasmic localisation. In addition, a strong differ-
ence between the piRNAs in Miwi2 libraries from testis, human testis libraries
and Hiwi2 libraries from breast cancer cells was detected. If the Hiwi2-bound
piRNAs from these cancer cells, which derive predominantly from tRNAs, are
functional, however needs further experimental support [Keam et al., 2014]. In
addition, also other components of a Piwi pathway would need to be expressed
in conjunction with Hiwi2, which have not yet been indicated.
1.5.8 Additional Nuclear Functions of Ago Proteins
Regulation of Splicing
Another mechanism, which was linked to nuclear Ago function is alternative
splicing. Using siRNAs against specific intron or exon sequences, Allo et al. [2009]
showed increased inclusion of an alternative exon into the mature mRNA of fi-
bronectin (FN1). SiRNA knockdown of either Ago1 or Ago2 in combination with
the siRNA treatment promoting alternative exon inclusion inhibited the effect.
This is astonishing as Ago1 and Ago2 can bind to the intron targeting siRNA
and could therefore complement the knockdown of their homologue. The iden-
tification of an antisense transcript overlapping the coding sequence, raised the
possibility that both siRNA strands could be effectively targeting the locus and
supported a possible TGS like mechanism. Along this line also the processivity of
RNA PolII was reduced upon treatment with the intron targeting siRNA, which
explained the increase of exon inclusion. The alternative splicing effect could also
be linked to accumulation of H3K9me2, K3K27me3, HP1α and DNA methylation
at the targeted intron [Allo et al., 2009].
These findings are in part supported by phorbol-12-myristate-13-acetate (PMA)
induced alternative splicing [Ameyar-Zazoua et al., 2012]. Mass spectrometric
analysis of Ago associated proteins revealed among others also factors involved
in splicing: snRNP U2 and U5 subunits which are part of the core spliceosome
[Alberts et al., 2002]; several SR proteins which are involved in alternative splic-
ing, mRNA export and translation [Long and Caceres, 2009]; PTBP1 and PTBP2
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which bind intronic polypyrimidine tracts and are involved in splicing [Kafasla
et al., 2012]; Sam68, which was implicated in alternative splicing of CD44, induc-
ing exon V5 inclusion upon phosphorylation [Matter et al., 2002]. In knockdown
experiments using siRNAs against Ago1, Ago2 and Dicer a slight reduction of
alternative splicing was shown. Additionally, physical interaction of Ago1 and
Ago2 with the gene locus of the alternative spliced transcript was demonstrated
by ChIP experiments. In addition, Ameyar-Zazoua et al. [2012] could show a de-
pendence on HP1γ for Ago1 and Ago2 in induction of alternative splicing. The
mechanism behind, is explained by an increase in H3K9me3 methylation marks
which reduce the elongation rate of RNA-PolII and thus allow for integration
of alternative exons similar to the hypothesis by Allo et al. [2009]. Here, the in-
crease in H3K9me3 does lead to a slow down of RNA-PolII while the CD44 tran-
script level persists. However, these findings stand in contrast to the mechanism
described for C. elegans where NRDE3-dependent inhibition of RNA PolII is fol-
lowed by RNA PolII depletion form the genomic locus and silencing [Guang et al.,
2010]. In conclusion, many potential factors involved in RNAi dependent splic-
ing have been suggested. However, given the role of Sam68 in CD44 regulation
[Matter et al., 2002], which has to be separated from the proposed Ago function
[Ameyar-Zazoua et al., 2012] and the current lack of Ago proteins in spliceosome
preparations [Meister, 2013], more experimental work has to be performed to
conclusively explain the role of Ago proteins in splicing.
Ago Proteins and DNA Double Strand Break Repair
Recently, evidence for involvement of Ago proteins and Dicer in DNA double
strand break (DSB) repair was found in A. thaliana and humans [Wei et al., 2012].
Working with GFP reporter cell lines inducing only specific DSB breaks, Wei et al.
[2012] were able to use high-throughput sequencing to characterize potentially
DSB-induced small RNAs. Within the libraries, small RNAs surrounding the DSB
sites were indeed identified. In addition, DSB repair efficiency was severely re-
duced after Ago2 or Dicer knockdown [Wei et al., 2012]. These small DSB-induced
RNAs (diRNAs) were shown to guide Ago2 to the specifically induced DSB sites
on the DNA using ChIP experiments [Gao et al., 2014]. Furthermore, direct inter-
action of Ago2 with the ssDNA binding protein RAD51, a well known compo-
nent of the homologous recombination repair mechanism [Yamanaka and Siomi,
2014], was demonstrated [Gao et al., 2014]. Ago2 mutants deficient in small RNA
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binding or slicer activity still bound to RAD51 but were unable to recruit RAD51
to DSB sites or restore homologous recombination repair [Gao et al., 2014]. In con-
trast to this, an earlier study implied Drosha and Dicer involved in DNA double
strand break repair [Francia et al., 2012]. Even though the study by Gao et al.
[2014] nicely explained the link of Ago2 with RAD51 and its importance for ho-
mologous recombination, many open question regarding the production of pre-
cursors, the processing and loading of diRNAs remain [Yamanaka and Siomi,
2014].
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1.6 Objectives of this Work
RNA interference (RNAi) is a potent regulatory mechanism, were a small RNA
bound to an Argonaute protein targets a complementary RNA sequence resulting
in many diverse processes such as translational repression, mRNA decay, DNA-
methylation or heterochromatic gene silencing (Dueck and Meister [2014]). En-
couraged by RNAi mediated heterochromatic silencing mechanisms in yeast and
plants, reports accumulated were siRNAs were successfully used to trigger tran-
scriptional gene silencing in mammalian cells (see Table 1.1). In addition, several
studies implied markers of heterochromatin at the targeted gene promoters, rem-
iniscent of pathways described in S. pombe, A. thaliana and C. elegans (compare
Section 1.5.3, 1.5.4, 1.5.6). Furthermore, Ago proteins are found in the nucleus of
many different somatic cell types.
Thus, the aim of this work was, to gain insight into a possible endogenous driven
Ago-protein-chromatin interaction. First, the nuclear localisation and chromatin
interaction of Argonaute proteins was analysed using biochemical assays. Sec-
ond, a ChIP Sequencing approach was undertaken to identify potential chro-
matin interaction sites of Argonaute proteins. Third, an antibody-independent
approach was established, called DNA Adenine Methyltransferase Identification
(DAM-ID) [Steensel and Henikoff, 2000], where the potential binding sites were
marked by a fusion protein of Dam and Argonaute at GATC stretches. Forth,
bioinformatic analyses were planned to be applied in order to map potential
Ago binding sites to the human genome. With these approaches we aimed at a
comprehensive overview on chromatin loci potentially regulated by small RNA-
guided mechanisms in human somatic cells.
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Chapter 2
Material
2.1 Antibodies
Name Epitope Technique Species Brand Publication
07-599 hAgo1 (1-46) ChIP rabbit pAB Millipore
1525 hAgo1 (pep-
tide)
ChIP rabbit pAB own
1C9 hAgo1 ChIP rat mAB own
1C9 hAgo1 WB (1:10) rat mAB own
4B8 hAgo1 ChIP rat mAB own Beitzinger et al. [2007]
07-590 hAgo2 (7-48) ChIP rabbit pAB Millipore
1526 hAgo2 (pep-
tide)
ChIP rabbit pAB own
1526 hAgo2 (pep-
tide)
WB(1:200) rabbit pAB own
2A8 HAgo2 (47-879) ChIP mouse mAB Nelson et al. [2007]
5D4 hAgo2 ChIP rat mAB own Beitzinger et al. [2007]
11A9 HAgo2 (1-15) ChIP rat mAB own Rüdel et al. [2008]
11A9 HAgo2 (1-15) WB (1:10) rat mAB own Rüdel et al. [2008]
hCox6A WB rabbit pAB Rehling lab
ABIN968286 hERP72 WB (1:500) mouse mAB antikörper-
online.de
mms-101p HA-tag 16B12 WB (1:1000) mouse mAB Convance
ab1791 hHistone H3 WB rabbit pAB Abcam
sc-20681 hLamin A/C WB (1:1000) rabbit pAB Santa Cruz
hMFN2 WB rabbit pAB Rehling lab
hMITRAC12 WB rabbit pAB Rehling lab
hMITRAC15 WB rabbit pAB Rehling lab
hMRPS15 WB rabbit pAB Rehling lab
Rabbit IgG ChIP rabbit pAB Santa Cruz
Rat IgG ChIP rat pAB Santa Cruz
ab24758 hRNA Pol II
phospho S2
ChIP mouse mAB Abcam
hSEC61β WB rabbit pAB Rehling lab
continued on the next page
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Name Epitope Technique Species Brand Publication
hTim23 WB rabbit pAB Rehling lab
hTim44 WB rabbit pAB Rehling lab
hTom70 WB rabbit pAB Rehling lab
T9026 hTubulin α
(DM1A)
WB (1:10000) mouse mAB Sigma-
Aldrich
sc-931 hUBF (1-220) ChIP rabbit pAB Santa Cruz
AB3792 V5-tag WB rabbit pAB Millipore
15164 His-Probe-HRP WB Ni2+-POD Thermo
115-035-068 anti-mouse IgG WB (1:10000) goat POD Jachskon
Research
112-035-068 anti-rat IgG WB (1:5000) goat POD Jackson Re-
search
A2074 anti-rabbit IgG WB (1:10000) mouse POD Sigma-
Aldrich
IRDye 800CW mouse anti-mouse IgG WB (1:15000) goat LI-COR-
Biosciences
IRDye 800CW rat anti-rat IgG WB (1:15000) goat LI-COR-
Biosciences
IRDye 800CW rabbit anti-rabbit IgG WB (1:20000) goat LI-COR-
Biosciences
Table 2.1: Antibodies used in this work
2.2 Enzymes
Benzonase Merck
DNase RQ1 Promerga
DPN I NEB
DPN II NEB
T4-DNA-Ligase NEB
Lysozyme AppliChem
Phusion ® High-Fidelity DNA Polymerase New England Biolabs
λ Protein Phosphatase New England Biolabs
Proteinase K Thermo Scientific
Restriction endonucleases Thermo Scientific and New England Biolabs
RNAse A Thermo Scientific
Taq-DNA-Polymerase Thermo Scientific
T4-DNA-Ligase Thermo Scientific
T4 Polynucleotide Kinase (PNK) Thermo Scientific
Tobacco Etch Virus nuclear inclusion a en-
dopeptidase (TEV)
lab stock
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2.3 Chemicals, Enzymes, Peptides and Oligonucleo-
tides
All chemicals were, unless stated otherwise, purchased from one of the following
companys: Amersham Bioscience (Buckinghamshire, UK), AppliChem GmbH
(Darmstadt, Germany), Biorad (Hercules, USA), GE Healthcare GmbH (Chal-
font St Giles, UK), Macherey-Nagel GmbH & Co.KG (Düren, Germany), Merck
(Darmstadt, Germany), Qiagen (Hilden, Germany), Roche (Basel, Switzerland),
Roth (Karlsruhe, Germany) and Sigma-Aldrich (Munich, Germany). Radiochem-
icals were provided by Hartmann Analytic GmbH (Braunschweig, Germany).
Commonly used enzymes were purchased from New England Biolabs (Ipswich,
USA) and Thermo Fisher Scientific Inc. (Waltham, USA). DNA oligonucleotides
were synthesized by Metabion (Martinsried, Germany). siRNAs were produced
by MPI for Biochemistry (Martinsried, Germany) or Biomers (Ulm, Germany).
Plastic consumables and labware were supplied by Sarstedt (Nümbrecht, Ger-
many) and BD Biosciences (San Jose, USA).
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2.4 Buffers and Solutions
general buffers
PBS NaCl 137 mM
KCl 2.7 mM
Na2HPO4 10 mM
KH2HPO4 1.8 mM
adjust with HCl or NaOH to pH
7.5
TAE Tris 40 mM
Glacial Acetic Acid 20 mM
Na2-EDTA pH 8.0 2 mM
TBE Tris 89 mM
Boric Acid 89 mM
Na2-EDTA pH 8.0 2 mM
TBS NaCl 150 mM
Tris pH 8,0 10 mM
TE Tris/HCl pH 7.5 10 mM
Na2-EDTA pH 8.0 1 mM
DNA-loading dye Tris/HCl, pH 7.8 10 mM
Na2-EDTA pH 8.0 1 mM
Bromphenolblau 2.5 mg/ml
Glycerin 300 mg/ml
Buffer for chemically compe-
tent bacteria
Tfb I KOAc 30 mM
MgCl 2 50 mM
KCl 100 mM
Glycerin 15 %
H2O ad 250 ml
adjust pH 5.8 with Acertic Acid (0.2 M)
sterile filtrate solution
Tfb II MOPS 10 mM
CaCl 2 75 mM
KCl 10 mM
Glycerin 15 %
H2O ad 50 ml
adjust pH 7.0 with NaOH (diluted)
sterile filtrate solution
SDS-PAGE, Western Blot and
Coomassie
Lämmli-Loading buffer (4×) Tris/ HCl pH 6.8 240 mM
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SDS 8%
Glycerin 50 %
Bromphenolblue 800 µg/ml
β-Mercaptoethanol 10 %
SDS running buffer Tris 25 mM
Glycine 50 mMÂ
SDS 1 %
Towbin blotting buffer Glycine 192 mM
Tris 25 mM
adjust with HCl to pH 8.6
Methanol 20%
TBS-T NaCl 150 mM
Tris pH 8.0 10 mM
Tween (100 %) 0.1 %
PonceauS staining solution Ponceau-Red 0.2 %
Acetic Acid 1 %
Coomassie straining solution Acetic Acid 10 %
Ethanol 20 %
Coomassie R250 0.25 %
Coomassie destaining solution Acetic Acid 10 %
Ethanol 30 %
Immunprecipitation
IP wash buffer Tris/ HCl pH 7.5 50 mM
NaCl 300 mM
MgCl2 5 mM
NP-40 0.05%
NaF 1 mM
Lysis buffer Tris/ HCl pH 7.5 25 mM
KCl 150 mM
Na2-EDTA pH 8.0 2 mM
NP-40 0.5 %
NaF 1 mM
DTT 0.5 mM
AEBSF 1 mM
Proteinase K buffer NaCl 300 mM
Tris/ HCl pH 7.5 200 mM
Na2-EDTA (0,5 M) 25 mM
SDS 2%
Northern Blot
MOPS-NaOH (50x) MOPS 1M
adjust with NaOH to pH 7
Keep in the dark at 4 ◦C
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RNA sample buffer (2x) Bromphenolblau 0.25 %
Xylencyanol 0.25 %
Formamid
SSC (20x), pH 7 NaCl 3 MÂ
Trinatriumcitrat-Dihydrat 0.3 mM
Adjust with HCl to pH 7
5 x SSC/ 1 % SDS SSC (20 ×) 5 ×
SDS 1 %
1 x SSC/ 1 % SDS SSC (20 ×) 1 ×
SDS (20 %) 1 %
50 x Denhardts solution Albumin fraction V 1 %
Polyvinylpyrrolidon K30 1 %
Ficoll 400 1 %
Store at 20 ◦C
Hybridisation buffer SSC (20x) 12.5 ml
Na2HPO4 pH 7.2 (1M) 0.996 ml
SDS (10%) 34.86 µl
Denhardtâs solution (50 x) 0.996 ml
H2O ad 1 litre
Media
LB-Medium NaCl 10 g
Yeast-Extract 5 g
Bacto-Trypton 10 g
adjust with NaOH to pH 7.2 - 7.5
i.e.(Ampicillin (50 mg/ml) 100 µg/ml
LB-Platten LB medium
Agar 1,5 %
2.4.1 Oligonucleotides
Target Name Sequence 5′-3′ Purpose
Tubulin Tubulin-Pr-qPCR-F CCCTCTCCTTTCTCCCTCTC ChIP-qPCR
Tubulin Tubulin-Pr-qPCR-R CAGGCTGGAAGGTTGGAAT ChIP-qPCR
UBF UBF-qPCR-F GTGTGTGGCTGCGATGGT ChIP-qPCR
UBF UBF-qPCR-R CGACTCGGAGCGAAAGATA ChIP-qPCR
Chr10-248 chr10-248-ChiPqPCR-F CTCAAGGCAATATTTCTGTTCTCA ChIP-qPCR
Chr10-248 chr10-248-ChiPqPCR-R CACTTGGTTGGAAAGGTGC ChIP-qPCR
Chr1-191 chr1-191-ChiPqPCR-F GAGTGTGCCACCACATTCAG ChIP-qPCR
Chr1-191 chr1-191-ChiPqPCR-R GAGCCAGGAGTTTGAAACCA ChIP-qPCR
chr1-191-Co-5000 chr1-191-Co-5000-
ChiPqPCR-F
GCATTTTGCTACACTGACCACT ChIP-qPCR
chr1-191-Co-5000 chr1-191-Co-5000-
ChiPqPCR-R
CCACAAGTTTGGTGCTGTTC ChIP-qPCR
Chr12-169 chr12-169-ChiPqPCR-F TTTTATGTGATGGCACACAGG ChIP-qPCR
chr12-169-ChiPqPCR-R chr12-169-ChiPqPCR-R TTGTGCAGTTCATGCCCTAA ChIP-qPCR
chr1-2490-ChiPqPCR-F chr1-2490-ChiPqPCR-F GATCCTCCCACCACATTCC ChIP-qPCR
chr1-2490-ChiPqPCR-R chr1-2490-ChiPqPCR-R GGGAGACCCCATCTCTACAAA ChIP-qPCR
continued on the next page
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Target Name Sequence 5′-3′ Purpose
chr13-1-ChiPqPCR-F chr13-1-ChiPqPCR-F AGTGTTCTGGCGAGCAGTTT ChIP-qPCR
chr13-1-ChiPqPCR-R chr13-1-ChiPqPCR-R AACACACAATAGCTAAGACCCAAA ChIP-qPCR
chr1-436-ChiPqPCR-F chr1-436-ChiPqPCR-F GCATTGGTAAGGGCGACTAA ChIP-qPCR
chr1-436-ChiPqPCR-R chr1-436-ChiPqPCR-R CAGAAGAGTTGCGCTCACTG ChIP-qPCR
chr1-628-ChiPqPCR-F chr1-628-ChiPqPCR-F GCCTTGGAAATGGCAAATAG ChIP-qPCR
chr1-628-ChiPqPCR-R chr1-628-ChiPqPCR-R TGGACAGAGTTATGATGAAGAAAGA ChIP-qPCR
chr16-73-ChiPqPCR-F chr16-73-ChiPqPCR-F ACTCCACTTCCATGGGACAC ChIP-qPCR
chr16-73-ChiPqPCR-R chr16-73-ChiPqPCR-R TTTTCCTTGCAGCTCCATCT ChIP-qPCR
chr17-360-ChiPqPCR-F chr17-360-ChiPqPCR-F CTGCACCTGCATTACCAGAA ChIP-qPCR
chr17-360-ChiPqPCR-R chr17-360-ChiPqPCR-R AGCTGTAAGCCACCACAACC ChIP-qPCR
chr18-157-ChiPqPCR-F chr18-157-ChiPqPCR-F TTCCATTCATCGAATTCTTCAC ChIP-qPCR
chr18-157-ChiPqPCR-R chr18-157-ChiPqPCR-R TGAGCAACAAAGTCAACAAACA ChIP-qPCR
chr18-47-ChiPqPCR-F chr18-47-ChiPqPCR-F TCTTCTCTCCCGTAGCTCCTT ChIP-qPCR
chr18-47-ChiPqPCR-R chr18-47-ChiPqPCR-R GGGATTTACAAAACCCAACAAA ChIP-qPCR
chr19-32-ChiPqPCR-F chr19-32-ChiPqPCR-F ATTCTTTCAAAACCCACAACAATTA ChIP-qPCR
Chr19-32-ChiPqPCR-R Chr19-32-ChiPqPCR-R TGGGGATACCACAAATCCTG ChIP-qPCR
chr19-41-ChiPqPCR-F chr19-41-ChiPqPCR-F TGAGACAGGGTCTCGCTTTT ChIP-qPCR
chr19-41-ChiPqPCR-R chr19-41-ChiPqPCR-R AATCAAGGCTGCAGTGAACC ChIP-qPCR
chr20-189-ChiPqPCR-F chr20-189-ChiPqPCR-F CCTGCTCCATGTGTCTCTGA ChIP-qPCR
chr20-189-ChiPqPCR-R chr20-189-ChiPqPCR-R GCAACCTCCTCTTCCCAGTA ChIP-qPCR
chr20-189-Co-5000-ChiPqPCR-F chr20-189-Co-5000-
ChiPqPCR-F
TGCAGGTGAAAGTTTTGGTTT ChIP-qPCR
chr20-189-Co-5000-ChiPqPCR-R chr20-189-Co-5000-
ChiPqPCR-R
TGGGCAGAAATCATGTGAAA ChIP-qPCR
chr2-244-ChiPqPCR-F chr2-244-ChiPqPCR-F GGAACTCAGCTCAACATCAGGT ChIP-qPCR
chr2-244-ChiPqPCR-R chr2-244-ChiPqPCR-R CATAGTGCCATAGATGGTTCTCAA ChIP-qPCR
chr2-65-ChiPqPCR-F chr2-65-ChiPqPCR-F CACCCATGTTTTTAAACAAAACTTAAA ChIP-qPCR
chr2-65-ChiPqPCR-R chr2-65-ChiPqPCR-R TCAAGCATTGTTAAGGGAAGAAA ChIP-qPCR
chr2-82-ChiPqPCR-F chr2-82-ChiPqPCR-F CCACCACGTCTGGCTAATTT ChIP-qPCR
chr2-82-ChiPqPCR-R chr2-82-ChiPqPCR-R GCAGATGGATCACTTGAGGTC ChIP-qPCR
chr2-8-ChiPqPCR-F chr2-8-ChiPqPCR-F GTATGGCCCACCATAATTGC ChIP-qPCR
chr2-8-ChiPqPCR-R chr2-8-ChiPqPCR-R TTTTATGGGCTTTGGTGAGG ChIP-qPCR
chr3-119-ChiPqPCR-F chr3-119-ChiPqPCR-F TGCTTTCCCTTGAGCTAACC ChIP-qPCR
chr3-119-ChiPqPCR-R chr3-119-ChiPqPCR-R ATTCTGGGACCACATGGAAA ChIP-qPCR
chr3-47-ChiPqPCR-F chr3-47-ChiPqPCR-F ACCCCACTCCCCAAATCTAC ChIP-qPCR
chr3-47-ChiPqPCR-R chr3-47-ChiPqPCR-R TTCAGGCGCATTATACGTGA ChIP-qPCR
chr6-557-ChiPqPCR-F chr6-557-ChiPqPCR-F CTTCCTGATTCACGGTTGGT ChIP-qPCR
chr6-557-ChiPqPCR-R chr6-557-ChiPqPCR-R TTTAACTTTGTGGGGCCTTG ChIP-qPCR
chr8-271-ChIPqPCR-F chr8-271-ChIPqPCR-F GCAGAGCGTGGCTTAGTTTC ChIP-qPCR
chr8-271-ChIPqPCR-R chr8-271-ChIPqPCR-R GATCCGGGATTCTGCAGTTA ChIP-qPCR
chr8-84-ChiPqPCR-F chr8-84-ChiPqPCR-F GCCTGGCCACGTAATTGTAA ChIP-qPCR
chr8-84-ChiPqPCR-R chr8-84-ChiPqPCR-R TGGAGGAACATCCAGTGACA ChIP-qPCR
chrX-33-ChiPqPCR-F chrX-33-ChiPqPCR-F CCTCACCAAATAAACACAGGTCT ChIP-qPCR
chrX-33-ChiPqPCR-R chrX-33-ChiPqPCR-R TCTGTTTTGTGGATATTGGGGTA ChIP-qPCR
Control3-47-2000-ChiPqPCR-F Control3-47-2000-
ChiPqPCR-F
CGATCTGTTGCCTTAGGTTCA ChIP-qPCR
Control3-47-2000-ChiPqPCR-R Control3-47-2000-
ChiPqPCR-R
CCCCTGTGCCTTCTGAGTAGT ChIP-qPCR
Control3-47-6000-ChiPqPCR-F Control3-47-6000-
ChiPqPCR-F
CATCTCCCCACAACAGGTCT ChIP-qPCR
Control3-47-6000-ChiPqPCR-R Control3-47-6000-
ChiPqPCR-R
GAGAAGAGAGGGGGACCATC ChIP-qPCR
chr1-191-bChiPqPCR-F chr1-191-bChiPqPCR-F GGCTCAAGCAATCTGCCTAC ChIP-qPCR
chr1-191-bChiPqPCR-R chr1-191-bChiPqPCR-R ATACGGCATCTGTGCCAAG ChIP-qPCR
chr8-84-5000ChiPqPCR-F chr8-84-5000ChiPqPCR-F CCTTGTCAGAGGATTGCTGAA ChIP-qPCR
chr8-84-5000ChiPqPCR-R chr8-84-5000ChiPqPCR-R CAAGCACACACCCTAGAGCA ChIP-qPCR
chrX-33-5000ChiPqPCR-F chrX-33-5000ChiPqPCR-F TCACAGGCTGCATTAACAGC ChIP-qPCR
chrX-33-5000ChiPqPCR-R chrX-33-5000ChiPqPCR-R TTGTCTGCGCAATCTTTTTG ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 401_F TTCATCTTGGCAAATGCTGT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 51_F GCTACTCAGGCACACATAGGC ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 851_F TCTTCTCTCCCGTAGCTCCTT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 402_F CACTCAGGAGAACAATTTCACA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 52_F TCCTTTTCTCACTTAGACTTTCCA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 351_F AACAAGTTACCCTAAGACCGACTG ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 202_F TCTATCATGAGGGCTGACTTTTT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 1_F GAGGTTGCCAACACAAGCTA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 53_F TAGCTCAGTGGGGGAGAAGA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 101_F CATCATGCTGTATGGTGGAAA ChIP-qPCR
continued on the next page
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Target Name Sequence 5′-3′ Purpose
DAM-ID-Seq-Ago2-Targets 2_F GACATTAAGAAGGTTCATGTCATTTT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 402-Co_F CAAAGTCAATGGATTTGCTTTATTT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 53-Co_F TCAGTCCCCACCTGTGAAAT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 401_R TGTTTATCTGAAGGAGAGCAACAA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 51_R TGCAAATGAAGAGCAAGTTTGT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 851_R GGGATTTACAAAACCCAACAAA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 402_R AAGCCAAATAATCATTTCTTTTAATC ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 52_R TTCAAAGTGCCTAGGGATTCA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 351_R TCAGATACCAAGTGGAATAGGTG ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 202_R TTTTGCAGTTTCGGTGTTGA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 1_R TGTGCCCTAGGATTCCTCAC ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 53_R GCCAGTTGCACAGCATACAT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 101_R GAGTGGTGAAAGTGGGCATC ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 2_R TGTTTGATGCTGGACATTGTT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 402-Co_R TGCCTGGCTAAATCCTTTCT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 53-Co_R GTGACCTCCTTGCTGGAGAC ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 351-U1-F GCTTCCCAGAAAACATACGG ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 351-U1-R tttcctgtctgcaggcttgt ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 351-U2-F CCATTGGGCTGGTAGGATAA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 351-U2-R GCACTCAGAACATCCAAGCA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 351-U3-F TCACAGATTTCAAGCCTCAAGTT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 351-U3-R CTTACGGGATTGGGTGCTT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 351-U4-F AAAATATTTGTGGCAGGCAGA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 351-U4-R GACCCTCAATTGTTGTGTTGG ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 351-IN2-F catgtgctcaacaggtacgc ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 351-In2-R ctttctgtgatgatggaaatgtt ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 351-D1-F AGCTAGCCTGGCCTAGAAGG ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 351-D1-R CCTGATAACCCCAGACAGGA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 351-D2-F TTGACTAATCACTGCTCCCAAA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 351-D2-R GAAAACGTCCCTGGGAAAAT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 351-D3-F GATAATCAGGGGCAACAGGA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 351-D3-R TCTTCTCAACCTGGTGTGTATGA ChIP-qPCR
DAM-ID-Seq-DAM-Targets DAM-P1-F CAGCTAAGCCTCCATTCCTG ChIP-qPCR
DAM-ID-Seq-DAM-Targets DAM-P1-R CTCCTTGTCTGGCTGGGATA ChIP-qPCR
DAM-ID-Seq-DAM-Targets DAM-P2-F ACAGCACAGGCAAGGTTTTT ChIP-qPCR
DAM-ID-Seq-DAM-Targets DAM-P2-R AGCAGCCACCTAGATTTCCA ChIP-qPCR
DAM-ID-Seq-DAM-Targets DAM-Co1-F TCCAAACCAGTAAATGAGCAAA ChIP-qPCR
DAM-ID-Seq-DAM-Targets DAM-Co1-R CCTTCAAAGGGAGGTTGTGA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 401-U1-F ATGCCCAGCCGTATGTTTTA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 401-U1-R CCACTCAAATGAGGGGTGTT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 401-IN2-F acagctggctagtgcgtacc ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 401-IN2-R gcctggagaccaagagacag ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 401-IN3-F gctttgggacctggtgtaga ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 401-IN3-R AAGGGAACCATCCAAGGACT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 401-D1-F CCACCACACCTGGCTAATTT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 401-D1-R AGGTGGGTGAATCGTCTGAG ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 401-D2-F ATTTCTGCATGACTGCACCA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets 401-D2-R GGCACCCAATTTTCCTTTTT ChIP-qPCR
DAM-ID-PCR-Cloning Ago2-clBaC3-1-F TGGACACAGCTGGGATTACA ChIP-qPCR
DAM-ID-PCR-Cloning Ago2-clBaC3-1-R GAGTTCGAGACCAGCCTGAC ChIP-qPCR
DAM-ID-PCR-Cloning Ago1-clBaC1-1-F AGCTTGGCGTAATCATGGTC ChIP-qPCR
DAM-ID-PCR-Cloning Ago1-clBaC1-1-R TTTATGCTTCCGGCTCGTAT ChIP-qPCR
DAM-ID-PCR-Cloning ChrM-12754F ACTGTTCATCGGCTGAGAGG ChIP-qPCR
DAM-ID-PCR-Cloning ChrM:12852R ATTGCTTGAATGGCTGCTGT ChIP-qPCR
DAM-ID-PCR-Cloning Ago1-Mito2F GGCTCACATCACCCCATAAA ChIP-qPCR
DAM-ID-PCR-Cloning Ago1-Mito2R AACTCACTGGAATGGGGATG ChIP-qPCR
DAM-ID-PCR-Cloning Ago1-Mito3F AAATCTTACCCCGCCTGTTT ChIP-qPCR
DAM-ID-PCR-Cloning Ago1-Mito3R CTACCTTTGCACGGTTAGGG ChIP-qPCR
DAM-ID-PCR-Cloning Ago2-8108-F AATTCCCGGACGTCTAAACC ChIP-qPCR
DAM-ID-PCR-Cloning Ago2-8205-R TGAAACTGTGGTTTGCTCCA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets ChrM-13247-f TTCTCCACTTCAAGTCAACTAGGAC ChIP-qPCR
DAM-ID-Seq-Ago2-Targets ChrM-13247-r CTTTGAAGAAGGCGTGGGTA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets chrM-13762-f ATCCCCCTTCCAAACAACA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets ChrM-13762-r TGGTTAGGTAGTTGAGGTCTAGGG ChIP-qPCR
DAM-ID-Seq-Ago2-Targets ChrM-14253-f CCAATAGGATCCTCCCGAAT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets chrM-14253-r GGGTGGTGGTTGTGGTAAAC ChIP-qPCR
DAM-ID-Seq-Ago2-Targets chrM-8515-f CCTGAGAACCAAAATGAACGA ChIP-qPCR
continued on the next page
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DAM-ID-Seq-Ago2-Targets chrM-8515-r CAGTACTGCGGCGGGTAG ChIP-qPCR
DAM-ID-Seq-Ago2-Targets chrM-8959-f CGAAACCATCAGCCTACTCA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets chrM-8959-r AGGTGGCCTGCAGTAATGTT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets chrM-9515-f CACTCCAGCCTAGCCCCTAC ChIP-qPCR
DAM-ID-Seq-Ago2-Targets chrM-9515-r GAGTGGGACTTCTAGGGGATTT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets chrM-7539-f GAAAAACCATTTCATAACTTTGTCA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets chrM-7539-r GCTGCATGTGCCATTAAGAT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets chr1:24611176-f CCTGCACAATTGTTGTCTCG ChIP-qPCR
DAM-ID-Seq-Ago2-Targets chr124617731-r CCATGGGCTGGTTAGTCAAT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets chrM-6300-f gtgatgatgtgaggccatgt ChIP-qPCR
DAM-ID-Seq-Ago2-Targets chrM-11139-r gcaaccctacacggaggtaa ChIP-qPCR
DAM-ID-Seq-Ago2-Targets Ago1-c1-226144392 AGCTGCAGACCCACAACTTT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets Ago1-c1-226144395 TTCTATTTGGACAATCCACAGATTT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets Ago2-chrM-6905 CACACTCCACGGAAGCAATA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets Ago2-chrM-6908 GCCACCTACGGTGAAAAGAA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets Ago2-chrM-1229 GCTAAGACCCAAACTGGGATT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets Ago2-chrM-1232 AGTGTTCTGGCGAGCAGTTT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets Ago2-c2-46623686 TCATAGAGAAAAACTGGGTGTGAG ChIP-qPCR
DAM-ID-Seq-Ago2-Targets Ago2-c2-46623689 GATTTACAGAAAAATTGCAAAAATCA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets Ago2-chrM-3660 ATGGCCAACCTCCTACTCCT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets Ago2-chrM-3663 GAATTTTTCGTTCGGTAAGCA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets Ago2-chrM-15592 GCCCTCGGCTTACTTCTCTT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets Ago2-chrM-15595 GTCGCCTAGGAGGTCTGGT ChIP-qPCR
DAM-ID-Seq-Ago2-Targets Ago2-chrM-953 CCCCTCCCCAATAAAGCTAA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets Ago2-chrM-956 TCAGATATGTTAAAGCCACTTTCG ChIP-qPCR
DAM-ID-Seq-Ago2-Targets Ago2-chrM-1001 CCAGTTGACACAAAATAGACTACGA ChIP-qPCR
DAM-ID-Seq-Ago2-Targets Ago2-chrM-1102 GGGCTAAGCATAGTGGGGTA ChIP-qPCR
Ago2 Ago2-seq2 ACCGTGTCTGCAATGTGAC Sequencing
Ago3 Ago2-seq3 GGCCATTGCGTGCTTC Sequencing
Ago4 Ago2-seq4 TGCGCGTGCAGCAG Sequencing
Ago5 Ago2-seq5 CGAGTTCGACTTCTACCTG Sequencing
VP5-DamV5-Fw ACTGGCGCGCCCAATTCAGATCTCGGCCGCA Cloning pIRES-Neo
VP5-DamV5Ago2-Rev GATGCGGCCGCTCTCGATCGTAGAATCGAGAC Cloning pIRES-Neo
VP5-DamV5-Stop-Rev ACAGAATTCTCACTCGATCGTAGAATCGAGAC Cloning pIRES-Neo
DHFR DHFR-F-SalI gtagtcgac ATGGTTGGTTCGCTAAACTG Cloning pGEM-Teasy
DHFR DHFR-R-NdeI tagcatatgTTAATCATTCTTCTCATATACTTCAAAT Cloning pGEM-Teasy
Ago2 Ago2_1-F-SacII att ccgcgg ATGTACTCGGGAGCCGGC Cloning pGEM-Teasy
Ago3 Ago2_222-R-SpeI tgtactagtcGATTTCCCTGTTAACTCTCCTC Cloning pGEM-Teasy
AdRT AdRT ctaatacgactcactatagggcagcgtggtcgcggccgagga DAMID
AdRb AdRb tcctcggccg DAMID
AdPCR AdPCR ggtcgcggccgaggatc DAMID
Ago2-attB1-F Ago2-attB1-F GGGGacaagtttgtacaaa aaa gca ggc t tc-
ATGTACTCGGGAGCCGGCCCCGCAC
GatewayCloning
Ago2-attB1-R Ago2-attB1-R gggaccactttgtacaagaaagctgggtTCAAGCAAA-
GTACATGGTGCGCAG
GatewayCloning
Ago1-attB1-F Ago1-attB1-F GGGGacaagtttgtacaaa aaa gca ggc t tc A-
TGGAAGCGGGACCCTCGGGAG
GatewayCloning
Ago1-attB1-R Ago1-attB1-R gggaccactttgtacaagaaagctgggtTCAAGCGAAG-
TACATGGTG
GatewayCloning
Ago3-attB1-F Ago3-attB1-F GGGGacaagtttgtacaaa aaa gca ggc t tcAT-
GGAAATCGGCTCCGCAGGAC
GatewayCloning
Ago3-attB1-R Ago3-attB1-R gggaccactttgtacaagaaagctgggt TTAAGCGAA-
GTACATTGTGCGTAAG
GatewayCloning
Ago4-attB1-F Ago4-attB1-F GGGGacaagtttgtacaaa aaa gca ggc t tc AT-
GGAGGCGCTGGGACCCGGACCTC
GatewayCloning
Ago4-attB1-R Ago4-attB1-R gggaccactttgtacaagaaagctgggt TCAGGCAAAA-
TACATCGTGTGCTG
GatewayCloning
Illumina Adapter PE PCR Primer 1.0 AATGATACGGCGACCACCGAGATCTACACT-
CTTTCCCTACACGACGCTCTTCCGATCT
qPCR
Illumina Adapter PE PCR Primer 2.0 CAAGCAGAAGACGGCATACGAGATCGGTCT-
CGGCATTCCTGCTGAACCGCTCTTCCGATCT
qPCR
Illumina Adapter PE Read 1 SeqNP GATCTACACTCTTTCCCTACACGAC qPCR
Illumina Adapter PE Read 2 SeqNP GTCTCGGCATTCCTGCTG qPCR
RPPH1-F1 RPPH1-F1 CAGCGAAGTGAGTTCAATGG qPCR
RPPH-R2 RPPH-R2 aatgggcggaggagagtagt qPCR
GAG-F1 GAG-F1 ggagctagaacgattcgcagtta qPCR
GAG-R1 GAG-R1 ggttgtagctgtcccagtatttgtc qPCR
GAPDH RV GAPDH-R CGCCCCACTTGATTTTGG RT-qPCR
continued on the next page
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Target Name Sequence 5′-3′ Purpose
GAPDH FW GAPDH-F AATGGAAATCCCATCACCATCT RT-qPCR
Ago1 Ago1 qPCR-fwd tttcctggtttcccactagg RT-qPCR
Ago2 Ago1 qPCR-rev aaccaccaccttctccagtc RT-qPCR
Ago3 Ago2 qPCR-fwd cgtggtcatgaggcacttgcca RT-qPCR
Ago4 Ago2 qPCR-rev gatggaagccaaaccacacttc RT-qPCR
MultiBac MCS1 GGTACCGCATGCTATGCATCAGCTGC Sequencing
Multibac LP14rev TCATTTTATGTTTCAGGTTCAGGG Sequencing
MultiBac/pFL LP6for AAATGATAACCATCTCGCAAATAAA Sequencing
HILI Seq 4 HILI Seq 4 fwd ATCTCACCCTCACAAAATGGTATT Sequencing
HILI Seq 1 HILI Seq 1 fwd GTGGTATCAGCAGAGAAGTGGAC Sequencing
HILI Seq 2 HILI Seq 2 fwd CTAGCATCCGAAGGACAGATG Sequencing
HILI Seq 3 HILI Seq 3 fwd CAAAAGGATGTACATAAGATTGAAGGAC Sequencing
HILI Seq 506 HILI Seq 506 rev TTGTCCACTTCTCTGCTGAT Sequencing
HIWI Seq1 HIWI Seq1 AAAAACAGGTTCTTCAGGCATT Sequencing
HIWI Seq2 HIWI Seq2 AACAATAAGACATACAGAGTGGATGA Sequencing
HIWI Seq3 HIWI Seq3 TGAAGCAGCCAATTCATTGAT Sequencing
HIWI Seq4 HIWI Seq4 CCAGCTGAAAACACTGGTGA Sequencing
HIWI Seq (455) HIWI Seq (455) TGAAAAAGAAGAGCTGAACG Sequencing
HIWI2 (488) HIWI2-seq1 GGTGCCATCCTTTTTCTGTCAC Sequencing
HIWI2 (1002) HIWI2-seq2 ATGGCACCGAGATCACCTATG Sequencing
HIWI2 (1522) HIWI2-seq3 GAACTGCTTGAGAAGAGTTGCAG Sequencing
HIWI2 (2088) HIWI2-seq4 TGCTGGTGTAGGGGATGGTCAG Sequencing
VP5 VP5-Seq-F CGAAATTAATACGACTCACTATAG Sequencing
VP5 VP5-Seq-R CCCAACAGCTGGCCCTCGCAGA Sequencing
Ago3 Ago3-seq1 TTCTCCGCTCCAGAÂ Â AGGATA Sequencing
Ago3 Ago3-seq2 GTAATATTGTGGCAGGGCAAC Sequencing
Ago3 Ago3-seq3 TATTATCÂ Â GTCATCCTGCÂ Â CGG Sequencing
Ago3 Ago3-seq4 AGAAÂ Â GCCTGCATCAÂ Â GTTTGGA Sequencing
Ago4 Ago4-Seq1 GGTCTGGTTTÂ Â GGTTTTCATCÂ Â A Sequencing
Ago4 Ago4-Seq2 AAGCÂ Â TACAGCAAGAÂ Â TCTGCTCC Sequencing
Ago4 Ago4-Seq3 TGAAACGTGTÂ Â TGGAGATACCÂ Â C Sequencing
Ago4 Ago4-Seq4 CAGÂ Â GTAGCTTGGC 2051Â Â CAGAACT Sequencing
universal R-Gerhard caggaaacagctatgac Sequencing
Ago1 Ago1 Seq1 CCTGGATGTGGCCATGAG Sequencing
Ago1 Ago1 Seq2 CAGACAGACAGGAGGAGATCAG Sequencing
Ago1 Ago1 Seq3 CTGGGAGCAGATGTTACACAC Sequencing
pLGW-DAM_SEQ CAAGTAAATCAACTGCAACTACTG Sequencing
DAMseq DAMseq GCTGACTAGGGAGTGGTATCAG Sequencing
Table 2.4: Oligonucleotides used in this work
2.4.2 Plasmids
Name Insert Backbone Source
pIRESneo-EcoDAM-V5-
Ago2
HSP-EcoDam-V5-Ago2 pIRESneo this work
pIRESneo-EcoDAM-V5 HSP-EcoDam-V5 pIRESneo this work
pFastBac HT A Ago1 Ago1 pFastBac HT A lab stock
pFastBac HT A Ago2 Ago2 pFastBac HT A [Pfaff et al., 2013]
pFastBac HT A HILI HILI pFastBac HT A lab stock
pFastBac HT A HIWI HIWI pFastBac HT A lab stock
pFastBac HT A HIWI2 HIWI2 pFastBac HT A lab stock
pGEM-T-Easy pGEM-T-Easy Promega
pLGW-EcoDam-V5-
ccdB
EcoDam-V5-ccdB pLGW [Vogel et al., 2007]
pLGW-V5-EcoDam V5-EcoDam pLGW [Vogel et al., 2007]
pLGW-Cbx1-V5-
EcoDam
Cbx1-V5-Dam pLGW [Vogel et al., 2007]
continued on the next page
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Name Insert Backbone Source
pLGW-EcoDam-V5-
Ago1
EcoDam-V5-Ago1 pLGW this work
pLGW-EcoDam-V5-
Ago2
EcoDam-V5-Ago2 pLGW this work
pLGW-EcoDam-V5-
Ago2-Y529E
EcoDam-V5-Ago2-Y529E pLGW this work
pLGW-EcoDam-V5-
Ago3
EcoDam-V5-Ago3 pLGW this work
pLGW-EcoDam-V5-
Ago4
EcoDam-V5-Ago4 pLGW this work
pIRESneo-FlagHA-
Ago1
Flag-HA-Ago1 pIRESneo [Meister et al., 2004]
pIRESneo-FlagHA-
Ago2
Flag-HA-Ago2 pIRESneo [Meister et al., 2004]
PIRESneo-FlagHA-
Ago2-Y529E
Flag-HA-Ago2-Y529E pIRESneo [Rüdel et al., 2011]
psPAX2 HIV-GAG, GAG-Pol psPAX2 gift Nevels, Regens-
burg/Trono Lab
pMD2G VSV-G pMD2G gift Nevels, Regens-
burg/Trono Lab
pET-28a-Ago1 Ago1 pET-32 lab stock
pET-28a-Ago2 Ago2 pET-32 lab stock
pGem-Teasy-Ago2-∆C-
DHFR
Ago2-∆C-DHFR pGem-Teasy this work
Table 2.5: Plasmids used in this work
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Chapter 3
Methods
3.1 Working with Bacteria
The amount of bacterial cells is frequently referred to in OD600 where 1 OD600
equals about 107 cells. E. coli and mammalian cell specific shuttle vectors were
cloned using the bacteria strain E. coli XL1-blue. Bacteria were grown at 37 ◦C in
LB media containing the required selection.
Genotype: recA1 endA1 gyrA96 thi−1 hsdR17 supE44 relA1 lac [ F° proAB lacIq
ZδM15 Tn10 (Tet r)].
3.1.1 Preparation of Chemical Competent Cells
E. coli cells were grown overnight in SOB medium (50 ml) with respective an-
tibiotics at 37 ◦C. On the following morning a culture (200 ml) was inoculated at
0.2 OD600 and grown to 0.5 OD600. After harvesting the cells at 4500 rpm for 10
minutes at 4 ◦C, the cell pellet was resuspended in Tfb I (15 ml per 50 ml of liquid
culture) and incubated on ice for 20 minutes. The cells were again collected by
centrifugation and dispersed in Tfb II (4ml per 200ml of bacterial culture). Finally,
the cells are incubated on ice for another 10 to 20 minutes, aliquoted (50 µl per
transfection) and snap frozen in liquid nitrogen. The chemical competent cells
are stored at -80 ◦C.
3.1.2 Transformation of E. coli by Heat Shock
Chemical competent E. coli were thawn on ice for 10 minutes, mixed with plas-
mid DNA and incubated for 30 minutes at 4 ◦C. The DNA was transferred into
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the bacteria by a heat shock (45 seconds) applied in a 42 ◦C waterbath. Immedi-
ately afterwards, the cells were cooled down on ice for 3 minutes. For recovery
and expression of the antibiotic resistance gene, bacteria were grown at 37 ◦C for
1 hour and plated on a Petri dish containing LB mixed with the respective antibi-
otic.
3.2 Working with Insect Cells
For recombinant protein expression Sf21 insect cells were used. This cell line orig-
inated from the IPLBSF cell line, which derives from the pupal ovarian tissue of
the fall army worm, Spodoptera frugiperda [Vaughn et al., 1977]. The advantage
of insect cells lays in their ability of posttranslational modification of proteins,
which is absent in /coli/. Furthermore,proteins are fully processed and targeted
to their subcellular locations [Invitrogen, 2000]. Sf21 cells were grown in Gibco
SF900 medium (Thermo Scientific) either adherent in a 6 well plate or in suspen-
sion cultures of 0.3− 2.0 ∗ 106cells/ml at 27 ◦C shaking at 100 rpm.
3.2.1 Sub-culturing Insect Cells
When the culture reached a density of 2 ∗ 106cells/ml, it was diluted in growth
insect growth medium. The culture flask was changed every other week as the
cells attached to the surface [Fitzgerald et al., 2006].
3.2.2 Freezing of Insect Cells
Cells from a 100 ml Sf21 suspension culture were collected by centrifugation at
136 ×g for 10 minutes and resuspended in freezing medium (Sf900 Medium sup-
plemented with 10%FBS and 10% DMSO) at 60 ∗ 106cells/ml and aliquoted to
freezing tubes [Fitzgerald et al., 2006]. The cells were frozen by storing them for 1
hour at -20 ◦C in an isopropanol filled freezing container, followed by incubation
overnight at -80 ◦C. Eventually the cells were stored in liquid N2.
3.2.3 Thawing of Insect Cells
Pre-warmed medium (60 ml) was transferred into a new culture flask. Frozen
cells were collected form the N2 freezing container and quickly thawn in a 37 ◦C
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waterbath. After dispersion of the nearly thawn cells in pre-warmed medium,
the culture was grown for three days to ensure proper division of cells before
they were used for virus preparation [Fitzgerald et al., 2006].
3.2.4 Transfection of Insect cells for Virus Production
The Baculovirus protein expression system usually uses the Autographa califor-
nica nuclear polyhedrosis virus (AcNPV) as vector, which belongs to the family of
Baculovirdiae [Berger et al., 2004]. This virus contains a double stranded circular
DNA genome and employs two different infectious viral particles. During the
late phase of infection (18 to 36 hours after infection), a membrane surrounded
viral particle buds from the cell to infect the surrounding tissue. The second form
is produced from 24 to 96 hours post infection and consists of virions embedded
in a crystalline polyhedra matrix [Invitrogen, 2000], which is released by cell ly-
sis. For expression of recombinant proteins the strong promoters of polyhedra
matrix genes are exploited. This leads to high levels of protein production dur-
ing the very last phase of infection [Okano et al., 2006]. In addition to this also
the budded form of the virus (budded virus, BV) is used. After harvesting the
BV from the medium, between 18 and 36 hours, this highly infectious virus is
employed for efficient infection of Sf21 cells for high level protein production.
3.2.5 Reconstitution of the Baculovirus
Insect cells were seeded in a 6-well plate 0.5 ∗ 106 cells per well and transfected
with freshly prepared bacmid (see Section 3.4.3). For the transfection reaction
the lipofectant Fugene ® HD (10 µl, Promega) diluted in insect medium (100 µl)
was mixed with bacmid DNA (20 µl) in medium (200 µl), incubated at 25 ◦C for
15 minutes and dispersed equally on two wells of the 6-well plate. The cells
were grown for 48 hours to produce viral particles. This could by monitored by
fluorescence microscopy due to the YFP integrated into the MultiBac [Fitzgerald
et al., 2006].
3.2.6 Harvesting of V0 Virus Stock
During the late phase of the infection (24 - 48 hours) membrane coated viral
particles were harvested by collecting the culture medium. The infection was
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controlled by fluorescence microscopy detecting the expression of YFP, which is
encoded in the genetically modified viral genome. After another 48 hours of in-
cubation in fresh medium, the cells were harvested (2 wells), lysed in PBS (500 µl)
combined with 20 pulses of sonication (duty cycle: 50%, output: 1.5, microtip).
To examine the expression of the recombinant protein SDS-PAGE or WB (see Sec-
tion 3.5.3, 3.5.5) was used.
3.2.7 Creating a High Titre V1 Virus Stock
An optimal viral infection is achieved, when the targeted cells arrest their cell
cycle shortly after exposure to the virus [Fitzgerald et al., 2006]. However, as the
virus contains many repetitive sequences, promoters, terminators and recombi-
nation sites, special care must be taken to keep the multiplicity of infection (MOI)
during virus production at 1. This is one infectious virus per cell. Otherwise,
several viral genomes accumulate in one cell and recombination occurs, which
results in defective viruses and loss of protein production [Fitzgerald et al., 2006].
Thus, different dilutions of the V0virus stock produced, were taken to infect sus-
pension cultures of insect cells (50 mlat 1 ∗ 106cells/ml). In case several of these
infection conditions resulted in a growth arrest, the one with the lowest viral
concentration was chosen to prevent over infection of the cells. Then the viral
particles from this condition were harvested 24 hours after the cell cycle arrest,
to gain a highly concentrated virus stock in the supernatant of the used culture.
Subsequently, the best concentration for infection by the V1 virus was determined
using above mentioned titration method. Using these cultures, it was also possi-
ble to monitor the production rate of the recombinant protein during the next 48
hours by SDS-PAGE or UV-spectrophotometric measurements of YFP.
3.2.8 Expression of Recombinant Proteins
For protein production large cultures of SF21 cells (two times 600 ml) were inoc-
ulated and infected with the required amount of V1 virus stock (see above). The
cells were harvested at the time point when most of the recombinant protein was
expressed ( 60 hours after growth arrest), which is during the very late phase of
the infection with these modified baculoviruses [Fitzgerald et al., 2006].
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3.3 Methods for Culturing Mammalian Cells
Human cells used in this study are HeLa, HEK293, H1299, HeLaS3, MRC-5. All
cells were grown in DMEM supplemented with FBS (10 %) and P\S (1 %), which
will be referred to as medium, in a CO2 chamber at 37 ◦C with evaporation driven
humidity level. Mouse cells (mESCs) were cultured in DMEM (Invitrogen), con-
taining 15% of a special selected batch of fetal bovine serum (FBS; Life Technolo-
gies) tested for optimal growth of mESCs, 1000 U/ml LIF (Millipore), 0.1 mM
2-β-mercaptoethanol (Life Technologies), 0.05 mg/mL of streptomycin, and 50
U/mL of penicillin (Sigma) on a gelatin coated support in the absence of feeder
cells. The mouse cells were grown by C.Constance at ETH Zürich.
3.3.1 Sub-culturing of Adherent Cells
To dissociate the cells from the culture dish (15 cm), these were washed with PBS
(18-20 µl) to deplete Ca2+ ions from the bonds of the cell to the surface of the
plate. Then Trypsin (3-4 ml) was used to digest the cells attachments at 37 ◦C,
followed by addition of medium (6-8 ml) to stop the reaction. Then the cells were
diluted according to experiment and growth behaviour of the cell line and spread
on new culture plates.
3.3.2 Freezing of Mammalian Cells
Cells were collected by centrifugation at 200 ×g for 10 minutes and gently resus-
pended in freezing medium (DMEM Medium supplemented with 10% FBS and
20% DMSO) and aliquoted to freezing tubes. The cells were frozen by storing
them for 1 hour at -20 ◦C in an isopropanol filled freezing container, followed by
incubation overnight at -80 ◦C. Eventually the cells were stored in liquid N2.
3.3.3 Thawing Mammalian Cells
Pre-warmed medium was transferred into a 15 mlFalcon tube. Frozen cells were
collected form the N2 freezing container and quickly thawn in a 37 ◦C waterbath.
After dispersion of the nearly thawn cells in pre-warmed medium, the tube was
centrifuged at 200 ×g for 10 minutes. The cell pellet was carefully dissipated and
spread on new 10 (15) cmculture plate pre-filled with 10 (25) mlof medium.
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3.3.4 Collagen Coating of Culture Dishes
The adherence of some cell lines i.e. HEK293 to the tissue culture plate can be
increased by coating the plates with collagen. A mixture of collagen (final con-
centration 50 µg/ml) in sterile filtrated acetic acid (20 mM) was applied to clean
culture dishes (5 ml per 10 cm plate) and incubated on a shaker at RT for two
hours. Then unbound collagen was removed by washing step with PBS and two
washes with sterile water. Then the plates were dried under the hood for 1 hour,
stored at 4 ◦C or used immediately.
3.3.5 Plasmid Transfection of Cells
To analyse expression level, localisation or function of a tagged exogenous pro-
teins, mammalian expression vector in combination with the easy transfectable
HEK293 cells were used. HEK293 cells were seeded at 40 % confluence (10 cm
plate) one day ahead of transfection. One hour before treatment the growth
medium was renewed. Then the cells were transfected by calcium phosphate
co-precipitation [Green and J. [2012]]. The expression plasmid (10 µg) and CaCl2
(125 mM) were combined in water (ad 500 µl). While vortexing this solution, 2×
HPS (500 µl 140 mM NaCl, 1.5 mM Na2,HPO4, 50 mM Hepes-NaOH pH 7.0) was
added drop wise, resulting in formation of tiny DNA containing crystals. After-
wards, the suspension was incubated at RT for 15 minutes and was slowly and
carefully applied to the cells. The cells were moved to a growth cabinet overnight
and incubated for 24 to 72 hours.
3.3.6 Transfection of Mammalian Cells with siRNA
Transfection of cells with siRNAs leads to a transient knock down of the target
protein, which is a vital tool for determining the role and function of a protein. Be-
fore siRNA transfection single stranded siRNAs, the sense and antisense strand
(40 µM) were mixed, diluted two fold in siRNA annealing buffer () and annealed
by 95 ◦C for 1 minute followed by 25 ◦C for 1 hour. Annealed siRNA (20 µM) were
stored at -80 ◦C. For transfection the respective cells (1 ∗ 105) were dispersed in a
6 well plate one day before transfection. SiRNA (5 - 50 nM final concentration)
were mixed with Optimem Medium (250 µl), RNAimax (3 µl) was dissolved in
Optimem Medium (250 µl) in a separate tube. Then both solutions were mixed
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and incubated for 15 minutes at RT. When the nucleic acid filled lipofectant vesi-
cles had formed, the suspension was carefully applied to the cells.
3.3.7 Production of Lentiviruses
To produce lentiviruses HEK293T cells were used as a host for production as
suggested by the group of Bas v. Steensel [Vogel et al., 2007]. HEK293T cells were
seeded at 40 % confluence (10 cm plate) one day ahead of transfection. One hour
before treatment the growth medium was renewed. Then the cells were trans-
fected by calcium phosphate co-precipitation [Green and J., 2012]. In order to
reconstitute viral particles, the envelop plasmid pMD-2G (3 µg), the packaging
plasmid psPAX2 (8 µg), the flanking LTR and insert containing transfer vector
pLGW-X (10 µg) and CaCl2 (125 mM) were combined in water (ad 500 µl) [Vogel
et al., 2007]. While vortexing this solution, 2× HPS (500 µl 140 mM NaCl, 1.5
mM Na2,HPO4, 50 mM Hepes-NaOH pH 7.0) was added drop wise, resulting in
formation of tiny DNA containing crystals. Afterwards, the suspension was incu-
bated at RT for 5 minutes and was slowly and carefully applied to the cells. The
cells were moved to a growth cabinet overnight. Following replacement of the
medium (6 ml), the cells were left to grow for another 24 hours. On the next three
days the virus is harvested. The virus containing cell supernatant was filtered
through a 0.45 µm filter into a fresh Falcon tube and replaced by fresh medium
(6 ml). The filtered virus containing solution was stored at 4 ◦C. After the final
virus harvest the filtered supernatants are combined, aliquoted in 1 ml fractions
and stored at -70 ◦C.
3.3.8 Infection of Tissue Culture Cells with Lentiviral Particles
For stable and high efficiency integration of a target gene into the cell genome,
lentiviral transduction was used. Cells (4 ∗ 105 per well) were seeded on a 6 well
plate and grown overnight. On the following day lentivirus stocks were quickly
thawn and mixed 1:2 with pre-warmed medium (0.9 ml). After aspiration of the
growth medium from the cells, the virus dilution (1.5 ml) was added. The cells
were incubated for 24 hours in the presence of the virus. Then the medium was
replaced and the cells were grown for another 48 hours. After this time the cells
were harvested and genomic DNA was isolated.
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3.3.9 Creation of Stably Transfected Mouse Cell Lines
The male E14 WT mESC line (129/Ola background) [Hooper et al., 1987] was
used to create E14-DAM-ID independent mESCs clones by stable transfection
of plasmids pIRESneo-EcoDAM-V5 (HSP-EcoDam-V5) and pIRESneo-EcoDAM-
V5-Ago2 (HSP-EcoDam-V5-hAGO2) and selection on G418-containing medium.
Screening has been done by QPCR on hAGO2 mRNA level. Two independent
clones for each plasmid were selected and amplified before DNA extraction. This
work was done by C.Ciaudo (ETH Zürich).
3.4 Genetic and Molecular Techniques
3.4.1 Purification of Plasmid DNA Using Affinity Columns
For column purification of plasmid DNA the Plasmid Kit of Macherey-Nagel was
used. For large amounts of plasmid DNA the Midi Kit of Macherey-Nagel was
used.
3.4.2 Production of recombined Bacmid
Chemical competent DH10MultiBac-YFP [Berger et al., 2004] bacteria were trans-
fected with a pFastBac HT A vector (Invitrogen), carrying the target gene in the
MCS, preceded by a 6× His-tag. During transfection the pFastBac vector re-
combined with the Baculo virus Bacmid via Tn7 recombination sites. After the
heat shock, the bacteria were grown in LB medium without selection marker at
37 ◦C overnight. On the next morning the transfected cells were spread on LB (10
µg/ml Gentamycin, 50 µg/ml Kanamycin,10 µg/ml Tetracyclin,0.5 mM IPTG,
100 µg/ml X-Gal) plates to select for white colonies after 24 hours at 37 ◦C. The
positive clones were re-streaked on another LB (Gentamycin, Kanamycin, Tetra-
cyclin, IPTG, X-Gal) plate to confirm the blue white screening result. Positive
clones were used for bacmid isolation and reconstitution of Baculovirus in SF21
insect cells [Fitzgerald et al., 2006].
3.4.3 Purification of Bacmid DNA
An overnight culture (2 ml) of successfully transfected DH10MultiBac cells was
grown in the respective selection medium. After collection of the cells, these were
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resuspended in buffer P1 (300 µl) containing RNAase A, followed by alkalic lysis
using P2 (200 µl) and neutralized after exactly 5 minutes with P3 (200 µl). The
white, denatured protein mass was pelleted by 11,000 ×g for 10 minutes at 4 ◦C.
The Bacmid DNA in the supernatant was precipitated using isopropanol (600 µl)
at 11,000 ×g for 30 minutes and 4 ◦C. The pellet was washed in ethanol (1 ml, 75
%), followed by a second wash with ethanol (50 µl, 75%). This volume was left
on the DNA till it was transferred to the clean bench for transfection into insect
cells.
3.4.4 Purification of DNA form Cultured Cells
The extraction of mammalian DNA from cultured cells was performed using the
Blood and Tissue Kit form Qiagen with the following adaptations. The RNase
digest was included in step 2 from the isolation procedure. The elution was per-
formed twice with 200 µl buffer AE into a 2 ml tube. Followed by concentration
of the DNA by Ethanol Precipitation.
3.4.5 Purification of RNA form Cultured Cells
For the purification of RNA from cultured mammalian cells the Trizol Reagent of
Life Technologies was used, according to manufacturers recommendations.
3.4.6 Measurement of Concentration and Purity of Nucleic Acid
Solutions
The concentration of DNA/RNA solutions was measured with the Nanodrop
UV-spectrophotometer. Therefore the extinction E at 260 and 280 nm was esti-
mated. For double stranded DNA the calculation was based on the correlation
E260 = 1 equals 50 µg/ml. For RNA the calculation was based on E260 = 1 equals
40 µg/ml. The purity of a nucleic acid can be assessed by the quotient E260/E280,
which should resemble values 1.8 for clean DNA and 2.0 for clean RNA.
3.4.7 Restriction Digest of DNA
All restriction digests were performed according to the following basic protocol:
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basic reaction mix: DNA 0.5-1 µg
(20 µl) 10x restriction buffer 2 µl
restriction enzyme 0.5 µl
H2O ad 20 µl
The specific buffer and temperature conditions and, furthermore, the inactivation
method were chosen according to the enzyme properties described by the manu-
facturer (Thermo Scientific/NEB). The incubation time was 1-2 hours. For larger
quantities of DNA fragments the digests was scaled accordingly.
3.4.8 Ligation of Plasmids with DNA Fragments
Ligation reactions prepared according to the following basic protocol, were incu-
bated for 1 hour at room temperature:
basic reaction mix: Vector-DNA 50 ng
(10 µl) Insert-DNA 3-5 times Vector-DNA
10x Ligase buffer 1 µl
T4-DNA-Ligase 1 µl
H2O ad 10 µl
3.4.9 Gel Electrophoresis of DNA
In order to separate DNA due to its size, agarose gel electrophoresis was used.
Negatively charged DNA fragments migrate in the electric field at a rate mainly
influenced by the density of the polymer network and the fragment size. The gels
were made by boiling 0.75 to 4 % agarose in TBE. When the gel had cooled down
to about 55 °C ethidiumbromide (0.2 µg/ml) or ServaStain (1 µl) was added and
the gel was poured into a mold (custom-made). The solid gel was subsequently
mounted in the electrophoresis-tank (custom-made), where the DNA samples
mixed with 10x loading-dye were loaded. The separation was performed in TBE
(1x) at a voltage of 80-100 mV.
3.4.10 Recovery of DNA from Agarose Gels
DNA was isolated from agarose gels using the Gel-Extractionkit of Macherey-
Nagel, according to manufacturers recommendations.
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3.4.11 Purification of DNA Fragments after PCR or Restriction
Digests
DNA from enzymatic reactions (PCR, Restriction Digest) was purified employing
the PCR-Purificationkit of Macherey-Nagel, according to manufacturers recom-
mendations.
3.4.12 Amplification of DNA by the Polymerase Chain Reaction
(PCR)
The polymerase chain reaction invented by Mullis is a method to quickly am-
plify specific DNA-fragments [Mullis et al., 1986]. For amplification of a specific
gene, primers aligning with the borders of the target DNA were chosen and in-
cubated with a thermostable DNA-polymerase. The basic principle of the PCR is
a repeating temperature cycle comprising a DNA denaturing step, a primer an-
nealing step and a DNA-extension step, which is the activity period of the DNA-
polymerase. For amplification of genes for subsequent cloning and expression a
proof reading (3′-5′ excision repair) DNA-polymerase was used (Phusion, NEB).
3.4.13 Amplification of Genes
For preparative amplification of genes from genomic or plasmid DNA, oligo-
nucleotides were used carrying specific restriction sites in addition to the gene
aligning parts. These sites were chosen with respect to the multiple cloning site
of the vectors used for subsequent work.
basic reaction mix: 5x HF buffer 10 µl
(50 µl) dNTP-Mix (10 mM) 1 µl
primer forward (10 pmol/µl) 2.5 µl
primer reverse (10 pmol/µl) 2.5 µl
Phusion DNA Polymerase (1 U/µl) 1 µl
DNA template 10 ng
H2O ad 50 µl
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temperature cycle: denature (DNA) 98 °C 2 min
denature (DNA) 98 °C 20 sec
annealing (primer) Tm °C 20 sec
extension 72 °C 1 sec/kb
final extension 72 °C 5-10 min
The melting temperature (Tm) of the primer was computed by Primer3Plus. The
extension time was chosen according to the estimated length of the DNA frag-
ment. The amount of template DNA needed for the reaction is dependent on its
concentration.
3.5 Biochemical Methods for Protein Analysis
3.5.1 Preparation of Whole Cell Lysates
Exponentially growing cells were washed twice with PBS, if needed scraped from
the culture dish, and collected by centrifugation at 200 ×g for 10 minutes at
4 ◦C. The cell pellet was resuspended in 5 Vol. of ice cold lysis buffer (25 mM
Tris-HCl pH 7.5, 300 mM KCl, 2 mM EDTA, 0.3% Nonidet P-40, 1 mM AEBSF)
and incubated for 20 to 30 minutes on ice. For break down of genomic DNA,
which otherwise will result in a smear on the SDS-PAGE gel, the lysate was soni-
cated (microtip, 20 pulses, output 1.5, duty cycle 50 %). Cell debris was removed
by centrifugation at 17000-20000 ×g for 30 minutes at 4 ◦C. For analysis with
SDS-PAGE a volume equivalent to 20000-40000 cells was mixed with loading dye
heated to 95 ◦C for 5 minutes and applied to one lane of a gel.
3.5.2 Immunoprecipitation (IP)
For IPs, Protein G Sepharose (4FF GE Healthcare) beads were washed three times
with PBS (supplemented with 0.1% Triton X-100) and collected by centrifugation
at 1000 ×g for two minutes at 4 ◦C. Hybridoma supernatant or antibody sera
were first cleaned from debris or precipitates by high speed centrifugation for 15
minutes at 4 ◦C, before these were incubated with the beads on a rotating wheel
at 4 ◦C overnight. Before the bead bound antibodies are applied to a homogenate,
the beads are washed two times with PBS (supplemented with 0.1% Triton X-100)
and two times the respective buffer of the homogenate. Following an incubation
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on a rotating wheel for three hours, the beads are washed 5 times in the respective
buffer, once in PBS and eluted by 2× SDS-Loading Dye at 65 ◦C at 850 rpm for 15
minutes.
3.5.3 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
A method to separate proteins according to their size is SDS-polyacrylamide Gel
electrophoresis [Laemmli, 1970]. In order to only assess the primary structure,
the secondary and tertiary structure of the proteins are dissolved by the deter-
gent sodium dodecyl sulfate (SDS) and the reducing agent β-mercaptoethanol.
Additionally, the negatively charged SDS associates with the proteins and leads
them to the anode, when an electric field is applied. The density of the poly-
acrylamide network reduces the migration speed of every protein depending on
its size. First the gel matrix of the resolving gel is mixed and poured between
two clean glass plates, overlaid with isopropanol and left to polymerize at RT.
Then the organic solvent is washed away to add the stacking gel mixture and a
comb. For electrophoresis the samples are loaded on the stacking gel where they
are compressed by the glycine of the running buffer as soon as the electric field
is launched. When the proteins pass into the resolving gel, they have all reached
the same starting point and separate according to their size. For standard analysis
resolving gels with an acrylamide concentration of 10 % were used (Composition
see Green and J. [2012]). The gel electrophoresis was launched with 15-35 mA per
gel and was followed by Western blotting.
3.5.4 UREA-Polyacrylamide Gel Electrophoresis (UREA-PAGE)
For separation of 35S labelled proteins UREA-PAGE gels were used. The me-
thod works as the SDS-PAGE above only modified by the addition of urea in the
running buffer, the resolving and stacking gel. First a 10% resolving gel (6.2 ml
Acrylamide:Bis-Acrylamid [60% :0.8%], 7.8 ml Tris-HCl [1M, pH 8.8], 41.5 µlNaCl
[4 M], 6.925 g urea, 193.8 µl SDS [10%], 69.3 µl APS [10%], 13.8 µl TEMED) was
pored between glass plates and overlaid by isopropanol. Second the stacking gel
(0.56 ml Acrylamide:Bis-Acrylamid, 0.85 ml Tris-HCl [1M, pH 6.8], 1.25 g urea,
3.5 ml H2O, 75 µl SDS, 79 µl APS [10%], 6.9 µlTEMED) was layered on top of the
resolving gel.
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3.5.5 Western Blotting and Immunological Detection of Proteins
(WB)
By means of Western blot analysis proteins separated by SDS-PAGE can be de-
tected specifically. For further analysis the proteins were transferred form the
acrylamide gel to a nitrocellulose or PDVF membrane. The protein of interest is
then recognised by a specific primary antibody, which is itself bound by a sec-
ondary antibody. The secondary antibody is covalently linked to fluorophore
(CW700-CW800; Licor) or horse radish peroxidase (HRP). Then the proteins can
be detected on a Fluorescence Scanner (Odyssey,Licor) or an X-ray film, by incu-
bating HRP with its substrate, which results in chemiluminescence. For transfer
of the proteins from the gel onto the nitrocellulose membrane, a Whatman pa-
per GB005 soaked in transfer buffer was placed on the graphite electrode (anode)
of the blotting device. On top of it the water activated nitrocellulose membrane
and the acrylamide gel, both equilibrated in transfer buffer, were superimposed.
Finally, another soaked Whatmann paper was laid down on the pile, which is
followed by another graphite electrode (cathode) of the lid. The transfer was
performed with an electric current of 40 mA (160 mA) per gel for 1 hour 10 min-
utes (45 minutes). The protein carrying nitrocellulose membrane was afterwards
stained with Ponceau S for 10 minutes and scanned after 10 minutes of destain-
ing. This served as control to compare the protein amounts loaded in the different
lanes. Subsequently, the membrane was blocked with TBS-T milk (5 % milk dis-
solved in TBS-T) for 45-60 minutes. The blocked membrane was incubated with
primary antibody diluted in TBS-T milk (7 ml) at 4 ◦C overnight on a shaker. Next
morning the membrane was washed three times for 5 minutes with TBS-T (10 ml)
and then incubated for another hour with a HRP linked secondary antibody di-
luted in TBS-T milk at room temperature. Again the blot was washed three times
for 5 minutes with TBS-T (10 ml). Finally,it was transferred to TBS. To detect the
protein by the HRP signal the membrane is placed on a glass plate and incubated
with a chemiluminescence blotting substrate by Roche. Thus,reagent A (10 µl)
were mixed with reagent B (990 µl) and spread on the membrane in the dark-
room. On top a plastic foil was placed. Then an X-ray film was exposed to the
chemiluminescence. The positions of the specific protein appear as dark spots on
the X-ray film.
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3.5.6 Cellular Fractionation
A method to fractionate cells in cytoplasm and nuclei, was originally published
by Dignam et.al for preparing a nuclear cell extract with high transcription initia-
tion activity [Dignam, 1983]. Taking care while preparing the extracts, a relatively
clean fractions of cytoplasm and nuclei can be achieved. Cells were harvested by
centrifugation at 1000 ×g for 10 minutes at 4 ◦C washed in ice-cold PBS and re-
suspended in five packed cell pellet volumes of buffer A (10 mM Hepes-KOH pH
7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT). After incubation for 10 minutes on
ice, the cells are collected by centrifugation as above and lysed in two volumes of
buffer A by 10 strokes of a Kontes Dounce homogenizer (B type Pestle). The cell
lysis was examined microscopically by tryphan blue staining. The crude nuclei
were pelleted at 1000 ×g for 10 minutes at 4 ◦C and the supernatant was care-
fully transferred to a new tube and mixed with 0.11 volumes of buffer B (0.3 M
Hepes-KOH pH 7.9, 1.4 M KCl, 30 mM MgCl2). To remove residual debris and
precipitates, the crude cytoplasmic fraction was centrifuged at 50000 ×g for 60
minutes at 4 ◦C in a Beckman JA-25.50 rotor. The nuclei containing pellet was
washed two times in buffer A and two times in buffer C-NP40 (3 ml per 109cells,
0.3 % NP-40, 20 mM Hepes-KOH pH 7.9, 10 % glycerol, 150 mM NaCl, 1.5 mM
MgCl2, 1 mM AEBSF, 0.5 mM DTT) and was further purified from cytoplasmic
material by a high speed centrifugation at 25000 ×g for 20 minutes at 4 ◦C. The
crude nuclei were lysed in buffer C-Triton X-100 (3 ml per 109cells, 0.5 % Triton
X-100, 20 mM Hepes-KOH pH 7.9, 10 % glycerol, 150 mM NaCl, 1.5 mM MgCl2,
1 mM AEBSF, 0.5 mM DTT) for 15 minutes at RT. Then buffer C-NP40 (3 ml, ad-
justed to 10 mM MgCl2, 10 mM CaCl2) containing DNase (80 µl RQ1 RNase-free,
Promega, USA) was added and DNA was digested for 20 minutes at 4 ◦C on a
rotating wheel. After addition of 20 mM EDTA to stop the DNase, the samples
were centrifuged in a microfuge at 4 ◦C for 1 hour at maximum speed. Then a
standard IP with the Ago2 (4E1, Hybridoma SN) was performed see below. The
IP was washed four times with buffer C-NP40 supplemented with 0.1 % Triton
X-100.
3.5.7 Chromatin Association Assay
An assay which was original designed to preserve nuclear matrix structures [Fey
E G, 1986], was used by Cernilogar et al. [2011] to fractionate cells and probe for
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protein chromatin association. HeLa cells (1.8 − 3.6 ∗ 108cells) were washed in
ice-cold PBS on the plate, scraped form the culture dishes and collected by cen-
trifugation at 200 ×g for 10 minutes at 4 ◦C. After a further washing step in PBS,
the cells were lysed in CSK 1 buffer (7.2 ml 10 mM Pipes pH 6.8, 100 mM NaCl,
1 mM EDTA, 300 mM Sucrose, 1 mM MgCl2, 0.5% Triton X-100, 1 mM NaF, 0.5
mM DTT, 1 mM AEBSF) for 15 minutes on ice. A centrifugation step at 500 ×g
for 3 minutes at 4 ◦C separated the lysate into a SN1 (supernatant not bound to
chromatin) and P1 (pellet chromatin bound) fraction. After two washing steps
in CSKI, the pellet was resuspended in CSK 2 (7 ml 10 mM Pipes pH 6.8, 50 mM
NaCl, 300 mM Sucrose, 6 mM MgCl2, 1 mM NaF, 0.5 mM DTT, 1 mM AEBSF). In
the next step chromatin was solubilised by addition of CaCl2 (to a final concentra-
tion of 10 mM), MgCl2(to a final concentration of 10 mM) and DNase (140 µl RQ1
RNase-free, Promega) at 20 ◦C for 30 minutes. Then (NH4)2SO4 (250 mM final
concentration) was applied for 10 minutes at 25 ◦C to stop DNase. The nuclease
treated samples was centrifuged at 1200 ×g for 6 minutes at 4 ◦C. The chromatin
bound supernatant was designated SN2 and the matrix and hnRNP containing
Pellet P2. The P2 fraction was finally solubilised in RIPA buffer (150 mM Tris-
HCl, pH 8.0, 150 mM NaCl, 0.5% Na-Deoxycholate, 0.1% (w/v) SDS, 1% (v/v)
NP-40, 1 mM AEPBF, 1 mM NaF) for 30 minutes on ice followed by sonication.
A fraction of P1 and of untreated cells were also resuspended in RIPA buffer and
sonicated. The samples (20 µg) were analysed by SDS-PAGE and WB.
3.5.8 Mitochondrial Isolation
HEK293 cells (4 culture dishes) were washed from the plate with PBS and col-
lected at 4700 ×g for 15 minutes at 4â¯ ◦C. The pellet was resuspended in
TH buffer + BSA (1 mlper plate; 10 mM KCl, 10 mM Hepes-KOH pH 6.9, 300
mM trehalose, 0.1 % BSA) and 4 mlwere transferred into a 15 mlpotter. To isolate
mitochondria, the potter was submerged and carefully moved up and down in
the lysate for 20 times under constant rotation of the teflon rod (680 rpm). The
suspension was separated into unbroken cells and debris in the pellet and a mi-
tochondria containing supernatant by centrifugation at 400 ×g . The pellet was
resuspended in TH buffer + BSA and extracted as before. The pooled supernatant
form both extractions (400 ×g centrifugation step) was depleted from debris and
nuclei by 800 ×g at 4 ◦C for 7 minutes. The mitochondria were then pelleted
by 10000 ×g at 4 ◦C for 10 minutes. The mitochondrial fraction was then re-
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suspended in TH buffer and pooled. Then mitochondria were collected by cen-
trifugation at 10000 ×g at 4 ◦C for 5 minutes and dispersed in a small volume
of TH buffer (i.e. 200 µl). The concentration of mitochondria in the solution is
measured by Bradford. For fractionation assays mitochondria can be stored at
-80 ◦C.
3.5.9 Carbonate Extraction of Mitochondria
Frozen mitochondria or freshly isolated mitochondria were resuspended in PBS,
aliquoted (6 ×; 50 µgper tube) and centrifuged at 10000 ×g for 5 minutes at 4 ◦C.
The supernatant was removed and the were pairwise resuspended in: a) SEM
(45 µl,Sucrose, EDTA, MOPS-KOH pH 7.2), KCl (45 µl, 1 M),Triton-X100 (10 µl);
b) Na2CO3, NaHCO3, pH 10.8 (100 µl, 0.1 M); c) Na2CO3, pH 11.5 (100 µl, 0.1
M). The samples were dispersed in the respective buffer and incubated on ice
for 20 minutes. One sample of each pair was transferred into polyallomer tubes
and applied to 45000 rpm (124517 ×g ) at 4 ◦C for 45 minutes. Subsequently, the
supernatant was carefully saved in a new tube and the high speed pellet was re-
suspended in SEM (100 µl). All samples were precipitated with TCA (15 % final
concentration) and Na-Deoxycholate (5 µlper 100µlof sample, 1.25%) by vortex-
ing and incubation for 30 minutes on ice. The samples were centrifuged at 10000
×g for 30 minutes at 4 ◦C and the supernatant was discarded. The pellet was
washed with ice cold acetone (150µl) and collected by centrifugation at 10000 ×g
for 20 minutes at 4 ◦C with the tubes turned by 180 ◦. The pellets were dried at
37 ◦C for 15 minutes, dissolved in loading dye (60 µl) and heated for 20 minutes
at 55 ◦C. For analysis by SDS-PAGE and WB 30 µl were loaded per lane.
3.5.10 Swelling of Mitochondria
The mitochondria swelling assay distinguish the localisation of mitochondrial
proteins into outer membrane, intermembrane space (IMS) and matrix. Fresh mi-
tochondria were isolated form HEK293 cells (4 culture dishes) as described above
Section 3.5.8. After quantification, two tubes containing 100 µg mitochondria and
one tube with 80 µg mitochondria was prepared and centrifuged at 10000 ×g for
5 minutes at 4 ◦C. The mitochondrial pellet in the first tube (100 µg) was resus-
pended carefully in SEM (100 µl) and split to three new tubes. The pellet of the
second tube (100 µg) was dispersed in EM (50 µl) by pipetting 40× up and down
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(yellow tip), followed by another addition of EM (50 µl, 20× up and down), be-
fore it was split to three fresh tubes. All samples were incubated on ice for 25
minutes. Then different amounts of Proteinase K (1 mg/ml; 0 µl, 5µl, 10 µl) were
added to each of the three tubes. The sample (80 µg), which was serving as son-
ication control, got resuspended in EM (80 µl, 20 × up and down) and aliquoted
into two tubes. One of those was the no Proteinase K control, the other one was
treated with Proteinase K (1 mg/ml; 10 µl). Then both tubes were sonicated three
times 20 pulses. Subsequently, all samples were incubated on ice for 10 minutes,
to digest all accessible proteins. The reaction was stopped by addition of PMSF
(3 µl; 100 mM in ethanol) on ice for 10 minutes. The Mitochondria were pelleted
at 10000×g for 10 minutes at 4 ◦C. The pellet was resuspended in LD (50 µl) and
boiled at 95 ◦C for 5 minutes. The samples (25 µlper lane) were analysed using
SDS-PAGE and WB (Section 3.5.3, 3.5.5).
3.5.11 Percoll Gradient of Mitochondria
Percoll Gradient for HEK293 cells The Percoll gradient was performed by C.
Dennerlein. HEK293 cells (minimum 6 × 15 cm dishes) were grown and har-
vested in ice cold PBS + EDTA (1 mM). The cells were pelleted by centrifugation
at 400 ×g for 5 minutes at 4 ◦C. The cells were resuspended in homogenization
buffer (HB,220mM mannitol, 70mM sucrose, 10 mM HEPES-KOH (pH 7.4), 1 mM
EDTA, 1mM PMSF, 2 mg/ml BSA), incubated for 10 minutes on ice and homoge-
nized with potter S (20 strokes, 800 rpm). Using centrifugation (400 ×g 4 ◦C 10
minutes), the cell debris was pelleted and the supernatant was saved. The pellet
was extracted again in HB and homogenized (20 strokes, 1000 rpm). After cen-
trifugation, see above, both supernatants were pooled. Following another low
speed centrifugation step at 400 ×g for 5 minutes at 4 ◦C the mitochondria were
pelleted at 11000 ×g for 10 minutes at 4 ◦C. The supernatant was removed, the
mitochondria containing pellet was washed in 1× Isolation buffer (IB, 2× IB: 440
mM Mannitol, 140 mM Sucrose, 20 mM HEPES-KOH (pH 7.4), 2 mM EDTA) and
centrifuged at 11000 ×g for 5 minutes at 4 ◦C. Finally, the mitochondria in the
pellet were resuspended in IB buffer (1×, 520 µl), a small sample was taken for
WB analysis and the rest (500 µl) was loaded on top of a Percoll gradient. The
Percoll gradient was reversely layered (2 ml 12% Percoll, 2 ml 26% Percoll, 500 µl
40% Percoll) in ultra-clear ultracentrifugation tubes for MLS-50 rotor. Then the
loaded gradient was centrifuged in the Optima Max Ultracentrifuge (23.000 rpm,
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45 minutes, 4 ◦C Deceleration 9). After the centrifugation all protein layers at the
interphases of the gradient were transferred to Eppendorf tubes (2 ml) (Top layer
"#1", 12% -26% interphase "#2", 26% -40% interphase "#3"). To remove the Per-
coll from the different fractions, these were diluted 1:5 with IB and centrifuged
in a tabletop centrifuge (4700 ×g 15 minutes, 4 ◦C). After careful removal of the
supernatant above the rather loose pellet, residual Percoll was depleted by addi-
tional washing steps in 1× IB, till the pellet was tightly bound to the tube after
centrifugation. At last the pellet was resuspended in the appropriate amount of
1× IB and protein concentration was estimated by a Bradford assay. For analysis
the different fractions were loaded on a WB (10-20 µgper lane).
Percoll solutions (40%: 4 ml Percoll solution, 5 ml 2× Buffer IB, 1 ml MP-H2O
26%: 3.25 ml 40% Percoll solution, 1.75 ml 1 × IB Buffer; 12%: 1.65 ml 40% Percoll
solution, 3.35ml 1 × IB Buffer)
Percoll Gradient for MRC5 cells MRC5 cells (23 × 15 cm dishes) were har-
vested in 4 ml ice cold PBS. After spin at 200 ×g for 10 minutes at 4 ◦C and
several washes in PBS, the cells were lysed in five cell volumes of 1 × SEM buffer
(20 mM MOPS pH 7.2, 250 mM Sucrose, 1 mM EDTA, 1 mM AEBSF) by douncing.
The pellet, containing nuclei and unbroken cells, was removed by centrifugation
at 700×g for 10 minutes at 4 ◦Câ. The supernatant containing the cytoplasm was
transferred to a new tube. Following another extraction of the pellet, the nuclei
were pelleted and washed 2 times with 1 × SEM. The mitochondria were sepa-
rated from the cytoplasm by centrifugation at 13000 ×g for 10 minutes. After
a washing step the mitochondria were resuspended in 10% Percoll buffer (2 ml)
and loaded on top of a discontinuous Percoll gradient (24% [7.8 ml] and 40% Per-
coll [2.5 ml], all Percoll solutions were prepared in 1 × SEM). The gradient was
centrifuged for 1 hour at 40000 ×g in Ti70.1 rotor at 4 ◦C in a Beckman ultracen-
trifugation with no break. After the run, twelve 1 ml fractions were taken. The
first four fractions were discarded. The residual eight fractions were diluted ten
fold in 1 × SEM and centrifuged at 16000 ×g for 15 minutes at 4 ◦C with decel-
eration set to slow due to the lose mitochondrial pellet. Following another two
washes to completely remove any residual Percoll the samples were resuspended
in loading dye (50 µl) and incubated for 15 minutes at 70 ◦C.
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3.5.12 35S Labelling of Proteins in vitro
For 35S-methionine labelling of proteins the TnT® Quick Coupled Transcription/-
Translation System for T7 promoter was used. A plasmid encoding the protein of
interest under the T7 promoter (500 ng) was mixed with TnT® T7 Mastermix (50
µl) and 35S-methionine (5 µl; 10mCi/ml). After brief vortexing the reticulocyte
lysate was incubated at 30 ◦C for 1.5 hours at 450 rpm. The reaction was stopped
by addition of methionine (5 µl; 1 mM) for one minute at 30 ◦C followed by su-
crose (7.5 µl). To examine the result of the coupled transcription and translation
reaction a Sample (1 µl) was analysed on an SDS-mini gel. The rest of the labelling
reaction was stored at -80 ◦C for later use.
3.5.13 In vitro Import of Proteins into Mitochondria
Fresh mitochondria were isolated form HEK293 cells (4 culture dishes) as de-
scribed above Section 3.5.8. After quantification mitochondria were aliquoted
into five tubes (150 µg) and centrifuged at 10000 ×g for 5 minutes at 4 ◦C. The
pellets were carefully resuspended in import buffer (150 µl; 250 mM sucrose, 5
mM MgOAc, 20 mM Hepes-KOH pH 7.4; add fresh: 2.25 mM ATP [stock 200
mM], 2.25 mM NADH [stock 200 mM], 15 mM Na-succinate [stock 1 M], 15 mM
malat [stock 1 M]. One tube was treated with AVO (3 µl; 1 µM valinomycin,
20 µM oligomycin, 8 µM antimycin in ethanol, stored at -20 ◦C), to destroy the
membrane potential of the mitochondria and, thus, inhibit membrane potential
dependent protein import. All other tubes were supplemented with ethanol (3
µl). Following an incubation at 37 ◦C for 3 minutes, the import was started by
addition of the reticulocyte lysate (4 µl). The import reaction was stopped after
30 minutes by addition of AVO (3 µl). The samples were split into two tubes
and one of each pair was incubated with Proteinase K (2.5 µl, 1 mg/mlin SEM)
on ice for 10 minutes. The Proteinase K was inactivated by covalent binding to
the active centre of PMSF (2 µl, 100 mM) and left on ice for another 10 minutes.
The mitochondria were collected by centrifugation at 10000 ×g for 10 minutes
at 4 ◦C. In order to wash the mitochondria, SEM (80 µl) was carefully added and
the tubes were turned by 180 ◦, which leads to centrifugation (settings as above)
through the washing solution. The pellet was resuspended in LD ( 30 µl), boiled
at 95 ◦C for 5 minutes and analysed by a UREA-Page gel and WB.
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3.5.14 35S Labelling of Mitochondrial Proteins in vivo
Given that the mitochondria contain 70 S ribosomes, it is possible to stop the cyto-
plasmic protein production by selectively inhibiting the eukaryotic 80 S ribosome
by emetine. Thus, only mitochondrial proteins are labelled with 35S methionine,
when this is supplemented to the growth medium. This is a straight forward me-
thod to analyse the impact of target proteins on mitochondrial protein synthesis
[Mick et al., 2012]. Cells were grown in 25 cm2flasks for the experiment. Knock-
down of respective proteins was performed by transfection with specific siRNAs
(33 nM). For transfection in a 25 cm2 flask siRNA (8.96 µl 20 µM) were mixed
with Lipofectamine RNAimax (4.48 µl, Thermo Scientific) and Optimem medium
(1120 µl). After incubation for 20 minutes, HEK293 cells were added (5.6 ∗ 105).
Finally, medium (up to 5600 µl) was added and the cells were split to two 25 cm2
flasks. After siRNA knockdown for 72 hours medium was replaced by FBS/me-
thionine free media (2 ml) and the cells were incubated for 10 minutes at 37 ◦C.
This step was repeated another time with media containing FBS but no methio-
nine (1.5 ml), before the addition of medium with FBS, Emetine (100 µg/mlfinal
concentration) and no methionine. After incubation for 10 minutes at 37 ◦C, 0.5
mlmedium were removed and the mitochondrial translation was pulsed with 35S
methionine (20 µl, 10mCi/ml) at 37 ◦C for one hour. The labelling was stopped
by removal of the 35S containing medium. The cells were harvested in PBS and
collected by centrifugation at 2000×g for 2 minutes at 4 ◦C. Following a washing
step in ice cold PBS, the cells were resuspended in cold PBS ( 200 µl) and protein
concentration was measured using Bradford. Finally, the cells (50 µg) were lysed
in LD (25 µl; containing 0.25 µlBenzonase (25 kU)) for 20 minutes at 37 ◦C and
analysed by an UREA-PAGE gel (see Section 3.5.4), autoradiography (Phospho-
rImager) and WB (Section 3.5.5).
3.5.15 Purification of Argonaute Proteins
SF21 cells were grown (600 ml, 1 ∗ 106 cells/ml) and infected with Baculo virus.
The cells were harvested 48 hours after infection at 136 ×g for 10 minutes. The
cell pellet was lysed in 30 ml lysis buffer (50 mM Hepes-KOH pH 7.5, 500 mM
NaCl, 0.1 % NP-40) supplemented with Benzonase (9 µl, 25 kU) and pipetted
up and down for at least 25 times. The cells were broken by vortexing at maxi-
mum speed for 40 seconds, followed by cooling on ice for 20 seconds, this was
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repeated another time. Then the cells were incubated on ice for 5 minutes and
vortexed again as before. The lysate was centrifuged at 4000 rpm for 5 minutes
at 4 ◦C. The Argonaute containing supernatant was saved and the pellet was ex-
tracted again with lysis buffer (20 ml) as described above. The supernatants from
both extractions were mixed and applied to high speed centrifugation 50000 ×g
for 1 hour. The cleared lysate was filtered through a 0.45 µm low protein bind-
ing filter, supplemented with glycerol (10% final concentration) and imidazol (10
mM final concentration; pH 7.5) and loaded on a Ni-NTA column (5 ml) coupled
to a AKTA-purifier system. After loading the sample, the bound protein was
washed 40 column volumes of 0.5 M salt wash buffer (50 mM Hepes-KOH pH
7.5, 500 mM NaCl,10 % glycerin, 20 mM imidazol pH 7.5). This was followed by
a 2 M salt wash (50 mM Hepes-KOH pH 7.5, 2 M NaCl,10 % glycerin, 20 mM
imidazol pH 7.5) for 5 column volumes, to remove unspecifically attached nuclei
acids. The column was re-equilibrated to normal salt conditions by washing with
10 column volume 0.5M salt wash buffer. Finally, the protein was eluted with
5 column volumes of 50% elution buffer (50 mM Hepes-KOH pH 7.5, 300 mM
NaCl,10 % glycerin, 500 mM imidazol pH 7.5). If the HIS-tag had to be removed,
the eluate was dialysed overnight against 0.5 M wash buffer and the HIS-tag was
cleaved of at an internal TEV recognition site using TEV protease. The tag and the
His-tagged TEV protease were removed by another run on a Ni-NTA column (5
ml). The flowthrough containing the purified protein was saved. Either the first
eluate or the flowthrough were concentrated in a Vivaspin 20 (50 kDa MCWO)
membrane based centrifugal concentrator at 3000×g and 4 ◦C. The concentrated
protein was further purified using gelfiltration on a HiLoad 16/600 Superdex 200
in gelfiltration buffer (100 mM Hepes-KOH pH 8.3, 10% glycerin, 500 mMNaCl,
5 mM MgCl2). During the run, the 260 nm reading, detecting nucleic acids, was
higher than the absorption at 280 nm which is specific for the amino acid trypto-
phan.
3.5.16 Protein Coupling to CNBr Beads
For purification of an Ago2 antibody, the purified protein was coupled to a CNBr
column. To prepare the column, CNBr FF4 Beads (1 g) were soaked in HCl (1
mM) for 20 minutes, applied to a disposable plastic column for gravity flow. The
column was washed another 10 times with HCl (5 ml, 1 mM) for 2 minutes rotat-
ing. The beads were collected by 100 ×g for 20 seconds at 4 ◦C. The column was
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prepared for coupling by two washes with coupling buffer (100 mM Hepes-KOH
pH 8.3, 10% glycerin, 500 mMNaCl, 5 mM MgCl2). Then Ago2 (1 mg), diluted
in coupling buffer (9 ml), was applied to the beads and covalently bound to the
beads during incubation overnight on a rotating wheel. On the next day the beads
were blocked with ethanolamin (5 ml, 1 M, pH 8.0), rotating for 2 hours at 4 ◦C.
Then the column was washed (5 ml) - three times each - with acidic buffer (0.1 M
NaOAc pH 3.5, 0.5 M NaCl) and basic buffer (0.1 M Hepes pH 8.5, 0.5 M NaCl).
The alternating washes were repeated for another two times before the column
was left in basic buffer for storage overnight at 4 ◦C.
3.5.17 Antibody Purification against Target Protein
The Ago2 antibody serum was centrifuged at 20000 ×g for one hour at 4 ◦C.
Subsequently the supernatant was filtered through silanized glasswhool to re-
move lipids. The Ago2-CN-Br column was equilibrated by 10 column volumes
of binding buffer (50 mM Hepes pH 8.0, 500 mM NaCl). Then the cleared anti-
body serum was applied to the column, which was filled up to 10 ml with binding
buffer, and left for binding on rotating wheel at 4 ◦Cfor 2 hours. Afterwards the
column was washed with 10 × 10 column volumes of binding buffer. The Anti-
body was eluted by three column volumes of elution buffer (96% citrate [0.2 M],
4% Na2PO4 [0.2 M] pH 2.4) into 2 mlEppendorf tubes containing Tris-HCl pH 9.0
(125 µl). Following elution the pH of the antibody solution was titrated by Tris-
HCl pH 9.0 to roughly pH 7.5. The antibody was concentrated in a vivaspin 6 (50
MWCO) concentrator and stored in glycerol (50 % final concentration) at -80 ◦C.
3.6 Biochemical Methods for Nucleic Acid Analysis
3.6.1 Size Separation of RNAs via UREA-TBE Gels
Standard UREA-TBE gels and Sequencing Gels of different concentrations were
poured between clean glass plates using the SequaGel (UreaGel System), accord-
ing to manufacturers recommendations. Before use, the UREA gels were heated
by applying 400 V (∼ 51 mA) for 20 to 30 minutes. After boiling the RNA samples
(20 µg) in RNA LD for 5 minutes at 95 ◦C, the samples were immediately loaded
into the carefully flushed wells of the UREA gel. A radioactively labelled stan-
dard was used. The gel was run at 320 to 400 V for one hour or until the dye front
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had a distance of 6 to 7 cmfrom the bottom of the well. To control for proper sep-
aration the gel was stained with EtBr for 15 minutes in TBE and analysed using a
UV screen.
3.6.2 Northern Blot
Northern blots for detection of small RNAs were essentially performed as de-
scribed by Pall and Hamilton [2008] with minor modifications. The RNA from
the stained UREA gel (Section 3.6.1) was blotted onto a nylon membrane (N-
Highbond) with three Whatman paper each on top and at the bottom of the
sandwich in a semi-dry blotting chamber using Milliq-H2Ofor blotting (20 V, 30
minutes). After blotting the transferred RNA was crosslinked with EDC (61.25 µl
Methylimidazol, 2.25 ml H2O, 75 µl HCl [1 M], 188,3 mg EDC, at 6 mlH2O; pH
8.0) by soaking a Whatman paper in EDC and placing the membrane on top (RNA
faces upwards). The Whatman and membrane are then wrapped into a cling film
and incubated for 1 hour at 50 ◦C in hybridisation oven. For specific analysis of
an RNA, a complementary DNA (∼ 20 bp) probe is radioactively labelled. For
this the DNA probe is incubated with PNK and 32P-γ-ATP:
PNK labelling reaction: PNK 10× buffer A 2 µl
(20 µl) DNA oligo (20 µM) 1 µl
PNK (10 U/µl) 1 µl
32P-γ-ATP (10 mCi/ml) 2 µl
H2O 14 µl
Following incubation for one hour at 37 ◦C, the reaction is stopped by EDTA (30
µl, 30mM) the labelled DNA is purified using gel filtration on MicroSpin G25
columns. Before the membrane was exposed to the DNA probe, it was blocked
for one hour at 50 ◦Crotating in hybridisation solution (12.5 ml 20× SSC, 0.996 ml
Na2HPO4 1 M 34.86 µl10% SDS, 0.996 ml Denhardts [in case of unspecific back-
ground; 0.498 mlSalmon Sperm DNA 10 mg/ml], ad 50 ml H2O). Then the DNA
probe (∼ 60 µl) was added to the hybridisation solution and incubated at 50 ◦C
overnight, rotating in a hybridisation oven. On the next morning the probe con-
taining hybridisation solution is saved and stored at -20 ◦C for further use. The
membrane is washed for 10 minutes in wash solution I (10 ml;5× SSC, 1% SDS) at
50 ◦C rotating. This is wash is repeated, before the membrane is incubated with
wash solution II (10 ml;1× SSC, 1% SDS) as above. To expose the membrane to
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a blanked phosphor (BaFBr:Eu) screen, the membrane is wrapped in a cling film
and placed in film cassette. After exposure for several hours or overnight, the
stored radioactive signal (oxidized phosphor) is released form the phosphor by
stimulation with visible laser light (635 nm) see Biorad [2005]. The photons emit-
ted by the reduction reaction of the phosphor are captured by a photomultiplier
and processed into a digital file.
3.6.3 Proteinase K digest of co-precipitated RNAs
For the analysis of co-precipitated RNAs, samples were treated with Proteinase
K (Roth) in 250 µl of Proteinase K buffer (0.3 mg/ml Proteinase K, 300 mM NaCl
25 mM EDTA, 2% SDS, 200 mM Tris-HCl, pH 7.5) and incubated for 15 minutes
at 65 ◦C. RNA was extracted with one Vol acidic phenol (pH 4.0) by vortexing
for 10 seconds. After incubation of ice for 10 minutes and centrifugation at 12000
×g for 20 minutes, the aqueous supernatant was re-extracted with acidic phenol.
The resulting supernatant was precipitated by addition of NaCl (300 mM final
concentration), glycogen (1 µl, 20 mg/ml) and 2.5 vol of pure ethanol, followed
by incubation overnight at -20 ◦C. On the next morning the samples were cen-
trifuged at 20000 ×g for 1 hour at 4 ◦Cand washed two times with ethanol (1
ml,80%, -20 ◦C). After complete removal of the ethanol the RNA was dried for 3
minutes at RT and resuspended in H2O(20 µl).
3.6.4 Chromatin Immunoprecipitation (ChIP)
ChIP is an antibody based technique to select chromatin regions bound by the
protein of interest. Subsequently, DNA is purified form the enriched chromatin
and quantified or analysed regarding their sequence composition. The ChIP ex-
periments were essentially preformed as described by Luo [1998]; Braunstein
[1993]. To crosslink proteins with DNA, two culture dishes of cells (1.5 ∗ 107 cells
per 15 cm plate) were treated with formaldehyde (1 %) and incubated for 10 min-
utes at RT. The reaction was stopped by addition of glycine (125 mM) for another
5 minutes at RT. Subsequently, the cells were washed three times with ice cold
PBS and collected by centrifugation at 200 ×g for 10 minutes at 4 ◦C. The cells
were lysed in ChIP-Lysis buffer (1 ml, per cell pellet from two plates; 1% SDS, 10
mM EDTA and 50 mM Tris, pH 8.1, 1 mM AEBSF) for 10 minutes on ice. Son-
ication was performed in the Diagenode Bioruptor UCD-200 (settings: High, 30
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seconds ON, 30 seconds OFF for 3 times 5 minutes) in 15 ml tubes (Falcon) with
an ultrasound reflective metallic bar inside the tube and an approximately 0.5 cm
thick layer of ice in the waterbath. Every 5 minutes the ice was replaced to ensure
proper cooling of the samples during sonication. Cellular debris was removed by
centrifugation at 20000×g , for 15 minutes at 4 ◦C. The cleared lysate was diluted
10 fold in (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl pH
8.1, 167 mM NaCl) and 5-10 µg of antibody was added per 2 ml at 4 ◦Covernight
on a rotating wheel. A sample (1/10 Vol of IP) was taken as input control. On
the next morning Protein A Agarose/Salmon Sperm DNA (Millipore 17-295, 50
µl) were added per 2 ml tube and left at 4 ◦C for another hour. Subsequently, the
beads were washed for 5 minutes with 1 mlof the buffers: low salt (0.1% SDS, 1%
Triton X-100, 2 mM EDTA, 20 mM Tris-HC1 at pH 8.1, 150 mM NaCl), high salt
(0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HC1 at pH 8.1, 500 mM
NaCl),LiCl buffer (0.25 M LiC1, 1% Nonidet P-40, 1% Na-Deoxycholate, 1 mM
EDTA, 10 mM Tris-HC1 pH 8.1) and two times TE (10 mM Tris-HCl pH 8.0, 1 mM
EDTA). The bound DNA was eluted by incubating the beads two times for 15
minutes in elution buffer (0.1 mMNaHCO 3, 1% SDS, 200 µl) at 65 ◦Cin a shaker
850 rpm. The formaldehyde crosslinks were reversed by addition of NaCl (ad 200
mM) and heating to 65 ◦Covernight. The eluted DNA was treated with Proteinase
K (1 µlof 20 mg/ml) after supplementing the solution with EDTA (10 µl of 0.5 M)
and Tris-HCl(20 µlof 1 M, pH 6.5) for one hour at 45 ◦C. After PCI extraction,
the DNA was recovered by ethanol precipitation (1/10 Vol. Na-Acetate pH 5.2,
1 µl Glycogen, 2 Vol. Ethanol 100 %) at -20 ◦Covernight. The precipitated DNA
was collected by centrifugation at 20000 ×g for 45 minutes at 4 ◦C, washed with
Ethanol (75%), centrifuged for another 10 minutes and air-dried for 10 minutes
at RT. The purified DNA was resuspended in TE or water (for qPCR 200 µl for
input and IP samples) by incubation for 15 minutes at 37 ◦C and 850 rpm.
Enrichment of Nuclei was performed for the ChIP-Sequencing experiment to de-
plete the cells of cytoplasmic Argonaute [Janowski et al., 2006]. After the form-
aldehyde crosslink, the samples were washed two times with ice-cold PBS. Two
culture dishes (15 cm) were harvested, pooled in one falcon tube and collected
by centrifugation at 500 ×g for 10 minutes at 4 ◦C. To remove the cytoplasm, the
crosslinked cell pellet was washed in hypotonic buffer (10 mM Tris-HCl pH 7.5,
10 mM NaCl, 2 mM MgCl2, 0.5% Nonidet P-40, 1mM AEBSF) by pipetting ten
times slowly up and down. The crude nuclei were centrifuged at 200 ×g for
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10 minutes at 4 ◦C. After a second washing step the pellet was frozen in N2 or
immediately used for ChIP assays.
For the ChIP-Seq experiment the eluted DNA was treated with Proteinase K,
extracted with PCI and chloroform. Subsequently, contaminating RNA was re-
moved by RNase A digestion for 1 hour at 37 ◦C followed by extraction with PCI
and two times with chloroform. This was needed to remove trace amounts of
phenol, which could negatively affect library generation. The library preparation
and NGS was performed by Fasteris (Plan-les-Ouates, Switzerland). Libraries
were constructed in paired-end mode including barcodes sequences for multi-
plexing. Sequencing was performed in two lanes of one flow cell. Four samples
GPK1-4 and GPK5-8 were pooled and measured on a HiSeq2000 for 100 sequenc-
ing cycles plus another seven cycles for identification of the index. The pictures
were taken in 32 tiles, which were then processed by the software packages HiSeq
Control 1.1.37.8, RTA 1.7.48 and Casava 1.7.
3.6.5 DNA-Adenine-Methyltransferase Identification (DAMID)
The DAMID technique, an antibody independent approach to map chromatin
interactions of proteins, was developed by Bas van Steensel and used as a com-
plementary method to ChIP [Steensel and Henikoff, 2000]. The protein of interest
is fused to DNA Adenine Methyltransferase from E. coli and expressed in the re-
spective cell line. Here the protocol of Vogel [Vogel et al., 2007] was used. For
transduction of the fusion protein encoding genomic sequence a lentiviral sys-
tem was used (Section 3.3.8). After infection and incubation for 72 hours, DNA
was isolated form the cells using the DNeasy Blood and Tissue Kit (Qiagen) with
following modifications. An RNase A digest was included in the first solubili-
sation step and the elution was performed two times with buffer AE (200 µl) in
one 2 ml Eppendorf tube. The genomic DNA was subsequently precipitated with
NaOAc (0.1 Vol, 3 M pH 5.2) and Ethanol (2 Vol, 100%) and stored at -20 ◦C for
30 minutes. After centrifugation at 20000 ×g for 30 minutes, the supernatant
was removed and the pellet was washed with Ethanol (70%) and air-dried for 10
minutes. The genomic DNA was resuspended in TE ( 10 mM Tris-HCl pH 7.5,
0.1 mM EDTA) at 1 µg/µl and incubated at 55 ◦C for 30 minutes to completely
dissolve the DNA. To select for methylated GATC sites, the purified DNA (2.5
µg) was digested with Dpn I (10 U, NEB) in Buffer 4 (NEB) in a total volume of
10 µlat 37 ◦C overnight. The restriction enzyme was heat inactivated by 80 ◦C
for 20 minutes. The GATC site was restored by ligation of the dsAdR adaptor
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to the digested DNA. The dsAdR is an equimolar mixture of the oligonucleotides
AdRt (5′-CTAATACGACTCACTATAGGGCAGCGTGGTCGCGGCCGAGGA-3′)
and AdRb (5′-TCCTCGGCCG-3′)
basic ligation mix: DpnI digested DNA 10 µl
(20 µl) 10 × ligation buffer 2 µl
Apdaptor dsAdR (50 µM) 0.8 µl
T 4 Ligase (5 U/µl) 1 µl
H2O ad 20 µl
The ligation reaction was performed at 16 ◦C for four hours and finally inacti-
vated by 65 ◦C for 10 minutes. During the following DpnII digest, only unmethy-
lated GATCs cut by the restriction enzyme, leading to selection of double methy-
lated, adaptor carrying fragments.
basic DpnII digest mix: Ligated DNA 20 µl
(50 µl) 10 × DpnII buffer (NEB) 5 µl
DpnII (NEB 10 U/µl) 1 µl
H2O ad 50 µl
The DNA was incubated with DpnII at 37 ◦C for one hour. Subsequently, the
digested DNA was used as input for the methyl PCR, which specifically amplifies
nucleic acid fragments methylated on both sides.
basic PCR digest mix: DpnII digested DNA 10 µl
(50 µl) 5 × HF buffer (NEB) 10 µl
Primer Adr PCR (100 µM) 0.625 µl
dNTP mix (10 mM) 1 µl
DpnII (NEB 10 U/µl) 1 µl
H2O ad 50 µl
The PCR was performed under following cycling conditions using the Primer
AdR_PCR (5′-GGTCGCGGCCGAGGATC-3′):
Cycle Denature Anneal Extend
1 72 ◦C for 10 minutes
2 98 ◦C for 1 minute 65 ◦C for 5 minutes72 ◦C for 15 minutes
3-6 98 ◦C for 1 minute 65 ◦C for 1 minutes72 ◦C for 10 minutes
7-24 98 ◦C for 1 minute 65 ◦C for 1 minutes 72 ◦C for 2 minutes
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After analysis of the Samples (4 µl) on a Agarose Gel (1 %), the Samples were
purified with the Qiaquick PCR purification kit and eluted with EB buffer (15 µl).
3.6.6 DAMID-Next Generation Sequencing (NGS)
For NGS the size of the fragments has to be in the range of 200-500 bp. Therefore,
the up to 3000 bp long fragments form DAMID had to be shortened. The samples
were diluted (4 ng/µl in 50 µl) and sonicated (18 cycles, low setting, 30 sec on,
30 sec off). Then the samples were applied to the NEBNext® Library Prepara-
tion Kit. For purification and size selection AMPure® XP Beads were used. For
size selection the sample was incubated with 0.33 Vol of AMPure® XP Beads to
remove long fragments, which bound to the beads under these conditions. The
supernatant was then applied to 0.87 Vol of AMPure® XP Beads, which favours
the binding of fragments between 500 and 200 bp. All lower size fragments were
still in the supernatant, which was removed at this step. The beads were then
washed and eluted and the purified DNA was once more applied to a bead clean
up with 0.9 Vol of AMPure® XP Beads. After the final enrichment PCR (15 cycles)
the samples were purified with AMPure® XP Beads and eluted in 30 µl. Then the
samples were passed to the KFB (NGS Sequencing Facility) for quality control
(Bioanalyzer), quantification (KAPA-PCR) and NGS on an Illumina HiSeq 2000
machine.
3.6.7 Quantification by PCR (qPCR)
For relative quantification of DNA or cDNA fragments the real-time quantitative
PCR mix SsoFast EvaGreen of Biorad was applied according to the manufactur-
ers recommendations. Here a fluorescent dye is incorporated into freshly synthe-
sized double stranded DNA and measured. The increase of fluorescence signal
is measured over the number of PCR cycles performed. For ChIP experiments
input samples were diluted 10 fold and 8 µl of IP and diluted input DNA was
used. For cDNA analysis 2 µg of total RNA were treated with DNaseI and re-
verse transcribed. The resulting cDNA was diluted 10 to 20 fold and 8 µl were
used per qPCR reaction. Primers were used in a final concentration of 500 nM.
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3.6.8 Quantification of Viral Genome Insertions for Transduc-
tion Based DAMID experiments
During transduction the viral genome is stably integrated into the host genome.
To quantify the insertion rate, a standard plasmid containing the coding sequence
for Ribonuclease P RNA Component H1 (RPPH1) and the transfer vector (pLGW)
encoding viral sequences were sequentially diluted (10 fold, starting with 1 ∗ 107
molecules per reaction) [Salmon and Trono, 2001]. The samples (Qiagen Blood
and Tissue Kit isolated DNA) were diluted 10 fold and measured in a qPCR along
with the dilutions. The quantification was performed using two primer sets, the
first one specific for RPPH1 to quantify the host genome content [Baer et al., 1990]
and the second one directed against the viral GAG gene on the transfer plasmid,
which is integrated in the host genome during transduction.
3.6.9 Cleavage Assay
In the cleavage Assay Ago2,the only cleavage competent of the four Ago proteins,
is incubated with a radioactively labelled target RNA sequence, resulting in a
shorter cleaved RNA fragment, which can be visualised with autoradiography
(see Meister et al. [2004]).
RNA target Sequence Preparation At first the coding sequence of the target
RNA is amplified by PCR. The purified PCR product (80 ng/µl) was used in a T7
RNA-Polymerase reaction:
T7 reaction mix NTP (0.2 M each) 10 µl
(100 µl) DTT (1 M) 1 µl
Triton X-100 (1%) 1 µl
Spermidin (1 M) 0.2 µl
MgCl2 2.5 µl
Tris-HCl pH 8.0 (1 M) 3 µl
Template (1 µg/100bp) 25 µl
Pyrophosphatase 0.2 µl
T7 RNA Polymerase (5 mg/ml) 2 µl
H2O(DEPC) as 100 µl
The RNA was transcribed for 4 hours at 37 ◦Cand was stopped by addition of
DNaseI (0.2 µl; 40 U/µl) for 15 minutes at 37 ◦C. Subsequently the RNA was
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denatured by 2× RNA LD (100 µl) and 5 minutes at 95 ◦C. The RNA was purified
via an UREA-TBE Gel (8%) (Section 3.6.1). After a gel run for 1 hour at 350 V the
RNA fragment was visualised by UV shadowing and cut from the gel. To elute
the RNA form the gel, it was cut in small pieces and squeezed through a 0.5
ml tube, punctured by a G21 needle (0.8×40mm), by centrifugation at maximum
speed for 5 minutes. The gel particles were resuspended in elution buffer (350 µl;
300 mM NaCl, 2 mM EDTA) and incubated on a rotating wheel at 4 ◦C overnight.
On the next day the gel slurry was transferred into a SpinX Column (Costar)
and centrifuged for 1 minute at maximum speed. The flowthrough was saved in
a low bind tube (Eppendorf) and precipitated by 2.5 vol ethanol (100%). After
centrifugation at 17000 ×g for 45 minutes at 4 ◦C, the RNA pellet was washed
with ethanol (80%) and finally dissolved in H2O(20 µl). The RNA concentration
(3.32 µg/µl was measured and the molecular mass (340 pmol) was calculated.
Cap Labelling of the Target RNA In order to make the cleavage reaction vis-
ible, the target RNA sequence is cap labelled with 32P-α-GTP. For labelling the
following reaction mix is used:
Cap labelling re-
action
(20 µl)
Guanyltransferase buffer
(400 mM Tris-HCl pH 8.0, 60 mM
MgCl2,150 mM NaCl, 20 mM
Spermidine)
2 µl
Ribolock 0.25 µl
SAM (500 µM) 1 µl
Guanlytransferase 2 µl
32P-α-GTP 2 µl
traget RNA (40 pmol) 0.78 µl
H2O(DEPC) ad 20 µl
The cap labelling was performed for 3 hours at 37 ◦C. The reaction was stopped
by addition of 2×RNA LD (20 µl). The radioactive target RNA was then loaded
on a 8% UREA gel (Section 3.6.1). The radioactive signal was detected by autora-
diography, exposing an film for 5 minutes to the gel. The developed film was
then placed under the gel and the labelled target RNA was cut from the gel. The
RNA was extracted and precipitated as described before (Section 3.6.9).
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Argonaute IP and Cleavage Assay HEK293 cells (10/15 cm plate) were once
washed with ice cold PBS. Then the cells were treated with lysis buffer (200/400
µl, 25 mM Tris-HCl pH 7.5, 0.5% NP-40, 150 mM KCl, 2 mM EDTA, 1 mM NaF, 0.5
mM DTT, 0.5 mM AEBSF) and pipetted up and down. The lysate was incubated
on ice for 5 minutes and centrifuged at 17000 ×g for 10 minutes at 4 ◦C. The
supernatant was saved into a new tube and frozen in N2. Protein G Sepharose
beads (40 µl per IP) were washed in PBS and incubated in PBS + BSA (5 mg/ml)
on a rotating wheel for one hour at 4 ◦C. The protein lysates were thawn on
ice: For V5-tagged proteins, the V5 antibody (2 µg) was added to the lysate and
incubated for one hour. Followed by another hour of incubation in the presence
with PBS washed Sepharose beads (40 µl). For Flag-tagged proteins, the lysate
was incubated for two hours with PBS washed Flag beads (40 µl) at 4 ◦Con a
rotating wheel. After binding of the target proteins, the beads were washed three
times for 10 minutes on a rotating wheel. The samples were centrifuged at 700
×g for 2 minutes at 4 ◦C to collect the beads. A WB sample (25 %) was taken from
the last washing step, pelleted and the protein was eluted by boiling the beads in
2× LD (5 µl) for 5 minutes at 95 ◦C. The rest of the sample (75 %) were used for
cleavage assay:
Cleavage reac-
tion
(25 µl)
beads 15 µl
TM buffer 7.5 µl
Cap labelled RNA 2 µl
H2O(DEPC) ad 25 µl
TM buffer ATP (100 mM) 3.33 mM
GTP (100 mM) 0.67 mM
RNAsin (33 U/ml) 0.033 U/µl
KCl(3 M) 333 mM
MgCl2 (2 M) 5 mM
DTT (1 M) 1.67 mM
H2O N.A.
The cleavage reaction was incubated for 1.5 hours at 30 ◦C. Beads were mixed
every 10 minutes at 400 rpm. The reaction was stopped by addition of Proteinase
K solution (200 µl, 300 mM NaCl 25 mM EDTA, 2% SDS, 200 mM Tris-HCl, pH
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7.5, 0.2 mg/mlProteinase K [20 mg/ml]) and incubation at 65 ◦Cfor 15 minutes.
The samples were extracted with PCI (1 Vol) 10 minutes shaking at 25 ◦C. The
phase separation was achieved by centrifugation at 17000 ×g for 5 minutes. The
labelled RNA was precipitated with ethanol (2.5 Vol, 100%) overnight, dried and
dissolved in H2O(10 µl). For loading the RNA was boiled in RNA LD (10 µl) at
95 ◦Cfor 5 minutes. The cleavage products were separated on a sequencing gel
(8%), dried on a gel dryer for 2 hours at 80 ◦C and visualised by autoradiography.
3.6.10 siRNA Binding Assay
For the Ago1-siRNA binding assay, siRNA#2 guide strand was radioactively la-
belled by PNK (Fermentas)-mediated 5′-phosphorylation using 32P-γ-ATP (Hart-
mann Analytics). In addition, siRNA#2 guide and passenger strands were phos-
phorylated in the presence of cold ATP. Free ATP and PNK were removed from
the labelling reactions by gel filtration with MicroSpin G25 columns. Concen-
trations of the purified siRNA strands were measured, and the radioactively la-
belled and unlabelled siRNA#2 guide strand was mixed in a ratio of 1:10, respec-
tively. Subsequently, half of the mixture was pre-annealed with an equal amount
of siRNA#2 passenger strand. The other half was diluted with an equal volume
of water. To test siRNA#2 guide strand and duplex interactions with Ago1, 10
nM of purified His-Ago1 was incubated with 0.5 nM of either siRNA#2 guide
strand or duplex in buffer (50 mM HEPES pH 7.5,300 mM NaCl, 10% glycerin, 2
mM MgCl2 , 0.5 mg/ml BSA) for 90 min at 24 ◦C. As control samples, the siRNA
single- and double-strands were incubated in the absence of His-Ago1. After-
wards, His-Ago1 was immunoprecipitated from the binding reaction for 60 min
by the addition of anti-Ago1 antibody loaded Protein G Sepharose 4 Fast Flow.
The IP samples were washed two times with 1 mL of binding buffer lacking BSA
and another two times with 1 mL PBS containing 0.01% Tween. Thereafter, the
samples were Proteinase K digested as described above. Samples were diluted
in 5 mL Unisafe I emulsifying scintillator (Zinser Analytic) and measured on a
LS6500 scintillation counter (Beckmann).
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3.7 Bioinformatic Methods
For bioinformatic analysis of NGS data commonly used programmes and open
source software was used. Where custom solutions were needed, python pro-
grammes were written to perform the required task. The data was received
a .fastq files encoding for read ID, sequence and phred quality score for each
called base of the sequence. The ChIP data contained base qualities encoded
as Phred+64, the newer DAMID data sets were encoded with Phred+33 (see
http://en.wikipedia.org/wiki/FASTQ_format).
3.7.1 Quality Control by FastQC
In order to get quick, first impression of the data, the quality of 1 ∗ 106 reads were
assessed using FastQC [Andrews]. This software displays for example: the per
base quality,
per base quality: helps to identify a trend to low quality bases, often
found at start and end of the reads
per base sequence con-
tent:
informs about a bias to certain sequences at specific
positions, i.e. for DAMID the signature of the PCR
primer could be identified
Sequence duplication
levels
shows if clonal reads are observed, which normally is
based on low sample complexity and overamplifica-
tion by PCR
overrepresented se-
quences
checks for recurring sequences in the reads,i.e. de-
tection of adapter sequences form Illumina or PCR
primers or adapters form DAMID
3.7.2 Adapter Removal
Contaminating adapters at the 5′ and 3′ ends of reads caused by library prepara-
tion and the DAMID procedure were removed using custom made python scripts
(www.python.org) called 5p-primerem.py and 3pRC-primerrem.py. These cus-
tom scripts required as input the .fastq files and a text file containing all the con-
taminating adapter sequences, including the DAMID primer sequence: GGTCG-
CGGCCGAGGATC, a truncation at the 5′ end of it and one mismatch mutation at
any position. The python scripts can be found in the appendix (5.6)
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3.7.3 Trimming
For quality trimming and paired-end consistency the trimmomatic software was
used [Bolger et al., 2014]. Quality trimming is performed to remove low qual-
ity bases from the start or end of the read, which potentially create mismatches
with the reference genome and therefore reduce the quality of the mapping of the
read. This improves the subsequent alignment with Bowtie2. The program was
invoked using the following parameters:
TrimmomaticPE : S t a r t e d with arguments :\\
−phred33 i n p u t f i l e−read1 . fq . gz i n p u t f i l e−read2 . fq . gz read1−output_paired . fq . gz read1−
output_unpaired . fq . gz read2−output_paired . fq . gz read2−output_unpaired . fq . gz LEADING
: 2 6 TRAILING: 2 6 SLIDINGWINDOW: 5 : 2 0 MINLEN: 2 5
Leading cut bases at the start of read with quality below threshold
Trailing as leading but for end of the read
Slidingwindow a slidingwindow of 5 bases must have an average quality
higher than threshold
Minlen the minimal length required to be taken forward
3.7.4 Read Alignment with Bowtie2
For read alignment the Bowtie2 package of Langmead et al. [2009] was used.
The indexes for h.sapiens, hg19, and for m.musculus, mm10, were taken from
http://bowtie-bio.sourceforge.net/bowtie2/index.shtml. Genome alignments were per-
formed on the Athene HPC-Cluster of the University of Regensburg using the
following code to invoke the program.
Bowtie2 : S t a r t e d with arguments :
bowtie2 −p 8 −−phred33 −q −D 20 −R 3 −N 0 −L 20 − i S , 1 , 0 . 5 0 −−rdg 5 ,10 −−r f g 5 ,10 −t −X
700 −−no−mixed −−no−discordant −−no−unal −x hg19 −1 read1−output_paired . f a s t q −2
read2−output_paired . f a s t q −S Bowite−output . sam
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p cpu nodes
phred33 quality scores used in the .fastq file
q a slidingwindow of 5 bases must have an average quality higher
than threshold
D number of failed seed extensions before bowtie2 moves on
R number of times bowtie2 will “re-seed” reads with repetitive
seeds
N number of mismatches allowed in a seed alginment during mul-
tiseed alignment
L length of seed substrings to align during multiseed alignment
i function governing the interval between seed substrings during
multiseed alignment
rdg gap penalties for reads
rfg gap penalties for reference
t print wall-clock time required to load index and align reads
k number of valid alignments looked for, if more than one is found
X maximum insert length
x reference genome
1,2 input: forward and reverse reads as tow separate .fastq files
S output as .sam files
For more information on Bowtie2 the settings,
see http://bowtie-bio.sourceforge.net/bowtie2/manual.shtml
3.7.5 GATC-genome
In order to select for reads resulting from DamID only and not from non specific
amplification of sequences closely related to the DAMID-PCR primer, a GATC
genome was constructed. A python script was created scanning each chromo-
some for the GATC sequence, producing one file per chromosome containing the
coordinates of all GATCs existing in the sequence from the hg19 genome build.
The python script can be found in the appendix (5.6).
3.7.6 R Analysis
The data analysis was performed with R and the DESeq package. Scripts are
supplied in the appendix (5.6).
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Chapter 4
Results
The main function of Ago proteins in the cell is the well characterized silencing
of mRNA expression in the cytoplasm [Huntzinger and Izaurralde, 2011]. How-
ever, during the last decade also nuclear functions of Ago proteins have been de-
scribed for plants, yeast, worms and flies [Gagnon and Corey, 2012; Huang and
Li, 2014]. In these studies, Ago proteins were implicated in DNA methylation,
heterochromatin formation and transposon silencing processes. But also human
Ago proteins were shown to be capable of TGS when artificially recruited to gene
promoters by exogenous small RNAs (see Table 1.1). In addition, several studies
were published applying Ago-specific ChIP-ChIP or ChIP-Seq experiments un-
der different conditions, which suggested chromatin interactions of Ago proteins
and their involvement in regulation of senescence, splicing or gene activation
[Benhamed et al., 2012; Ameyar-Zazoua et al., 2012; Allo et al., 2009; Huang et al.,
2013a]. However, endogenous Ago-chromatin interaction sites in somatic cells as
well as the functional mechanisms are still controversially discussed. Therefore,
we set out to identify gene loci showing Ago-chromatin association mediated by
endogenous targeting mechanisms.
4.1 Biochemical Analysis of Argonaute
Localisation
As a first step the cytoplasmic and nuclear localisation pattern of Ago proteins, as
described by [Robb et al., 2005; Rüdel et al., 2008; Ohrt et al., 2008], was reproduced
applying cellular fractionation to HeLa S3 cells (see Figure 4.1). In addition to
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the accumulation of Ago2 in the cytoplasm also localisation to the nucleus could
be confirmed. The nuclear pool of Ago2 was further precipitated with an Ago2
specific antibody (4E1 hybridoma supernatant) to identify the Ago2 specific band
in the WB (α-Ago2 (11A9)).
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Figure 4.1: Cellular Fractionation of HeLa S3 cells.
HeLa S3 cells (109) were harvested washed and lysed in hypotonic buffer. After douncing
(Pestle B 10 strokes) the nuclei were extensively washed and lysed in Triton X-100 (0.5%)
containing buffer. There is a strong Ago2 signal in the cytoplasm and a weaker one in the
nuclear supernatant and pellet. Both fractions are quite clean according to the nuclear lamin
A/C and cytoplasmic tubulin controls. Nuclear Ago2 was successfully precipitated with the
Ago2 (4E1 hybridoma supernatant) lacking a contaminating band described for the 11A9
antibody used by Rüdel et al. [2008]. Loading: ~20 µg per lane. WB: α-Ago2 (11A9). Samples
were loaded in equal amounts and order on two 10% SDS-PAGE gels (a, b). Further analysis
by WB was performed in parallel.
In a second experiment the chromatin association of Ago2 was examined similar
to an approach recently described by Cernilogar et al. [2011]. In this assay the
cells were lysed with a Triton X-100 containing buffer to remove the cytoplasm
and non chromatin associated proteins (S1) from the chromatin fraction (P1) (Fig-
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ure 4.2). Then, the chromatin was treated with DNase and salt, to release its
associated proteins into the soluble fraction (S2). The nuclear matrix components
were pelleted by centrifugation (P2) (see Figure 4.2). In this assay Ago proteins
could be detected in the S1 fraction but also in the chromatin associated P1 and
S2 fraction. This finding implies a potential involvement of Ago proteins in chro-
matin associated processes ranging from regulation of transcription or splicing to
an influence on chromatin structure.
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Figure 4.2: Analysis of the chromatin association of Ago proteins.
A) Outline representing the different fractionation steps of the chromatin association assay.
B) Western blot probing the different fractions for Ago2 and control proteins. HeLa cells
(4, 4 ∗ 108) were lysed applying a Triton X-100 comprising buffer. The resulting nuclei were
washed and treated with DNase to degrade the chromatin and eventually releasing associ-
ated components into the supernatant. Ago2 was found together with histone H3, a tight
bound chromatin marker, in the chromatin containing fractions P1 and S2. The cytoplasmic
pool of Ago proteins was found in the first supernatant (S1). The soluble protein marker
tubulin was only found in the lysate and soluble fraction. Lamin A/C was used to detect the
nuclear matrix. Loading: ~20 µg per lane. Samples were loaded in equal amounts and order
on two 10% SDS-PAGE gels (a, b). Further analysis by WB was performed in parallel.
4.2 Analysis of Argonaute Recruitment to Chromatin
by ChIP
Information on endogenous triggers for Ago-chromatin association, recruitment
mechanisms or its role in the nucleus is sparse and needs further independent
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validation ([Kim et al., 2008; Hansen et al., 2011; Benhamed et al., 2012; Huang
et al., 2013a]). As a first experimental approach to identify possible target regions
on the chromatin ChIP-sequencing was established and utilized.
4.2.1 Sonication Conditions
The first step in establishing a ChIP protocol in the lab is to find proper sonication
and crosslinking conditions for the cell type used. Therefore, a timecourse experi-
ment with HeLa cells was performed. Following the ChIP protocol (Section 3.6.4),
cells (∼ 3 ∗ 107) were crosslinked for 10 minutes with formaldehyde (1%) at RT,
which forms covalent bonds between proteins and nucleic acids at a distance of
about 2 Å [Das et al., 2004]. This was shown to be sufficient, to crosslink Ago
proteins with chromatin [Janowski et al., 2006]. After preparation of nuclei and
lysis (1.2 ml), the suspension was sonciated and samples (20 µl) were taken at
different time points (0, 5, 10, 15, 20, 25, 30, 35 minutes). Then the crosslink was
reversed by incubation at 65 ◦C and the DNA was precipitated and analysed by
agarose gel electrophoresis. A shortening of the fragment length over time was
observed, which reaches a halt at treatment times of 25 to 30 minutes (Figure 4.3
A). Therefore, a sonication time of 30 minutes which corresponds to a main DNA
fragment size of 100 to 300 nt was chosen for the ChIP-Sequencing experiment.
4.2.2 Control of ChIP Conditions with the Transcription
Factor UBF
The ChIP procedure was controlled by a test experiment using the upstream bind-
ing factor (UBF), an rDNA TF [Prieto and McStay, 2007]. UBF binds throughout
the rDNA repeat and leads to formation of a specialized chromatin structure,
found in nucleolar organizer regions (NORs). The binding of UBF in complex
with the essential transcription factor SL1 is needed for efficient RNA polymer-
ase I transcription initiation [Friedrich et al., 2005]. For this ChIP analysis, H1299
cells (∼ 3 ∗ 107) were crosslinked for 10 minutes with formaldehyde (1%) at RT,
nuclei were prepared and the lysate was sonicated for 25 minutes. For the IP,
protein G sepharose beads were prepared as described in Section 3.5.2, includ-
ing a blocking step with salmon sperm DNA (500 µg/ml) and BSA (100 µg/ml)
for two hours at 4 ◦C. Commercial antibodies specific for UBF and RNA Pol-II
(phospho S2) were used in the ChIP and were bound to the blocked beads for
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Figure 4.3: Establishing of a ChIP experiment.
A) HeLa cells (∼ 3 ∗ 107) were crosslinked for 10 minutes with 1% formaldehyde at RT. Nuclei
were prepared, lysed and sonicated for the indicated times. The samples (20 µl) were reverse-
crosslinked and purified. Then the DNA (2 µg) was analysed by agarose gel electrophoresis
(2 %). B) H1299 cells were crosslinked for 10 minutes with 1% formaldehyde at RT. Nuclei
were prepared and used for ChIP experiments with antibodies specific for UBF and RNA
PolII (phospho S2). An enrichment of UBF at the IGS was observed compared to RNA Pol-II.
Both proteins showed no association with the control locus (tubulin-β promoter). One of two
independent experiments is shown.
two hours at 4 ◦C. RNA PolII has been shown to be phosphorylated at serine
2 of the CTD repeats during the middle phase of transcript elongation, but not
during the initiation of transcription at the TSS [Kim et al., 2010]. The purified
DNA from the ChIP and the input sample were analysed by qPCR. As expected,
there was no accumulation of either of the proteins at the control locus tubulin-β
promoter (TSS). However, the intergenic spacer region of the rDNA (IGS-rDNA)
was clearly enriched for UBF (see Figure 4.3 B). Thus, a successful ChIP of the
known chromatin binding protein UBF indicates that the protocol is established
and can be used for analysis of Ago proteins.
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4.2.3 Analysis of Argonaute Precipitation under ChIP
Conditions
The first Ago ChIP was published by Janowski et al. [2006], for which they used
commercial antibodies against Ago1 and Ago2 designed and tested for WB ap-
plication (Merck, Germany). A test on the specificity of their antibodies under the
rather harsh ChIP conditions could, however, not be found in their study. Since
antibodies are key for the planned experiments and these reagents frequently
cause unspecific results, the ChIP sequencing experiment was designed to be
based on a diverse set of antibodies. Several high specificity antibodies against
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Figure 4.4: Immunoprecipitation of Ago1 and Ago2 under ChIP conditions analysed by
WB.
HeLa cells were crosslinked for 15 minutes with 1% formaldehyde at RT. Nuclei were pre-
pared and lysed by sonication for 10 minutes. The two Ago paralogues were precipitated
by protein-G sepharose beads (GE healthcare) blocked with salmon sperm DNA (500 µg/ml)
and BSA (100 µg/ml) using three different antibodies for each protein. A fraction (4%) of
the eluted chromatin complexes and the input (1%) was analysed by WB using antibodies
specific for Ago1 (1C9) and Ago2 (11A9). All three antibodies seemed to precipitate Ago
proteins, however, the sera 1525 and 1526 showed the highest affinities.
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both Ago1 and Ago2 are available in the lab allowing for ChIP experiments with
three different antibodies, including the ones already published [Janowski et al.,
2006]. The antibodies chosen for the ChIP of Ago1 consist of a hybridoma su-
pernatant (rat) 4B8, the rabbit serum 1525 and the commercial antibody 07-599
of Merck (Germany). The set of antibodies specific for Ago2 comprises the hy-
bridoma supernatant 5D4, the rabbit serum 1526 and the commercial antibody
07-590 of Merck (Germany). Given that Ago proteins do not contain a DNA bind-
ing domain, it was assumed that Ago proteins bind to chromatin mediated by a
nascent transcript (compare Table 1.1), which would in turn be recognized by
the associated miRNA, or by an unknown protein. Therefore, a longer crosslink-
ing time (15 minutes) was tested for the experiment on the pull-down efficien-
cies of the different antibodies. The concentrated commercial antibodies (5 µg)
were directly added to the diluted ChIP lysate and incubated overnight. On the
next morning the antibody Ago complexes were captured by an incubation with
blocked protein G sepharose beads for two hours at 4 ◦C. All other antibodies
(100 µl of serum for rabbit pAB or 1 ml of hybridoma supernatant for rat mAB)
were bound overnight to blocked protein-G sepharose beads on the previous day.
Then, they were incubated with the diluted ChIP lysate overnight. The ChIP con-
ditions and antibody amounts were chosen comparable to Janowski et al. [2006],
except that 1/10 of the beads was used for analysis of the precipitated proteins
by WB.
The western blot analysis of the anti-Ago1 immunoprecipitation under ChIP con-
ditions suggested a low affinity of the commercial antibody, which improved for
the hybridoma supernatant and was highest for the rabbit serum (Figure 4.4, left).
For Ago2, the hybridoma supernatant showed a weak immunoprecipitation effi-
ciency, which was slightly better for the purified commercial antibody. The rab-
bit serum, in turn, bound the highest amount of Ago2 (Figure 4.4, right). The
fragmentation pattern of input DNA after sonication was also analysed on a 2%
agarose gel. The extended crosslinking time of 15 minutes had an adverse effect
on the sonication efficiency and was therefore abandoned.
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4.2.4 Possible Recruitment of Ago to Chromatin Examined
by ChIP-Sequencing
In order to map endogenous chromatin interaction sites of Ago proteins a ChIP-
Sequencing experiment was performed. HeLa cells (∼ 3 ∗ 107 per IP) were form-
aldehyde crosslinked for 10 minutes. After isolation of the nuclei, the lysate was
sonicated for 30 minutes. For immunoprecipitation, the antibody amounts were
kept as before, only the amount of the commercial antibodies was increased to
10 µg per IP. The precipitated DNA was depleted for contaminating RNA or pro-
tein and submitted to Fasteris (Plan-les-Ouates, Switzerland) for library prepara-
tion followed by NGS.
4.2.5 Data Statistics from the NGS Experiment
Fasteris processed the samples as paired-end library including barcodes sequenc-
es for multiplexing. Four samples were mixed (GPK1-4; GPK5-8) and measured
on a HiSeq 2000 (Illumina) in one lane of a flow cell for 100 sequencing cycles.
The base quality of the reads, which is the probability that the corresponding
Figure 4.5: Insert length against read abundance plot of ChIP-Seq.
All reads were searched for occurrence of the 3′-adapter sequence. The sequence was
trimmed off and the length of the resulting inserts was plotted against their relative abun-
dance. The abundance was estimated as a fraction of all insert containing reads. A peak at
the 20th base is observed for all libraries beside the input library, which was supplied at a
higher concentration.
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base call is incorrect, was reported as Phred+64 score. The attributing of the reads
to the different libraries based on their indexes succeeded in 98 % of the reads.
Furthermore, the quality of the reads was in 83% of the cases equal or higher 30,
which is 1 of 1000 bases is incorrect or there is one mismatch in 1 of 10 reads
(length 100).
About 2% of the reads contained an adapter sequence, which was removed by
the company. In addition, a few reads from each library contained the 3′-adapter
from the 20th base on (Figure 4.5). This is a sign for the low DNA concentration
of the libraries according to Fasteris.
Sample Name Library code Index File name Reads
Input GPK-1 CGCATC 110121_SN365_B_s_4_seq_GPK-1.txt 23907169
A1-4B8 GPK-2 CTGAGG 110121_SN365_B_s_4_seq_GPK-2.txt 11116009
A1-Rabbit GPK-3 GTCGCT 110121_SN365_B_s_4_seq_GPK-3.txt 13992230
A1-Millipore GPK-4 TTTCTT 110121_SN365_B_s_4_seq_GPK-4.txt 11358686
Total: 60374094
A2-5D4 GPK-5 TGATAC 110121_SN365_B_s_5_seq_GPK-5.txt 12537320
A2-Rabbit GPK-6 GGTCGC 110121_SN365_B_s_5_seq_GPK-6.txt 14489939
A2-millipore GPK-7 GACAGA 110121_SN365_B_s_5_seq_GPK-7.txt 12361720
Beads GPK-8 AACGCG 110121_SN365_B_s_5_seq_GPK-8.txt 16649529
Total: 56038508
Table 4.1: NGS run information on the HeLa ChIP-Seq experiment.
The high-throughput sequencing experiment was performed on two lanes of a flow cell and
yielded 24 Mio reads for the input and 11 to 14 Mio reads for the different Ago-specific anti-
bodies.
The output of the NGS run is summarized in Table 4.1. The highest read number
was achieved for the input sample, which was supplied in sufficient amounts.
The amount of reads gained from the NGS for all other samples was a lot lower
and ranged from 11 to 16 million. This is due to the low amount of DNA normally
precipitated in a ChIP experiment, resulting in quite limited starting material for
library preparation. This is also supported by the absence of a peak at 20 bp
for the input sample in Figure 4.5, which is present for all immunoprecipitated
samples.
4.2.6 Results from the Bioinformatic Data Analysis
The bioinformatic analysis was performed by Eugene Berezikov (Groningen, Ne-
therlands). After quality control, the reads were mapped to the human genome
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name ID Input Not aligned Aligned exactly 1 Aligned multiple Alignment rate
Input GPK-1 22744602 668389 17217782 4858431 97.06%
A1-4B8 GPK-2 9463861 1003795 5890907 2569159 89.39%
A1-Rabbit GPK-3 12504515 1139482 7447732 3917301 90.89%
A1-Millipore GPK-4 9935458 1599115 5074154 3262189 83.90%
A2-5D4 GPK-5 11110703 945361 6565332 3600010 91.49%
A2-Rabbit GPK-6 12696692 1139457 7482646 4074589 91.03%
A2-millipore GPK-7 10828620 1342803 6638182 2847635 87.60%
Beads GPK-8 14846584 4834654 6944353 3067577 67.44%
Table 4.2: Sequencing depth and mapping of the ChIP-Seq experiment.
The sequencing experiment yielded about 23 Mio reads for the input sample and between
9.4 and 14.8 Mio reads for IP-Samples. The alignment with the human genome was with 83
to 97% quite good for input and IP-Samples and reduced for the beads control.
(hg19) by using the genomatix software (see Table 4.2). The mapping efficiency
ranged form 83 to 97 % and resulted in 9.4 to 14.8 million reads for the IP-Samples,
which could be used in the subsequent analysis. The peak calling was performed
with MACS [Liu, 2014] with the model fold values (10, 30) and a p-value cut off
of 0.00001.
overlap A1-4B8 A1-Rabbit A1-Millipore All peaks
A1-4B8 578 30 42 8
A1-Rabbit 1106 110 8
A1-Millipore 3699 8
A) The number of total and overlapping peaks for Ago1
overlap A2-5D4 A2-Rabbit A2-Millipore All peaks
A2-5D4 2863 71 69 10
A2-Rabbit 871 17 10
A2-Millipore 715 10
B) The number of total and overlapping peaks for Ago2
Table 4.3: ChIP Peak Analysis by MACS.
For all samples peaks were determined by MACS using the empty beads sample as con-
trol. The resulting peaks were compared for overlaps. Unfortunately, there were only a few
conserved peaks between antibodies, which even decreased, when all three antibodies were
included
When the ChIP samples were compared to the bead control for enriched sites,
several hundred peaks were found for each sample (see Table 4.3). Given the
low number of peaks especially for ChIP samples from the antibodies A1-4B8
and A2-Rabbit, the p-value cut off seems rather strict. In addition, the overlap of
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peaks between the different antibodies is a very stringent criterion, leading to se-
lection of only 8 common peaks for Ago1 and 10 for Ago2. Thus, one could think
about relaxing the p-value cut off to increase the pool of peaks for the selection of
overlaps.
For the few overlapping peaks from all three antibodies genomic annotation was
retrieved, to identify a potential common pattern (Table 4.4, see next page). The an-
notation demonstrated, that the peak caller identified repeat associated regions.
A fraction of the peaks localised to centromeric alpha satellites. Manual inspec-
tion of the peak profile in the genome bowser relative to input reads and beads
control convinced of false positive binding for the respective sites.
In summary, no strong enrichment of Ago1 and Ago2 at the chromatin com-
pared to the bead control could be detected under the applied experimental con-
ditions. However, due to the low number of overlapping peaks between the
different utilized antibodies also no pattern analysis for binding sites could be
used. Additionally, weak interaction sites may have been missed by our analysis
due to the limited sequencing depth and the lack of biological replicates for each
ChIP-experiment. Other possible explanations of these negative results could be
a low precipitation efficacy of chromatin-bound Ago by the utilized antibodies,
the limited fractionation efficiency of crosslinked cells, causing cytoplasmic Ago
proteins to be the dominant species in the ChIP lysate or high background noise,
due to the use of non-purified antibodies (4B8, 1525, 5D4 and 1526) in the IP. In
order to address these different questions we pursued two strategies. First, to
improve our results regarding antibody performance in ChIP experiments and
to reduce background noise, antibodies specific for Ago2 were generated and/or
purified against recombinant Ago2. Second, an antibody independent technique
for chromatin protein interaction, called DNA adenine methyltransferase identi-
fication (DAMID), was applied.
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Table 4.4: Annotation for overlapping ChIP peaks of three different antibodies for each
Ago protein.
The overlapping peaks from the three antibodies used for the Ago1 ChIP experiment (A) and
Ago2 ChIP experiment (B) were annotated. Additional information on overlapping repeats,
genes, TF or histione modifications was added based on UCSC.
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4.3 Generation and Purification of Ago Antibodies
The generation and purification of antibodies against a target protein relies on
its recombinant expression. The Ago2 protein was the first time successfully ex-
pressed in E. coli by Rivas et al. [2005] as a GST-fusion protein in HSP90 express-
ing bacteria. However, after several unsuccessful trials in E. coli, SF21 insect cells
were tested by our group for Ago expression. The cDNA sequences of Ago1
to Ago4 were cloned into the pFastBac-HTA vector (Invitrogen) by J.Pfaff and
L.Weinmann.
4.3.1 Expression of Ago Proteins in SF21 Insect Cells
The insect cell expression system utilizing a bacmid encoded Autographa cali-
fornica nuclear polyhedrosis virus in combination with SF21 cells to produce the
protein of interest was used [Fitzgerald et al., 2006]. It is based on the life cycle of
the genetically modified baculovirus, which consists of an early phase (0-6 hours
post infection (hpi)), a late phase (18-36 hpi) and a very late phase (24-96 hpi) [In-
vitrogen, 2002]. During the early phase, the virus gains control over the cell and
prepares for viral DNA replication. Subsequently, DNA replication starts and
membrane coated virus vesicles bud from the cell, to infect neighbouring tissue.
The last phase leads to very high expression of p10 and polyhedrous genes. The
corresponding proteins surround the viral genome and form, so called polyhe-
dral inclusion bodies, which are released by cell lysis [Okano et al., 2006]. The
proteins to be expressed are cloned under the control of the p10 or polyhedrous
promoter and accumulate therefore during the very late phase of infection. The
pFastBac-HTA vectors carrying the Ago cDNA were transformed into DH10B
MultiBac-YFP [Fitzgerald et al., 2006]. Additionally, this bacmid co-expresses YFP
under the polyhedrous promoter and thus facilitates screening and titration ex-
periments. After reconstitution of the virus, the initial virus stock (V0) was gener-
ated (see Section 3.2.6). The expression of HIS-TEV-Ago by cells infected with V0
was confirmed by SDS-PAGE stained with coomassie and also by western blot-
ting using Ago2-specific antibodies. Subsequently, V1 was produced and titrated
for large scale infections. The procedure and workflow for expression of recombi-
nant HIS-TEV-Ago2 is illustrated in Figure 4.6. The titration was monitored over
a time of 72 hours after the day of proliferation arrest (DPA) by SDS-PAGE and
quantification of the YFP fluorescence (Figure 4.6). Measuring the fluorescence of
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Figure 4.6: V1 Virus titration for Ago2.
To determine the optimal virus concentration for large scale infections, a test experiment was
performed. Insect cells were infected with different volumes of genetically modified bac-
ulovirus and were monitored for 72 hours after growth arrest. A) Analysis of Ago2 expres-
sion by SDS-PAGE and coomassie staining under different infection conditions. Ago2 was
strongly expressed at 48 hours in all treatments. B) The viral infection was monitored using
the co-expressed YFP. Here, the over-infection by higher volumes became obvious. For the
smallest volume, still leading to growth arrest (50 µl), a “burst of expression” was observed
for YFP, as described for p10 and polyhedrin genes [Okano et al., 2006].
the co-expressed YFP in cell lysates helped to detect the burst of transcription in
the very late phase of infection, which was described for proteins under control
of the very late promoters, p10 and polyhedrin [Okano et al., 2006](Figure 4.6 B).
As all infection volumes led to growth arrest after 24 hours, the smallest infec-
tion volume was chosen for the large scale infection to prevent negative effects
of over-infection. Furthermore, according to the YFP quantifications, the highest
amount of the recombinant expressed proteins was observed at 48 hours. Given
that huge amounts of cells started to die at 72 hours DPA, 48 hours seemed to be
the optimal time point for harvesting the cells.
4.3.2 Purification of Ago Proteins
The SF21 cells derived from the ovaries of Spodoptera frugiperda are very sensitive
to detergent. In case the target protein is solubly expressed, gentle lysis condi-
tions involving 0.1% NP-40, vortexing and Benzonase treatments are sufficient to
acquire high quality protein. As Ago proteins were soluble in the cytoplasm, gen-
tle lysis was applied. Following clarification by centrifugation and filtration, the
102
4.3. Generation and Purification of Ago Antibodies RESULTS
c
e
ll 
ly
s
a
te
s
o
lu
b
le
 S
N
p
e
lle
t
F
T
A
1
2
B
1
B
2
B
4
B
7
B
8
C
1
C
2
C
3
C
4
170
130
100
70
55
40
35
25
kDa la
d
d
e
r
la
d
d
e
r
HIS-TEV-
Ago2
high salt
wash
imidazol elution
B
1
2
e
m
p
ty
low salt
wash
Figure 4.7: HIS-TEV-Ago2 purification with Ni-IMAC-column.
HIS-TEV-Ago2 was expressed in SF21 cells. The clarified lysate was then applied to a Ni-
IMAC-column, connected to an Äkta purifier system. After three washing steps with differ-
ent salt concentrations, the protein was eluted with an imidazol containing buffer.
lysate was loaded on a Ni-IMAC-column, connected to an Äkta purifier system.
The Ni-IMAC-column was washed with a high salt buffer (2 M NaCl) to remove
nucleic acids, which are in part non-specifically bound, due to Ago2’s high pI
value of 9.32. For the elution step, several schemes were tried. An elution gra-
dient, did not lead to pure fractions of the protein but rather to its dilution. A
two step protocol starting with 3% elution buffer for 10 column volumes, fol-
lowed by a steep gradient to 50% elution buffer, led to a dirty first peak, which
was followed by a clean, but minor second peak. To generate more Ago in the
clean fraction an elution was performed with 50% elution buffer to recover all
HIS-TEV-Ago2. The first purification round yielded already a quite pure protein,
see Figure 4.7 fractions B12 to C4.
After TEV cleavage, the sample was loaded again on a Ni-IMAC-column. Nearly
all of the co-purified proteins stayed on the column, while Ago2, deprived of its
6×-HIS-tag, accumulated in the flow-through (Figure 4.8 A). After concentration
of the protein, the sample was loaded on a gelfiltration column (Superdex 16/60).
Ago2 eluted in two peaks: one around 39 to 64 ml (fractions A1-A5) and a second
one around 65 to 80 ml (Figure 4.8 B, fractions A6-A8).
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Figure 4.8: Ago2 purification by Ni-IMAC- and gelfiltration column.
A) The HIS-TEV-Ago2 protein eluted from the first Ni-IMAC purification was dialysed
overnight in TEV protease containing buffer. The protein, now released from the HIS-tag,
was loaded on a Ni-IMAC-column, to remove the HIS-tag and the TEV protease. Ago2 was
recovered in the flow-through and concentrated by a membrane based concentrator. B) Then
the protein was loaded on a gelfiltration column. Two peaks were observed in the 280 nm
absorption profile. Both peaks contained Ago2. The first peak with a high 260 nm absorption
comprised presumably nucleic acid bound Ago2, whereas the second had a lower 260 nm
reading.
The fractions of the second peak were again concentrated in a centrifugal concen-
trator and used for rabbit polyclonal antibody production by Davids Biotechnol-
ogy (Regensburg, Germany).
4.3.3 Side Project on Recombinant Expression of PIWI Proteins
In addition to Ago1 and Ago2, I also expressed other members of the Argonaute
protein family, the Piwi proteins in SF21 insect cells. Until today, biochemical
approaches characterizing human PIWI proteins lack far behind the genetic in-
formation gained. Therefore, trials for recombinant expression of Piwi proteins
were initiated. Based on the positive results for Ago proteins, human Piwis were
cloned into pFASTBac HTA by A.Frohn, a former graduate student. The reconsti-
tution of baculoviruses expressing Hili, Hiwi and Hiwi2 worked nicely. The viral
titres were also good enough to infect host cells and led to the expected growth
arrest. However, the protein production was really low and batch purification of
these constructs with an affinity matrix did not yield protein amounts, convinc-
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ing of a successful large scale production. Given that Piwi proteins play a role in
germ cell development, the overexpression of these proteins in an ovary derived
cell line (SF21) might not be tolerated. This may lead to the observed repression
of expression.
4.3.4 Test for Specificity of the Rabbit Sera
The rabbit sera against full length Ago2 were tested on wildtype as well as lysates
from FH-Ago1 to FH-Ago4 overexpressing HEK-293 cells. The lysates were load-
ed four times, in sets of five, on a SDS-PAGE gel. After blotting, the WB mem-
brane was cut in four pieces and either pre-immune serum or immunized serum
was applied (Figure 4.9 A). The serum of rabbit 1 showed signals above back-
ground at about 75 and 110 kDa in all lanes. Ago migrates at a size of 100 kDaon
an SDS-PAGE gel and the FH-tag adds another 5 kDa. For rabbit 2 samples
weaker signals were observed. Only in the lanes loaded with FH-Ago1 and 2 a
prominent band at approximately the right position was observed. Next, the an-
tibodies were tested against recombinant Ago2 (Figure 4.9B). Even though there
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Figure 4.9: Test on Ago2 specificity of rabbit serum.
Rabbit serum (pre-immune and final bleed) of two rabbits immunized with full-length Ago2,
was used as primary antibody for WB in a dilution of 1:10. A) The lanes contained HEK-293
cell lysates from untransfected cells and cells transfected with plasmids carrying FH-Ago1
to FH-Ago4. Serum 1 showed a signal for Ago1 through Ago4 and another presumably
unspecific band at around 75 kDa on the WB. The serum of rabbit 2 was specific for Ago1
and Ago2. B) Recombinant HIS-TEV-Ago2 was loaded and a WB was decorated with the
sera of rabbit 1 and 2. Here both sera detected Ago2.
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were 600 ng of recombinant protein loaded, the WB signals were weak. However,
both antibody sera recognized recombinant Ago2.
All in all, these data suggest that the antibody produced by rabbit 1 recognizes
Ago1 to 4 and the one from rabbit 2 seems to be more specific for Ago1 and 2. As
both antibodies were not entirely specific for Ago2 but for several Ago proteins
and the second rabbit serum seemed to give a weaker signal in WB, the serum of
rabbit 1 was chosen for further purification.
4.3.5 Affinity Chromatography of Antibodies Using the
Target Protein
There are two ways commonly used to purify antibodies by affinity purification
from serum. Either the serum is incubated with Protein-A/G, which binds to the
Fc part of any IgG antibody, or with the target protein containing the epitopes,
which are recognized by the variable domains of the antibody. In order to pu-
rify Ago2 antibodies specifically from rabbit serum, HIS-TEV-Ago2 was isolated
from insect cells and purified by a Ni-IMAC-column followed by gelfiltration on
a Superdex 16/60. The resulting protein (1 mg) was covalently coupled to CNBr
column material (1g) (see Section 3.5.16). Then, Ago2-specific antibodies were
purified from the serum 1526, taken form a rabbit, immunized with an Ago2
N-terminal peptide (serum already present in tha lab), and the serum of rabbit 1
from Davids Biotechnology, (see above; for method see Section 3.5.17). The pu-
rification process was analysed by SDS-PAGE is shown for the Ago2 antibody
from serum 1526 (Figure 4.10 A). Purification of the newly generated antibody
led to similar results (data not shown).
The detection limit in western blot of the purified 1526-Ago2-antibody was also
tested. Recombinant HIS-TEV-Ago2 protein and HEK-293 cell lysate were loaded
on a SDS-PAGE gel and Ago2 was detected by WB using the 1526 antibody (Fig-
ure 4.10 B). Here the antibody gave a good signal for recombinant HIS-TEV-Ago2.
The signal for endogenous Ago2 was rather low but still detectable. Since the
main aim of this project was to characterize potential Ago-chromatin interactions,
the Ago2 binding efficiency under ChIP conditions was tested next.
106
4.3. Generation and Purification of Ago Antibodies RESULTS
100
130
170
70
55
40
35
25
kDa la
d
d
e
r
S
e
ru
m
 1
:2
5
F
T
 1
:2
5
Wash
1
 1
:2
5
Eluate
F
T
 c
o
n
c
e
n
tr
a
to
r
c
o
n
c
e
n
tr
a
te
d
 A
B
P
e
lle
t 
1
1
0
0
0
2 3 4 5 1 2 3 la
d
d
e
r
e
m
p
ty
Coomassie: AB 1526 purification
A
100
130
170
70
55
40
35
25
kDa
15
WB: AB 1526
anti-Ago2 (1:500) 
Ago2
la
d
d
e
r
8
0
0
 n
g
8
0
 n
g
H
E
K
2
9
3
-c
e
ll 
ly
s
a
teB
8
 n
g
H
IS
-T
E
V
-
A
g
o
2
heavy
chain
light
chain
albumin
Figure 4.10: Antibody purification by Ago2 affinity column. A) For antibody (1526) pu-
rification, the rabbit serum (10 ml) was cleared by centrifugation and incubated with the
HIS-TEV-Ago2-CNBr-column rotating at 4 ◦C for 2 hours. After several washing steps the
antibody was eluted with acidc elution buffer and concentrated. The purification was anal-
ysed by SDS-PAGE. B) The detection limit of the antibody (1526) in WB was tested with
purified Ago2 protein and HEK293 lysate.
4.3.6 Efficiency of Immunoprecipitation under ChIP Conditions
After affinity purification of the antibodies against their target protein, the bind-
ing efficiency under ChIP conditions was tested (Section 3.6.4) and compared
with other antibodies (Figure 4.11). MRC-5 cells used in subsequent DAMID ex-
periments were crosslinked with 1% formaldehyde for 10 minutes at RT. The cells
were lysed by sonication for 10 minutes at 4 ◦C and cellular debris was pelleted
by high speed centrifugation. For the IP, the following purified Ago2-specific an-
tibodies were used: 11A9 (5 µg rat mAB), 1526 (5 µg rabbit pAB), rabbit 1 Davids
(4 µg rabbit pAB), 2A8 (5 µg mouse mAB) and rabbit IgG (5 µg) as negative con-
trol. All antibodies precipitated a band at a size of Ago2, detected by the 11A9
antibody (Figure 4.11). The band from the 11A9-IP migrated somewhat faster.
This might be due to the high amount of protein bound by the antibody, leading
to overloading the gel.
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Figure 4.11: Comparison of the pull-down efficiency of several Ago2 antibodies under
ChIP conditions.
MRC-5 cells were crosslinked with formaldehyde (1%) and sonicated. The clarified lysate
was diluted ten fold in ChIP dilution buffer and was incubated for 2 hours at 4 ◦C in the
presence of different Ago2 antibodies. Then Protein G agarose beads were added for another
hour at 4 ◦C. After several washing steps, the beads were eluted with SDS-PAGE loading
dye. Input and the IPs were loaded on a 10% SDS-PAGE gel and were analysed by WB. Ago2
was detected with the 11A9 antibody. It appears that all antibodies show an Ago2 band.
However, there seems to be a slight difference in migration speed of Ago2 for the different
lanes. Input, the 1526, the Rabbit 1 Davids and the 2A8 antibody showed a slightly slower
running behaviour compared to the Ago2 band recognized by 11A9. The 11A9 antibody
yielded also other signals apart from Ago2. A distinct band at 155 kDa, which was described
for the antibody and might be the SMRC1 protein, a member of the DNA remodelling com-
plex SWI/SNF, could not be found [Rüdel, 2011]. All the faster migrating bands were not
further evaluated in Rüdel [2011].
The 155 kDa protein, SMRC1, which is a member of the SWI/SNF complex and
was described to be pulled-down in IP’s of the 11A9 antibody [Rüdel, 2011],
was not observed (Figure 4.11). Unfortunately, both pan-Ago antibodies (rab-
bit 1 Davids and 2A8) precipitated less Ago2 than the Ago2-specific antibodies
11A9 and 1526.
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In conclusion, a set of two Ago2-specific purified antibodies: 11A9 (ProteinA pu-
rified, E.Kremmer, Munich, Germany) and 1526 (protein specific purification) as
well as a purified pan-Ago-specific antibody: rabbit 1 Davids (proteins specific
purification) are available for further ChIP experiments. All of these successfully
immunoprecipitated Ago2 under ChIP conditions and will hopefully result in
strong signal to noise ratios in subsequent validation experiments of peaks de-
tected by DAMID (see below).
4.3.7 Side Project on Ago1 Loading
Parallel to Ago2, also Ago1 was expressed in insect cells and successfully puri-
fied. Having the Ago1 recombinant protein at hand, a question regarding the
affinity for single or double stranded siRNA of Ago1 could be addressed. With
these experiments I contributed to the publication by Petri et al. [2011]. RNA
interference (RNAi) is a post transcriptional gene silencing mechanism found
in many eukaryotes. Its effector complex is the RNA induced silencing com-
plex (RISC), comprising an Ago protein and a single-stranded RNA, the guide
strand. The RISC targets complementary RNAs resulting in cleavage and even-
tually degradation of the respective RNA. In human cells this process is invoked
by transfection of a small double stranded RNA molecule with a length of ~21
nt, called siRNA [Meister and Tuschl, 2004]. Following transfection, siRNAs are
loaded into all four human Ago proteins Liu et al. [2004]. While Ago2 efficiently
removes one of the two RNA strands due to its cleavage activity [Matranga et al.,
2005; Rand et al., 2005; Leuschner et al., 2006], this mechanism is absent from
Ago1, 3 and 4, leaving them bound to the siRNA duplex [Liu et al., 2004; Meister
et al., 2004].
For Aquifex aeolicus Ago Yuan et al. [2005] tested the binding affinity for different
small single and double stranded nucleic acid molecules and found a strongly di-
minished binding to double stranded RNA as compared to single stranded RNA.
Thus, we wanted to test if human cleavage deficient Ago proteins also show
a higher affinity to single-stranded RNA as compared to siRNA duplexes. To
this end, recombinant Ago1 was incubated with a radio-labelled single-stranded
siRNA guide or double stranded siRNA. Ago1 was precipitated using Ago1-spe-
cific antibodies and washed several times. The bound RNA was eluted and the
associated radioactivity was quantified using a scintillation counter.
Excitingly, Ago1 bound ten fold stronger to the guide strand than to the duplex
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Figure 4.12: Analysis of Ago1 affinity for siRNA guide strand or duplex.
Recombinant Ago1 was purified from insect cells and incubated with radioactively labelled
siRNA guide strand or duplex. After precipitation of Ago1 with 4B8 antibody, immobilized
on Protein G Sepharose, or empty control beads, the bound proteins were washed and the
specifically bound siRNAs were eluted by Proteinase K digest. The radioactive signal of the
IP and Input samples was quantified with a scintillation counter. The affinity of Ago1 for
the guide strand was about ten fold higher than for the siRNA duplex. The average of three
independent experiments is shown. Error bars, SD
RNA (see Figure 4.12). Inside the cell this means that siRNA duplexes dissociate
from Ago1 with a high rate, while they are transformed into stable RISC com-
plexes by Ago2. This may result in an increased loading of Ago2 with siRNAs
compared to its relative cellular abundance, which can be further amplified by
thermodynamically stabilised siRNA duplexes as described in Petri et al. [2011].
4.4 Identification of Ago-Chromatin Interaction Sites
Applying DAMID
In previous experiments the interaction of Ago with chromatin was evaluated
using ChIP. Based on the negative result of the ChIP assay, which is especially
sensitive to cytoplasmic Ago contamination and the quality of the utilized anti-
bodies, an antibody-independent technique, called DAMID, was employed. This
in vivo method relies on the stable expression of a fusion protein consisting of
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Figure 4.13: Model of the DAMID procedure.
An N-terminal fusion of Dam with Ago is shown. The fusion protein is most likely recruited
to the chromatin by complementary base pairing of the bound small RNA with a nascent
transcript or by an unknown factor. Then, GATC stretches in the vicinity of the chromatin
binding site are methylated by Dam, whereas the GATCs further up- or downstream are not
modified. The specific methylation marks, absent from human DNA can be analysed by
enzymatic steps of the DAMID protocol.
DNA Adenine Methyltransferase (Dam) from E. coli and the target protein (Fig-
ure 4.13). Notably, Dam is fully functional as N- and C-terminal fusion [Steensel
and Henikoff, 2000]. Ago proteins, however, can only be modified at the N-termi-
nus because the C-terminal carboxyl-group is required for proper folding. Dur-
ing the course of the experiment, a fraction of the fusion protein accumulates in
the nucleus and marks native chromatin binding sites by preferential methyla-
tion of GATC residues at N6 of the adenine close to putative chromatin binding
sites [Greil et al., 2006] (Figure 4.13). Given that adenine methylation is absent
from mammals, DAMID produces a unique mark, which is selected for by DpnI
digestion (restriction site GmeATC) and selective PCR. Subsequently, the DNA
fragments are analysed by a high throughput method. Another critical point
is the low expression level of the Dam-fusion protein, otherwise saturation of
methylation levels are reached and a quantitative readout is impossible. This low
level is achieved by employing a non induced heat shock promoter for control
of Dam-fusion protein expression [Vogel et al., 2007]. The low expression level is
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an advantage of the technique, granting that the modified protein does not inter-
fere with critical functions of the endogenous protein, which could compromise
important cellular functions [Greil et al., 2006]. Even though the target protein
is present in low levels, it seems that the Dam-fusion protein can easily accom-
plish methylation of its target sites [Greil et al., 2006]. This is probably due to the
fact, that most chromatin modifying factors have residence times in the range of
minutes on a specific locus and therefore quickly change their positions [Phair
et al., 2004]. Consequently, a stable expression of the fusion proteins for incuba-
tion times above 24 hours should yield a detailed report on all possible binding
sites.
4.4.1 Design of the Ago-DAMID Experiment
Similar to the ChIP experiment described above, putative chromatin interaction
sites of Ago1 and Ago2 should be identified. To distinguish between miRNA or
other small RNA-guided Ago1/2 recruitment to chromatin, the Ago2-Y529E mu-
tant discovered by Rüdel et al. [2011], was included in the screen. The tyrosine to
glutamate substitution in the MID domain at position 529 of this mutant protein
creates a negative charge in the 5′-binding pocket of Ago2 and strongly dimin-
ishes small RNA binding due to repulsion of the 5′-phosphate. Furthermore, the
stacking interactions of the de-localised pi-system of the hydroxyl-phenyl ring of
tyrosine with the base at the 5′-position of the miRNA are also destroyed by this
mutation. Since this mutant is correctly folded and even functional in cleavage
assays with a 5′-methylated RNA, it is a perfect control for miRNA-independent
chromatin interaction [Rüdel et al., 2011]. In addition, the Dam protein alone
was used to control for the different accessibility states of chromatin [Greil et al.,
2006]. Serving as positive control, Cbx1, heterochromatin binding protein HP1-β
was included in the assay, for which DAMID has been performed and datasets
are available for comparison Vogel et al. [2007].
4.4.2 Test on Dam-Ago2 Functionality by Cleavage Assay
In order to use Ago2 in a DAMID experiment, the correct folding and function-
ality of the Dam-Ago2 fusion protein needs to be asserted. The Ago subfam-
ily of proteins consists of Ago1, Ago2, Ago3 and Ago4 [Carmell et al., 2002].
However, only Ago2 is able to cleave RNA, when loaded with a complementary
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small RNA [Meister et al., 2004; Liu et al., 2004; Hauptmann et al., 2013]. There-
fore, the cleavage assay used in the aforementioned publications, can be applied
to test the catalytic activity of the Dam-Ago2 fusion protein. After cloning of
the target proteins into lentiviral transfer vectors, the expression (Ago1, Ago2,
Ago2-Y529E) and cleavage competence (Ago2) of the N-terminally tagged pro-
teins were tested (Figure 4.14). The plasmids were transfected into HEK-293 cells
(see Section 3.3.6). The expression of the fusion constructs was tested by SDS-
PAGE and WB (Figure 4.14, A, B). Here, the size shift of the Dam-Ago fusion
proteins compared to the Flag-HA-tagged (FH-)Ago used as control and endoge-
nous Ago proteins is nicely shown. Then, the IP efficiencies were tested for the
different constructs, were FH-tagged proteins were highly enriched compared
to a rather intermediate level for Dam-Ago fusion proteins and low signals for
the Dam and Cbx1 controls (Figure 4.14, C, D). This difference in signal inten-
sity after IP is probably due to the lower expression level of the Dam-fusion
proteins compared to the FH-tagged ones (Figure 4.14, A, B). Subsequently, the
cell lysates were used for a cleavage assay (compare Section 3.6.9) [Meister et al.,
2004]. Here, the transfected Dam fusion proteins were immunoprecipitated from
the cell lysate and incubated with an artificial target RNA. This target RNA is
fully complementary to miR-19b, which is highly abundant in HEK-293 cells. For
in vitro cleavage reactions, 5′-cap-labelled substrate RNA was incubated with dif-
ferent fusion proteins. The reaction was stopped by Proteinase K digest and the
isolated RNA was size separated on a sequencing gel and visualised with auto-
radiography (Figure 4.14, E). FH-Ago1 and FH-Ago2 were included as controls
in the cleavage assay [Hauptmann et al., 2013].
Figure 4.14 (on the next page): Test on expression and cleavage competence of Dam-Ago.
HEK-293 cells were transfected with Dam-fusion constructs and several controls. The ex-
pression of the fusion proteins was analysed by WB: A) using Ago-specific antibodies and
B) V5- and HA-tag antibodies. C, D) The immunoprecipitation efficiencies of the different
tagged fusion proteins were analysed. E) For the cleavage assay V5-tagged Dam-fusions and
FH-tagged Ago1 and Ago2 were immunoprecipitated. The proteins were incubated with
radioactively labelled RNA substrate and the cleaved fragments were size separated on a se-
quencing gel followed by auto-radiography. Flag-HA-Ago2 and Dam-V5-Ago2 were able to
cleave the target-RNA, as expected. FH-Ago1 and the Dam fusion proteins of Ago2-Y529E,
Dam-Cbx1 and Dam showed only background activity.
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In summary, both Ago2 constructs were able to cleave the target RNA, comple-
mentary to miR-19b. The intensity difference is explained by the much stronger
expression level of FH-Ago2 compared to a moderate to low expression of Dam-
Ago2, which results in a higher cleavage rate for FH-Ago2. All other constructs
were correctly expressed and, as expected, inactive in the cleavage assay. Thus,
the Dam-Ago2 constructs are correctly folded and a meaningful DAMID experi-
ment can be performed.
4.4.3 DAMID Experiment with MRC-5 cells
As Ago1 and Ago2 were both implied to have a nuclear function for example
[Robb et al., 2005; Janowski et al., 2006], this project focused on these two mem-
bers of the Ago subfamily. To elucidate their endogenous chromatin interac-
tion sites, MRC-5 cells, primary human lung fibroblasts, were transduced with
lentiviruses encoding for Dam-Ago1, Dam-Ago2, Dam-Ago2-Y529E, Dam-Cbx1
and Dam. After 72 hours of incubation time, the experiment was stopped and
genomic DNA was isolated, following RNaseA treatment.
The viral titre was estimated using a PCR-based protocol (Section 3.6.8) and con-
firmed that the cells were infected with a multiplicity of infection (MOI)<1. This
low MOI, which is less than one infectious virus per cell, reduces the risk of sev-
eral Dam-fusion protein insertions in the genome of the cells and thus ensures the
low expression level required for DAMID (Figure 4.15a). Subsequently, the DNA
fragments, methylated by the Dam moiety, were enriched by enzymatic digest
and GATC selective PCR (Section 3.6.5). A fraction of the amplified fragments
was analysed on an agarose gel (2%). The different Dam-Ago proteins produced
a strong band pattern overlaying a weak background smear. This suggests ampli-
fication of only a few selected target sequences or sequences of a certain length.
In contrast, the controls, Dam and Dam-Cbx1, produced a smear ranging from
about 100 bp to 3 kb, implying a vast amount of different amplified sequences.
The specificity of the DAMID procedure was additionally controlled by samples
lacking DpnI or T4-DNA-Ligase. DpnI digestion specifically recognizes methy-
lated GATC residues, while the T4-DNA-Ligase is required for fusion of a specific
PCR adapter. Therefore, both samples should not contain PCR-amplifiable frag-
ments, which is demonstrated in Figure 4.15a. As the range of the enriched DNA
fragments was between 100 bp and 3kb and thus too long for applying NGS di-
rectly, the DNA was sonicated to a mean fragment length of 250 bp, which is
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required for Illumina NGS. Then paired-end NGS-libraries were prepared from
these shorter DNA pieces using the Illumina NGS library preparation kit. This
treatment rendered the low complexity samples of the Dam-Ago experiments
into higher complexity libraries, regarding the length of the sequences and to
a minor part, the difference in start and/or end points. The overall sequence con-
tent, of course, was restricted to the few selected input sequences visible on the
agarose gel for the Dam-Ago treated cells.
Figure 4.15: Preparation of methylated DNA fragments from DAMID.
MRC-5 cells were transduced with lentiviruses encoding for Dam-fusion proteins. Following
an incubation for 72 hours, the DNA was extracted from the cells. A) The viral titre was es-
timated by qPCR, comparing the genome-integrated, viral DNA to an endogenous genomic
locus. Here a MOI of 0.2 was found. B) The methylated DNA fragments, marking Ago
chromatin interaction sites, were selected, enriched by PCR and analysed on an agarose gel
(2%). Dam-Ago fusion proteins produced a weak background smear with several prominent
bands, which was rather unexpected. The control proteins Dam and Dam-Cbx1, showed a
homogeneous smear, indicating a broad range of different bound loci. DpnI and T4-DNA-
Ligase controls confirmed the specificity of the method.
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The Illumina libraries were sent to the Kompetenz Zentrum für Fluoreszente Bio-
analytik (KFB, Regensburg, Germany) for high-throughput sequencing. Due to
technical problems at the KFB the libraries were finally sequenced by an Illumina
Sequencing Facility (Keith Moon, Illumina Union City, CA, USA) on a HiSeq2000.
4.4.3.1 Analysis of the Band Pattern in Ago DAMID Experiments
As the band pattern observed for Dam-Ago treated cells was unexpected and im-
plied a specific amplification of only few selected genomic loci, a deeper analysis
of these bands was performed. Therefore, the DNA extracted from Dam-Ago
treated cells was subjected to the DAMID protocol and loaded on an agarose gel.
Some of the prominent bands observed for cells expressing Ago fusion proteins
but not for control proteins were isolated from the gel. After gel extraction and
purification of the DNA fragments, these were cloned into pGEM-T-easy vec-
tors. Four different DNA bands, starting from the strongest, were selected for
Dam-Ago1 and Dam-Ago2 and for each band eight bacterial clones were anal-
ysed by Sanger sequencing. Subsequently, the sequencing reads were mapped to
the human genome using the blast algorithm [Altschul et al., 1990]. The results
are summarized in Table 4.5. Unfortunately, only few of the sequencing runs for
Dam-Ago2 clones were successful due to technical problems at GATC Biotech
AG (Konstanz, Germany).
There were several mitochondrial DNA sequences found in bacterial clones from
Dam-Ago1 and Dam-Ago2 bands (Table 4.5). Furthermore, sequences from var-
ious chromosomes were identified, which did not converge to one gene locus or
type of repetitive element. In order to get a better understanding of the sequence
fragments found here, they could be compared with the NGS data of the Dam-
Ago1 and Dam-Ago2 libraries. The high number of mitochondrial sequences
cloned especially from Dam-Ago1 bands, suggests that the observed band pat-
tern in Dam-Ago Samples of the DAMID experiment may derive from mitochon-
drial sequences.
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Ago1 bands comment length seq frag chrom start end length aligned
Ago1-1_1 match 1043 chrM 1917 2917 1000
Ago1-1_2 match 1128 chrM 1940 2940 1000
Ago1-1_3 match 999 chrM 1966 2966 1000
Ago1-1_4 match 1009 chrM 10990 11800 810
Ago1-1_5 no sequence
Ago1-1_6 match 924 chrM 11074 11870 796
Ago1-1_7 match 1169 chr2 154726508 154727508 1000
Ago1-1_8 match 1029 chrM 10965 11900 935
Ago1-2_1 match 571 chr1 50204840 50205365 525
Ago1-2_2 match 1139 chr6 56688282 56689282 1000
Ago1-2_3 no sequence
Ago1-2_4 match 1025 chrM 12418 13318 900
Ago1-2_5 match 1041 chrM 12402 13302 900
Ago1-2_6 match 1056 chr19 867534 868434 900
Ago1-2_7 match 800 chrM 12279 13179 900
Ago1-2_8 no sequence
Ago1-3_1 match 1124 chr19 21775122 21776022 900
Ago1-3_2 no sequence
Ago1-3_3 no sequence
Ago1-3_4 no sequence
Ago1-3_5 match 1120 chr21 37578897 37579771 874
Ago1-3_6 match 640 chr3 19988849 19989349 500
Ago1-3_7 no sequence
Ago1-3_8 match 1133 chr20 61070495 61071495 1000
Ago1-4_1 match 1097 chr1 167794091 167794851 760
Ago1-4_2 match 262 chrM 552 754 202
Ago1-4_3 no sequence
Ago1-4_4 match 801 chr17 29257881 29258618 737
Ago1-4_5 match 823 chr1 567455 568212 757
Ago1-4_6 match 769 chr1 180126402 180127106 704
Ago1-4_7 match 849 chr1 568209 568988 779
Ago1-4_8 match 724 chr19 17598466 17599066 600
Ago2 bands comment length seq frag chrom start end length aligned
Ago2-1_1 no match 1204
Ago2-1_2 no sequence
Ago2-1_3 no match 1148
Ago2-1_4 no match 1178
Ago2-1_5 match 1162 chrM 1211 2347 1136
Ago2-1_6 no sequence
Ago2-1_7 no sequence
Ago2-1_8 no match 1076
Ago2-2_1 no sequence
Ago2-3_1 no sequence
Ago2-3_2 match 1007 chr3 93636845 93637835 990
Ago2-3_3 match 1117 chr3 93636846 93637949 1103
Ago2-3_4 match 1104 chr16 89343144 89343370 226
Ago2-3_5 match 1067 chr3 93636842 93637816 974
Ago2-3_6 match 1152 chr21 46723557 46724574 1017
Ago2-3_7 match 1051 chr3 93636849 93637835 986
Ago2-3_8 no sequence
Ago2-4_1 match 847 chr16 88620267 88621049 782
Ago2-4_2 match 725 chrM 7886 8599 713
Ago2-4_3 match 1169 chr3 170108506 170109348 842
Ago2-4_4 no sequence 0
Ago2-4_5 no match 42
Ago2-4_6 match 1099 chr9 99678548 99679240 692
Ago2-4_7 match 1125 chr16 4512923 4513722 799
Ago2-4_8 match 1116 chr16 83554430 83555221 791
Table 4.5: Sanger analysis of Ago1 and 2 band pattern on Agarose Gels. DNA result-
ing from the DAMID procedure was loaded on an agarose gel. The four most prominent
bands of the Dam-Ago1 and Dam-Ago2 samples were extracted from the gel, cloned and
sequenced. The resulting sequences were mapped to the human genome using the blast
algorithm [Altschul et al., 1990].
118
4.4. Ago Chromatin Interaction Sites by DAMID RESULTS
4.4.3.2 Bioinformatic Analysis of DAMID in MRC-5
The Dam-Ago libraries were generated in paired-end mode and sequenced on an
Illumina HiSeq2000 with a read length of 100 bp for forward and reverse read.
The samples were indexed with different primers during library preparation and
could therefore be mixed and sequenced in parallel on several lanes of a flowcell.
Sample name Library code Index Reads
Dam-Ago1 1 CGATGT 18516843
Dam-Ago2 2 TGACCA 23181289
Dam-Ago2-Y529E 3 ACAGTG 17882388
Dam-Cbx1 4 GCCAAT 20021720
Dam 5 CAGATC 19134936
Table 4.6: NGS-DAMID run information for MRC-5 Cells.
The read numbers received were comparable for all libraries, setting a good basis for further
analysis.
The received reads were of good quality and general information on the samples
is shown in Table 4.6. For each sample at least 17 Mio reads were generated
forming a good basis for subsequent analysis.
4.4.3.3 Data Analysis Using the Software Homer
The data from the NGS run was forwarded to the Institute for Functional Ge-
nomics at University of Regensburg (Engelmann and Wang) for bioinformatic
data analysis. The reads were aligned to the human reference genome using the
alignment software Bowtie [Langmead et al., 2009]. The overall alignment rate
was good for all samples (Table 4.7).
Sample Name Mapping Rate
Dam-Ago1 98.75%
Dam-Ago2 98.54%
Dam-Ago2-Y529E 98.87%
Dam-Cbx1 97.39%
Dam 98.67%
Table 4.7: Mapping rate of MRC-5 DAMID samples against the human reference genome.
Using the read alignment software Bowtie the data from the NGS analysis was mapped to
the human genome with good alignment rates for all samples.
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Sample Name Total Total size:1kB
Dam-Ago1 48864 6289
Dam-Ago2 42882 866
Dam-Ago2-Y529E 73217 8828
Dam-Cbx1 75569 1723
Dam NA NA
Table 4.8: Peak calling with the software package homer. The aligned reads were analysed
with the ChIP-Seq analysis package homer. The control sample Dam was used as input
control and enrichment was assessed for the different samples. A huge number of peaks was
identified for all samples. As a filter only peaks with a size around 1 kB were taken forward.
Applying the software homer, which is designed for ChIP analysis, peaks were
called using the reads from the DAMID control experiment Dam as input sam-
ple (Salk Institute: http://homer.salk.edu/homer/chipseq/). In theory, the Dam
protein should be able to randomly GATC-methylate all accessible DNA and thus
create fragments from these loci across all cells used for the experiment. As the
Dam-fusion proteins are bigger and sterically hindered compared to Dam, the
non-specific methylation rate should be reduced and most of the methylation
events should occur at the in vivo targeting site in the treated cells. This causes
an increased methylation ratio of targeted regions for Dam-fusion proteins com-
pared to Dam integrating over the respective cell population. The results of the
peak calling are summarized in Table 4.8. Between 42000 and 75000 potential
peaks were identified by homer. As a first filter only peaks of a length around 1
kB were taken forward for validation.
Homer leaves the user with two scores, the peak score and the focus ratio (see
Table 4.9, 4.10). Both values were used to sort the data and top peaks were anal-
ysed manually using the UCSC genome browser in combination with .bedGraph
files depicting the read distribution and accumulation at a peak site. Here, the
focus ratio showed to be the better value to identify peaks for subsequent valida-
tion. The top 40 peaks defined by homer sorted according to their focus ratio are
shown for Dam-Ago1 and Dam-Ago2 in the Tables 4.9, 4.10 (see next pages).
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Table 4.9: Dam-Ago1 enriched sites in MRC-5 based defined by homer analysis.
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Table 4.10: Dam-Ago2 enriched sites in MRC-5 called by the homer package.
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Subsequently, the peaks were classified in genomic elements and the frequencies
were compared to the human genome (build hg19) (see Figure 4.16). The peaks
from the Dam-Ago1 and 2 transduced cells showed enrichment for the class of
LINE elements and intronic regions. A comparison of Dam-Ago2 with Dam-
Ago2-Y529E hints to a potentially small RNA-dependent recruitment to SINE
elements, which are, however, not enriched compared to the frequency of the ele-
ment in the human genome (hg19). The enrichment of the class of LINE elements
is seen for Dam-Ago2 and Dam-Ago2-Y529E suggesting either non-specific or
small RNA-independent association of Dam-Ago2 with the respective chromatin
(Figure 4.16). As mentioned before, we observe a strong enrichment of Dam-Cbx1
for SINE elements compared to the frequency in the human genome (hg19).
Figure 4.16: Classification of detected peaks into genomic elements.
Comparison of the frequencies of peaks in certain genomic classes of Dam-Ago1 and Dam-
Ago2 with the human genome revealed a potential enrichment for the class of LINE elements
and introns. Dam-Cbx1 was highly associated with SINE elements.
The positive control Dam-Cbx1 was included in our analysis and yielded 1723
peaks. To assess the quality of our experiment we compared our data with the
original publication [Vogel et al., 2006]. Ten of our peaks overlapped with ex-
onic regions of genes, seven of these were also found enriched in the Dam-Cbx1
of MCF7 cells [Vogel et al., 2006]. When a broader set of peaks was examined,
which also containing gene introns, 66 of 79 peaks were found enriched in the
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reference data set [Vogel et al., 2006]. Given that the DAMID-Seq experiment
detected Cbx1 association sites genome wide whereas the study of Vogel et al.
[2006] analysed only genes and their respective transcripts, the total overlap is
reduced. In addition, we find strong enrichment of Cbx1 at repetitive elements,
which are not properly captured by the experiments of Vogel et al. [2006] and
therefore further diminish the number of peaks spanning protein coding genes
(compare Figure 4.16). In summary, these findings suggest that we successfully
established the DAMID technique.
4.4.3.4 Validation of Homer Peaks for Ago2
For validation only peaks derived from Dam-Ago2 were analysed. The peaks
were manually inspected using the UCSC genome browser in combination with
.bedGraph files depicting the read distribution and accumulation at a peak site.
Based on this, two to three peaks form different genomic elements as for example
exon, intron, SINEs and LINEs were chosen, which scored high in the bioinfor-
matic analysis and showed no accumulation of reads in the Dam-Ago2-Y529E
sample. Subsequently, a total of 24 primer sets specific for these peaks were de-
signed for Ago2-ChIP (11A9 antibody) validation experiments followed by qPCR
analysis (Figure 4.17). For a subset of peaks also control primers were designed in
the vicinity of the peak, located 2000 or 5000 bp upstream of the respective peak.
The promoter region and transcription start site was tested using the primer sets
chr10-248 and chr8-271. Here, no enrichment compared to the bead control was
observed. Exons were analysed with the primer sets chr1-628, chr3-47 and chr3-
47-2000 (upstream control). Both showed a signal slightly higher than their re-
spective bead control. However, the non targeted locus chr3-47-2000 was for
Ago2 and empty beads relatively more enriched compared to its input than chr1-
628 and showed a similar enrichment for Ago2 over beads as several target peaks.
The peak chr3-47 was only 1.5 fold enriched over its unspecific control locus and
the empty bead control. Introns were probed with the primer sets chr20-189 and
chr20-189-5000 (upstream control) and chr6-557 (not shown). Here again, only 1.5
fold enrichment compared to empty beads were observed. The 3′-UTR compris-
ing peaks were examined with the primer sets chr16-73, chr19-32 and chr2-244,
which showed no enrichment compared to the control.
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Figure 4.17: ChIP experiment of several potential target loci. FA-Crosslinked chromatin
was prepared from MRC-5 cells and incubated with Ago2-antibody (11A9) or empty beads
as control. The precipitated DNA was analysed by qPCR with respective primer sets. In
order to control for specificity of a target locus, another primer set was designed for some
sites binding several kb upstream of the target site. However, the enrichment observed was
often less than twofold which might either hint to a rather indirect interaction of Ago2 with
the chromatin, loss of signal in the background noise level or a lack of identification of valid
peaks.
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Also repeat associated regions and transpoable elements were tested. SINE el-
ements were analysed with the primer sets chr1-191, chr1-191-5000 (upstream
control), chr1-2490, chr2-82 (not shown) and chr2-8 (not shown). Here, no enrich-
ment was found for the target regions, unexpectedly, the control region chr1-191-
5000 yielded higher signal than the respective target site. LINE elements were
assessed with the primer sets chr17-360, chr18-157, chr19-41. Here 1.5 fold en-
richment over the bead control was found for the peaks chr17-360 and chr19-
41, while chr18-157 did not show positive association. Long terminal repeats
and other repeat elements were analysed with the primer sets chr1-436, chr2-65,
chr18-47 (CT-rich, not shown), chr3-119 (hTA-Charlie, not shown). All of these
peaks displayed 1.5 to 2 fold enrichment but gave lower ChIP/input ratios than
upstream controls from other loci.
At last, also intergenic regions were tested with the primer sets chr12-169, chr13-
1, chr8-84, chr8-84-5000 (upstream control) and chrX-33. Whereas chr12-169 and
chr13-1 showed no enrichment, chr8-84 and chrX-33 enrichment levels ranged
between 1.5 to 2 fold.
In summary, no strong enrichment of Ago2 at the validation sites (at the most 2
fold) could be shown (compare Figure 4.17). In addition, no genomic element was
consistently enriched over bead controls and the non-specific “upstream” primer
sets. Unfortunately, optimization experiments using the 1.5 and 2 fold enriched
sites failed to increase the signal to noise ratio. Therefore, no further validation
of this analysis was undertaken.
4.4.3.5 GATC-Centered Analysis of DAMID Data
Inspired by the thesis of Zhou [2012], who analysed chromatin regulation us-
ing ChIP and a modified DamID protocol, an alternative analysis method for the
DAMID data set was developed. In their methods Zhou [2012] described a peak
caller, which counts the reads per GATC site and then sums up the read counts
for all GATC sites per 5 kB stretches in the genome. This GATC-specific anal-
ysis could reduce background noise from non-GATC containing fragments non-
specifically amplified during the PCR step of the DAMID experiment. Those frag-
ments deriving from repetitive elements not containing GATC sites were found
in the read coverage-based analysis by homer. However, no code or programme
was available from their side. Therefore, a similar approach based on counts
of reads overlapping GATC sites was pursued, because these sites are directly
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modified by the Dam-fusion proteins. In the course of this analysis, the library
composition, read trimming and analysis of the resulting count tables using the
R software and the Bioconductor package DESeq, was performed.
4.4.3.6 Library Composition and Alignment
The quality control of the reads using FastQC [Andrews] returned good over-
all quality and, as expected, several contaminating sequences resulting from the
DAMID-PCR primer. Bolger et al. [2014] found that the number of reads prop-
erly aligning to the genome, especially under strict conditions, is tremendously
improved when contaminating sequences and bases of bad quality are trimmed.
Therefore, the DAMID-PCR primer sequence, which does not match with the hu-
man genome and can be found at either end of the reads in forward or reverse
orientation, had to be removed.
This placement of the primer sequence is caused by the sonication of the adapter-
flanked, methylated fragments of the DAMID experiment preceding library pre-
paration. Therefore, three types of reads are expected in the libraries: those con-
taining the DAMID-PCR primer at the 5′-end, the ones containing the reverse
complement of the primer at the 3′-end and lastly reads which arise from the mid-
dle of the methylated fragments carrying no primer sequence. As no programme
was publicly available for this task, custom made python scripts were developed
for the removal of DAMID-based contaminating sequences (Section 3.7.2). The
programmes removed all sequences matching the DAMID-PCR primer, while a
5′-truncation of one base and sequences containing exactly one mismatch were
allowed. The resulting sequences were quality trimmed at the 5′- and 3′-ends
Sample Name Input Read Pairs Both Surviving Forward only Reverse only Dropped
Dam-Ago1 18516843 13583063 930541 2873297 1129942
Dam-Ago2 23181289 16264668 1244820 4096875 1574926
Dam-Ago2-Y529E 17882388 13062886 854161 2929537 1035804
Dam-Cbx1 20021720 12301959 965335 4922841 1831585
Dam 19134936 12379749 969645 4101014 1684528
Table 4.11: DAMID-preprocessing with Trimmomatic.
Reads from the DAMID Libraries, were depleted of contaminating DAM-PCR-Primer. The
resulting reads were loaded into Trimmomatic for quality trimming, removal of reads shorter
than 25 bp and checking for read pairs. Roughly 65 to 70 % of the reads were then used for
alignment.
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and reads of a length below 25 bp were removed using the Trimmomatic soft-
ware [Bolger et al., 2014]. In the last step, the forward and reverse files containing
each one read of a pair were checked for consistency (Table 4.11). Reads having
no paired mate were removed from the downstream analysis.
Figure 4.18: Length distribution of NGS data after quality trimming.
Three peaks were observed in the distribution profile. The first marks sequences containing
the fully DAMID-Adapter, the second consists of sequences, where the DAMID-PCR primer
was removed and the third comprises all reads internal to DAMID fragments or those escap-
ing the adapter/primer removal scripts.
The resulting length distribution of the reads was plotted (Figure 4.18). Three
major peaks were produced: 1. the peak at 60 bp, resulting from the removal of
the DAMID-Adapter; 2. the peak at 87 bp, based on the deletion of the DAMID-
PCR primer sequence; 3. the peak at 100 bp, consisting of reads not carrying
a DAMID-PCR primer sequence or truncations and mutations of this sequence,
not recognized by the custom python scripts.
After preprocessing, about 60 to 70% of the reads were used for alignment against
the human genome. (Dam-Ago1: 73%, Dam-Ago2: 70%, Dam-Ago2-Y529E: 73%,
Dam-Cbx1: 61%, Dam: 65 %). The alignment was performed using Bowtie2,
which supports paired-end alignments [Langmead et al., 2009]. With an overall
alignment rate of 90 % (except for Cbx1 75%), nearly all reads could be assigned
a position in the genome (Table 4.12). However, also a substantial fraction of the
reads mapped at more than one position.
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Sample Names Input Pairs Aligned Exactly Aligned More than Once Sum of Aligned
Dam-Ago1 13583063 6887834 5926546 12814380
Dam-Ago2 16264668 9188295 5809520 14997815
Dam-Ago2-529E 13062886 7846576 4580777 12427353
Dam-Cbx1 12301959 7023116 2254000 9277116
Dam 12379749 10327232 1001407 11328639
Table 4.12: Read alignment using Bowtie2.
The reads from NGS were aligned using Bowtie2. The overall alignment rate was over 90 %
for all samples apart from Cbx1, where only 75 % of read pairs could be aligned. Of the
aligned reads between 50 % and 60 % of read pairs aligned exactly, except for Dam, for which
83% of reads could be aligned exactly.
The aligned reads were further processed into .bam files, which were used for
downstream analysis. Here, some of the multiple aligned reads were also taken
forward, if one of mates of a pair mapped at a unique position. Then possible
PCR duplicates were removed with samtools rmdup (remove duplicates) option
[Li et al., 2009b], leading to the aligned unique reads in Table 4.13. For Dam-
Sample Name All Aligned Reads Aligned Reads Unique
Dam-Ago1 6910145 4856874
Dam-Ago2 9220488 7097486
Dam-Ago2-Y529E 7874048 6230759
Dam-Cbx1 7070474 6272561
Dam 10364235 8535734
Table 4.13: Aligned and unique reads classified by samtools.
The reads from the different samples were analysed with samtools rmdup, which compares
the outer coordinates of all reads and removes duplicates. Unfortunately, up to 30% of the
read pairs of Dam-Ago libraries were duplicates and mapped to exactly the same position.
Ago transduced cells, the duplication level ranged from 20 to 30%. The controls
contained fewer duplicates ranging from 12 to 18% for Dam-Cbx1 and Dam, re-
spectively.
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The ratio of unique reads to PCR duplicate-containing reads was plotted per chro-
mosome for each sample. Concentrating on chromosomes 1 to Y, it seems that for
all samples the over-amplification leading to PCR duplicates was limited (com-
pare Figure 4.19). However, for the mitochondrial chromosome (chrM), a high
level of duplicate reads (~80 %) was observed in the Dam-Ago samples, which
was reduced for Dam (~65 %) and on background level for the nuclear localised
Dam-Cbx1 (~30 %) (Figure 4.19). If the fraction of removed reads are real PCR
duplicates or result from DNA fragments actually present in the sample, can not
be ruled out.
Figure 4.19: Analysis of PCR-duplicates.
The number of unique reads was plotted against the number of aligned reads (unique +
duplicate reads). For the human genome only about 10 % of the read pairs align at multiple
locations. For the mitochondrial genome nearly 80% of the reads from the Dam-Ago libraries
were removed by the “rmdup” option of samtools.
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4.4.3.7 Analysis of Aligned and Unique Reads
Further analysis and identification of enriched regions was performed using R
and the DESeq package. In order to get a first impression of the distribution of the
data, reads were plotted per chromosome (bp) for all aligned (Figure 4.20 A) and
for unique reads (Figure 4.20 B). All samples showed similar read numbers per
chromosome for the nuclear encoded DNA. A striking difference was observed
for the mitochondrial chromosome. Here, Dam-Ago reads were enriched at least
20 fold over Dam and nearly 200 fold compared to Dam-Cbx1 even for the unique
reads, hinting at a potential mitochondrial function of Ago. This is analysed in
Section 4.5. In the next step, it had to be determined, if Ago is enriched at specific
regions of the genome.
Figure 4.20: Distribution of reads per chromosome.
A) All aligned reads were plotted per chromosome (bp). B) All unique reads were plotted
per chromosome (bp). Comparing both analyses, it became apparent, that despite the high
duplication level of the data, mitochondria derived sequences were strongly enriched for
samples transduced with Dam-Ago.
Analysis Based on Aligned Reads
The first analysis was performed based on all aligned reads. To select for reads
resulting from Dam methylation, only reads containing GATC had to be counted.
Therefore, a GATC genome was constructed. This consists of the positional in-
formation of all GATCs found per chromosome (Section 3.7.5). Then an R script
was used to count all the reads overlapping a GATC. The count table for all chro-
mosomes was loaded into DESeq and analysed [Anders and Huber, 2010]. For a
peak to be selected for analysis, however, reads in the Dam-Ago as well as in the
Dam control were required, to estimate a proper difference between the samples.
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Unfortunately, no statistically significant hits could be achieved. This is due to
many regions without coverage by the Dam control. Furthermore, missing repli-
cates resulted in a lack of data to estimate the dispersion of the count values at a
given position and to calculate a false discovery rate needed for differential peak
assessment. This means, that there are no ways to distinguish a random asso-
ciation from a targeted binding event causing a high amount of false positives
under the top peaks further complicating the identification of promising candi-
date peaks.
Therefore, all regions enriched over the Dam control with a log2-fold change
above two were selected and treated as potential peaks. A list of the GATC
sites most enriched for Dam-Ago1 and Dam-Ago2 is presented below (Table 4.14,
4.15). A full peak list can be found on the CD accompanying the thesis, deposited
at the library of the University of Regensburg. Remarkable at the peak list for
Dam-Ago proteins is the accumulation of mitochondrial peaks as the strongest
enriched ones. This supports the theory, that the band pattern observed during
the DAM-ID experiment (Figure 4.15) might be due to mitochondrial localisation
of Dam-Ago.
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Table 4.14: Ago1 enriched sites in MRC-5 based on all aligned reads.
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Table 4.15: Ago2 enriched sites in MRC-5 based on all aligned reads.
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Subsequently, the peaks were classified in genomic elements and the frequen-
cies were compared to the ones in the human genome (build hg19) (Figure 4.21).
The peaks from the Dam-Ago1 and 2 transduced cells showed enrichment for
the class of SINE elements, LTR transposons and exons, whereas intergenic se-
quences appeared to be reduced. Only a few peaks mapped to the intergenic
space compared to the relative abundance in the human genome. The enrich-
ment of SINE elements, LTR transposons and exons across all peaks in Ago1
and 2 samples (Figure 4.21) is in good agreement with the peaks showing the
strongest log2-fold enrichment (Table 4.14, Table 4.15). In the latter, especially
the mitochondrial peaks are supported by high read counts (median count value
13456 for Ago1 and 18091 for Ago2), whereas the genomic peaks show compa-
rably low read numbers with a median count value of 19 for Ago1 and 17 for
Ago2. Therefore, also the classification into genomic elements derived from the
Dam-Ago1 and Dam-Ago2 peaks is based on low read numbers (median count
value 18) and has to be interpreted very carefully.
Figure 4.21: Comparison of the frequencies of genomic elements between samples and the
human genome.
The peaks of all samples, which showed a log2-fold change higher two, were classified in
genomic elements and compared to the frequencies of the respective elements in the human
genome. Dam-Ago1 and 2 seemed to be enriched in SINE elements and exons. Only a few
peaks mapped to intergenic positions.
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Analysis Based on Unique Reads1
In order to generate a complete picture a second analysis was performed on
the GATC overlapping reads after removal of potentially duplicated sequences.
Again, a count table was generated and analysed with DESeq [Anders and Hu-
ber, 2010]. In this analysis some of the peaks reached estimated p-values close
to the commonly accepted 0.05. In order to get a good overview, values with
the strongest log2-fold changes (p < 0.07) are shown for Dam-Ago1 and Dam-
Ago2 in the following (Table 4.16, 4.17). Unfortunately, only eight peaks from the
Dam-Ago1 experiment and 40 for Dam-Ago2 met these criteria. For both samples
the analysis based on only unique reads identified mitochondrial regions as the
strongest enriched ones. This is in good agreement with the observed band pat-
tern from the DAMID enrichment PCR (Section 4.4.3.1). For these bands, Sanger
sequencing revealed a high frequency of mitochondrial derived sequences.
However as described above, none of these peaks are statistically significant. Due
to the lack of replicates, the dispersion of the count values at a given position
could not be evaluated. Further, no good estimation of p-values and correction
for multiple testing, which is the calculation of a false discovery rate, could be
performed. Therefore, we can not decide on true and false positive peaks among
the lists presented. Nevertheless, these lists are a very conservative evaluation of
the data and therefore could contain some true positive peaks.
1This analysis was performed after my contract ended at the department of Prof. Dr. G. Meis-
ter, therefore no experimental validation of the identified peaks was possible.
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Table 4.16: Ago1 enriched sites in MRC-5 based on unique reads.
N
r
ch
ro
m
st
ar
t
en
d
A
go
1
D
am
lo
g2
Fo
ld
C
ha
ng
e
pv
al
re
pc
la
ss
ex
te
rn
al
_g
en
e_
id
G
O
_d
om
ai
n
so
ur
ce
1
ch
rM
85
93
85
96
19
5
8
4.
82
97
22
73
51
0.
05
01
52
57
9
N
A
M
T-
A
TP
6
m
it
oc
ho
nd
ri
al
A
TP
sy
nt
he
si
s
co
up
le
d
pr
ot
on
tr
an
sp
or
t
ex
on
2
ch
rM
11
92
3
11
92
6
18
1
8
4.
72
22
38
30
84
0.
04
98
45
64
18
N
A
M
T-
N
D
4
A
TP
sy
nt
he
si
s
co
up
le
d
el
ec
tr
on
tr
an
sp
or
t
ex
on
3
ch
rM
36
94
36
97
14
9
8
4.
44
15
60
94
18
0.
05
23
34
27
31
N
A
M
T-
N
D
1
m
it
oc
ho
nd
ri
al
el
ec
tr
on
tr
an
sp
or
t,
N
A
D
H
to
ub
iq
ui
no
ne
ex
on
4
ch
r1
2
98
70
40
08
98
70
40
11
79
5
4.
20
42
45
07
46
0.
06
46
07
96
82
LI
N
E/
C
R
1
N
A
N
A
in
te
rg
en
ic
5
ch
r4
40
85
80
22
40
85
80
25
60
4
4.
12
92
83
01
69
0.
06
24
40
79
56
N
A
A
PB
B2
ex
tr
ac
el
lu
la
r
m
at
ri
x
or
ga
ni
za
ti
on
in
tr
on
6
ch
rX
13
98
46
40
8
13
98
46
41
1
58
4
4.
08
03
73
41
65
0.
06
37
79
40
38
N
A
LI
N
C
00
63
2
N
A
in
tr
on
7
ch
r1
1
94
42
17
03
94
42
17
06
54
4
3.
97
72
79
92
35
0.
06
66
31
42
86
SI
N
E/
A
lu
R
P1
1-
86
7G
2.
8
N
A
in
tr
on
8
ch
r1
0
50
61
02
50
61
05
50
4
3.
86
62
48
61
11
0.
06
98
39
19
39
N
A
D
IP
2C
m
et
ab
ol
ic
pr
oc
es
s
in
tr
on
137
RESULTS 4.4. Ago Chromatin Interaction Sites by DAMID
Table 4.17: Ago2 enriched sites in MRC-5 based on unique reads.
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4.4.3.8 Validation of DAMID Results
In the above analyses, based on either all aligned or only on unique reads, mi-
tochondrial peaks emerged as highly enriched. This correlates with the high fre-
quency of mitochondrial sequences observed in direct cloning experiments from
the strong bands of the DAMID enrichment PCR.
Therefore, specific primer sets were designed for validation of the Ago2 associa-
tion with mitochondrial DNA by ChIP experiments. Similar to the first validation
approach primer sets were picked using the UCSC genome browser together with
indexed .bam files representing the number of observed reads at each genomic
position. Two Ago2-specific purified antibodies (11A9 and 1526) were used for
ChIP validation (Figure 4.22).
Figure 4.22: Validation of Dam-Ago2 association with mitochondrial DNA by ChIP.
MRC-5 cells were crosslinked with formaldehyde for 10 minutes at RT and sonicated. The
resulting lysate was cleared by centrifugation and used for ChIP using two Ago2-specific
antibodies (rat mAB:11A9, rabbit pAB: 1526) and rabbit IgG as control. Several mitochondrial
and human genomic DNA specific primers sets were used for qPCR amplification following
PCI extraction of the precipitated DNA. However, no locus showed enrichment compared to
IgG control. One of several optimisation experiments shown.
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Several mitochondrial loci were tested for Ago2 association in a row of ChIP op-
timisation experiments applying several Ago2-specific antibodies on lysates of
crosslinked MRC-5 cells. However, non of the tested loci showed any enrichment
compared to the IgG background control. The high amounts of mitochondrial
DNA in the input samples, which were readily amplified, suggest that lysis con-
ditions were also efficient for mitochondria and sufficient crosslinked DNA was
present in the ChIP lysates used for Ago2 IP. In addition, crosslink and sonication
conditions were controlled by agarose gel electrophoresis of input DNA. These
results imply that no direct interaction of Ago2 with mitochondrial DNA can be
trapped applying formaldehyde crosslink followed by ChIP.
4.4.3.9 Summary of the MRC-5 DAMID Experiment
In summary, no direct interaction of Ago2 with human chromatin, which was
analysed in Section 4.4.3.3, or mitochondrial DNA, examined in Section 4.4.3.5,
could be demonstrated. Even though a set of 18 genomic (Figure 4.17) and 7
mitochondrial loci (Figure 4.22) were tested by ChIP experiments, no peak could
be validated.
The observed GATC-methylation in mitochondria, which was supported by high
read counts in Dam-Ago samples, can also be interpreted as positional informa-
tion, thus supporting mitochondrial localisation of Ago proteins. In this case,
mtDNA methylation is just a by-product due to the limited space in mitochondria
and the open accessible mitochondrial DNA. In human lung fibroblasts about
300 mitochondria are found, each of which contains 2-3 DNA copies [Robin and
Wong, 1988]. The circular mitochondrial DNA has a size of ~16 kB and contains
24 GATC sites. Furthermore, the level of mitochondrial DNA methylation mea-
sured for Dam-Cbx1 was even lower than that for the Dam control, which marks
as entirely nuclear protein the level of non specific mitochondrial methylation.
Both observations suggest that the high level of GATC methylation observed in
Dam-Ago treated cells might be due to a specific import of Ago proteins into
mitochondria. This hypothesis is tested in Section 4.5.
4.4.4 DAMID Experiment with Mouse Embryonic Stem Cells
The validation of potential chromatin interaction sites of Ago2 in MRC-5 cells
failed, suggesting non-specific Ago chromatin interactions in these assays. Nev-
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ertheless, Ago2 might associate with chromatin in earlier steps of development.
For LINE L1 elements, which are reactivated by hypomethylation in the early
blastocyste, it was shown, that Dicer and Ago2 are required to restrict retrotrans-
position [Ciaudo et al., 2013]. Knock out of Dicer or Ago1 to 4 led to increased
retrotransposition of L1 elements and a differentiation defect in Dicer -/- mESCs.
The repression of L1 transcripts seems to be RNAi-mediated based on 22 nt endo-
siRNAs derived from sense and anti-sense transcripts of L1, which are at least in
part processed by Dicer [Ciaudo et al., 2013]. By partially restoring the Ago2 level
in Dicer -/- mESC, which is normally strongly diminished, the differentiation
ability of Dicer -/- mESCs could be rescued [Ciaudo et al., 2013]. This suggests
that Ago2 inhibits the detrimental effect of retrotransposition and enables the si-
lencing of the coding sequence of L1 elements. However, the mechanism of L1
transcriptional silencing remains to be elucidated.
Therefore, a second DAMID experiment with the human Ago2 as bait in mouse
embryonic stem cells (mESCs), was performed to examine, if Ago2 plays a role
in transcriptional silencing of repetitive genomic elements. In collaboration with
Prof. Dr. C. Ciaudo (ETH Zürich) stable Dam or Dam-Ago2 expressing mESCs
were created and chromatin association sites were analysed using DAMID. Hu-
man Ago2 differs from the mouse protein only by 7 amino acids within the first
35 residues at the N-terminus, therefore we assume a similar target range for
the exogenous protein. Another advantage of mESC as model system is that cell
differentiation can be induced which may lead to a change in binding site speci-
ficities of Ago2. These variations in the binding pattern of Ago2 will strengthen
the analysis and interpretation of discovered target sites.
Cells from the male E14 WT mESC line (129/Ola background) [Hooper et al.,
1987] were stably transfected with constructs carrying Dam-Ago2 or only Dam
as inserts. The constructs contained also the HSP promoter controlling the ex-
pression of the Dam fusion proteins, granting the low expression level required
for DAMID. Following screening for hAgo2 expression, two independent clones
for each construct were chosen (Dam-Ago2: clone 4 and D, Dam: clone 30b and
F) and expanded before the methylated DNA was extracted. This work was
contributed by C. Ciaudo (ETH Zürich). The isolated DNA was subsequently
shipped to Regensburg and DAMID was performed (see Section 3.6.5).
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Figure 4.23: Examination of the DNA fragments of the mESC DAMID experiment.
The DNA was extracted from the different stable mESCs and prepared according to the
DAMID procedure. After selection for methylated DNA fragments, the samples were loaded
on an agarose gel (2 %). The Dam control cell lines led to enrichment of a broad range of tar-
get sequences, as proven by a smear. The Dam-Ago2 expressing cells showed a band pattern
reminiscent of the one observed for MRC-5 cells. The specificity of the assay was controlled
by samples not treated with either DpnI or T4-DNA-Ligase.
After GATC-selective PCR amplification, the DNA fragments methylated by Dam
or Dam-Ago2 were analysed on an agarose gel (Figure 4.23). The DAMID ex-
periment was controlled by samples lacking DpnI or T4-DNA-Ligase (compare
Section 4.4.3). Omitting these steps prevented the formation of PCR-amplifiable
fragments confirming the specificity of the method. Dam yielded a smear as ex-
pected for an amplification of a broad range of targets. On the contrary, Dam-
Ago2 in mESCs resulted again in the band pattern already observed for Dam-
Ago2 in MRC-5 cells. Then, the replicates were fragmented by sonication to about
250 bp and NGS libraries were prepared with the NEB Next Library preparation
kit. High-throughput sequencing was performed by the Kompetenz Zentrum für
Fluoreszente Bioanalytik (KFB, Regensburg, Germany).
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4.4.4.1 Bioinformatic Analysis of DAMID in mESCs
As the libraries contained different barcodes, they were pooled and sequenced in
one lane on an Illumina HISeq 1500 machine. The results from the NGS run are
shown in Table 4.18.
Sample Name Index Yield
(Mbases)
Reads % of Raw
Clusters per
Lane
% Per-
fect Index
Reads
% of
=> Q30
Bases
Mean
Quality
Dam_30b ACTTGA 5,884 58,844,556 17.80 99.04 93.38 35.98
Dam_Ago2_4 ATCACG 5,204 52,036,500 15.74 99.17 95.09 36.64
Dam_Ago2_D TTAGGC 6,505 65,050,460 19.68 99.22 95.18 36.75
Dam_F GATCAG 4,9 49,004,476 14.82 99.12 92.97 35.78
Table 4.18: Run information of the Illumina HiSeq.
The NGS yielded high read numbers for all samples. Also the quality of the reads was nearly
perfect with a mean Phred score of 36, which is a probability that 1 in 4000 bases is called
wrong.
The numbers of reads acquired for each sample ranged from 50 to 65 million
reads, with each library generating between 15 and 20 % of the sequencing clus-
ters on the lane of the flowcell. Nearly all reads could be assigned to their library
(99%) and the quality of the reads was explicitly good. At least 93 % of the reads
had quality values equal or higher than the Q30 score, which is 1 in 1000 bases is
wrongly called. In the next step, contaminating sequences had to be removed and
quality trimming was performed, as it greatly enhances the mapping efficiency
of aligners [Bolger et al., 2014].
4.4.4.2 Library Composition and Alignment
As described above, the read quality and sequencing biases were assessed us-
ing FastQC (Section 3.7.1)[Andrews], which reported good quality of reads but a
high duplication rate. Then, the DAMID-PCR primer sequences and sequencing
adapters were removed by custom python scripts (see Section 3.7.2). The reads
were checked for consistency of pairs, minimal read length (25 bp) and quality
using Trimmomatic (Section 3.7.1) [Bolger et al., 2014]. After these selection steps,
the resulting length distribution of the reads was analysed (Figure 4.24).
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Figure 4.24: Length distribution of mESC NGS data after quality trimming.
Three peaks were observed in the distribution profile, consistent with the data for MRC-5.
The first marks sequences containing the fully DAMID-Adapter, the second comprises se-
quences, where the DAMID-PCR primer was removed and the third consists of all reads
internal to methylated fragments or those escaping the adapter/primer removal scripts.
Three major peaks were produced: 1. the peak at 60 bp, caused by the depletion
of the DAMID adapter sequence; 2. the peak at 87 bp, due to the removal of
the DAMID-PCR primer sequence; 3. the peak at 100 bp, consisting of reads not
carrying a DAMID-PCR primer sequence or truncations and mutations of this
sequence being not recognized by the python scripts (Figure 4.24).
The results from the trimming are summarized in Table 4.19. Nearly all reads (at
least 95 %) survived the primer removal and quality trimming. However, one
third of the reads contained a removable DAMID-PCR primer sequence as can be
seen in the length distribution signature of the DAMID adapter and primer at 60
and 87 bp, respectively (Figure 4.24).
Sample Name Input Surviving Both Surviving F Surviving R Dropped
Dam_30b 29422278 28120075 (95,57%) 829464 (2,82%) 314931 (1,07%) 157808 (0,54%)
Dam_F 24502238 23294495 (95,07%) 778890 (3,18%) 276694 (1,13%) 152159 (0,62%)
Dam_Ago2_4 26018250 25051661 (96,28%) 596399 (2,29%) 262247 (1,01%) 107943 (0,41%)
Dam_Ago2_D 32525230 31487411 (96,81%) 657336 (2,02%) 1281824 (0,87%) 98659 (0,30%)
Table 4.19: Summary of the trimming process.
The reads removed of contaminating adaptor and primer sequences were loaded into the
trimming programme. After a check for quality and paired mates, the reads were mapped.
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The alignment of the trimmed reads to the mouse genome (build mm10) was
performed using bowtie2 (see Section 3.7.4) [Langmead et al., 2009], with the only
difference, that instead of one reported alignment, up to five valid alignments
were recorded (Table 4.20). Here, the overall alignment rate was the lowest for
Dam_Ago2_D. The low rate of exactly aligned read pairs already observed for
Dam-Ago2 in MRC-5 (56 %) (compare Table 4.12) was even more severe in mESCs
with only 20 % of pairs. This is in contrast to the Dam control reads of which at
least 66 % were assigned to exact genomic positions. However, given that the
mESC cells derived from the mouse strain 129/Ola and the mouse genome build
(mm10) is based on the C57BL/6J strain, a reduced mapping rate is expected.
Sample Name Paired Aligned
Exactly Once
Aligned Mul-
tiple Times
Aligned
0 Times
Overall
Alignment
Rate
Exact Align-
ment Rate
Dam_30b 28120075 21068368 5157670 1894037 93% 75%
Dam_F 23294495 15305718 5735976 2252801 90% 66%
Dam_Ago2_4 25051661 5649204 17033104 2369353 90% 23%
Dam_Ago2_D 31487411 6225457 20042102 5219852 83% 20%
Table 4.20: Bowtie2 alignment to the mouse genome.
Trimmed reads were mapped to the mouse genome (build mm10) with a good overall align-
ment rate ranging between 83 and 93 %. However, the number of exactly mapping reads for
both Dam_Ago2 samples is remarkably low when compared to the Dam control samples.
As up to five valid alignments were reported per read pair, a python script was
created sorting the reads in exactly aligned reads, reads mapping to chrM, reads
mapping putatively to chrM (based on comparison with the data of MRC-5 cells)
and a last set of multiple aligning reads called repetitive. A summary of the
sorting process can be found in Table 4.21.
Sample Name Aligned Pairs Exactly Aligned ChrM
Assigned
Putative
ChrM
Repetitive Total Repet-
itive Pairs
Dam_30b 26226038 23677576 103758 519542 1925162 18553154
Dam_F 21041694 17959258 145982 670160 2266294 22077582
Dam_Ago2_4 22682308 13102643 1457365 6003177 2119123 20891320
Dam_Ago2_D 26267559 14847216 1082752 5752629 4584962 45323234
Table 4.21: Sorting of mESC DAMID reads after alignment.
After applying bowtie2 with the setting to return up to five valid alignments, the read pairs
were sorted according to their mapping behaviour and, if not unique, due to their location.
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For the Dam control samples 23.7 and 17.9 Mio paired reads aligned exactly. Pairs
mapping to the mitochondrial DNA were less than 4% and about 2 Mio (10%)
paired reads aligned to repetitive sequences. For Dam_Ago2 only 13.1 and 14.8
Mio paired reads could be assigned to one genomic position. A large number of
paired reads, 1.4 and 1.0 Mio, mapped exactly to mitochondrial DNA, while 6
and 5.7 Mio paired reads mapped to multiple positions, with the best alignment
score for chrM. The class of repetitive sequences contained 2.1 and 4.5 Mio paired
reads (Table 4.21). In the subsequent analysis only exactly matching read pairs
and read pairs for which one of the pair could be exactly assigned were used.
The FastQC analysis of the data had already revealed a high number of dupli-
cate reads. This rises the question, if the large amount of duplicates is due to
over-amplification during library preparation or results from the PCR step in the
DAMID protocol which is used for specific signal amplification. Given that in the
course of the Dam_Ago2-specific DAMID experiment only a limited number of
target sequences were amplified by PCR, this step could also cause the observed
amount of duplicate reads. To properly assess both scenarios, two data sets were
created with the samtools package [Li et al., 2009b], one carrying all duplicates
and a second with duplicates removed (Table 4.22). Especially for Dam_Ago2
samples the numbers of paired reads dropped to only 14% and 28% of aligned
pairs, when duplicates were removed. Whereas the control samples contained
88% and 81% unique reads.
Sample Name Aligned Reads Unique Reads
Dam_30b 23781334 20771640
Dam_F 18105240 14076653
Dam_Ago2_4 14560008 1821198
Dam_Ago2_D 15929968 3387090
Table 4.22: Aligned and unique reads from mESC as determined by samtools.
The reads from the different samples were analysed with samtools rmdup, which compares
the outer coordinates of all reads and removes duplicates. Unfortunately, 72 to 86% of the
paired reads from Dam_Ago2 samples were duplicates mapping to exactly the same position.
Then, the ratio of uniquely to all aligned reads was plotted per chromosome (Fig-
ure 4.25). In contrast to the MRC-5 cells, where 10% of the duplicate reads derived
from the human genome (Figure 4.19), several mouse chromosomes gave rise to
high duplication rates comprising chromosome 1, 2, 9, 12 and 14 (Figure 4.25).
If the set of mouse chromosomes generating high amounts of PCR-duplicates in
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DAMID experiments is a specific effect or caused by non-specific Dam_Ago2 as-
sociation, needs to be examined. In depth analysis of read distribution and the
underlying DNA sequence may help to explain this finding.
Regarding mitochondrial DNA, there were about ~80 % duplicates observed for
the Dam control in mESCs compared to ~65 % of duplicate reads identified in
MRC-5 cells. The numbers of duplicate reads for Dam-Ago2 in MRC-5 (see Fig-
ure 4.19) and Dam_Ago2 in mESCs (Figure 4.25) ranged for both experiments at
roughly 90 %. Here, it seems that the generation of stable cell lines led to a slightly
higher level of duplicate reads for the Dam control.
Figure 4.25: Analysis of PCR-duplicates.
The number of unique reads was plotted against the number of aligned reads (unique + du-
plicate reads). For the mouse genome the chromosomes 1, 2, 9, 12 and 14 contained high rates
of duplicates, while the other chromosomes showed rather low duplication rates. For the mi-
tochondrial genome nearly 90% of the reads from the Dam_Ago libraries were removed by
the “rmdup” option of samtools, while ~80 % were removed for the Dam control.
In order to assess the read coverage of the different mouse chromosomes, addi-
tionally, reads per base pair were calculated for each chromosome and plotted
for all aligned and only unique read pairs (Figure 4.26). In this analysis the read
coverage for chromosomes 1, 2, 9, 12, 14 and M was elevated for the data set com-
prising duplicate read pairs. In the unique dataset only chromosomes 2, 9, 14 and
M showed an increased read coverage.
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Figure 4.26: Distribution of reads per chromosome in mESCs.
A) All aligned reads were plotted per chromosome (bp). B) All unique reads were plotted
per chromosome (bp). Comparing both analyses, it became apparent, that despite the high
duplication level of the data, mitochondria derived sequences were strongly enriched for
samples transduced with Dam_Ago2.
In agreement with the data from MRC-5 high enrichment for mitochondrial se-
quences for Dam_Ago2 containing mESCs over the Dam controls was observed
for aligned reads (~10 fold) and for unique reads (~5 fold) (Figure 4.26). This
could hint to a potential mitochondrial localisation of Ago2 proteins which is
assessed in Section 4.5. If the duplicated reads derive from certain loci on the
specific chromosomes or from random positions needs to be further analysed.
To further analyse if duplicate reads are caused by the DAMID method and are
therefore specific or if these reads are introduced by the PCR amplification step
during library preparation, both data sets were used for downstream analysis.
Based on the data sets comprising all aligned reads or only unique reads, reads
overlapping a GATC sequence were counted applying an R script. These count
tables were then loaded into the DESeq package. Here, only those locations were
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selected in which all replicates yield a value above zero. Locations with zero
counts can derive from a lack of enrichment or an escape from the NGS reaction
and thus no conclusions can be drawn from these count values.
The correlation of the different samples was first examined by scatter plots drawn
from log2 count values of the different samples (Figure 4.27). Here, the Dam
controls showed some correlation, as did the Dam_Ago2 treated replicates.
Figure 4.27: The correlation plot of control and Dam_Ago2 treated samples.
The correlation of Dam and Dam-Ago2 treated samples was assessed by performing scatter
plots based on log2 count values for all samples.
But no strong correlation was found between DamAgo2 expressing cells and con-
trols when low to intermediate counts are examined. For very high counts, how-
ever, all samples showed clustering. These counts correspond to reads mapping
to mitochondrial DNA. Here, the Dam controls display the same association pat-
tern as Dam-Ago2, only the read numbers are increased by a factor of 10. This
hints to a rather random association with mitochondrial DNA which only dif-
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fers by the amount of methylation observed for Dam_Ago2 compared to Dam
controls. As the higher methylation level could be caused by a mitochondrial
localisation of Dam_Ago2, further experiments on a potential role of Ago2 in mi-
tochondria were conducted (Section 4.5).
4.4.4.3 Analysis of Aligned Reads with DESeq
Based on the read count values form the DAMID-Seq experiment in mESCs con-
taining also duplicate reads, an analysis with the DESeq package was performed
[Anders and Huber, 2010]. After loading raw read counts into the software (Ta-
ble 4.24, columns with sample names), DESeq performed library normalisation,
which was modified by supplying the library sizes from the NGS run. Then,
the average count values of all samples (baseMean), the average count value for
replicates (baseMeanA, baseMeanB) of aligned reads and enrichment levels (fold-
Change, log2FoldChange) could be estimated for the replicates of treated and
control samples (Table 4.24). Based on the count values and their variance among
replicates of treated and control samples, p-values and false discovery rates (padj)
were determined (Table 4.24). Using a padj value of 10 % as threshold, 470 peaks
showing enrichment for Dam_Ago2 at the chromatin were identified. The re-
sulting peaks were annotated using the Bioconductor package Biomart on the
Ensembl database (gene_ids, GO_domain, source) and repeatmasker (http://re-
peatmasker.org, repclass) and the top 40 peaks ranked by their log2FoldChange
can be found in the following tables. The first table shows the genomic annota-
tion and classification (Table 4.23), while the second one holds information on the
peak statistics (Table 4.24). Here, peaks with high counts were observed for many
regions in the mitochondrial DNA, but also for some loci on chromosome 1, 2, 9,
10 and 18. This overlaps in part with the chromosomes showing especially high
duplication rates (chromosomes 1, 2, 9, 12, 14 and M). For the chromosomes 10,
12, 14 or 18, however, the read counts of the significant loci, did not correlate with
the rate of duplicate reads.
Therefore, it seems that the duplication rate does not correlate with the specific
association of Dam_Ago2 proteins with chromatin. From this, we can conclude
that at least a fraction of duplicate reads derive from over-amplification during
the PCR step of the library preparation.
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Table 4.23: Ago2 enriched sites in mESC based on all aligned reads.
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RESULTS 4.4. Ago Chromatin Interaction Sites by DAMID
Table 4.24: Ago2 enriched sites in mESC statistics for all aligned reads.
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4.4. Ago Chromatin Interaction Sites by DAMID RESULTS
Given that we observe some distortion of the read numbers due to over-amplifi-
cation, the peaks identified based on aligned reads including duplicate reads are
not reliable. Therefore, no further analysis is performed on the data set containing
duplicate reads. A more conservative approach is to use only unique reads for
peak calling, which was performed in the following part.
4.4.4.4 Analysis of Unique Reads with DESeq
A second analysis of only the unique reads acquired from the DAMID exper-
iment in mESCs was performed. Applying the DESeq package on raw reads
(Table 4.26, columns with sample names), corrected for library size, the average
count values of all samples (baseMean), the average count value for replicates
(baseMeanA, baseMeanB) of unique reads and enrichment levels (foldChange,
log2FoldChange) could be estimated for the replicates of treated and control sam-
ples (Table 4.26). Here, it is very important to not use the default library size nor-
malisation estimated from the reads in the count table but to estimate the library
size from the NGS run, because the input to the DAMID experiment as well as
for the library preparation were kept constant. Again, mean counts were calcu-
lated and compared. Also p-values (pval) and false discovery rates (padj), which
correct the estimated p-values for testing of multiple features, were determined
(Table 4.26). The loci were annotated with Biomart and repeatmasker as described
for the previous tables. The first of the following tables shows the genomic anno-
tation and classification (Table 4.25), while the second one holds information on
the peak statistics (Table 4.26). However, only 24 peaks could be identified with
a p-value (p<0.05) and a false discovery rate lower than 10 %.
The genomic sites Dam_Ago2 bound to comprise mitochondrial DNA, LINE L1,
satellites and exonic sequences of several genes. The exonic sequences are part of
four different predicted genes (Gm13340, GM13441, Gm11512, Gm13341), which
are classified by GO term analysis into sensory perception of sound (GM13340 &
GM13441), protein targeting (GM11512) and ATP catabolic processes (GM13341).
The satellite peaks map all to a region on chromosome 9 (3000001-3013073), four
of the five peaks overlap with Gm26870, a predicted lincRNA. The LINE L1 el-
ement, which Dam_Ago2 is associated with, is called L1Md_T. It has a length
of 5191 bp and is localised on chr18:44177905-44183095. These regions were re-
ported to our collaborator C. Ciaudo (ETH Zürich) for independent validation in
mESCs, which is currently performed.
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RESULTS 4.4. Ago Chromatin Interaction Sites by DAMID
Table 4.25: Ago2 enriched sites in mESC based on unique reads.
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4.4. Ago Chromatin Interaction Sites by DAMID RESULTS
Table 4.26: Ago2 enriched sites in mESC statistics on unique reads.
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RESULTS 4.5. Analysis of Potential Mitochondrial Localisation of Ago Proteins
The strong enrichment of Dam_Ago2 at mitochondrial regions suggests, that the
band pattern found for Dam_Ago2 samples after DAMID, most likely results
from mitochondrial DNA. However, based on these observations the question
arises, how Ago proteins enter mitochondria. Therefore, the mitochondrial local-
isation and import was assessed for Ago proteins (see Section 4.5).
4.5 Analysis of Potential Mitochondrial Localisation
of Ago Proteins
Mitochondria are organelles surrounded by a double membrane, which reside
in the cytoplasm and potentially derived form an endosymbiontic event early in
the evolution of eukaryotes. In HeLa cells the estimated number of mitochondria
ranges from 380 to 880 per cell depending on the cell cycle stage [Posakony et al.,
1977]. They serve the cells by converting pyruvate, the product of the anaerobic
glycolysis, by means of the citric acid cycle and oxidative phosphorylation into
high amounts of ATP. In addition, mitochondria are involved in the metabolism
of amino acids, lipids, haem and iron-sulphur clusters and in regulation of pro-
grammed cell death [Schmidt et al., 2010].
4.5.1 Introduction to Mitochondria
The mitochondrial genome contains 16569 nt and encodes for 13 protein cod-
ing genes and 22 tRNAs [Alberts et al., 2002]. In contrast to its small genome,
mitochondria import about 1000 proteins from the cytoplasm by various import
mechanisms [Schmidt et al., 2010]. But also the destination of the imported pro-
teins differ and comprise the outer membrane, the inter membrane space, the
inner membrane and its inner lumen called the mitochondrial matrix.
Protein Import Mechanisms
The main import route into mitochondria is via the translocase of the outer mem-
brane complex (TOM). In order to get transported across the double membrane
proteins contain presequences, which are proteolytically cleaved of after import,
or internal targeting signals [Schmidt et al., 2010]. There are four main pathways
and several minor routes into the organelle. The first requires a cleavable prese-
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quence and transfers the protein from the TOM complex to the inner membrane
TIM23 (translocase of the inner membrane, TIM) complex for lateral release into
the inner membrane or matrix import. Many proteins of the inner membrane are
imported through a combination of the TOM complex and TIM22, which com-
prises the second pathway. The third is called oxidative folding pathway and is
mainly used by inter membrane space proteins. Following translocation by TOM,
the proteins are delivered to the mitochondrial inter membrane space assembly
complex. The last pathway is taken by outer membrane proteins which contain
again internal import signals [Schmidt et al., 2010]. For some proteins the import
into mitochondria is also facilitated by localisation of their mRNA to the mito-
chondrial surface, mediated by a targeting sequence in the 3′-UTR. These pro-
teins require a mitochondrial targeting signal peptide at the N-terminus and are
co-translational imported into the organelle [Sylvestre et al., 2003; Kaltimbacher
et al., 2006]. For mitochondrial import two sources of energy are described. The
membrane potential gradient across the inner membrane (ψ) drives the translo-
cation across the TIM complex and ATP which is utilised by Tom70 to unfold and
import the preproteins across the outer membrane [Schmidt et al., 2010]. Upon
entering the mitochondrial matrix, the targeting sequence of most presequence
containing proteins is proteolytically removed from the proteins by the matrix
processing peptidase (MPP). In addition, also other peptidases with a smaller
target range and different cleavage patterns were described [Schmidt et al., 2010].
RNAi in Mitochondria
Recently, also the RNAi pathway was linked to the mitochondria. Several stud-
ies described miRNA or also Ago2 in mitochondria, which are summarized in
Table 4.27.
MiRNA Detection in Lysate of Mitochondria The first report by Kren et al.
[2009] identified 15 miRNAs associated with highly purified mitochondria from
rat liver by microarray experiments. However, based only on sequence analysis
the miRNAs were linked to the apoptosis pathway, however, lacking further in-
dependent validations of this proposed function [Kren et al., 2009]. Subsequently,
the hypothesis of miRNAs in mitochondria was supported by a row of publi-
cations which identified miRNAs by microarrays and NGS, but included also
validation experiments like in situ hybridisation and qRT-qPCR in their analyses
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miRNAs Species Methods Ago
localisa-
tion
Reference
miR-130a, miR-130b, miR-140, miR-320,
miR-494, miR671
Ratus norvegicus, liver Microarray [Kren et al., 2009]
miR-21, miR-130a, miR-130b, miR-140,
miR-320, miR-494
Ratus norvegicus, liver TaqMan-mRNA assay [Kren et al., 2009]
miR-365, pre-miR-302a, pre-let7b, miR-
1974
Homo sapiens, myo-
blasts
in situ hybridisation [Barrey et al.,
2011]
miR-720, miR-133b, miR-1974, miR-24,
miR-133a, miR-125a-5p, miR-1979, miR-
103, miR-125b, miR-103, miR-221, miR-23a
(CT >33)
Homo sapiens, myo-
blasts
qRT-PCR [Barrey et al.,
2011]
miR-705,miR-202-5p, miR134 Mus musculus, liver Microarray, qRT-PCR, WB yes [Bian et al., 2010]
miR-705, miR-122, miR-805, miR-690, miR-
451,miR-7b, miR-26a
Mus musculus, liver Microarray [Bian et al., 2010]
s miR-638, miR-1977, miR-1972,miR-1908,
miR-1246, miR-513A-5P, miR-494, miR-
1974 and miR-1275
Homo sapiens, HeLa Mircoarray yes [Bandiera et al.,
2011]
miR-494, miR-1974 and miR-1275 Homo sapiens, HeLa Mircoarray, qRT-PCR [Bandiera et al.,
2011]
let7b, let7g, miR-107, miR-181a, miR-221
and miR-320a,
Homo sapiens,
HEK293, HeLa
NGS, qRT-PCR EGFP-
Ago2
[Sripada et al.,
2012]
miR-320, miR-22, miR-883, several mouse
and human miRNAs
Ratus norvegicus,
heart myocytes
Microarray [Das et al., 2012]
miR-181-c (human) Ratus norvegicus,
heart myocytes
RIP, protein level (COX1), Microarray yes [Das et al., 2012]
miR-1 Homo sapiens, C2C12;
Mus musculus, heart
Protein level (ND1, COX1), Translation
assay, CLIP-Seq, complementation assay,
WB, mitoplast preparation
yes [Zhang et al.,
2014]
Table 4.27: List of publications on miRNA and Ago localisation in mitochondria. The table
contains the detected miRNAs, the species or cell line the study was conducted in, the main
methods used, if Ago2 localisation was tested and found and the reference.
[Bian et al., 2010; Barrey et al., 2011; Sripada et al., 2012; Das et al., 2012].
Ago Localisation in Mitochondria The localisation of Ago2 was also examined
by some of the previously cited studies. Thus, fractionation by differential cen-
trifugation was used to successfully detect mitochondrial Ago2 [Bian et al., 2010].
However, these preparations are often heavily contaminated by other organelles
[Reinhart et al., 1982]. In 2011 Bandiera et al. reported on Ago localisation in
immunopurified mitochondria from HeLa cells. Also the mitochondrial locali-
sation of EGFP-Ago2 was shown, however, only very limited overlap with their
mitochondrial marker was detected by Sripada et al. [2012].
Functions of RNAi in Mitochondria Applying RNA isolated from mitochon-
dria of rat hearts to Affymetrix transcript microarrays, Das et al. [2012] detected
several miRNAs, among other they found enrichment of miR-181c. Using qRT-
PCR and Ago2-RIP assays they could validate enrichment of miR-181c and asso-
ciation of miR181c and COX-1 mRNA with Ago2. COX-1 stands for Cytochrome c
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oxidase I, which is a subunit of the respiratory complex IV and encoded by the
mitochondrial DNA. Here, only protein levels of COX-1 but not mRNA levels
were decreased by miR181c and resulted in an increase of O2 consumption of
transfected cells [Das et al., 2012].
Another example of a functional miRNA-Ago2 complex in mitochondria was
shown in mouse myoblasts (C2C12) cells. Analysing miR-1, which is specifi-
cally induced during myogenesis, Zhang et al. [2014] found mitochondrial en-
richment of the miRNA in differentiated C2C12 (Myotubes) coinciding with the
localisation of Ago2 to this compartment. Ago2 but not miR-1 was also present
in undifferentiated C2C12. Unlike earlier studies, the localisation of Ago2 in mi-
tochondria, was tightly controlled using appropriate antibodies (esp. for ER pro-
teins) and preparation of so called mitoplasts, where the outer membrane of mi-
tochondria is removed suggesting matrix localisation of the still detectable pro-
teins. When they examined the effects on expression of mitochondrial encoded
genes, they found an enhancement of the protein levels of ND1 (NADH dehydro-
genase 1) and COX1 in radioactive translation assays upon miR-1 transfection in
undifferentiated C2C12. In order to demonstrate target interaction, they used
Ago2-CLIP assays, where they found enrichment of several mitochondrial en-
coded transcripts. They also tested their system in mouse embryonic fibroblasts
(MEFs), where they observed rescue of the mitochondrial expression enhance-
ment after transfection of miR-1 in combination with HA-Ago2 or a mitochon-
drial targeted versions of Ago2 in WT and Ago2 knockout MEFs. However, it
still needs to be shown if Ago2 localisation to mitochondria is C2C12 specific and
in other cells miR-1 dependent or a general mechanism observed also in other
cell types.
In summary, all the above described studies suggest a mitochondrial localisation
of miRNAs and Ago proteins based on mitochondria isolated by fractionation or
immunoprecipitation. However, the import mechanism of Ago proteins or their
effect on transcripts was not conclusively assessed.
In our own DAMID experiments, a ladder of certain highly enriched amplicons
appeared in the Dam_Ago2 samples from mESCs (Figure 4.23) as well as for
Dam-Ago proteins in MRC-5 cells (Figure 4.15). In contrast to this, control pro-
teins showed a DNA smear for both cell lines, indicating a broad target range.
Some of these bands resulted supposedly from mitochondrial DNA, which is
supported by Sanger Sequencing of the respective bands and high read counts
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for mitochondrial DNA, 10 to 20 fold above the level of control samples in the
NGS data (Figure 4.26, 4.20). Given the lack of targets positive in Ago ChIP as-
says, we interpreted the methylation of mitochondrial DNA as a side effect of
a mitochondrial-specific Dam-Ago localisation. Taking into account the set of
publications reporting mitochondrial localised miRNAs and Ago proteins, we
decided to closely examine a potential Ago localisation to mitochondria, which
would be a requirement for a potential small RNA induced function in this com-
partment. As our lab had limited experience with the experimental methods spe-
cific for the field of mitochondrial research, the association of Ago with this or-
ganelle was further analysed in collaboration with the lab of Professor Dr. P.
Rehling, namely Dr. S. Dennerlein (University of Göttingen, Germany).
4.5.2 Localisation of Argonaute in Different Compartments
In a first step, the localisation of Ago proteins in mitochondria was tested with
a biochemical approach. HEK-293 cell lysates were fractionated by differential
centrifugation in cytoplasm, nuclei and crude mitochondria.
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Figure 4.28: Localisation of Ago2 in different cellular compartments.
Following lysis and differential centrifugation of HEK-293 cells, the different fractions en-
riched for cytoplasm, nuclei and crude mitochondria were analysed by WB. Ago2 yielded a
distinct band in the cytoplasm, which split into several for nuclei∗ and mitochondria∗. The
nuclear fraction was controlled by Lamin A/C and mitochondria by Tim44.
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The resulting lysates were analysed by Western Blot against different marker pro-
teins (Figure 4.28). The nuclear fraction was controlled by LaminA/C, showing
a clean cytoplasm and trace amounts of nuclei in the mitochondria containing
fraction. The mitochondrial marker protein Tim44 resulted in a weak signal for
nuclei and a high signal for mitochondrial fractions. The Ago2 protein was de-
tected with the 11A9 antibody, which produces a distinct signal in the cytoplasm
and several bands for the other compartments. Given that mitochondria acquired
by differential centrifugation always co-purify with large amounts of the ER, the
crude mitochondria purified by this assay were further analysed.
In summary, a strong signal for Ago2 was observed in the mitochondria contain-
ing fraction. This signal was clearly not derived from the nuclear contamination
(see Figure 4.28, Lamin A/C control) but could originate from trace amounts of
cytoplasm or contaminating ER.
4.5.3 Separation of Mitochondria from ER
In a next step, the contaminating ER was separated from mitochondria. There-
fore, crude mitochondria from HEK-293 cells were applied to a Percoll gradient
for density centrifugation (see Section 3.5.11). In the lower third of the gradient,
mitochondria accumulated as distinct layer. The gradient was divided into three
fractions. After several washes to completely remove the Percoll, which other-
wise leads to aberrant migration behaviour on SDS-PAGE gels, the three fractions
were analysed by WB (Figure 4.29, fractions F1-F3). This work was contributed
by C. Richter-Dennerlein (collaboration, lab of Prof. Dr. Rehling, University of
Göttingen, Germany).
The first fraction (Figure 4.29, F1) was highly enriched in ER vesicles, which can
be appreciated by the strong signal of SEC61β, the central component of the ER
protein translocation machinery. This protein is nearly completely absent from
fractions F2 and F3. Mitochondria were analysed by the following marker pro-
teins: MFN2, an integral membrane protein of the outer mitochondrial mem-
brane, participating in fusion processes; MITRAC15, an integral membrane pro-
tein of the inner membrane, involved in complex I and IV biogenesis [Mick et al.,
2012]; and MRPS15, the mitochondrial ribosomal protein S15, a member of the
28S subunit. All of these proteins were detected already in F1, but were strongly
enriched in F2. F3 seemed to be only enriched for MRPS15.
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Figure 4.29: Purification of mitochondria from HEK-293 cells using Percoll.
Crude mitochondria (C), isolated as above, were applied to density centrifugation on a Per-
coll gradient to separate mitochondria from contaminating ER. The gradient was divided in
three fractions: F1: top layer to 12% Percoll transition; F2: interphase at 12% to 26 % Percoll;
F3: interphase 26% to 40 % Percoll. Ago2 was found as double band in the fractions C and F1,
which was enriched for ER. In the F2 and F3 fractions, which were highly enriched for mito-
chondria and nearly completely depleted for ER, the Ago2-specific 11A9 antibody detected
a single slower migrating protein. The distribution of the different compartments was exam-
ined with the following antibodies: SEC61β: the main mediator of ER protein translocation;
MFN2: an outer membrane component; MITRAC15: an integral inner membrane protein;
MRPS15: the ribosomal protein S15, part of the S28 subunit of the mitochondrial ribosome.
Ago2 was found in all fractions, however, a double band was observed for crude
mitochondria and F1. For F2 and F3 the double band detected by 11A9 was re-
duced to the protein with the higher molecular weight (Figure 4.29).
Therefore, it seems that the lower band results from an ER associated Ago2 spe-
cies [Stalder et al., 2013], whereas the slower migrating form is found also in mi-
tochondria. As ER and mitochondria are surrounded by a membrane, the inter-
action of Ago proteins with membranes was further analysed.
4.5.4 Membrane Association of Ago
The membrane association of proteins can be probed by treating the respective
membrane with carbonate buffers of ascending pH [Fujiki et al., 1982]. At a pH
value of 10.8 integral membrane proteins are retained as well as proteins associ-
ated via protein-protein interactions. Rising the pH to 11.5, however, destabilises
protein-protein interactions and thus selects for integral membrane proteins.
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In order to test the association of Ago with mitochondrial membranes, isolated
mitochondria (Section 3.5.8) were exposed to different carbonate buffers (pH 10.8
and pH 11.5) and Trition X-100 containing buffer, which is a strong detergent
solubilising membranes and proteins alike. Each sample was split in input (total),
supernatant (SN), containing free proteins, and a 100.000×g pellet (P), consisting
of membrane-associated plus integral membrane proteins (pH 10.8) or integral
membrane proteins only (pH 11.5). All fractions were analysed by SDS-PAGE
and WB against Ago and various marker proteins (Figure 4.30).
Lysis by Triton X-100 was used as solubilisation control. Different mitochon-
drial proteins were used as controls for membrane association. Cox6A is part
of the cytochrom c oxidase, which is the last complex in the mitochondrial elec-
tron transport chain residing in the inner membrane and catalysing the transfer
of electrons to oxygen. As integral membrane protein, Cox6A was, as expected,
found in the membrane fraction for both carbonate treatments (Figure 4.30, Pellet
(P)). Tim44 is a part of the TIM complex, resides on the matrix side of the inner
mitochondrial membrane and is bound to the membrane by protein-protein in-
teractions with the integral membrane protein Tim23 [Rehling et al., 2001]. In the
carbonate extraction experiment Tim44 was bound to the membrane by protein-
protein interactions and found in the pellet fraction at pH 10.8 (Figure 4.30, P at
pH 10.8). However, the interaction of the protein with Tim23 was lost when the
membranes were treated with carbonate buffer of pH 11.5 releasing Tim44 into
the supernatant (Figure 4.30, SN at pH 11.5).
The marker protein for the ER is the lumenal protein ERp72 which is a protein
disulfide isomerase-like protein and primarily functions as a chaperone [Prins
and Michalak, 2011]. ERp72 seems to be membrane associated by protein-protein
interactions, showing a pattern comparable to Tim44 (Figure 4.30, P at pH 10.8
and SN at pH 11.4). The Ago1 protein, detected by the 1C9 antibody, was not as-
sociated with the membrane fractions under all tested conditions and thus found
consistently in SN fractions throughout the experiment (Figure 4.30). For Ago2
two bands were observed. The faster migrating form behaved similar to Ago1,
can be regarded as soluble protein and is most likely Ago2 (Figure 4.30, SN at pH
10.5 and 11.8). The slower migrating protein detected by the Ago2-specific anti-
body (11A9) showed membrane association even under treatment with carbonate
buffer pH 11.5 (Figure 4.30, P at pH 10.8 and pH 11.5).
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Figure 4.30: Analysis of mitochondrial membrane association of Ago proteins.
Isolated mitochondria were lysed by different carbonate buffers (pH 10.8 and 11.5), which
render membrane vesicles into sheets containing interacting proteins or only integral mem-
brane proteins, respectively. Ago1 seems not to be bound to any membrane, which is also
observed for the faster migrating form of Ago2. However, there is also a band with a slower
migration rate detected by the Ago2 antibody (11A9). The respective isoform or protein
behaves like an integral membrane protein, given its resistance to pH 11.5. When the WB
membrane used for Ago1 detection was developed with a rabbit antibody specific for Ago2
(1526), only the faster migrating form was detected. ERp72: ER lumen; Tim44: Mitochon-
dria inner membrane, bound by protein-protein interaction to integral membrane protein.
Cox6A: member of the complex IV of the electron transport chain, integral membrane pro-
tein. One of two experiments is shown. Samples were loaded in equal amounts and order on
a 10% (a) and 16% (b) SDS-PAGE gel. Further analysis by WB was performed in parallel.
Exposure of the Ago1 WB membrane (rat mAB) to an antibody specific for Ago2
(1526 rabbit pAB) (Figure 4.30, top blot) led only to detection of the faster mi-
grating form of Ago2. Therefore, it is possible that the slower migrating band
resembles an antibody cross-reactivity.
In conclusion, Ago1 and Ago2 (faster migrating band) were soluble proteins un-
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der all tested conditions and were clearly not associated with any membrane.
However, a slower migrating protein, detected by an Ago2-specific antibody
(11A9), showed strong membrane interaction, which was comparable to Cox6A.
This protein is therefore most likely an integral or covalently anchored membrane
protein. If this band is a true isoform of Ago2 or a non-specific cross-reactivity
still needs to be determined. Given the negative results from the membrane asso-
ciation assay regarding Ago association with the outer and inner mitochondrial
membrane, the two lumenal compartments of mitochondria, the inter membrane
space and the matrix, were tested next (Section 4.5.5).
4.5.5 Localisation of Ago Inside Mitochondria
Mitochondria consist of an outer membrane which surrounds a lumenal space
called the inter membrane space. This is separated from the inner mitochondrial
lumen, the matrix, by the inner mitochondrial membrane. In order to test, if
Ago proteins reside in one of these compartments a mitochondrial swelling assay
was applied. Here, isolated mitochondria are treated with either an isosmotic
buffer (SEM) stabilising whole mitochondria or a hypotonic buffer (EM) which
causes water to enter the inter membrane space. The rapid expansion of the outer
membrane due to the osmotic pressure in the inter membrane space results in
little ruptures of the outer membrane. Inter membrane space components will
thus leak out through these tears and are removed by applying protease digestion
and washing steps.
Mitochondria were freshly isolated from HEK-293 as described in Section 3.5.8
and split in three fractions: The first was resuspended in isosmotic buffer (SEM),
the second was resuspended in hypotonic buffer (EM) and the third was resus-
pended in hypotonic buffer and served as control for protein degradation by Pro-
teinase K combined with sonication. After swelling of the mitochondria treated
with hypotonic buffer, three different amounts of Proteinase K were added to the
mitochondria (SEM, EM: 0, 5, 10 µg; sonication: 0, 10 µg). Following digestion
of the accessible proteins, the samples were analysed by SDS-PAGE and western
blot against Ago and several other marker proteins (Figure 4.31).
Several mitochondrial proteins were used as controls. Tom70 is a receptor for
hydrophobic preproteins at the translocon of the outer membrane and was, as
expected, accessible to protease treatment under all conditions [Rehling et al.,
2001] (Figure 4.31, SEM, EM). Tim23 is a preprotein receptor and potential pro-
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tein channel at the inner membrane [Rehling et al., 2001]. Thus, the IMS exposed
epitope detected by the Tim23 antibody, was digested by Proteinase K only un-
der swelling conditions (Figure 4.31, EM). MITRAC12 is an integral inner mem-
brane protein involved in cytochrome c oxidase biogenesis. Its C-terminus, rec-
ognized by the antibody, protrudes into the inter membrane space and was there-
fore also degraded by externally added protease under hypo-osmotic conditions
[Mick et al., 2012] (Figure 4.31, EM). Tim44 is bound to Tim23 on the matrix side
and was so protected from any protease under swelling conditions (Figure 4.31,
SEM, EM). The protease digest was controlled by a combination with sonication
of isolated mitochondria. Here, all soluble proteins were successfully degraded
(Figure 4.31, sonication: PK+). Ago1 was only partially protected from protease
digestion under stabilising conditions (Figure 4.31, SEM).
- + -PK μg:
P SNP SN
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Figure 4.31: Localisation of Ago in mitochondria.
Isolated Mitochondria were treated with isosmotic or hypotonic buffer, followed by Pro-
teinase K digest of the accessible proteins. Ago1 and Ago2 seemed to be partially protected
from protease, when the outer membrane was still intact. Under hypotonic conditions all
signals were lost. The treatment was controlled by several mitochondrial proteins with well
established topology: Tom70: outer membrane protein, accessible to protease under all con-
ditions; Tim44: inner membrane-associated matrix protein, protected under all treatments;
Tim23 and MITRAC12: integral inner membrane proteins with protease accessible regions,
which are used for antibody detection. Samples were loaded in equal amounts and order on
a 10% (a) and 16% (b) SDS-PAGE gel. Further analysis by WB was performed in parallel.
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When the outer membrane was destructed, Ago1 was completely degraded by
Proteinase K (Figure 4.31, EM). The same was observed for Ago2, which was to a
certain extent resistant to Proteinase K addition, when the outer membrane was
still intact (Figure 4.31, SEM). However, Ago2 signal was lost when the outer
membrane was porous (Figure 4.31, SEM).
In summary, Ago1 and Ago2 proteins were partially protected from Proteinase K
treatment under isosmotic conditions (SEM) but were lost from mitochondria un-
der hypotonic conditions (EM). These findings suggest that a fraction of Ago pro-
teins may be protected from protease digestion by the mitochondrial outer mem-
brane, an interaction with contaminating ER, which is always present in these
isolations, or another unknown complex which is sensitive to hypotonic condi-
tions. Therefore, it might be interesting to also analyse the behaviour of a lumenal
ER protein in this assay.
4.5.6 35S Labelling of Mitochondrial Proteins Under Ago
Knockdown Conditions
So far four experiments were performed assessing mitochondrial localisation of
Ago proteins (Figure 4.28, 4.29, 4.31) and membrane association (Figure 4.30),
suggesting that Ago proteins potentially reside in the inter membrane space and
do not associate with the membrane, except for the larger potential isoform de-
tected by the Ago2-specific antibody 11A9. These findings are in contrast to our
in vivo DAMID experiments, which showed Dam-Ago-dependent methylation of
mitochondrial DNA and encouraged us to examine a possible function of Ago
proteins in mitochondria. In order to further dissect these contradicting findings,
we thought of another in vivo approach focussing on mitochondrial translation.
In addition, this assay is independent of biochemical isolation of mitochondria
which was required for all previous experiments (Figure 4.28, 4.29, 4.31, 4.30).
The proposed experiment utilises the difference in ribosomal subunits between
the mitochondria, comprising a prokaryotic-related 30S small and 50S large sub-
unit, and the human translation machinery, consisting of a 40S and 60S subunit.
In the 35S-labelling assay the chemical compound emetine is applied to human
cells to irreversibly inhibit the 40S small subunit [Jimenez et al., 1977]. Subse-
quently, radioactively labelled 35S-methionine is added to the cells which is, due
to the block of eukaryotic translation, only incorporated into freshly translated
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mitochondrial proteins. In order to test, if Ago proteins have an influence on mi-
tochondrial translation similar to their cytoplasmic function, HEK-293 cells were
transfected with two different siRNAs against Ago1 and Ago2 (Si1 and Si2) 72
hours before the labelling reaction. As control, cells were transfected with a non-
targeting siRNA (NT). Then, the cellular ribosomes were inhibited by emetine
and 35S-methionine was added to the cells for labelling of mitochondrial proteins
(see Section 3.5.14). After a radioactive pulse for 1 hour, the cells were harvested
and analysed by auto-radiography and WB (Figure 4.32).
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Figure 4.32: Analysis of mitochondrial translation under Ago knockdown conditions.
Ago proteins were knocked down by transfection of two siRNAs (Si1 and Si2, 33nM) and a
control siRNA (NT) for 72 hours. Afterwards, the cellular translation machinery of HEK-293
cells was inhibited by exposure to emetine. Then 35S-methionine was added to the medium
and mitochondrial translation was monitored for one hour. Subsequently, the cells were
lysed and analysed by WB. A) For autoradiography of mitochondrial proteins the samples
were loaded on an 18% UREA-SDS-PAGE gel and transferred to a nylon membrane. Knock-
down of Ago1 or Ago2 by two different siRNAs (Si1 and Si2) showed no change in translation
rate when compared with the control transfection with non-targeting siRNA (NT). Addition-
ally, WB analysis of the membrane transferred 18% UREA-SDS-PAGE was performed with
antibodies specific for Ago2 and tubulin (loading control). The successfully knockdown of
Ago2 with both siRNAs (middle band missing in lanes Ago2-Si1 and Ago2-Si2) was con-
trolled for equal loading by tubulin. B) The knockdown of Ago proteins was also examined
on 10% SDS-PAGE gels (same samples and volumes loaded as for UREA-PAGE, A). For both
Ago1 and Ago2 successful siRNA knockdown (Si1 and Si2) compared to the control (NT)
was demonstrated. One of two experiments is shown.
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The knockdown of either Ago1 or Ago2 did not seem to influence the translation
of all 12 mitochondria encoded proteins (Figure 4.32, A). The knockdown of Ago2
and equal loading was confirmed by detection of Ago2 and tubulin by WB (18 %
UREA-PAGE)(Figure 4.32, A, lower part). Due to the low resolution of the 18 %
UREA gel the Ago2 band is surrounded by two cross-reacting bands. In order
to get a better resolution of the knockdown, sample volumes equal to the UREA-
PAGE were loaded on a 10% SDS-PAGE (Figure 4.32, B). Analysis by western
blot revealed a good knockdown of Ago1 and Ago2, which was, however, not
complete for Ago1. Interestingly, the WB probed for Ago2 (Figure 4.32, B) re-
vealed two bands. The faster migrating protein (~95 kDa) was sensitive to siRNA
treatment with Ago2-specific siRNAs and thus comprises Ago2. The slower mi-
grating band, which was not altered by the siRNA treatment is most likely a
cross-reactivity of the 11A9 antibody.
In conclusion, the above findings suggest that neither Ago1 nor Ago2 have an
influence on mitochondrial translation as the successful knockdown of both pro-
teins did not change the signal strength of the 12 mitochondria encoded pro-
teins. Furthermore, the Ago2 knockdown experiment suggests that the siRNA-
insensitive, slower migrating protein detected by the Ago2-specific 11A9 anti-
body, is most likely a cross-reactivity. This is also supported by the different lo-
calisation patterns of the faster (Ago2) and slower migrating proteins observed in
the Percoll gradient (Figure 4.29) and membrane association assays (Figure 4.30).
However, our results from swelling assays (Figure 4.31), suggest mitochondrial
inter membrane space localisation for Ago proteins. In contrast, the DAMID ex-
periments from mESC and MRC-5 cells (Figure 4.26, Figure 4.20) support Ago
matrix localisation. Even though these findings contradict each other, both re-
quire a successful import of Ago proteins into mitochondria. Therefore, the trans-
location of Ago proteins into mitochondria was analysed by an in vitro import
experiment (Section 3.5.13).
4.5.7 In Vitro Import of Ago Proteins into Mitochondria
For these assays the protein of interest is radioactively labelled with 35S-methio-
nine in a coupled transcription-translation reaction. Subsequently, the labelled
protein is incubated with isolated mitochondria and energy. In the case of a suc-
cessful import of a preprotein, which comprises a target peptide, a radioactive
signal inside mitochondria as well as a size shift to a faster migrating form, due
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to target peptide cleavage, can be observed. As explained in Section 4.5, there are
four import pathways described, today. However, all of these require the proteins
to contain a presequence, which is proteolytically removed after import, or an in-
ternal targeting signal, which is retained [Schmidt et al., 2010]. Unfortunately, no
presequence could be predicted for Ago proteins based on several online predic-
tion programmes.
In the first step of the import experiment mitochondria were freshly isolated
from HEK-293 cells and incubated with radioactively labelled preproteins (Sec-
tion 3.5.12). After the import reaction, mitochondria were treated with protease
(PK-/+) to degrade any residual protein on the outside (Figure 4.33). Following a
washing step, mitochondria were analysed by SDS-PAGE and auto-radiography.
For the import reaction the following proteins were chosen: First, His-Ago1 and
His-Ago2 (pET-32), to analyse the influence of an N-terminal modification on the
import. Second, Ago2-∆ C-DHFR, which comprises amino acids 1 to 222 of Ago2
fused to Dihydrofolate reductase, is much shorter than the His-Ago proteins and
should, therefore, be more readily imported. Third, Cox6A which is commonly
used as positive control for the import reaction.
On the autoradiograph of the import reaction His-Ago proteins are found asso-
ciated with mitochondria before and after Proteinase K (PK-/+) treatment (Fig-
ure 4.33), indicating protection of a fraction of the proteins inside mitochondria.
The Ago2-∆-C-DHFR fusion protein is stable in the untreated sample (PK-), but
degraded in the presence of the protease (PK+), suggesting a lack of import (Fig-
ure 4.33). This is further supported by the complete degradation of the input
control His-Ago2 confirming the efficiency of the Proteinase K treatment (Fig-
ure 4.33). As import control Cox6A was used, which is commonly imported with
high efficiency and N-terminally cleaved during translocation resulting in an ob-
servable size shift [Lazarou et al., 2009]. In the autoradiograph, however, Cox6A
(12 kDa) was not properly resolved due to the SDS-PAGE gel (10%), in which it
migrated together with the dye front (Figure 4.33, last band in all lanes). Unfortu-
nately, the signal of Cox6A can only be distinguished from the background signal
in the non-protease treated samples (Figure 4.33).
The decrease in signal intensity of the His-Ago-specific bands upon protease
treatments suggests that His-Ago import was only limited. This might be im-
proved by adapting the import reactions to the needs of these large proteins. Ex-
citingly, a size shift of His-Ago1 and His-Ago2 was observed when the bands
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Figure 4.33: In vitro Import of Ago proteins in Mitochondria.
Mitochondria, freshly isolated form HEK-293 cells, were incubated in the presence of ra-
dioactively labelled preproteins in an import reaction. For the control protein Cox6A, also
a control on membrane potential dependence was included (−ψ). After incubation for 30
minutes the import reaction was stopped and split into two tubes. One set of samples was
treated with protease, the other was used as control. All proteins were successfully translated
and stable in the import reaction, as shown in the non protease treated samples. After pro-
tease treatment a weak signal for full length Ago proteins and Cox6A were observed, while
Ago2-∆C-DHFR was completely degraded.
with and without Proteinase K treatment were compared, indicating a recogniz-
able targeting sequence and a cleavage event following import. However, given
that the Ago2-∆-C-DHFR fusion protein, carrying the endogenous N-terminus is
not imported, the question arises if the modified N-terminus of His-Ago2 carries
the characteristics of a targeting sequence and by this triggers the mitochondrial
import of the protein. Therefore, the sequence of the His-Ago fusion proteins was
applied to the target prediction software targetP [Emanuelsson et al., 2000]. Re-
markably, the score for mitochondrial localisation was highly increased for His-
Ago2 (0.737) compared to the endogenous N-terminus (0.204). This means, that
mitochondrial import of endogenous Ago proteins is more likely represented by
the Ago2-∆C-DHFR fusion protein, while N-terminal modification with a His-
tag may lead to false positive signals. The endogenous N-terminus is, therefore,
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not sufficient for Ago import into mitochondria. In addition to independent val-
idations of these findings, optimisation of the import efficiency and a control for
dependence on mitochondrial membrane potential, driving the import across the
inner mitochondrial membrane, is needed. A reliable signal for the positive con-
trol Cox6A is required, as well.
In summary, the above experiments suggest that Ago2 is not imported into the
mitochondrial matrix, while N-terminal extensions (6xHis or Dam) may cause a
limited degree of import. This is in agreement with the non-mitochondrial lo-
calisation of Ago1 and Ago2 from Percoll gradients (Figure 4.29) and the lack
of membrane association (Figure 4.30). Further support comes from the absence
of mitochondrial DNA in Ago-ChIP experiments and unchanged mitochondrial
translation under Ago protein knockdown (Figure 4.32). Here, only the swelling
assay (Figure 4.31) with its potential ER contamination, suggests a potential inter
membrane space localisation, while supporting the absence of Ago proteins from
the mitochondrial matrix. However, more experiments under Ago knockdown
or knockout conditions also including the DAM-Ago fusion proteins are needed
to fully explain above experiments.
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Discussion
Ago proteins mediate small RNA induced post-transcriptional gene silencing in
the cytoplasm but also nuclear localisation and functions were described in sev-
eral organisms (see Section 1.5.3, 1.5.4, 1.5.5, 1.5.6). The latter range from small
RNA induced heterochromatin formation in S. pombe [Aravind et al., 2000; Volpe
et al., 2002] to Ago4 dependent recruitment of the DNA and histone methylation
machinery in plants [Zilberman et al., 2003]. Inspired by the findings in other or-
ganisms, the search for indications on nuclear localisation and function of human
Argonaute proteins began.
Applying cellular fractionation, the nuclear localisation of Ago2 was reproduced
(see Section 4.1), as has been shown in similar experiments by [Robb et al., 2005;
Rüdel et al., 2008; Ohrt et al., 2008; Chu et al., 2010; Gagnon et al., 2014] and by
detection of nuclear miRNA and cleavage competent complexes in Meister et al.
[2004]. This was further confirmed by studies applying confocal microscopy on
Ago1 and Ago2 [Rüdel et al., 2008; Ameyar-Zazoua et al., 2012; Benhamed et al.,
2012; Huang et al., 2013a].
During the last 11 years many hints on the nuclear functions of human Ago1 and
2 were gathered (Section 1.5.7, 1.5.8). These include, the targeting of Ago proteins
to chromatin by promoter complementary siRNAs. However, an Ago pathway
guided by endogenous small RNA species that targets mammalian chromatin
had not been convincingly reported. To elucidate such a pathway, potential chro-
matin association sites of Ago proteins had to be identified in somatic cells. In
order to test if a fraction of nuclear Ago proteins are associated with chromatin
even in the absence of promoter targeting siRNAs, a chromatin association assay
was performed [Cernilogar et al., 2011]. In this assay (Figure 4.2) a sub set of Ago
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proteins were found in a chromatin containing pellet, which has been described
for human Ago1 and Ago2 proteins also by other studies [Cernilogar et al., 2011;
Ameyar-Zazoua et al., 2012; Huang et al., 2013a; Gagnon et al., 2014]. When the
chromatin pellet was further digested with DNAse, Ago proteins and integral
chromatin components (histone H3) were released, arguing for a strong interac-
tion of Ago proteins with chromatin, which was only destroyed by removal of the
DNA. This finding supports a potential targeting of Ago proteins to chromatin
by endogenous triggers, which could result in the regulation of transcription and
heterochromatin formation as observed in other organisms [Bühler et al., 2006;
Guang et al., 2008; Naumann et al., 2011; Kuhlmann et al., 2014] but also in in-
volvement in splicing or DNA DSB repair (compare Section 1.5.8). Based on the
encouraging result from the chromatin association assay, we set out to elucidate
potential sites for Ago dependent transcriptional regulation or epigenetic mod-
ifications by ChIP and DAMID experiments in HeLa, MRC-5 and mESC cells,
respectively.
5.1 Results from the ChIP Experiment
For the study of Ago-chromatin interaction ChIP-sequencing experiments were
applied, using three different antibodies each for Ago1 and Ago2 (Section 4.2).
To select for regions with a high potential for being true Ago binding sites, only
overlapping peaks from all three different antibody-libraries were regarded as
functional binding sites. This was done to exclude non-specific binding sites from
potentially cross-reacting proteins or other unspecific interactions of the antibod-
ies. Unfortunately, only nine regions for Ago1 and ten regions for Ago2 were
found to be enriched in all of the three different ChIP preparations.
5.1.1 Limitations of the ChIP-Sequencing Experiment
In general, the number of overlapping peaks is too low to draw any conclusions.
The amount of overlapping peaks is, however, restricted by the number of peaks
per antibody used for the overlap analysis. In the case of Ago1, the input set of
peaks for the analysis across three different antibodies comprised only 578 (A1-
4B8), 1106 (A1-Rabbit) and 3699 (A1-Millipore) regions while the set for Ago2
contained 2863 (A2-5D4), 871 (A2-Rabbit) and 715 (A2-Millipore) sites (see Ta-
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ble 4.3) for a genome of 3 ∗ 109bp. As the analysis used a stringent p-value of
0.00001 to identify the sites of Ago enrichment in the first place, the overlap be-
tween the heterogenic set of antibodies used, was rather limited. Therefore, it
might be worthwhile to use the overlap across the different antibodies as strin-
gent selection criterion and start on a rather broad basis of potential peaks.
Another reason for the low amount of detected peaks may be the read depth.
When the NGS-data from the conducted Ago1/2 ChIP experiments with at least
10 million reads per sample, is compared with the first successful ChIP studies
using two to five million reads and the ENCODE consortium guidelines of 20 mil-
lion reads per TF [Sims et al., 2014], the data set seemed large enough to get a first
glimpse of the potential Ago1 and 2 chromatin interaction sites. Low strength in-
teraction sites and low abundant components would have probably escaped our
analysis. However, several studies implied that Ago1 and Ago2 may bind rather
indirect to the DNA [Schwartz et al., 2008; Chu et al., 2010; Younger and Corey,
2011], thus aggravating our experiments because our measurements might be
close to the background noise. Along these lines, low read numbers were found
in our ChIP-sequencing experiments, which hint at an indirect binding mecha-
nism but made it difficult to set a threshold to clearly separate the signal from the
background noise. This problem might have also been severed by the purifica-
tion state of the used antibodies. Here, the rat monoclonal antibodies (A1-4B8,
A2-5D4) and the rabbit antibodies (A1-rabbit, A2-rabbit) were only purified on
ProteinA-Sepharose beads used for IP and not added in concentrated form to the
ChIP lysate. In addition, the lack of replicates made statistic analysis impossible
and thus selection of potential peaks for validation by other techniques.
During the preparations for the ChIP-Seq experiment we have also tested several
antibodies and cell lines, including siRNA mediated targeting of Ago proteins to
the progesteron receptor promoter in MCF7 cells [Janowski et al., 2007], miR-320
targeting to POLR3D in HEK293 [Kim et al., 2008] and endogenous targeting to
the CD44 locus [Ameyar-Zazoua et al., 2012] to optimise our ChIP experiments.
Unfortunately, these sites turned out to be non-reproducible in our hands. There-
fore, we can not decide, if the negative ChIP results were caused by a lack of
chromatin association sites or weak precipitation capability of our antibodies un-
der ChIP conditions.
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5.1.1.1 Results from the ChIP-Sequencing Experiment
Both Ago1 (6 peaks) and Ago2 (10 peaks) were enriched at satellites sequences
annotated as Alpha repetitive DNA (ALR), which is a human satellite consen-
sus sequence found at the centromeres of the human chromosomes [Vissel and
Choo, 1987]. Our observed association of Ago1 and Ago2 with the pericentric
chromatin could suggest a potential involvement of the RNAi machinery in het-
erochromatin formation similar to yeast (Section 1.5.3). According to this hy-
pothesis, small RNAs deriving from centromeric satellites are needed to guide
Ago proteins to complementary sequences on the chromatin. As small RNAs
are commonly processed in a Dicer-dependent manner, Dicer could be also in-
volved. Therefore, Ago or Dicer depletion should result in defects of centromer
function and increased transcription from pericentric satellites as described for
yeast [Volpe et al., 2002].
This hypothesis is supported by studies form mESCs deprived of Dicer, which
showed strong defects in differentiation, an increase in the expression of cen-
tromeric transcripts and reduced levels of small RNAs (25-30 bp) descending
from minor satellite sequences [Kanellopoulou et al., 2005; Murchison et al., 2005].
However, a role of mouse Ago2 in silencing by DNA methylation of centromeric
repeats, imprinted genes and methylation of the inactivated X chromosome was
ruled out by studies of Ago2 knockout animals [Morita et al., 2007]. Despite of
this, the potential enrichment of Ago proteins at satellite sequences is highly in-
teresting and needs experimental validation. Unfortunately, this data was sup-
plied by the bioinformatician only after the end of the experimental part of my
thesis.
Recently, a NGS study analysed 80-100 million reads form Ago1 and Ago2 ChIP
samples isolated from PC3 cells [Huang et al., 2013a]. As they found some overlap
between peaks of the activating histone mark H3K4me3, Ago1 and RNA PolII
ChIP-Seq experiments, the authors speculated about a transcription promoting
function of Ago1 at the transcription start sites of most of their identified genes
[Huang et al., 2013a]. Since replicates were not performed [Huang et al., 2013a],
the significance of this study is not clear and needs further validation.
The suggestion of human Ago1 as being responsible for transcriptional gene reg-
ulation, while excluding Ago2, which was implied by others, stresses once more
the controversial findings regarding Ago chromatin interaction (see Table 1.1). In
our data we found overlap between Ago1 and Ago2, at least regarding the ge-
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nomic element bound, which may support a potential role of Ago1 and Ago2 at
pericentric satellites. As described above, the limited number of peaks, lack of
validation and replicates, prohibits further speculations (Section 5.1.1).
5.2 Results from the DAMID-Seq Experiments
In addition, we used DAMID, an antibody independent in vivo approach, to ex-
amine Ago1 and Ago2 chromatin association [Steensel and Henikoff, 2000]. After
successful confirmation of expression of all Dam-fusion proteins and slicer ac-
tivity of Dam-Ago2 (Figure 4.14), DAMID experiments followed by NGS were
performed in MRC-5 cells and mESCs.
5.2.1 High Rates of Duplicate Reads in DAM-ID Experiments
When DAMID-libraries form human and mouse cells were analysed with respec-
tive bioinformatic methods, a high rate of duplicate reads, which are reads with
identical start and end coordinates deriving from the same DNA strand, were ob-
served. While duplication levels of ~15 % for controls, Dam-Ago samples showed
high rates of duplicate reads ranging form ~30 % for human cells to ~80 % for
mESC (Table 4.13, 4.22). When single chromosomes were analysed, human mito-
chondria, several mouse chromosomes and mouse mitochondria were identified
to generate most of the duplicate reads (Figure 4.19, 4.25).
Influence of PCR Amplification on Rates of Duplicate Reads
These high duplication rates are probably caused by the PCR amplification step in
the NGS-library preparation. The observed over-amplification is most likely due
to a low diversity of DNA sequences in the input sample, which was already im-
plied by the band pattern observed for Dam-Ago2 fusion proteins (Figure 4.15b).
In contrast to Dam-Ago, samples from Dam-Cbx1 and Dam control transduced
cells comprised a highly diverse composition of DNA fragments, which resulted
in a smear on the agarose gel (Figure 4.15b), and showed markedly reduced rates
of duplicate reads (Figure 4.19). This trend can be improved by using more input
material [Casbon et al., 2011], but is in turn aggravated by reduced input amounts
or a high number of PCR cycles during library preparation. Given that the orig-
inal DAMID protocol is based on microarray analysis, these problems were not
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addressed by Vogel et al. [2007]. Low complexity DAMID reactions were only de-
scribed in the protocol for DNA samples from transiently transfected cells, which
was in human cells prevented by transduction of cells using lentiviruses and in
mESC by generating stable cell lines.
Additional Causes for Duplicate Reads
Another reason for the high duplication rate observed in above described exper-
iments is inherent to the DAMID technique, as all amplified fragments start and
end with GATC. However, during size fractionation by sonication, the respective
5′ and 3′-ends of the reads should be caused by sonication and thus at least re-
duce the fraction of reads with exactly matching start and end coordinates in the
genome. The fragmentation of DAMID amplicons to a mean fragment length of
~250 bp was examined by Bioanalyzer analyses following sonication.
The especially high rate of duplicate reads deriving from mitochondria is ex-
plained by the nature of the mitochondrial genome. First, the mitochondrial
DNA is quite short comprising only ~16 kB. Second, it contains 24 (32 for mouse)
GATC sites. This is a mean distance of 679 bp (447 bp for mouse) and a maximum
distance of 2334 bp (1605 bp for mouse) between two GATC sites. Therefore, all
GATC flanking sequences from mitochondria can be easily amplified during the
PCR amplification step during the DAMID experiment while some even longer
fragments deriving from the nuclear genome are deselected [Vogel et al., 2007].
Finally, human lung fibroblasts contain about 300 mitochondria, each of which
contains 2-3 copies of DNA [Robin and Wong, 1988].
When comparing mitochondrial reads from the samples Dam-Cbx1, Dam and
Dam-Ago2 (Figure 4.19), a specific problem of the experimental setting becomes
apparent. The number of mitochondrial reads per sample increase steadily, start-
ing lowest for the strictly nuclear Dam-Cbx1 (HP1-β), to Dam, which is equally
distributed in the cell [Steensel and Henikoff, 2000], peaking for the Dam-Ago2
protein, which is assumed to distribute in a ratio of 4 to 1 between cytoplasm and
nucleus [Ohrt et al., 2008]. Even though N-terminally GFP-tagged Ago2 correctly
localises to the cytoplasm and the nucleus [Ohrt et al., 2008] and a note in the
DAMID protocol on likely similar behaviour of GFP- and DAM- tagged proteins
[Vogel et al., 2007], the extent of nuclear localisation of Dam-Ago2 needs to be
tested experimentally.
In summary, the Dam-Ago libraries from human cells contained many duplicate
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reads, which was even more severe for the mouse samples. If the high number
of reads deriving from mitochondrial DNA was caused by Ago localisation to
mitochondria was experimentally assessed and will be discussed in Section 5.3.
Future experiments could be significantly improved by directing the Dam-tagged
target protein to the nucleus by fusing it to a nuclear localisation signal (NLS),
which is unlikely to cause any defects in the cell due to the low expression level
of the fusion-proteins. In addition, maximising the sample input in the library
preparation while concomitantly reducing the PCR cycles in the library prepara-
tion to a minimum will considerably increase the quality of the NGS results.
Another improvement to the DAMID technique was suggested by Zhou [2012].
Her workflow follows the general approach including the DPN I digest and adap-
tor ligation [Vogel et al., 2007], which selects for methylated fragments. Instead
of the DPN II digest, used to deprive of non-methylated fragments, an adaptor
specific PCR is performed with a biotinylated primer. This amplification step
enriches all methylated fragments including those with non-methylated sites in
between. After fragmentation to a size range amenable to NGS the DPN II di-
gest is performed to cleave non-methylated sites. Then methylated sites are en-
riched by avidin-pull down and NGS-libraries are prepared from the enriched
fraction [Zhou, 2012]. In the resulting library, methylation levels of GATCs can
be distinguished by their accompanying sequence, which is either the DAM-ID
PCR primer in the case of methylation, or no sequence, as the associated library
adapter is automatically removed by the sequencing facility. The proposed work-
flow leads to selection of GATC-containing sequences for NGS-library prepa-
rations and thus reduces non-specific background DNA notably improving the
signal-to-noise ratio of the original DAMID protocol.
5.2.2 Shared Sequence Between Mouse DNA and Mitochondrial
Genome
A remarkable feature of the mouse genome, which became apparent during bio-
informatic analysis, is the identification of a 4136 bp long sequence shared be-
tween the mitochondrial DNA (6600 to 10735) and chromosome 1 of the mouse
genome (24611842 to 24615978) (Table 5.1). In the respective region a strong ac-
cumulation of reads could be seen, which could not be unambiguously assigned
to any of the above mentioned regions.
179
DISCUSSION 5.2. Results from the DAMID-Seq Experiments
SCORE START END QSIZE IDENTITY CHRO STRAND START END SPAN
4137 1 4136 4136 100% M − 6600 10735 4136
4133 1 4136 4136 100% 1 + 24611842 24615978 4137
Table 5.1: Identical DNA fragment of mouse ChrM and Chr1
Many nuclear DNA sequences of mitochondrial origin, called NUMTs, have been
found in organisms ranging from yeast to humans [Ricchetti et al., 2004]. There
are several evolutionary conserved mitochondrial DNA integrations found in eu-
karyotes but also new integration events occur and are suggested to be caused by
environmental conditions causing DNA DSBs. [Ricchetti et al., 2004]. Unfortu-
nately, no hints on a functional role of the mitochondrial sequence on chromo-
some 1 of the mouse genome, presented above, could be found in the current
literature.
5.2.3 Identified Peaks and Validation of DAMID-MRC-5 Exper-
iment
Based on the first bioinformatic analysis (Homer, Section 4.4.3.3), we could con-
firm the successful establishment and application of the DAMID technique by
overlap of the CBX1-Dam sample with a reference data set [Vogel et al., 2006].
The strong association of CBX1 with SINE elements, found in our genome wide
study, was not supported by the reference study, which was, however, based on
an exon-array of chromosome 19 with very limited representation of SINE ele-
ments. Even though the method was successfully applied with respect to Cbx1,
none of the peaks selected for validation for Ago proteins by could be verified
by ChIP validation experiments of 25 selected loci, (Figure 4.17, 4.22), comprising
also peaks from the genomic element classes exon and SINE, which were found
to be enriched for Dam-Ago1 and Dam-Ago2. Due to the lack of replicates for the
human cell line the bioinformatic toolset to select for likely candidate regions was
limited and false discovery rates could not be predicted. This might have ham-
pered the identification of true enrichment sites in the data and their subsequent
validation. In addition, low read counts for human genomic DNA loci (median
count 17, second analysis) and high background noise in DAMID-Seq experi-
ments negatively affected the data analysis. Therefore, a repetition of the experi-
ment under improved experimental conditions as outlined in (Section 5.2.1) will
help to gain further insights into Ago chromatin interaction.
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Recently, Ago-chromatin interactions were analysed in pre-senescent versus se-
nescent primary lung fibroblasts (WI-38) [Benhamed et al., 2012], which are simi-
lar to the fetal primary lung fibroblasts, tested in our DAMID experiment. Apply-
ing ChIP-on-ChIP against Ago proteins using a pan-Ago antibody they identified
4516 bound promoters in senescent cells compared to 2619 for pre-senescent con-
trol cells [Benhamed et al., 2012]. In addition, they could link the target promoters
of the E2F transcription factor with 320 and 77 promoters bound by Ago proteins
(described in Section 1.5.7). This is the only high throughput experiment probing
Ago-chromatin interactions using replicates (compare Table 1.1). Therefore, they
were able to apply statistic methods to remove random binding sites and enrich
for true positive peaks. In addition, this study was conducted in a closely related
cell line. Due to these reasons we used the reported chromatin interaction sites
of Benhamed et al. [2012] to assess the different analyses methods applied to our
DAMID experiment.
The first analysis was conduced using the software Homer. Here, 628 of 6289
predicted Dam-Ago1-chromatin interaction sites were found to overlap with the
gene list from pre-senescent cells [Benhamed et al., 2012] (Table 4.9). For Dam-
Ago2, 89 of 866 binding sites were in common with the data set from pre-senes-
cent cells (Table 4.10). The homer software supplies the user with two values
to decide on the quality of the peaks: the peak score and the focus ratio. Un-
fortunately, both values which were used for selection of peaks for validation
did not help to identify any of these overlapping, potentially true positive sites.
Therefore, replicates would have helped to remove false positives from our list of
predicted peaks and to decide for reproducible candidate regions.
The second approach based on the DESeq package and all mapped reads, iden-
tified 1583 peaks for Dam-Ago1 and 870 for Dam-Ago2. When the overlap with
the data from Benhamed et al. [2012] was examined 101 and 53 peaks were found.
However, only one overlapping peak was detected within the first 40 peaks sor-
ted by their log2-fold change for Dam-Ago1 compared to Dam (Table 4.14). The
first 40 peaks of Dam-Ago2, did not contain any of the peaks identified by Ben-
hamed et al. [2012] (Table 4.15). Thus, the overlapping peaks were again not
sorted to the top of the list and escaped our validation experiments. The DE-
Seq package relies on replicates to estimate the false discovery rate, discard false
positives and calculate proper p-values.
The last analysis which applied the DESeq package on unique reads was con-
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ducted after my contract ended. Here, very stringent selection criteria were used
which resulted in very low numbers of detected peaks yielding 8 peaks for Dam-
Ago1 and 40 peaks for Ago2 (Table 4.16, 4.17). When compared with the genes
identified in pre-senescent cells [Benhamed et al., 2012], one peak of Dam-Ago1
and three peaks of Dam-Ago2 were found to overlap. However, the p-values,
which are not corrected for false positives due to the lack of replicates, still not
met the commonly accepted threshold of 0.05 (compare Table 5.2). If these over-
lapping peaks are true Ago-chromatin association sites, needs to be shown in
independent experiments.
Dam-fusion chrom start end Ago Dam log2-
Fold
Change
pval repclass external-
gene-id
GO-
domain
source
Ago1 (1/8) chr10 506102 506105 50 4 3.866 0.069 NA DIP2C metabolic pro-
cess
intron
Ago2 (3/40) chr1 92455156 92455159 44 4 3.781 0.057 SINE/Alu BRDT positive re-
gulation of
transcription
during meiosis
intron
Ago2 (3/40) chr17 30651373 30651376 34 4 3.409 0.065 NA RHBDL3 proteolysis exon
Ago2 (3/40) chr1 43995062 43995065 32 4 3.322 0.067 NA PTPRF transmembrane
receptor pro-
tein tyrosine
phosphatase
signaling path-
way
intron
Table 5.2: Peaks of the DAMID experiment overlapping with potential chromatin associ-
ation sites identified in pre-senescent cells Benhamed et al. [2012].
In summary, we do see overlapping peaks between our analysis and predicted
Ago-chromatin association sites in pre-senescent WI-38 cells [Benhamed et al.,
2012]. This suggests, that the DAMID experiment was also successfully applied
for Dam-Ago proteins. The lack of detection of true peaks is probably caused
by the absence of replicate experiments, the low median read count values for
nuclear encoded genes and many duplicate reads (see Section 5.2.1). This is most
likely caused by a low nuclear import rate of the Dam-Ago proteins, which could
be increased by fusion of a NLS. Since we have not yet tested these overlapping
peaks in validation experiments, we can still only speculate about Ago-chromatin
interactions.
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5.2.4 Identified Peaks and Validation of the DAMID-mESC ex-
periment
In the case of mESC cells a very limited number of binding sites with high sig-
nificance was reported by the DAMID experiment. Therefore, no binding pattern
or class of transcripts could be inferred from the sites of enrichment. In addition
to a set of mitochondrial genes which will be discussed in Section 5.3, also seven
genomic sites could be identified (Table 4.25) (p-value <0.05). These comprise
several predicted genes potentially associated with perception of sound, a telom-
eric satellite region, which partly overlaps with a predicted lincRNA, and a LINE
L1 element. Since mESC are not cultured in our lab, the gene list was sent to the
lab of our collaborator Prof. C. Ciaudo, for independent validation experiments,
which are currently conducted.
Unfortunately, no information could be found for most of the genes or regions
enriched in the DAMID experiment in mESC cells. For chr9 (3000001-3007435),
which maps to a telomeric satellite sequence, the only link to the RNAi machinery
is presented in S. pombe where RNAi plays a redundant role in silencing and
heterochromatin formation at telomers Kanoh et al. [2005]. Therefore, it might be
possible, that mouse RNAi is involved in heterochromatin formation at telomers.
Given, that we identified only one locus this is rather speculative. Interestingly,
the LINE L1 element (L1Md-T) has been already implied in a PTGS mechanism
in mESC and will be discussed in the following.
The LINE L1Md_T
Ago2 seems to be recruited to a region in the second ORF of the LINE L1Md_T
element in the DAMID experiment (p-value < 0.05). Line elements are transpos-
able elements, which consist of a 5′-UTR, ORF1 and ORF2 and a 3′-UTR, trans-
lated by RNA Polymerase II. In germ cells, retrotranposons are silenced by Piwi
proteins via TGS and PTGS [Aravin et al., 2008]. In somatic tissues, transposable
elements are suppressed by DNA promoter methylation, which is established at
the stage of embryonic implantation [Smith et al., 2012]. However, the various
ways how methylation is restored, remain elusive. The LINE class L1Md_T is de-
methylated during fertilisation and activated, which has been shown by reduced
representation in bisulfite sequencing experiments by Smith et al. [2012]. In bisul-
fite sequencing experiments the methylation of cytosine in CpG dinucleotides, an
183
DISCUSSION 5.2. Results from the DAMID-Seq Experiments
epigenetic mark implicated in transcriptional repression, is probed [Smith et al.,
2012]. During the early blastocyste stage, modelled by mESCs, the transcripts
of de-repressed LINEs are controlled by RNAi-dependent mechanisms [Ciaudo
et al., 2013]. Ago2 complexes seem to target especially the 5′-UTR, as these se-
quences could be precipitated in an Ago2-IP [Ciaudo et al., 2013]. In contrast,
Dam-Ago2 was possibly recruited to a sequence in ORF2 of L1Md_T, based on
the genomic region enriched in the DAMID experiment. Excitingly, Ciaudo et al.
[2013] identified a second small RNA peak in their Ago2-IPs and small RNA iso-
lations from whole cells, likely mapping to the same position. Therefore, further
analysis and experiments are needed to examine this link. This is currently per-
formed by our collaborator Constance Ciaudo.
Another source of endo-siRNAs are antisense promoters in the 5′-UTR of LINE
L1 analysed in HEK293 and HeLa cells [Yang and Kazazian, 2006]. These give rise
to long dsRNAs involving an antisense transcript and the LINE element and are
presumably processed by nuclear Dicer [Yang and Kazazian, 2006; Doyle et al.,
2013; Gagnon et al., 2014]. However, these siRNA were implicated especially in
targeting of transposable elements by PTGS mechanisms in cytoplasm. However,
Yang and Kazazian [2006] can not exclude other RNA silencing mechanisms like
TGS.
Further down this line, Chen et al. [2012] analysed retrotransposition of L1 el-
ements in breast cells. In normal cells L1 retrotransposition is extremely rare,
while L1 activity is highly increased in breast cancer cell lines accompanied by
hypomethylation of the L1 promoter. Knockdown of Dicer or Ago2 in normal
breast cells resulted, however, in increased retrotransposition activity of a L1 re-
porter construct. Comparing small RNA libraries from normal breast cells and
T47D breast cancer cells, they could identify endo-siRNAs targeting the 5′-UTR
of L1 [Chen et al., 2012], which has also been observed in mESCs [Ciaudo et al.,
2013]. Applying bisulfit sequencing of the promoter of the L1 element in T47D
and other breast cancer cells expressing sh-constructs of the endo-siRNAs, re-
vealed increased DNA methylation of the promoter compared to hypomethyla-
tion in wild type cells. This silencing coincided with reduced expression of L1
in the respective cells. Therefore, targeting of reactivated L1 elements by endo-
siRNA in somatic cells as suggested by Chen et al. [2012] seems a likely mech-
anism, but still needs independent validation. We do, however, not see an as-
sociation of Dam-Ago2 with the 5′-UTR but with a sequence in the second ORF
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of the L1Md_T. This could be due to a lack of GATC sites in 5′-UTR. In addi-
tion, the observation of only one incidence of LINE L1 binding may be caused
by a reduced library sensitivity due to the over-amplification of mitochondrial
sequences (see Section 5.2.1). Despite of this, more examples of Dam-Ago2 LINE
association would be needed to support such a pathway. Furthermore, details on
the proteins involved and the mechanism remain elusive.
5.3 Potential Ago2 Localisation and Function in Mi-
tochondria
The notion of a potential mitochondrial localisation of Ago proteins was fostered
by the high coverage of mitochondrial DNA fragments in the DAMID experi-
ments for Dam-Ago compared to the Dam control (Figure 4.20, 4.26). As this
enrichment of Ago at mitochondrial DNA could not be validated by ChIP (Fig-
ure 4.22), the idea emerged that methylation of mitochondrial DNA could just be
a side effect of its localisation to this compartment. Therefore, a cellular fraction-
ation experiment was conducted showing a clear enrichment in the mitochondria
containing fraction (Figure 4.28).
Furthermore, several publications implied mitochondrial localisation of Ago pro-
teins. Bandiera et al. and Barrey et al. [2011] rely on immunopurification of mi-
tochondria via a Tom20-specific antibody from fractionated cell lysates. Here,
special care must be taken. On the one hand, mitochondria were described to
associate with P-bodies [Huang et al., 2011], where also a big fraction of the cyto-
plasmic Ago is found. On the other hand, the ER was shown to be a nucleation
site for the RISC complex [Cikaluk et al., 1999; Stalder et al., 2013]. Addition-
ally, already early fractionation studies applying Percoll gradients implied the
problems to separate mitochondria and the ER into pure fractions [Reinhart et al.,
1982]. Unfortunately, both of the studies lack this important control.
In several publications also small RNAs were isolated from mitochondria, which
might suffer from contaminating Ago bound to co-purifying ER or associated P-
bodies [Kren et al., 2009; Bandiera et al., 2011; Barrey et al., 2011; Sripada et al.,
2012]. Most recently, Ago2 was shown to be localised inside mitochondria and
mitoplasts from isolated mouse heart and C2C12 cells [Zhang et al., 2014]. In
contrast to previous studies, the potential contamination with ER was tightly
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controlled and therefore this study presents a first solid link between increased
translation of mitochondrial encoded proteins (ND1, COX1) and the presence of
Ago2 associated with miR-1 in mitochondria [Zhang et al., 2014].
In collaboration with the lab of Professor Dr. P. Rehling (Dr. S. Dennerlein), which
is specialized on mitochondria, including protein import and functional analysis,
the association of Ago proteins with this organelle was examined. In a first step
of our experimental analysis, the separation of the ER and mitochondria was ac-
complished by Percoll density gradient centrifugation of mitochondria, following
isolation by differential centrifugation. Here, Ago2 fractionated in a slower and
faster migrating form with ER marker proteins. However, these fractions were
also rich in mitochondrial marker proteins. Only the slower migrating form was
associated with the mitochondria enriched fraction F2 and the pure mitochon-
drial fraction F3, controlled by the mitochondrial marker proteins MITRAC15,
MFN2 and MRPS15 (Figure 4.29). The lower migrating form seems to solely as-
sociate with the ER, as it is absent from the latter fractions, which is in agreement
with the results from Stalder et al. [2013]. The larger migrating form might ei-
ther be a modified Ago protein, a larger isoform or an unspecific band of the
Ago2 antibody (11A9) (compare Figure 4.29: F2, F3). This cross-reacting epitope
might only become visible in cytoplasm-depleted fractions, from which the main
fraction of Ago proteins had been removed. As mitochondria and the ER are
surrounded by membranes, this structure was analysed in more detail.
5.3.1 Membrane Association of Ago1 and Ago2
The association of Ago1 and Ago2 with mitochondrial membranes was examined
by carbonate extraction [Fujiki et al., 1982]. In this assay, the membrane vesicles
are broken into sheets. Integral membrane proteins and associated proteins still
fractionate with the membrane sheets in the pellet, as Tim44 (see Figure 4.30).
Under more basic, conditions protein-protein interaction is lost, as can be see by
dissociation of Tim44 from the translocase subunit Tim23. In this assay, Ago1
and the similar sized Ago2 band showed no membrane association under both
treatments. For Ago2, however, a second slower migrating protein or isoform
was detected by the Ago2 antibody (11A9), which behaved like an integral mem-
brane protein and resisted membrane extraction (see Figure 4.30, pH 11.5). The
very last finding is in agreement with experiments by Bandiera et al. [2011], who
demonstrate membrane association of Ago2 under similar conditions. In their
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gi |119612614| gb|Iso_CRA_b MAASLPLRLASRGIICFMFFCRDKGINRVTRVKNAEKAKEDAKSDERALAPPAPPPPIQG 60
gi |29171734| ref|NP_036286 .2| Iso_1 ----------------------------------------MYSGAGPALAPPAPPPPIQG 20
gi |257467482| ref|NP_001158095 .1| Iso_2 ----------------------------------------MYSGAGPALAPPAPPPPIQG 20
conservation .. *************
Figure 5.1: Clustal ω alignment of Ago2 isoforms.
The first line of the alignment is shown, comprising the mitochondrial localisation signal and
the difference in the amino acids at position 41 to 47, which might negatively influence the
epitope recognition by the Ago2 antibody (11A9)
publication, the authors mention a longer Ago2 isoform, called CRA_b, which is
extended by 40 amino acids at the N-terminus (Figure 5.1) and carries an insertion
of 6 amino acids at the end of the PAZ domain relative to Ago2, isoform 1 [Schirle
and MacRae, 2012]. Applying targetP on the CRA_b isoform a high prediction
score (0.79) is gained for mitochondrial localisation in contrast to a score of 0.2 for
isoform 1 and 2 [Emanuelsson et al., 2000]. There are, however, further concerns
regarding the CRA_b isoform. At least in our membrane association assay the de-
tection of the potentially expressed longer CRA_b isoform with the Ago2 (11A9)
antibody may be hampered given that 7 of the 15 amino acids of the peptide
used as immunising antigen are not conserved in the longer isoform. In addi-
tion, the longer CRA_b isoform does not explain the strong methylation rate of
mitochondrial DNA caused by Dam-Ago1 and Dam-Ago2. Both fusion proteins
were based on isoform 1 of the respective protein. Furthermore, no mitochon-
drial import was observed for fusion proteins consisting of the N-terminus of the
CRA_b isoform and GFP [Zhang et al., 2014]. Therefore, further experiments are
needed confirming the expression of the CRA_b isoform in different cell types at
transcript level as well as the detection by available antibodies.
5.4 Localisation and Import of Ago Proteins into Mi-
tochondria
The localisation of Ago proteins in mitochondria was further dissected by apply-
ing swelling assays. Here, mitochondria were treated either with a stabilising
buffer or a swelling buffer leaving only the inner membrane intact, while large
holes formed in the outer membrane. The accessibility of proteins under each
condition was probed with Proteinase K treatment which lead to degradation of
accessible proteins (i.e. Tom70). Under stabilising conditions, Ago1 and Ago2
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were in part protected by the outer membrane (Figure 4.31). Under swelling
conditions, when the outer membrane was broken, all Ago proteins were di-
gested similar to the IMS protein Tim23 and in contrast to matrix control pro-
teins (i.e Tim44). This supports a potential inter membrane space localisation
of Ago proteins or can be interpreted as Ago proteins being protected by one
membrane layer sensitive to hypo-osmotic conditions. In addition, also in vitro
import into mitochondria of N-terminally His-tagged forms of Ago1/2 and the
Ago2 N-terminus (1-74 aa) fused to di-hydrofolate reductase was tested. Suc-
cessfully imported proteins are resistant to protease treatment, while stability of
the proteins under experimental conditions is demonstrated in the absence of the
enzyme. Here, the Ago2 N-terminus fused to DHFR was stable under standard
conditions but completely degraded upon protease treatment, suggesting that no
mitochondrial targeting sequence is present in residues 1 to 74 of the endogenous
protein (Figure 4.33). For His-Ago1 and Ago2 only a weak slightly shorter protein
band was observed, which implies a limited import and N-terminal processing
of the proteins (Figure 4.33). When targetP analysis was performed with the His-
Ago2 protein sequence a high mitochondrial targeting peptide score of 0.7 was
predicted compared to 0.2 for the endogenous protein [Emanuelsson et al., 2000].
Therefore, it seems that an N-terminal His-tag can lead to false positive signals in
import assays at least in the case of Ago1/2.
Taken together, the failed import into mitochondria, the lack of a mitochondrial
transport signal in the amino acid sequence and no matrix localisation of Ago2
in the swelling assay, a protein import into the mitochondrial matrix seems to
be a rather unlikely explanation for the reads observed in the DAMID experi-
ment. This stand in contrast to a recent publication working with C2C12 cells
and mouse heart, showing mitochondrial localisation for a fraction of the cellular
Ago2 pool [Zhang et al., 2014]. Additionally, the transfection of MEF and HeLa
cells with miR-1 leads to enhanced translation of the mitochondrial encoded pro-
teins ND1 and Cox1, which was suggested by Zhang et al. [2014] to be dependent
on the import of Ago2 into mitochondria. Here, the localisation of Ago2 in HeLa
cells, however, still needs to be shown.
Similar to the study above, also a functional experiment inquiring a potential
role of Ago in mitochondrial translation was performed (see Section 3.5.14). Af-
ter knockdown of Ago2 and inhibition of the cellular translation machinery by
emetine, mitochondrial proteins were radioactively labelled. When the pattern
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of newly translated mitochondrial proteins were compared between Ago knock-
down and control cells, no influence on the expression level of mitochondria en-
coded proteins could be found. This suggests no involvement of Ago proteins in
the mitochondrial translation machinery. This is in agreement with data from
MEF and MEF-Ago2-knockout cells, which showed no change in the transla-
tion level of mitochondrial proteins transfected with control siRNAs, whereas en-
hanced mitochondrial translation was observed upon miR-1 transfection [Zhang
et al., 2014].
In addition, the knockdown of Ago proteins was controlled by western blot.
Here, the expression level of Ago1 and Ago2 were nicely reduced. Notably, a
slower migrating protein detected by the Ago2 (11A9) antibody, was not influ-
enced by the siRNA treatment. The visibility of the band was also reduced in
the presence of the correct Ago2 epitope under control conditions. This supports
the idea that there are cross-reacting epitopes expressed in the cell, which are
recognised by the 11A9 antibody and might accumulate in mitochondrial prepa-
rations as observed in the membrane association or the Percoll assay (compare
Figure 4.30, 4.29 F2, F3). An alternative explanation for the multiple bands de-
tected by the 11A9 antibody may, however, lay in posttranslational modifications
of Ago2 [Sahin et al., 2014].
5.5 Conclusion on Mitochondrial Localisation
The above discussed experiments on the protein level do not yield conclusive
support for a mitochondrial matrix localisation in HEK293 cells, which is fur-
ther supported by observation of normal mitochondrial translation also under
knockdown of Ago1 and Ago2. This is in line with the absence of Ago proteins
from large mass spectrometric analyses of the mitochondrial proteome [Pagliarini
et al., 2008]. However, Ago import into mitochondria could also be a cell type
specific event [Zhang et al., 2014]. The association of Ago proteins with the ER
is supported by the membrane association assay and the percoll gradient and
stands in agreement with the findings of Cikaluk et al. [1999]; Stalder et al. [2013].
The strong methylation signature from Dam-Ago on mitochondrial DNA, com-
pared to Dam or Dam-Cbx1 in MRC-5 or mESC cells might be explained by the
finding of Huang et al. [2011], who showed that mitochondria associate with P-
bodies, a main localisation site of Ago proteins [Sen and Blau, 2005; Rüdel et al.,
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2008]. Here, the inactivation of mitochondria decreased the efficiency of miRNA-
mediated gene silencing [Huang et al., 2011]. Therefore, one can assume a closer
spatial association of Dam-Ago with mitochondria compared to Dam or the nu-
clear Dam-Cbx1.
An alternative idea based on coinciding localisation is related to Ago and mito-
chondrial degradation. Recently, degradation of Ago by the autophagosome was
described [Gibbings et al., 2012]. SiRNA knockdown of autophagosome subunits
(Atg5-8) or the autophagy receptor NDP52 resulted in elevated protein levels of
Ago1 and Ago2. A similar behaviour was also seen by chemical inhibition of the
lysosomal acidification, which blocks autophagy [Gibbings et al., 2012]. The main
mechanism for control of the mitochondria population in the cell is mitophagy.
In the best studied pathway, mitochondria with aberrant membrane potential are
recognized by the E3-ligase Parkin, which is dependent on PTEN-induced puta-
tive kinase 1 (PINK1) and polyubiquitilates mitochondrial outer membrane pro-
teins. This leads to proteasomal digest of the outer membrane proteins and is
followed by recruitment of the autophagosome [Mishra and Chan, 2014]. There-
fore, Dam-Ago could associate with mitochondria inside autophagosomes, gain-
ing access to mtDNA. This process, however, seems rather unlikely, as the inner
mitochondrial membrane is still intact, despite its loss of membrane potential,
when the autophagosome is recruited. Shortly after, the mitophagosome acidi-
fies and fuses with lysosomes and hydrolyses its content within about 10 min-
utes [Lemasters, 2014]. It can be assumed, that Dam-Ago will denature already
during acidification of the mitophagosome and is thus unable to methylate mito-
chondrial DNA in this compartment.
Finally, Dam-Ago proteins, which are predominantly cytoplasmic, could methy-
late the abundant mitochondrial DNA during cell lysis. This is dependent on the
lysis buffers used and needs further testing.
The effect of mitochondrial DNA methylation seemed even more pronounced in
the stably transfected mESC cells as compared to the lentiviral transfected MRC-5
cells, which express Dam-Ago only for 72 hours. However, this might be caused
by the integration site or multiple insertions of the different transgenes. In the
case of mESC, a clonal cell line was produced, where Dam-Ago was readily de-
tected by RT-PCR. Thus, a region enhancing transcription of the transgene might
have been selected, while in the case of MRC-5 a random pool of integration
events was examined.
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5.6 Conclusion and Outlook
This study aimed to identify chromatin association sites of human Argonaute
proteins by applying the two high throughput techniques ChIP-Seq and DAMID-
Seq. Even though, peaks could be identified, there was no agreement on Ago-
chromatin associations sites between the different studies. Unfortunately, so far
none of the peaks could be validated, inhibiting further studies on the potential
nuclear functions and interactors of Ago proteins.
As outlined for ChIP-Seq (Section 5.1) and DAMID experiments (Section 5.2.1),
all three experiments suffered from rather low genomic coverage, resulting in
low signal-to-noise ratios, complicating peak detection. For the latter two, this
was found to correlate with a high mitochondrial read count (Section 5.2.1). As
discussed in Section 5.3, we have no evidence for mitochondrial matrix localisa-
tion of Ago proteins. Therefore, we conclude non-specific methylation of mito-
chondrial sequences by cytoplasmic Dam-Ago proteins leading to distortion of
the library complexity as observed in the NGS experiments. Consequently, we
ask the question, if the mitochondrial DNA sequences in the NGS-libraries are
caused by the lack of chromatin binding sites of Ago proteins or if these sequences
compromised the NGS-libraries in a way that prohibits identification of true Ago-
chromatin interaction sites. As we found overlapping peaks of the DAM-ID ex-
periment with a study conducted in WI-38 cells [Benhamed et al., 2012], it seems
rather likely that the mitochondrial DNA sequences negatively influenced the
NGS-libraries and thus detection of potential nuclear Ago-chromatin interaction
sites.
To successfully identify Ago-chromatin binding sites improved DAM-ID experi-
ments as suggested in Section 5.2.1 or alternative approaches like DAM-IP could
be used [Xiao et al., 2010]. DAM-IP is based on expression of a modified Dam-
fusion protein, which has a broader substrate specificity (recognition site: ATC)
and leads to an increased methylation rate and lower distance between methyla-
tion sites. The combination of the DNA-methylation with an IP approach using a
m6A-specific antibody additionally improves the signal-to-noise ratio.
In general, many functions have been proposed for nuclear Ago proteins, rang-
ing form TGS to DNA DSB repair (Section 1.5.7), which are sometimes most con-
troversially discussed. On the one hand, all these observations could be true
suggesting a stunning versatility of Ago proteins in the nucleus, compared to its
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exclusive function in the cytoplasm. On the other hand, one may argue that there
are only one or two true nuclear functions of Ago proteins, for example DNA DSB
repair, which, if perturbed or wrongly guided by i.e. promoter complementary
siRNAs, may lead to the observed results. Therefore, more experimental work
is needed involving critical assessment of the proposed pathways and search for
unifying principles, which may help to refine the current picture to a concise nu-
clear function of Ago proteins.
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Appendix
Python Programms
Pimer Removal
5P-primerrem.py
# ! / usr / b in / python
# −*− c od ing : i s o −8859−1 −*−
#Name 5p−primerrem− f i n a l . py
# Run programm as python programmname . py or f i n d pa th and put i t h e r e # ! / d i r / d i r / python
# then s t a r t wi th . / programmname . py
# Input name . f a s t q
#Remove Primer everywhere , 3 ’ s e q o f r e ad i s k e p t
# ###################
# g e t v a l u e s from comand l ine when programm was c a l l e d
import sys
print sys . argv # r e t u r n s : [ ’ param . py ’ ]
l e t t e r s = 'f:l:o:'# t h e : means an argument ne ed s t o be p a s s e d a f t e r t h e l e t t e r
# f : c a l l 5p−pr imerrem . py − f input− f i l e . f a s t q
# l : c a l l 5p−pr imerrem . py − l p r i m e r c o n t a i n i n g f i l e . t x t o r . f a s t a
#o : c a l l 5p−primerrem−py −o o u t p u t f i l e . f a s t q
import getopt
opts , extraparams = getopt . getopt ( sys . argv [ 1 : ] , l e t t e r s )
# s t a r t s a t t h e s e c ond e l emen t o f argv s i n c e t h e f i r s t one i s t h e s c r i p t name
# ex t r apa rms a r e e x t r a arguments p a s s e d a f t e r a l l o p t i o n / keywords a r e a s s i g n e d
# o p t s i s a l i s t c o n t a i n i n g t h e p a i r " o p t i o n " /" v a l u e "
print 'Opts:' , opts
print 'Extra parameters:' , extraparams
for o , p in opts :
i f o in [ '-f' ] :
i n p u t f i l e = p # f i l e h a n d l e i n p u t f i l e
e l i f o in [ '-l' ] : # f i l e h a n d l e p r i m e r l i s t
primer = p
e l i f o in [ '-o' ] : # f i l e h a n d l e o u t p u t f i l e
o u t p u t f i l e = p
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print 'Inputfile: ' , i n p u t f i l e
print 'Primerlist: ' , primer
print 'Outputfile: ' , o u t p u t f i l e
from Bio import SeqIO
def tr imm_all ( records , adaptors ) :
#""" Trims p e r f e c t a d a p t o r s e q u e n c e s .
# Th i s i s a g e n e r a t o r f un c t i on , t h e a d a p t o r s argument shou ld
# be a l i s t o r i t e r a t o r r e t u rn i n g SeqRecord o b j e c t s . """
for record in records :
c=1
index=−1
for adaptor in adaptors :
len_adaptor = len ( adaptor ) # c a c h e t h i s f o r l a t e r
index = record . seq . f ind ( s t r ( adaptor . seq ) )
i f index == −1 and c <39:
# ad ap t o r not found , t r y nex t a d a p t o r
c=c+1
pass
e l i f −1< index <100 and c <= 3 9 :
# t r im o f f t h e a d a p t o r and b r e a k l o o p
c leanrecord=record [ index+len_adaptor −4:]
c=c+1
break
else :
# ad ap t o r not found , so won ’ t t r im and y i e l d r e c o r d
c leanrecord = record
y i e l d c leanrecord
o r i g i n a l _ r e a d s = SeqIO . parse ( i n p u t f i l e , "fastq" )
l i = l i s t ( SeqIO . parse ( primer , "fasta" ) )
trimmed_reads = trimm_all ( o r i g i n a l _ r e a d s , l i )
count = SeqIO . wri te ( trimmed_reads , o u t p u t f i l e , "fastq" )
print "Saved %i reads" % count
3pRC-primerrem.py
# ! / usr / b in / python
# −*− c od ing : i s o −8859−1 −*−
#Name 3pRC−primerrem− f i n a l . py
# Run programm as python programmname . py or f i n d pa th and put i t h e r e # ! / d i r / d i r / python
# then s t a r t wi th . / programmname . py
# Input name . f a s t q
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#Remove Primer everywhere , 5 ’ s e q o f r e ad i s k e p t
# ###################
# g e t v a l u e s from comand l ine when programm was c a l l e d
import sys
print sys . argv # r e t u r n s : [ ’ param . py ’ ]
l e t t e r s = 'f:l:'# t h e : means an argument ne ed s t o be p a s s e d a f t e r t h e l e t t e r
# f : c a l l 5p−pr imerrem . py − f input− f i l e . f a s t q
# l : c a l l 5p−pr imerrem . py − l p r i m e r c o n t a i n i n g f i l e . t x t o r . f a s t a
#o : c a l l 5p−primerrem−py −o o u t p u t f i l e . f a s t q
import getopt
opts , extraparams = getopt . getopt ( sys . argv [ 1 : ] , l e t t e r s )
# s t a r t s a t t h e s e c ond e l emen t o f argv s i n c e t h e f i r s t one i s t h e s c r i p t name
# ex t r apa rms a r e e x t r a arguments p a s s e d a f t e r a l l o p t i o n / keywords a r e a s s i g n e d
# o p t s i s a l i s t c o n t a i n i n g t h e p a i r " o p t i o n " /" v a l u e "
print 'Opts:' , opts
print 'Extra parameters:' , extraparams
for o , p in opts :
i f o in [ '-f' ] :
i n p u t f i l e = p # f i l e h a n d l e i n p u t f i l e
e l i f o in [ '-l' ] : # f i l e h a n d l e p r i m e r l i s t
primer = p
e l i f o in [ '-o' ] : # f i l e h a n d l e o u t p u t f i l e
o u t p u t f i l e = p
print 'Inputfile: ' , i n p u t f i l e
print 'Primerlist: ' , primer
print 'Outputlist: ' , o u t p u t f i l e
from Bio import SeqIO
def tr imm_all ( records , adaptors ) :
#""" Trims p e r f e c t a d a p t o r s e q u e n c e s .
# Th i s i s a g e n e r a t o r f un c t i on , t h e a d a p t o r s argument shou ld
# be a l i s t o r i t e r a t o r r e t u rn i n g SeqRecord o b j e c t s . """
for record in records :
c leanrecord=−1
c=1
index=−1
for adaptor in adaptors :
len_adaptor = len ( adaptor ) # c a c h e t h i s f o r l a t e r
index = record . seq . f ind ( s t r ( adaptor . seq ) )
i f index == −1 and c <38:
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# ad ap t o r not found , t r y nex t a d a p t o r
c=c+1
pass
e l i f −1< index <100 and c <= 3 8 :
# t r im o f f t h e a d a p t o r and b r e a k l o o p
c leanrecord = record [ : index +4]
c=c+1
break
else :
# ad ap t o r not found , so won ’ t t r im and y i e l d r e c o r d
c leanrecord = record
y i e l d c leanrecord
o r i g i n a l _ r e a d s = SeqIO . parse ( i n p u t f i l e , "fastq" )
l i = l i s t ( SeqIO . parse ( primer , "fasta" ) )
trimmed_reads = trimm_all ( o r i g i n a l _ r e a d s , l i )
count = SeqIO . wri te ( trimmed_reads , o u t p u t f i l e , "fastq" )
print "Saved %i reads" % count
GATC genome
GATC.py
# ! / usr / b in / python
#programm to f i n d a l l GATC p o s i t i o n s p e r chromosome
# inpu t : chromosome . f a
# ############################
# from Bio impor t SeqIO
from optparse import OptionParser
import subprocess # , s h l e x
def main ( ) :
parser = OptionParser ( )
parser . add_option ( '-f' , '--file' , dest='inputfile' )
( options , args ) = parser . parse_args ( )
i f not options . i n p u t f i l e :
parser . e r r o r ( "Sequence file.fa is not given [-f]" )
i n p u t f i l e =opt ions . i n p u t f i l e
fp = open ( i n p u t f i l e , "r" )
l i =fp . read ( ) . s p l i t l i n e s ( )
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fp . c l o s e ( )
l i = l i [ 1 : len ( l i ) ]
record='' . j o i n ( l i )
record=record . upper ( )
print len ( record ) +len ( l i ) +1+ len ( i n p u t f i l e . r s t r i p ( 'fa' ) )
o u t p u t f i l e ='' . j o i n ( [ "/loctmp/pun06483/mESC-DAMID/index/GATCgenome/" , i n p u t f i l e . r s t r i p
( '.fa' ) ,"_GATCnoncase_sites.txt" ] )
fp=open ( o u t p u t f i l e , "a" )
fp . wri te ( " " . j o i n ( [ "chromosome" ,"start" ,"end" ,"\n" ] ) )
i =0
while i <len ( record )−3:
index= record [ i : len ( record ) ] . f ind ( "GATC" )
i f index > −1:
#GATC found g e t p o s i t i o n
fp . wri te ( " " . j o i n ( [ i n p u t f i l e . r s t r i p ( '.fa' ) , s t r ( i +index +1) , s t r ( i +index +4) ,"\n"
] ) )
i +=index+3
e lse :
break
fp . c l o s e ( )
i f __name__=="__main__" :
main ( )
Sam File Processing
samtoolsprocessing-rm.py
# ! / usr / b in / python
###############
#### Samtoo l s p r o c e s s i n g t o ind ex ed bam f i l e
from Bio import SeqIO
from optparse import OptionParser
import subprocess , sh lex
def main ( ) :
parser = OptionParser ( )
parser . add_option ( '-f' , '--file' , dest='inputfile' )
( options , args ) = parser . parse_args ( )
i f not options . i n p u t f i l e :
parser . e r r o r ( "list of .sam is not given [-f]" )
i n p u t f i l e =opt ions . i n p u t f i l e
fp = open ( i n p u t f i l e , "r" )
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l i =fp . read ( ) . s p l i t l i n e s ( )
fp . c l o s e ( )
print l i
for i in range ( 0 , len ( l i ) ) :
# s o r t in . sam a l l r e a d s which map e x a c t l y a t l e a s t f o r one read , y i e l d on ly r e ad
a as i t c o n t a i n s mapping i n f o s t a r t and end .
cmdline1 = "" . j o i n ( [ "awk '{if (NR<28) {print $0;} else {a=$0; getline; b=$0; if
(a ~ \"XS:i:\" && b ~ \"XS:i:\"); else print a\"\\n\"b}}' " , l i [ i ] , " > " , l i [
i ] . r s t r i p ( ".sam" ) ,"hf.sam" ] )
print cmdline1
p=subprocess . Popen ( cmdline1 , s h e l l =True )
p . wait ( )
cmdline2 = "" . j o i n ( [ "samtools view -bS " , l i [ i ] . r s t r i p ( ".sam" ) ,"hf.sam > " , l i [ i ] .
r s t r i p ( ".sam" ) ,"hf.bam" ] )
print cmdline2
p=subprocess . Popen ( cmdline2 , s h e l l =True )
p . wait ( )
cmdline3 = "" . j o i n ( [ "samtools sort " , l i [ i ] . r s t r i p ( ".sam" ) ,"hf.bam " , l i [ i ] .
r s t r i p ( ".sam" ) ,"hf-sorted" ] )
print cmdline3
p=subprocess . Popen ( cmdline3 , s h e l l =True )
p . wait ( )
cmdlinea = "rm -rf *hf.bam"
p=subprocess . Popen ( cmdlinea , s h e l l =True )
p . wait ( )
cmdlineb = "rm -rf *hf.sam"
p=subprocess . Popen ( cmdlineb , s h e l l =True )
p . wait ( )
cmdline4="ls *hf-sorted.bam"
print cmdline4
p=subprocess . Popen ( cmdline4 , s h e l l =True , stdout=subprocess . PIPE )
l i s t =p . stdout . read ( )
l i s t = l i s t . s p l i t ( )
# l i s t =[" f i l e 1 h f −s o r t e d . bam" ," f i l e 2 h f −s o r t e d . bam" ," f i l e 3 h f −s o r t e d . bam"]
i f len ( l i s t ) != len ( l i ) :
print "Not all files are processed"
return ;
e lse :
cmdline5 = "" . j o i n ( [ "samtools merge -f " , l i s t [ 0 ] . r s t r i p ( "01hf-sorted.bam" ) ,"-
merged.bam *hf-sorted.bam" ] )
print cmdline5
print l i s t
p=subprocess . Popen ( cmdline5 , s h e l l =True )
p . wait ( )
cmdlinec = "rm -rf *hf-sorted.bam"
p=subprocess . Popen ( cmdlinec , s h e l l =True )
p . wait ( )
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cmdline6 = "" . j o i n ( [ "samtools index " , l i s t [ 0 ] . r s t r i p ( "01hf-sorted.bam" ) ,"-merged.bam
" ] )
p=subprocess . Popen ( cmdline6 , s h e l l =True )
p . wait ( )
i f __name__=="__main__" :
main ( )
mESC-Sam-sortk5.py
# ! / usr / b in / python
#
# Name : Sam_sortk5 . py
# Run programm as python programmname . py or f i n d pa th and put i t h e r e # ! / d i r / d i r / python
# then s t a r t wi th . / programmname . py
# Input : l i s t o f f i l e . sam
# S e l e c t e x a c t l y match ing and Mi t o c h ond i r a l r e ad s , match ing on ly ;
#and move s a t e l l i t e s t o s e p a r a t e f i l e , move Mi t o r e ad s mu l t i p l e match ing t o s p e p a r a t e
f i l e .
# ###################
from optparse import OptionParser
from Bio import SeqIO
import HTSeq
import i t e r t o o l s
import numpy
from operator import i t e m g e t t e r
from i t e r t o o l s import i s l i c e
import time
def main ( ) :
parser = OptionParser ( )
parser . add_option ( '-f' , '--file' , dest='inputfile' )
( options , args ) = parser . parse_args ( )
i f not options . i n p u t f i l e :
parser . e r r o r ( "list of .sam is not given [-f]" )
i n p u t f i l e =opt ions . i n p u t f i l e
fp = open ( i n p u t f i l e , "r" )
l i =fp . read ( ) . s p l i t l i n e s ( )
fp . c l o s e ( )
print l i
countex=0
countMass=0
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countMput=0
c o u n t S a t e l l i t e =0
c o u n t S a t e l l i t e r e a d p a i r s =0
for r in range ( 0 , len ( l i ) ) :
with open ( l i [ r ] ) as myfi le :
header="" . j o i n ( l i s t ( i s l i c e ( myfile , 6 8 ) ) )
# p r i n t h e a d e r
a l i g n m e n t _ f i l e =HTSeq . SAM_Reader ( l i [ r ] )
# c o n t a i n s a l l r e a d s which can be e x a c t l y matched or s e c ond match worse
exsamOutFileHandle = open ( "" . j o i n ( [ l i [ r ] . r s t r i p ( ".sam" ) ,"-ex.sam" ] ) , 'w' )
exsamOutFileHandle . wri te ( header )
# c o n a t i n s a l l r e a d s which can be a s s i g n e d t o Mi t o c h ond r i a l b a s e d on GATC−p e a k s
MassignedsamOutFileHandle = open ( "" . j o i n ( [ l i [ r ] . r s t r i p ( ".sam" ) ,"-Mass.sam" ] ) , 'w
' )
MassignedsamOutFileHandle . wri te ( header )
# c o n a t i n s a l l r e a d s which can be p o t e n t i a l l y a s s i g n e d t o Mi t o chondr i a b a s e d on
compar i s on with human Seq exp
MputsamOutFileHandle = open ( "" . j o i n ( [ l i [ r ] . r s t r i p ( ".sam" ) ,"-Mput.sam" ] ) , 'w' )
MputsamOutFileHandle . wri te ( header )
# c o n a t i n s a l l l e f t o v e r r e a d s ( mu l i p l e mapping f i l e k =5)
S a t e l l i t e O u t F i l e H a n d l e = open ( "" . j o i n ( [ l i [ r ] . r s t r i p ( ".sam" ) ,"-Satellite.sam" ] ) ,
'w' )
S a t e l l i t e O u t F i l e H a n d l e . wri te ( header )
# a l i g nm e n t _ f i l e =HTSeq . SAM_Reader ( i n p u t f i l e )
# a l i g nm e n t _ f i l e =HTSeq . SAM_Reader ("
exSample_Dam_Ago2_4_ATCACG_L006_R1_allrem_paired_01−k5− t r i a l . sam ")
# c oun t e r f o r d i f f e r e n t f i l e s :
for bundle in HTSeq . bundle_mult iple_al ignments ( a l i g n m e n t _ f i l e ) :
# p r i n t l e n ( bund l e )
i f len ( bundle ) ==2:
countex=countex+1
for i in range ( 0 , len ( bundle ) ) :
exsamOutFileHandle . wri te ( "" . j o i n ( [ bundle [ i ] . get_sam_line ( ) , '\n' ] ) )
e lse :
# t r an s f o rm bund l e in d i c t i o n a r y , compare t h e d i f f e r e n t v a l u e s s e l e c t
keys= l i s t ( range ( 0 , len ( bundle ) ) )
# v a l u e s= l i s t ( bund l e . i t ems . o p t i o n a l _ f i e l d ( ’AS ’ ) )
keys
#make l i s t o f a l l n e ed ed i t ems from one bund l e and merge t h i s wi th k ey s t o
i d e n t i f i y t h e f i n a l r e a d s
values = [ ]
for j in range ( 0 , len ( bundle ) ) :
values . append ( ( keys [ j ] , bundle [ j ] . iv . chrom , bundle [ j ] . iv . s t a r t , bundle [ j ] .
mate_s tar t . s t a r t , bundle [ j ] . o p t i o n a l _ f i e l d ( 'AS' ) ) )
values
# s o r t r e a d s i n t o f i l e s :
# r e a d s which have t h e h i g h e s t a l i gnment s c o r e compared t o o t h e r s
even =[ values [ k ] for k in range ( 0 , len ( bundle ) , 2 ) ]
uneven =[ values [ l ] for l in range ( 1 , len ( bundle ) , 2 ) ]
AS1=sorted ( even , key= i t e m g e t t e r ( 4 ) , reverse=True )
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#AS1
AS2=sorted ( uneven , key= i t e m g e t t e r ( 4 ) , reverse=True )
#AS2
a=next ( ( i for i , v in enumerate ( AS1 ) i f v[1]=='chrM' ) ,None )
b=next ( ( i for i , v in enumerate ( AS2 ) i f v[1]=='chrM' ) ,None )
a
b
i f AS1 [ 0 ] [ 4 ] > AS1 [ 1 ] [ 4 ] and AS2[ 0 ] [ 4 ] >=AS2 [ 1 ] [ 4 ] and ( AS1 [ 0 ] [ 0 ] + 1 ) ==AS2 [ 0 ] [ 0 ] :
exsamOutFileHandle . wri te ( "" . j o i n ( [ bundle [ AS1 [ 0 ] [ 0 ] ] . get_sam_line ( ) , '\n' ] ) )
exsamOutFileHandle . wri te ( "" . j o i n ( [ bundle [ AS2 [ 0 ] [ 0 ] ] . get_sam_line ( ) , '\n' ] ) )
countex=countex+1
e l i f AS1[ 0 ] [ 4 ] >=AS1 [ 1 ] [ 4 ] and AS2 [ 0 ] [ 4 ] > AS2 [ 1 ] [ 4 ] and ( AS1 [ 0 ] [ 0 ] + 1 ) ==AS2 [ 0 ] [ 0 ] :
exsamOutFileHandle . wri te ( "" . j o i n ( [ bundle [ AS1 [ 0 ] [ 0 ] ] . get_sam_line ( ) , '\n' ] ) )
exsamOutFileHandle . wri te ( "" . j o i n ( [ bundle [ AS2 [ 0 ] [ 0 ] ] . get_sam_line ( ) , '\n' ] ) )
countex=countex+1
e l i f a i s not None and b i s not None and AS1 [ a ] [ 2 ] in range ( 10 73 4 , 11 1 76 ) and AS2
[ b ] [ 2 ] in range ( 10 73 4 , 11 1 76 ) :
MassignedsamOutFileHandle . wri te ( "" . j o i n ( [ bundle [ AS1 [ a ] [ 0 ] ] . get_sam_line ( ) ,
'\n' ] ) )
MassignedsamOutFileHandle . wri te ( "" . j o i n ( [ bundle [ AS2 [ b ] [ 0 ] ] . get_sam_line ( ) ,
'\n' ] ) )
countMass=countMass+1
e l i f a i s not None and b i s not None and AS1 [ a ] [ 2 ] in range ( 5 9 8 7 , 6 7 0 0 ) and AS2 [ b
] [ 2 ] in range ( 5 9 8 7 , 6 7 0 0 ) :
MassignedsamOutFileHandle . wri te ( "" . j o i n ( [ bundle [ AS1 [ a ] [ 0 ] ] . get_sam_line ( ) ,
'\n' ] ) )
MassignedsamOutFileHandle . wri te ( "" . j o i n ( [ bundle [ AS2 [ b ] [ 0 ] ] . get_sam_line ( ) ,
'\n' ] ) )
countMass=countMass+1
e l i f a i s not None and b i s not None and AS1 [ a ] [ 2 ] in range ( 6 7 0 1 , 1 0 7 3 3 ) and AS2 [
b ] [ 2 ] in range ( 6 7 0 1 , 1 0 7 3 3 ) :
MputsamOutFileHandle . wri te ( "" . j o i n ( [ bundle [ AS1 [ a ] [ 0 ] ] . get_sam_line ( ) , '\n'
] ) )
MputsamOutFileHandle . wri te ( "" . j o i n ( [ bundle [ AS2 [ b ] [ 0 ] ] . get_sam_line ( ) , '\n'
] ) )
countMput=countMput+1
e lse :
c o u n t S a t e l l i t e = c o u n t S a t e l l i t e +1
for n in range ( 0 , len ( bundle ) ) :
S a t e l l i t e O u t F i l e H a n d l e . wri te ( "" . j o i n ( [ bundle [ n ] . get_sam_line ( ) , '\n' ] ) )
c o u n t S a t e l l i t e r e a d p a i r s = c o u n t S a t e l l i t e r e a d p a i r s +1
exsamOutFileHandle . c l o s e ( )
MassignedsamOutFileHandle . c l o s e ( )
MputsamOutFileHandle . c l o s e ( )
S a t e l l i t e O u t F i l e H a n d l e . c l o s e ( )
# p r i n t " Saved %i r e a d s " % r e c o r dCoun t e r
t o t a l p a i r s =sum ( [ countex , countMass , countMput , c o u n t S a t e l l i t e ] )
outdata="""total pairs & exactly aligned & chrM assigned cc & putative chrM &
Satellites & total Satellite pairs \\\\
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%s & %s & %s & %s & %s & %s\\\\
""" % ( t o t a l p a i r s , countex , countMass , countMput , c o u n t S a t e l l i t e , c o u n t S a t e l l i t e r e a d p a i r s
)
reportFi leHandle = open ( "" . j o i n ( [ "sorting-report-" , time . s t r f t i m e ( "%d-%m-%Y" ) ,".txt"
] ) , 'w' )
reportFi leHandle . wri te ( outdata )
i f __name__=="__main__" :
main ( )
R scripts
Read counting script for R
counttable-singlereads-quick-uniq.R
# c o u n t t a b l e f o r GATCgenome
# supp ly with bam− f i l e _ l i s t . t x t c o n t a i n i n g b am f i l e s o f s amp l e s
# supp ly with "GATC−s i t e _ l i s t . t x t " c o n t a i n i n g GATCgenome
l i b r a r y ( Rsamtools )
l i b r a r y ( p a r a l l e l )
# l i b r a r y (DESeq ) #maskes t h e l e f t and r i g h t f u n c t i o n from gennomic r ang e s ! ! !
# l i b r a r y ( c h i p s e q )
l i b r a r y ( GenomicFeatures )
# l i b r a r y ( l a t t i c e )
# l i b r a r y (
# c o u n t t a b l e a f t e r rmdup
l i b r a r y ( Rsamtools )
l i b r a r y ( p a r a l l e l )
# l i b r a r y (DESeq ) #maskes t h e l e f t and r i g h t f u n c t i o n from gennomic r ang e s ! ! !
# l i b r a r y ( c h i p s e q )
l i b r a r y ( GenomicFeatures )
# l i b r a r y ( l a t t i c e )
# l i b r a r y (
f i l e p a t h u<−( " / loctmp / pun06483 / DamIDSeq-ana2013 / bam / " )
f i l e l i s t <−( " / loctmp / pun06483 / DamIDSeq-ana2013 / bam / bamulist.txt" )
f l s<−readLines ( f i l e l i s t )
names ( f l s )<− s t r s p l i t ( f l s , "u.bam" )
which<− RangesList ( chr19=IRanges ( 1 , 6 1 4 3 1 5 6 6 ) )
pl<− ScanBamParam ( which=which )
a ln<−readGappedAlignments ( paste ( f i l e p a t h u , f l s [ 1 ] , sep="" ) , format="BAM" , use . names=FALSE ,
param=pl )
whichname<−seqlengths ( aln )
output . path<−( " / loctmp / pun06483 / DamIDSeq-ana2013 / Ranalysis / analysis20140723_uniq / " )
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######### chromosomes
chrom<−c ( "1" ,"2" ,"3" ,"4" ,"5" ,"6" ,"7" ,"8" ,"9" ,"10" ,"11" ,"12" ,"13" ,"14" ,"15" ,"16" ,"17" ,"18
" ,"19" ,"20" ,"21" ,"22" ,"X" ,"Y" ,"M" )
chromos<−c ( paste ( "chr" , chrom , sep="" ) )
names ( chromos )<−chromos
############ f u n c t i o n s
########## l o a d i n g t h e d a t a
granger1<−
function ( f i l e p a t h , pl )
{
aln<−readGappedAlignments ( f i l e p a t h , format="BAM" , use . names=FALSE , param=pl )
# a l n f i n<−GRanges ( seqnames=seqnames ( l e f t ( a ln ) ) , r ang e s=IRanges ( s t a r t = s t a r t ( l e f t ( a ln ) ) , end=
end ( r i g h t ( a ln ) ) ) , s t r and=r ep (" * " , t ime s= l e n g t h ( l e f t ( a ln ) ) ) , s e q i n f o = s e q i n f o ( a ln ) )
}
########### l o a d i n g t h e f e a t u r e s t a b l e from GATC
GATC. path<−( " / loctmp / pun06483 / humanGenome" )
f i l e l i s t <−( "GATClist.txt" )
GATCfls<−readLines ( paste (GATC. path , f i l e l i s t , sep=" / " ) )
for ( o in 1 : length ( GATCfls ) ) { names ( GATCfls ) [ o ]<− s t r s p l i t ( GATCfls , "_" ) [ [ o ] ] [ 1 ] }
################ l o a dg i ng f u n c t i o n f o r f e a t u r e s
f e a t u r e l o a d<−
function (GATC. path , featname ) {
f e a t d a t a<−read . table ( paste (GATC. path , featname , sep=" / " ) , header=TRUE)
f e a t u r e s<−GRanges (
seqnames= f e a t d a t a $chromosome ,
ranges=IRanges ( s t a r t = f e a t d a t a $ s t a r t , end= f e a t d a t a $end ) ,
s trand=rep ( "*" , t imes=length ( f e a t d a t a $ chr ) ) ,
ID=paste ( f e a t d a t a $ chr , f e a t d a t a $ s t a r t , f e a t d a t a $end , sep="-" )
)
}
########## a n a l y s i s f u n c t i o n
#workchromosome wis e on 4 3 c o r e s
i<−1
overlapmacs<−
function ( o u t f i l e , modus) {
for ( i in 1 : length ( chrom ) )
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{
#a<−p a s t e ( c (" a n a l y s e chromosome : " , i , " f o r " , names ( f i l e p a t h ) ) , s ep ="")
# p r i n t ( a )
which<−GRanges ( seqnames=names ( chromos [ i ] ) , ranges=IRanges ( 1 , whichname [ names ( chromos [ i ] )
] ) )
print ( which )
pl<− ScanBamParam ( which=which )
# l o a d f e a t u r e s
featname<−GATCfls [ names ( GATCfls ) ==names ( chromos [ i ] ) ]
print ( featname )
f e a t u r e s<−f e a t u r e l o a d (GATC. path , featname )
f e a t u r e s s<− f e a t u r e s [ seqnames ( f e a t u r e s ) ==names ( chromos [ i ] ) ]
f e a t u r e s s<−s p l i t ( f e a t u r e s s , mcols ( f e a t u r e s s ) [ [ "ID" ] ] )
print ( head ( f e a t u r e s s ) )
# p r i n t ( f i l e p a t h )
# p r i n t ( names ( f i l e p a t h ) )
# p r i n t ( p l )
N=length ( f e a t u r e s s )
d a t a f i n<−data . frame ( in teger (N) , in teger (N) , in teger (N) , in teger (N) , in teger (N) )
names ( d a t a f i n )<−names ( f l s )
for ( j in 1 : length ( f l s ) ) {
re s<−granger1 ( paste ( f i l e p a t h u , f l s [ j ] , sep="" ) , pl )
print ( head ( r es ) )
solap<−summarizeOverlaps ( f e a t u r e s s , res , mode=modus)
rowsAsFeatures<−data . frame ( assays ( solap ) $ counts )
i f ( j ==1) {
row . names ( d a t a f i n )<−row . names ( rowsAsFeatures )
d a t a f i n [ , 1 ]<−rowsAsFeatures [ , 1 ]
# head ( d a t a f i n )
} e lse { d a t a f i n [ , j ]<−rowsAsFeatures [ , 1 ] } }
d a t a f i n<−d a t a f i n [ rowSums ( d a t a f i n ) ! = 0 , ]
print ( head ( d a t a f i n ) )
write . table ( data f in , f i l e =paste ( output . path , o u t f i l e , names ( featname ) ,"_20140723" ,".txt" ,
sep="" ) , col . names=TRUE, append=FALSE , sep="\t" )
}
}
overlapmacs ( "union" ,"Union" )
DESeq analysis with R
DESeq-analysis.R
#DESeq o f unique
#awk ’FNR ! =1 ’ * . t x t > un i o n a v a i l . t x t
# l o a d l i b r a r i e s
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l i b r a r y ( DESeq )
l i b r a r y ( g e n e f i l t e r )
f i l e . path<−( " / data / thesis / tables / mESC / DAMID-uniq / Data-Bioinfo / analysis20140331 / GATC-chr"
)
count tab le1<−read . table ( paste ( f i l e . path , "unionchrM_20140331.txt" , sep=" / " ) , header=TRUE,
sep="\t" , row . names=1)
names ( count tab le1 )
countcoln<−c h a r a c t e r ( length ( count tab le1 ) )
for ( i in 1 : length ( count tab le1 ) ) { countcoln [ i ]<−substr ( names ( count tab le1 ) [ i ] , 8 , nchar ( names
( count tab le1 ) [ i ] ) ) }
count tab le<−read . table ( paste ( f i l e . path , "unionavail.txt" , sep=" / " ) , header=FALSE , sep="\t" ,
row . names=1)
names ( count tab le )<−countcoln
DamDesign=data . frame (
row . names=countcoln ,
condi t ion=c ( "untreated" ,"treated" ,"untreated" ,"treated" ) ,
l ibType=c ( "paired-end" ,"paired-end" ,"paired-end" ,"paired-end" )
)
count f in _ hi1<−count tab le [ count tab le [ , 1 ] > 3 , ]
count f in _ hi1<−count f in _ hi1 [ count f in _ hi1 [ , 2 ] > 3 , ]
count f in _ hi1<−count f in _ hi1 [ count f in _ hi1 [ , 3 ] > 3 , ]
count f in _ hi1<−count f in _ hi1 [ count f in _ hi1 [ , 4 ] > 3 , ]
DamDesign
head ( count f in _ hi1 )
condi t ion=DamDesign$ condi t ion
condi t ion
cds=newCountDataSet ( count f in _ hi1 , condi t ion )
# t o t a l Colsums
#> colSums ( c o u n t t a b l e )
# Dam_F Dam_Ago2_4 Dam_30b Dam_Ago2_D
# 11963707 202191 14156753 440928
> colSums ( count f in _ hi1 )
Dam_F Dam_Ago2_4 Dam_30b Dam_Ago2_D
30495 103469 39949 203634
#chrM Colsums
> colSums ( count tab le [ sor ta , ] )
Dam_F Dam_Ago2_4 Dam_30b Dam_Ago2_D
24107 99452 31850 194559
> colSums ( count f in _ hi1 [ sor ta , ] )
Dam_F Dam_Ago2_4 Dam_30b Dam_Ago2_D
24106 99425 31843 194521
# a l l a p a r t from chrM Colsums
> colSums ( count tab le [ sortb , ] )
Dam_F Dam_Ago2_4 Dam_30b Dam_Ago2_D
11939600 102739 14124903 246369
> colSums ( count f in _ hi1 [ sortb , ] )
Dam_F Dam_Ago2_4 Dam_30b Dam_Ago2_D
6389 4044 8106 9113
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anal<−"hi3_all_sizelib_"
l i b s i z e<−c (26226038 ,22682308 ,26267559 ,21041694)
a=mean ( l i b s i z e )
s i z e F a c t o r s ( cds )<− l i b s i z e / a
head ( counts ( cds , normalized=TRUE) )
cds=es t imateDispers ions ( cds , f i t Type="local" )
######### ch e c k da t a
cdsBlind = es t imateDispers ions ( cds , method = "blind" , f i tTyp e="local" )
vsd = v a r i a n c e S t a b i l i z i n g T r a n s f o r m a t i o n ( cdsBlind )
###################################################
### cod e chunk number 71 : heatmap
###################################################
l i b r a r y ( "RColorBrewer" )
l i b r a r y ( "gplots" )
s e l e c t = order ( rowMeans ( counts ( cdsBlind ) ) , decreas ing=TRUE) [ 1 : 3 0 ]
hmcol = colorRampPalette ( brewer . pal ( 9 , "GnBu" ) ) ( 1 0 0 )
###################################################
### cod e chunk number 72 : f igHeatmap2a
###################################################
par ( mfrow=c ( 1 , 1 ) )
png ( f i l e =paste ( "Enriched-peaks-Heatmap" , anal , ".png" , sep="" ) )
heatmap . 2 ( exprs ( vsd ) [ s e l e c t , ] , col = hmcol , t r a c e ="none" , margin=c ( 1 0 , 6 ) )
dev . off ( )
###################################################
### cod e chunk number 74 : s amp l eC lu s t
# ##################################################
d i s t s = d i s t ( t ( exprs ( vsd ) ) )
###################################################
### cod e chunk number 75 : f igHeatmapSamples
# ##################################################
mat = as . matrix ( d i s t s )
rownames ( mat ) = colnames ( mat ) = with ( pData ( cdsBlind ) , paste ( condit ion , sep=" : " ) )
png ( f i l e =paste ( "Correlation" , anal , ".png" , sep="" ) )
heatmap . 2 ( mat , t r a c e ="none" , col = rev ( hmcol ) , margin=c ( 1 3 , 13) )
dev . off ( )
###################################################
### cod e chunk number 76 : figPCA
###################################################
plotPCAm<−
function ( x , intgroup = "condition" , ntop = 50)
{
rv = rowVars ( exprs ( x ) )
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s e l e c t = order ( rv , decreas ing = TRUE) [ seq_ len ( ntop ) ]
pca = prcomp ( t ( exprs ( x ) [ s e l e c t , ] ) )
f a c = f a c t o r ( apply ( pData ( x ) [ , intgroup , drop = FALSE ] , 1 ,
paste , c o l l a p s e = " : " ) )
colours = c ( "green" , "blue" )
xyplot ( PC2 ~ PC1 , groups = fac , data = as . data . frame ( pca$x ) ,
pch = 16 , cex = 2 , aspect = "iso" , col = colours , ylim=c (−50 ,50) , main = draw .
key ( key = l i s t ( r e c t = l i s t ( col = colours ) ,
t e x t = l i s t ( l e v e l s ( f a c ) ) , rep = FALSE) ) )
}
png ( f i l e =paste ( "PCA-top50-peaks" , anal , ".png" , sep="" ) )
print ( plotPCAm ( vsd , intgroup =("condition" ) ) )
dev . off ( )
cds=es t imateDispers ions ( cds , f i tT ype="local" )
r es=nbinomTest ( cds , "untreated" ,"treated" )
png ( f i l e =paste ( "chrall-Disp_20141108" , anal , ".png" , sep="" ) )
p lo tDispEsts ( cds )
dev . off ( )
png ( f i l e =paste ( "MAplot-chrall_20140228" , anal , ".png" , sep="" ) )
plotMA ( re s )
dev . off ( )
png ( f i l e =paste ( "hist-pval-chrall_20140228" , anal , ".png" , sep="" ) )
h i s t ( r es $pval , breaks =100 , col="skyblue" , border="slateblue" , main="" )
dev . off ( )
#############
N<−length ( r es [ , 1 ] )
pos<−data . frame ( c h a r a c t e r (N) , in teger (N) , in teger (N) , s t r i n g s A s F a c t o r s =FALSE)
names ( pos )<−c ( "chrom" ,"start" ,"end" )
for ( i in 1 :N) {
I D s p l i t<−u n l i s t ( s t r s p l i t ( r es $ id [ i ] , "-" ) )
pos [ i , 1 ]<−as . c h a r a c t e r ( I D s p l i t [ 1 ] )
pos [ i , 2 ]<−as . in teger ( I D s p l i t [ 2 ] )
pos [ i , 3 ]<−as . in teger ( I D s p l i t [ 2 ] ) }
d a t a f i n<−cbind ( ID=r es [ , 1 ] , pos , r e s [ , 2 : length ( r es ) ] )
write . table ( data f in , paste ( "GATC-peaks-all-" , anal , "2014-11-08.csv" , sep="" ) , col . names=TRUE
, sep="\t" , appen=FALSE , row . names=FALSE)
write . table ( data f in , paste ( "GATC-peaks-all-" , anal , "2014-11-08.txt" , sep="" ) , col . names=TRUE
, sep="\t" , appen=FALSE , row . names=FALSE)
240
Eidesstattliche Erklärung
1. Ich erkläre hiermit an Eides statt, dass ich die vorliegende Arbeit ohne un-
zulässige Hilfe Dritter und ohne Benutzung anderer als der angegebenen
Hilfsmittel angefertigt habe; die aus anderen Quellen direkt oder indirekt
übernommenen Daten und Konzepte sind unter Angabe des Literaturzitats
gekennzeichnet.
2. Bei der Auswahl und Auswertung folgenden Materials haben mir die nach-
stehend aufgeführten Personen in der jeweils beschriebene Weise unent-
geltlich geholfen:
(a) Bioinformatische Auswertung der ChIP-Seq Experiments: Eugene Be-
rezikov
(b) Bioinformatische Auswertung des DAMID-Seq Experiments mit der
Software Homer: Qian Yang and Julia Engelmann
(c) Stabile Zelllinen von mESCs und deren DNA Extraktion: Constance
Ciaudo
(d) Percoll gradient zur Trennung von ER und Mitochondria: C. Richter-
Dennerlein
3. Weitere Personen waren an der inhaltlich-materiellen Herstellung der vor-
liegenden Arbeit nicht beteiligt. Insbesondere habe ich hierfür nicht die
entgeltliche Hilfe eines Promotionsberaters oder anderer Personen in An-
spruch genommen. Niemand hat von mir weder unmittelbar noch mittel-
bar geldwerte Leistungen für Arbeiten erhalten, die im Zusammenhang mit
dem Inhalt der vorgelegten Dissertation stehen.
4. Die Arbeit wurde bisher weder im In- noch im Ausland in gleicher oder
ähnlicher Form einer anderen Prüfungsbehörde vorgelegt.
Regensburg, 07.Mai.2015
Unterschrift:
ACKNOWLEDGEMENTS
Acknowledgements
A special thank goes to Professor Dr. Gunter Meister for giving me the oppor-
tunity to conduct my thesis in his lab. During this time he supported me by
exciting scientific discussions and good supervision while granting at the same
time an open and inspiring scientific atmosphere. In addition, he showed me
great understanding and support for my young family.
I also want to thank Eugene Berezikov, Qian Wang and Julia Engelmann for bioin-
formatic analysis and interesting discussions. I am deeply grateful for my time at
the lab of Professor Peter Rehling, enabling me a quick start in mitochondrial bi-
ology. Here, I want to thank especially Dr. Sven Dennerlein, Dr. Ricarda Richter-
Dennerlein and Christin Helbig.
For a good working environment and constructive discussions, I want to give
thanks to Dr. Treiber (Nora and Thomas), Dr. Inga Lödige, Dr. Anne Dück,
Dr. Sebastian Petri, Daniele Hasler, Dr. Melina Musri, Dr. Mathias Stotz, Judith
Hauptmann, Ludwig Wankerl, Gerhard Lehmann, Norbert Eichner, Sigrun Am-
mon, Corinna Friedrich and Dr. Stefan Wenzl, who had always helpful advise.
I want to thank all those people who supported me while writing my thesis, es-
pecially all my friends in Regensburg, who accompanied me through all these
years, Georg, Wolfgang, Sabine, Malte, Uli, Michi, Dominika and Sandip.
My parents and my brothers and sisters I thank for supporting me and helping
me to find my way in life. Especially, I also want to thank my father- and mother-
in-law, who helped me on numberless occasions to find the time and inner-peace
for writing up the thesis.
Thanks Moogie for your belief in me and being right there when I needed you.
At last I want to thank my wonderful family, for supporting me, cheering me
up when needed or bringing me back to earth, when I was flying high.
Thank you Joshua and Lilly for all the laughter.
Thank you Katrin, for being the woman you are.
242
